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Abstract 
 
Herein, we report the results of research continuing previous successI in the field of enantioselective 
organocatalytic reduction of imines with trichlorosilane. Syntheses of various precursors (ketones) and 
substrates (imines) for the reduction reaction and their reduction following the protocol (Scheme A1) are 
described in this thesis.  
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1. Aromatic heterocycles containing nitrogen – good yields of the reduced product (68-85 %), the 
enantioselectivity depended on steric bulk in proximity to the nitrogen, steric bulk improved the 
enantioselectivity (up to 78 % ee), probably due to thwarting the coordination of the nitrogen to HSiCl3.  
2. Aromatic heterocycles containing sulfur – sulfur in the ring was tolerated well (89 % ee). 
3. Aromatic heterocycles containing oxygen – generally good yields (62-90 %), dependence on position 
isomer was observed: furan-2-yl-derived substrates were reduced in moderate enantioselectivity (45-85 
% ee), possibly due to the problem of coordination; in contrast, furan-3-yl derivatives were reduced in 
good enantioselectivity (77-91 % ee).  
4. Non-heterocyclic aromatic or aliphatic – good yields (62-98 %) but varied enantiomeric excess (10-97 
%). The high enantioselectivity values (76-97 % ee) were for substrates with significant contrast of the 
steric hindrance of the groups next to the reaction centre.  
 
Furthermore, an example of practical utilisation of the method is presented. Naturally occurring 
alkaloid N-acetylcolchinol was synthesised in 9 steps and overall 8 % yield (Scheme A2). The stereogenic 
centre was introduced using our method and afforded the desired enantioenriched amine in 96 % ee.   
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Abbreviations and Acronyms  
 
Ac   Acetyl  
ACh   Acetylcholine  
AcOH   Acetic acid  
BArF-   Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate  
Bn   Benzyl  
Bs   Besyl, benzenesulfonyl  
Bu   Butyl 
CAN   Cerium(IV)-ammonium nitrate  
Cat, cat*  Catalyst, chiral catalyst 
CIP   Cahn-Ingold-Prelog (for nomenclature purposes)  
Cy   Cyclohexyl 
DDQ   2,3-Dichloro-5,6-dicyanobezoquinone  
de   Diastereomeric excess  
DET   Diethyl tartrate  
DKR   Dynamic kinetic resolution  
DMF   Dimethylformamide  
DMSO   Dimethylsulfoxide  
DPP   Diphenyl phosphate  
E°   Standard reduction potential [V]  
EDG   Electron donating group 
ee   Enantiomeric excess  
Et   Ethyl 
EWG   Electron withdrawing group 
Glf   Glucofuranose 
Hex   Hexyl 
HMPA   Hexamethylphosphoramide  
HSD   Hydroxysteroid dehydrogenase  
i-, iso-   Isomeric (branched alkyl chain) 
L, L*  Ligand, chiral ligand 
LA, LA*  Lewis acid, chiral Lewis acid 
LB, LB*  Lewis base, chiral Lewis base 
Leu   Leucine  
M   Metal  
Me   Methyl 
MeCN   Acetonitrile 
mes   Mesityl; 2,4,6-trimethylphenyl  
n, n*  nonbonding occupied orbital (electron pair), nonbonding vacant orbital 
n- Normal (linear alkyl chain)  
NAC   N-Acetylcolchinol  
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Napht   Naphthyl 
Nu  Nucleophile  
OAB   Oxazaborolidine  
[ox]  Oxidising agent, oxidation, oxidative conditions  
PCC   Pyridinium chlorochromate  
PDC   Pyridinium dichromate  
Pent   Pentyl 
Ph   Phenyl 
pH  Negative logarithm of the hydrogen cation activity in aqueous solutions  
PIDA   Phenyliodonium diacetate  
PIFA   Phenyliodonium bis(trifluoroacetate)  
pKa  Negative logarithm of the acid dissociation constant Ka   
PMP   p-Methoxyphenyl 
PNP   p-Nitrophenyl 
PTMP   p-Trifluoromethylphenyl 
Pr   Propyl 
Pro   Proline  
π, π*  pi bonding orbital, pi antibonding orbital (multiple bond)  
[red]  Reducing agent, reduction, reductive conditions  
s-, sec-   Secondary (branched alkyl chain)  
σ, σ*   sigma bonding orbital, sigma antibonding orbital (single bond) 
TBHP   tert-Butyl hydroperoxide  
t-, tert-   Tertiary (branched alkyl chain) 
TBDMS  tert-Butyldimetylsilyl  
TCCA   Trichlorocyanuric acid  
TFA   Trifluoroacetic acid  
TFAA   Trifluororacetic acid anhydride  
TFAc   Trifluoroacetyl  
TfOH   Trifluoromethanesulfonic acid  
Tf2O   Trifluoromethanesulfonic acid anhydride  
THP   Tetrahydropapaverine (note the unusual use of the acronym)  
TIPS   Tri(iso-propyl)silyl  
TMS   Trimethylsilyl   
TOF  Turn-over frequency [s-1] (number of moles of formed product per mole of catalyst 
per unit of time)  
p-Tol   p-Toluyl, p-methylphenyl 
TON  Turn-over number (number of moles of formed product per mole of catalyst before 
becoming inactive)   
Tr   Trityl, triphenylmethyl 
TS   Transition state, transition structure  
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1. Introduction 
 
1.1. Development of Asymmetric Synthesis 
 
1.1.1. Chirality 
 
 The roots of the term chirality go back to the nineteenth century when 
stereochemistry acquired serious scientific base after several exquisite discoveries. The 
pioneer in stereochemistry was certainly the French microbiologist and chemist L. 
Pasteur1 who had done an extensive research on tartaric acid, both isolated from wine lees 
and prepared synthetically and he noticed that the latter one did not rotate the plane of 
polarised light as the natural did. He microscopically examined the crystals of sodium-
ammonium tartrate and observed that it was a mixture of two types of crystals, in all 
aspects identical except that they were mirror images of each other. He used the terms 
desymmetrisation or asymmetric for this and similar phenomena. In 1848, he separated the 
crystals manually and recorded that the polarisation of each type is the same but of 
opposite orientation and apparently, equal amount of both of them (one being natural) 
would give overall zero polarisation effect. His experiments in this field continued: 1853 – 
first separation of a racemate by diastereomeric crystallisation, 1858 – first racemate 
separation by fermentation (Penicillium glaucum).  
The year 1874 brought the real breakthrough in understanding the stereo-
arrangements on saturated carbon. Two chemists – a Dutch J. H. van’t Hoff2 and a French 
J. A. Le Bel3 – postulated independently that the four groups bonded to the central carbon 
atom point into the corners of a regular tetrahedron. This discovery was highly 
controversial, because it could so simply visualise the relation between optical activity and 
the structure! 
 
Chiral objects which are mirror images of each other are called enantiomorphic and 
they are a part of our everyday life [e.g. hands, screws, scissors, cars or roads;  Greek cheir 
(χειρ) means hand]. The fact that they cannot be superimposed onto their mirror images 
provides sufficient definition for what is a chiral object or molecule. The adjective chiral 
only refers to the property of the molecule having a stereogenic element. If a compound 
has more than one stereogenic element, it can exist as either of enantiomers or one of 
diastereoisomers (these are no longer mirror images to each other). The number of possible 
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diastereomers is given by 2n, where n is the number of stereogenic centres in the molecule. 
A molecule it is said to be prochiral if it can be converted into a chiral molecule in one 
step – typically, an sp2-hybridised carbon bearing three different substituents that is 
transformed to an sp3-centre or an sp3-carbon with two identical substituents where a 
change to one of these substituents leads to a chiral compound.  
 
1.1.2. Milestones in Asymmetric Synthesis 
 
From the time when alchemy evolved into an accredited science of chemistry, 
synthetic methods were focused mostly on building simple or more complex structures. 
When these synthetic tools together with structure elucidation methods improved enough, 
the accumulated synthetic and stereochemical knowledge of 19th century brought up one of 
the greatest questions in chemistry – how to set up a stereogenic centre in the target 
molecule, and how to control this process. The human desire to exploit contemporary 
understanding and specialise for more delicate traits has led to the development of several 
synthetic methods for obtaining a stereocentre in the molecule.   
 
Enantiopure Compounds - Setting up 1 Stereocentre
Chiral Pool Prochiral Substrates Racemates
Derivatisation Asymmetric Synthesis Resolution
Dynamic Kinetic Diastereomer Formation
Chiral Auxiliary Separation
Stoichiometric Catalytic
Enzymatic Chemical
 
 
Figure 1.1. Possible ways of Setting-up One Stereocentre 
 
There are three main approaches (Figure 1.1) yielding chiral compounds, by using:  
 
-  chiral pool, usually common natural products as amino acids or sugars,   
-  prochiral substrates used in asymmetric or stereogenic reactions,4  
-  optical resolution of racemic mixtures. 
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Nowadays, most of the reactions yielding chiral material are either manipulations 
of chiral pool or planning the synthesis enantioselectively.4 Use of chiral pool is the 
simplest way how to acquire a chiral centre as it already present in the starting material and 
only stereochemically unambiguous conversions are suitable to transform it:    
 
1.  Mechanism controlled reactions – unambiguous reaction mechanisms:  
- SN2 displacements,  
-  SN2’ displacements,  
-  SE2’ displacements,  
-  Wagner-Meerwein type [1,2]-migrations,  
-  sigmatropic rearrangements ([3,3]-Claisen, Cope, [2,3]-Wittig, etc.).  
 
2.  Substrate controlled reactions – in general, rigid cyclic substrates exhibit better 
controlling properties:  
- active via non-covalent interactions on one of the diastereotopic faces,  
-  passive via steric shielding of one of the diastereotopic faces,  
-  enhanced via cyclic TS.  
 
Reactions of two prochiral starting materials afford two (enantiomeric) pairs of 
diastereomers in a reaction-specific ratio, no enantiocontrol can be achieved:  
 
3.  Substrate and reagent controlled reactions – two stereogenic centres are formed 
from prochiral (sp2) starting material:  
- simple diastereoselectivity (aldol-type reactions, allylations of carbonyls),  
-  endo/exo diastereoselectivity (cycloadditions).   
 
The stereocontrol of reactions can become even more complicated if the starting 
material already contains a chiral centre due to the combination of their stereodirecting 
effects called double differentiation. The overall selectivity can be increased when the 
individual effects are matched or decreased when mismatched:  
 
4.  Auxiliary controlled reactions:  
- persistent auxiliary (recovered after the stereodifferentiating step),  
-  restorable auxiliary (removed at work-up, but restored by simple operations),  
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-  self-immolate auxiliary.  
 
5.  Catalyst controlled reactions – distinguished chiraphor (the chiral ligand bearing 
the chiral information) and catalaphor (the reactive site of the metal complex).  
 
The development of methods of asymmetric synthesis (vide supra, sub-group 4. 
and 5.) dates back to beginning of the 20th century, needless to say, starting with modifying 
the existing synthetic methods by using natural products as the source of chirality:4  
 
1908/1912 Hydrocyanation of benzaldehyde, in the presence of emulsine or    quinine/ 
quinidine, respectively (Rosenthaler, Bredig) – first organocatalysis,  
1939 Cinchonine-modified Pt for hydrogenation (Lipkin, Stewart),  
1956 Silk fibroin-modified Pd for hydrogenation (Akabori, Izumi),  
1960 Ketene methanolysis, O-benzoylquinine, 76 % ee (Pracejus),  
1961 Polymerisation of benzofurane with AlCl3/phenylalanine catalyst (Natta),  
1963 Raney Ni/tartrate for hydrogenation (Izumi).  
 
Publication of Wilkinson’s homogenous catalyst5 RhCl(PPh3)3 in 1966 was a 
breakthrough destroying the belief that only heterogenous systems can activate molecular 
hydrogen. The sixties brought more rationalisation of known metal-catalysed processes 
and also creating new ones based on this rationale, not just in hydrogenation reactions:  
 
1966 Asymmetric cyclopropanation, Cu/salen, 6 % ee (Nozaki, Noyori),  
1968 Asymmetric hydrogenation, Rh/chiral phosphine, 15 % ee (Knowles, Horner),  
1970 Intramol. aldol condensation, proline, 93 % ee (Hajos, Wiechert),  
1970 Monsanto L-DOPA process – asym. hydrogenation (Knowles),  
1971 Asymmetric hydrogenation, Rh/DIOP, 50 % ee (Kagan),  
1975 Sumitomo cilastatine process – asym. cyclopropanation (Aratani),  
1979 Hydrocyanation of benzaldehyde with a dipeptide catalyst, 97 % ee (Inoue),  
1980 Asymmetric epoxidation of allylic alcohols, Ti/TBHP/DET, 95 % ee (Sharpless, 
Katsuki),  
1983 Asymmetric hetero-Diels-Alder reaction, Eu(hfc)3, 58 % ee (Danishefsky),  
1985 Takasago (–)-menthol process – asym. hydrogenation (Noyori),  
1986 Theory of non-linear effects in asymmetric catalysis (Kagan, Agami),  
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1987 Oxazaborolidine reductions of carbonyls, 98 % ee (Itsuno, Corey),  
1988 Asym. dihydroxylation of olefins, Os/dihydroquinine, 85 % ee (Jacobsen, Sharpless),  
1988 LA*-catalysed Diels-Alder reaction, 90 % ee (Yamamoto, Narasaka),  
1990 Asymmetric epoxidation of olefins, Mn/salen, 98 % ee (Jacobsen, Katsuki),  
1994 LB*-catalysed allylation, 98 % ee (Denmark),  
1996 Asymmetric epoxidation of olefins, fructose-derived catalyst, 81 % ee (Shi),  
1998 Nucleophilic additions to imines, chiral H-donors, 96 % ee (Jacobsen),  
2000 Intermol. aldol condensation (enamine catalysis), proline, 96 % ee (Barbas, List),  
2000 Cycloadditions (iminium catalysis), imidazolidinone, 98 % ee (MacMillan),  
2001 Nobel Prize for asymmetric catalysis.6 
 
 
1.1.3. Nobel Prize for Asymmetric Synthesis vs. Hydrogenation  
 
The 2001 Nobel Prize awarded to three stars in asymmetric catalysis – Dr. W. S. 
Knowles (Monsanto, St. Louis, Missouri, USA), Prof. R. Noyori (Nagoya University, 
Chikusa, Nagoya, Japan) and Prof. K. B. Sharpless (The Scripps Research Institute, La 
Jolla, California, USA). The Royal Swedish Academy of Science rewarded these three 
scientists for “the development of catalytic asymmetric synthesis” where a half of the prize 
was received by Knowles and Noyori for “their work on chirally catalysed hydrogenation 
reactions” and the other half was awarded to Sharpless for “his work on chirally catalysed 
oxidation reaction”. All three of them have developed remarkably reliable methods for 
asymmetric reductions and oxidations.  
 
Ph
H2 (25 atm)
[RhCl3(2)3] (0.15 %)
Ph
1
COOH COOH
3 (15 % ee)
P
Ph
Men-Pr
2 (69 % ee)
 
 
Scheme 1.1. Knowles’ First Asymmetric Hydrogenation 
 
The publications about homogenous catalysis with Wilkinson’s catalyst5 in 
combination with new methods for preparation of optically active phosphines,7 triggered 
the interest of contemporary researchers. In 1968, Knowles showed that the chirality could 
be transferred from a small amount of chiral ligand 2 on a metal to a large quantity of non-
chiral substrate and an enantioenriched product could be obtained8 (Scheme 1.1).  
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Knowles, understanding the industrial needs, kept working on the efficiency of the 
transformation until it reached full conversion and 95 % ee and could be applied on large 
scale synthesis known as The Monsanto L-DOPA Process (Scheme 1.2) – the first 
commercialised chiral-metal-complex-catalysed asymmetric hydrogenation.9   
 
MeO
AcO
COOH
NHAc
H2 (3 atm)
[Rh(cod)5]+ BF4-(0.1 %)
MeO
AcO
COOH
NHAc
P
P
Ph
Ph (R,R)-5
4 (S)-6 (95 % ee)
OMe
OMe
 
 
Scheme 1.2. The Monsanto L-DOPA Process  
 
Noyori worked on different types of asymmetric reactions, his first remarkable 
success in asymmetric synthesis came in 1966 with his cyclopropanation reaction10 with a 
salen-copper catalyst 8 affording the cyclopropane product in 6 % ee (Scheme 1.3).  
 
Ph Ph
7
N2CHCOOMe
8
8 (0.9 %)
9 (6 % ee) O
Cu
N
N
O
Ph
Ph
COOMe
 
 
Scheme 1.3. Noyori’s First Enantioselective Cyclopropanation 
 
In 1980 Noyori and co-workers discovered that the atropoisomeric diphosphine 
BINAP could catalyse many types of asymmetric transformations including 
hydrogenations11 (Scheme 1.4) in highly enantioselective fashion.   
 
10
H2 (4 atm)
(S)-11: (S)-BINAP
[RhCl(11)] (0.7 %)
PPh2
PPh2Ph COOH
NHAc
Ph COOH
NHAc
(R)-12 (96 % ee)
 
 
Scheme 1.4. Noyori’s Enantioselective Rh-catalysed Hydrogenation 
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In continuation of Noyori’s research within hydrogenation with BINAP ligands, in 
1988, he came up with a novel idea of using Ru metal instead of Rh. This switch brought 
higher yields, enantioselectivity and reliability with a broad range of substrates12 (Scheme 
1.5). Noyori then developed several protocols for hydrogenation of carbonyls in the 
presence of double bonds13 or transfer hydrogenation of cyclic imines14 (vide infra).   
 
13
H2 (135 atm)
[Ru(11)(OAc)2] (0.5 %)
(S)-14 (97 % ee), 
Naproxen
MeO
COOH
MeO
COOH
 
Scheme 1.5. Noyori’s Enantioselective Ru-catalysed Hydrogenation 
 
Besides Knowles and Noyori, also Prof. H. B. Kagan (Université Paris-Sud, 
France) has been recognised as a pioneer of asymmetric catalysis and quoting Knowles 
“he was left out of the act”15 which caused controversy. Only three people could be 
awarded at a time, however, asymmetric catalysis might be too broad a field to be 
rewarded by one prize. Opposite processes as asymmetric hydrogenation or asymmetric 
oxidation are, each consistent field on its own. Furthermore, other types of asymmetric 
reactions have been studied only more recently (organocatalysis) and certainly, the 
possibilities of asymmetric synthesis were not exhausted in year 2001!   
 
Kagan published his hydrogenation protocol in 1971 using Rh metal and DIOP 
ligand16 (Scheme 1.6) which proved wrong the reasoning that the chirality must be directly 
on the phosphorus atom. Because of its easy preparation form tartaric acid, DIOP became 
widely used.17  
 
O
O
PPh2
PPh2
15: (−)-DIOP10
H2 (1.1 atm)
[RhCl(15)] (0.02 %)
Ph COOH
NHAc
Ph COOH
NHAc
(R)-12 (72 % ee)
 
 
Scheme 1.6. Kagan’s Enantioselective Rh-catalysed Hydrogenation 
 
Kagan and co-workers carried out an extensive research on the family of phosphine 
ligands derived from DIOP and also their structure-reactivity-enantioselectivity 
correlations. He improved diphosphine synthesis and applied his own hydrogenation 
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protocol for the first hydrogentaion of imines18 (see Chapter 2.2). He also worked on the 
theory of Rh-catalysed asymmetric reductions17,19 and many other types of asymmetric 
reactions, as an example serves the preparation of enantioenriched sulfoxides.20,21 Two 
alternative approaches were developed – the first was an enantioselective oxidation of 
sulfides20 to sulfoxides where a modified Sharpless epoxidation titanium reagent was used 
and sulfoxides were obtained in high ee’s (Scheme 1.7). The second approach exploited 
substitution reactions on sulfur in chiral sulfites21 (two consecutive steps with full inversion 
of configuration).  
 
Me
S
OOH Me
S
OTi(Oi-Pr)4 (1 eq), (R,R)-DET (2 eq), H2O (1 eq)
(R)-17 (99.5 % ee)16
 
 
Scheme 1.7. Kagan’s Enantioselective Ti-mediated Oxidation of Sulfides 
 
Kagan’s group was the first to investigate the phenomenon of nonlinear effects in 
asymmetric catalysis,4,22 first examples were found in asymmetric Sharpless epoxidations. 
Description and explanation of non-linear effects was built on the behaviour of 
organometallic species. The simplest and most common model is the ML2-model where it 
is assumed that the reaction occurs through a mixture of three stereoisomeric complexes – 
two homochiral MLRLR, MLSLS, and one meso MLRLS which are in amounts x, y, z and 
have different reactivity (khomo, kmeso) (Scheme 1.8) 
 
MLRLR  +  MLSLS
x              y
2MLRLS
z
K = z2/xy
kRR kSS kRS
product
eemax
product
−eemax
product
racemic
M + LR + LS g = kmeso/khomoβ = z/(x + y)
0
max
100
100
eeproduct 
(%)
eeauxiliary (%)
chiral amplification
(+)-NLE
(−)-NLE
chiral depletion
(A) (B)
 
 
Scheme 1.8. Non-linear Effects (A) and Model ML2 (B) 
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Then the enantiomeric excess of the product is calculated according to equation 1:   
 
eeproduct = eemax.eeaux.(1+β)/(1+gβ).       (eq1) 
 
If no meso complex is formed (β = 0) or both types have the same reactivity (g = 
1), the equation gives the linear correlation:  
 
eeproduct = eemax.eeaux.         (eq2) 
 
When the homochiral complex is more active than the meso one (khomo > kmeso, g 
<1) the ee of the product is higher than expected by linear dependence and positive non-
linear effect, chiral amplification is observed. The opposite case (g > 1) defines the 
negative non-linear effect or chiral depletion.  
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2. Reduction of Imines 
 
2.1.  Introduction  
 
2.1.1. Carbonyl Compounds – The Core of Amine Synthesis 
 
Carbonyl compounds, particularly aldehydes and ketones have always been 
favourites of synthetic chemists. They can be transformed easily to alcohols by reduction 
or addition of a nucleophilic species, having the advantage of choice of various reducing 
agents and nucleophiles. Furthermore, they can be used not just for introduction of an 
oxygen functionality but also for an indirect introducing of a nitrogen functionality and 
similarly, a wide selection of nitrogen sources is available. Therefore, the transformation 
ketone (aldehyde) – imine – amine is a powerful tool for obtaining amines (Scheme 2.1).  
 
R1
N
R2
R3
R3-NH2
R1
O
R2
Nu
[red]
R1
OH
R2
R1
OH
R2
Nu
R1
NHR3
R2
R1
NHR3
R2
NuNu
[red]
 
 
Scheme 2.1. Crucial Synthetic Utility of Carbonyl Compounds 
 
Obviously, the products of either of the above-mentioned synthetic ways can be – 
and in most cases are – chiral. Besides, all the effort exerted to prepare amines simply and 
efficiently is caused by the vast occurrence of amines in the nature and their biological 
activity. It is crucial to obtain the correct isomer in enantiopure form, as the opposite 
enantiomer may have severe adverse effects. Asymmetric synthesis, rather than resolution 
of racemic mixtures, has been applied in modern preparation (since 1970s) of enantiopure 
amines. Often enough, it provides more cost and/or time effective method of gaining these 
compounds than other preparative methods or isolation from natural sources.   
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2.1.2. Properties and Reactivity of the Carbon-Nitrogen Double Bond23 
 
The properties of carbonyl compounds and their nitrogen analogues are in many 
ways comparable and are often researched side by side. However, the progress in catalytic 
enantioselective reactions of imines is rather slower than their ketone counterparts. This is 
caused by the more complex behaviour of compounds containing carbon-nitrogen double 
bond.  
The very first fact that needs to be considered is nitrogen being trivalent causing the 
principal geometrical isomerism of C=N bond. Even if the isomers exist under rapid 
equilibrium, each of the isomers can yield different enantiomer (Scheme 2.2). Some 
synthetic methods preserve or even rely on the imine geometrical set-up which makes 
these protocols less attractive.  
 
R1
N
R2
R3
R1
N
R2
R3
R1
NHR3
R2
Nu
R1
NHR3
R2
Nu
Nu
back-side attack
Nu
back-side attack
Nu
front side attack
 
 
Scheme 2.2. Formation of Product Depending on Isomerism of Imine Bond and Attack Side 
 
Another reactivity issue stems from the lower electrophilicity of carbon atom in 
C=N bond compared to the C=O bond.26c That is due to four properties closely related to 
each other:23   
 
-  lower polarity of the C=N bond than of the C=O bond, quantified by dipole 
moment (µC=N = 0.9 D and µC=O = 2.3 D),  
-  smaller electronegativity of nitrogen than oxygen atom, Pauling eletronegativities 
are χN = 3.0 and  χO = 3.5,   
-  the C=N bond is slightly longer (1.28 Å) than C=O bond (1.20 Å),  
-  the energy of C=N bond is lower and much more variable, typically 615 ± 40 
kJ.mol-1 (147 ± 10 kcal.mol-1, mainly due to the impact of the N-substituent (vide 
infra) than the energy of C=O bond in ketones (750 kJ.mol-1 ~ 179 kcal.mol-1).  
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However, the lower electrophilicity of the imine bond can be modulated by the R3 
group or by Lewis acid activation (Scheme 2.3). A desirable group on nitrogen (R3) is a 
group stabilising the possible negative charge on nitrogen resulting from addition of a 
negatively charged nucleophile (organometallics or a hydride).  
 
R1
N
R2
R3
R1
N
R2
R3
LA
LA
R1
HN
R2
R3
R1
NHR3
R2
LA
LA
Nu Nu
 
 
Scheme 2.3. A Lewis Acid / Imine or a Lewis acid / Amine Adduct 
 
Another problem is the basicity of imine and/or amine nitrogen which may trap the 
Lewis acid before the catalytic cycle starts or is fully developed (Scheme 2.3). Typical pKa 
values of the conjugate acids of arylimines Ar(R2)C=NR3 are in the range 5.5-7.5 
(difficulties with measurements prevent obtaining more accurate data) and the basicity of 
the corresponding amines (i.e. N-substituted anilines) lies in a similar range. With 
increasing the electron density on the nitrogen atom, the basicity – in both cases – 
increases.  
 
As mentioned earlier, the geometry of the imine can influence the outcome of the 
reaction performed on it. Regarding the equilibrium distribution of the E/Z isomers [of a 
general arylimine Ar(R2)C=NR3], several attributes need to be taken into account:23,24  
 
1.  Steric and resonance factors:  
- increasing the bulk of C-substituent R2 (Ar = const.) destabilises the (E)-isomer 
and moves the equilibrium towards the (Z)-isomer,  
-  [1,2]-eclipsing effects – opposed to delocalisation energy – twisting of the C-
aryl ring  from the C=N-R3 plane decreases the steric interaction between the 
ortho-substituent (hydrogen or X) of the C-aryl and the N-R3  (e.g. for 
benzylideneaniline R2 = H, R3 = Ph, θ ~ 10 deg; Scheme 2.4).  
 
2.  o-Substituted C-aryl effects:  
- preference towards the (Z)-isomer (~ 9.5 kJ.mol-1, Ar = o-tolyl, R2 = R3 = Me),  
- the (E)-isomer might be destabilised by the repulsive interactions between the 
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nitrogen lone pair and the aromatic π-electrons (n-π repulsions),  
-  increase of the dihedral angle θ tends to reduce the adverse steric interactions of 
the o-substituent with the C-R2 and N-R3 in the dominant (Z)-isomer (typically 
θ ~ 10-30 deg).  
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Scheme 2.4. Equilibrium Distribution of E/Z Ketimines 
 
3.  p-Substituted C-aryl effects:  
- an electron-donating group tends to stabilise the coplanar conformation by 
increasing the delocalisation energy, which increases the barrier of rotation 
around the C-aryl bond and moves the equilibrium towards the (E)-isomer 
(Scheme 2.5; destabilisation effect has not been observed for p-EWGs),  
- n-π repulsions between the nitrogen lone pair and C-aryl decrease with the 
electron-deficiency of the aryl ring (opposite effect of p-EDGs, can be counter-
balanced by resonance energy).  
 
Y
R2
N R3
Y
R2
N R3
 
 
Scheme 2.5. Stabilisation of p-Substituted Ketimine 
 
4.  Stereochemical analysis:  
- (Z)-isomer shows N-alkyl signals at lower δ than the (E)- due to shielding effect 
of the C-aryl ring (ring-current effect, analogy for N-aryl imines),  
- IR absorption – cis-(Ar-C=N-R3) at ν ~ 700 cm-1, trans relation ν ~ 690 cm-1.   
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The energy of the “flip” is difficult to determine precisely as it strongly depends on 
all substituents (R1, R2, R3), their electronic and steric properties. The typical value of the 
isomerisaton barrier lies in the range ∆G‡ ~ 83-108 kJ.mol-1 24 which corresponds to half-
life of several hours. However, traces of Brønsted acid present in the solution can catalyse 
this isomerisation process and decrease the half-life to tens of seconds! Two types of 
mechanism can be outlined for acid-catalysed isomerisation (Scheme 2.6):25  
 
-  protonation of the imine nitrogen generates trace amounts of the iminium ion (b), 
the rate of isomeristaion is correlated linearly to the amount of the protonated 
species,  
-  rotation around carbon-nitrogen bond in the protonated species (c) (the bond order 
decreases with protonation and yet this might require up to ~ 190 kJ.mol-1 even for 
the stabilised carbcations generated from C-arylimines), 
 
R1 R2
N
R3H
H+
R1 R2
N
R3H
R1 R2
NR
3
-H+
X-
R1 R2
N
R3H
X
R1 R2
N R
3
-HX
(a) (b) (c)
(d)
(e)
 
 
Scheme 2.6. Brønsted Acid-catalysed Isomeration of Imines 
 
-  alternatively, less energy-demanding is the nucleophilic addition of the acid counter 
anion X- to (b) producing the corresponding tetrahedral intermediate (d), which 
then undergoes rotation about the C-N bond,  
-  elimination of the acid anion and proton loss from nitrogen, yielding the opposite 
geometrical isomer (e). 
 
 
2.1.3. Asymmetric Reactions Yielding Amines 
 
Amines, naturally occurring or their unnatural analogues, both types are 
pharmaceutically interesting groups of compounds. The need for their synthesis rather than 
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isolation is obvious. There are many approaches providing a way of obtaining 
enantioenriched amines from many different starting building blocks, mostly based on 
carbonyl compounds:26  
 
1.  Preparation of amines from imines by additions to:  
- N-alkyl/aryl imines, N-acyl imines,  
-  N-silyl, N-boryl, N-alumino, N-phosphinyl, and N-thio imines.  
 
2.  Additions to other N-derivatives of ketones:  
- hydrazones, oxime ethers, and nitrones.  
 
All of above-mentioned reactions are diastereoselective reactions performed with 
stoichiometric amount of the chiral inducer – chiral auxiliary which can be contained either 
in the substrate (carbonyl) or the attacking nucleophile. The formation of a new 
stereocentre is in relation to the already existing one in the chiral auxiliary and the product 
is a pair of diastereoisomers for each added centre. The separation of the diastereomers is 
feasible also on larger scale; however, this approach has some serious disavantages:  
 
-  the introduction and later removal of the auxiliary group might be problematic,  
-  the stoichiometric amount of precious enantiomerically pure chiral auxiliary is 
required.  
 
One way of overcoming these problems is to use sub-stoichiometric or catalytic 
amounts of the chiral source which is not chemically bound to either of the reactants, only 
interacting with them by weak interactions. When only a catalytic amount is used, the 
reaction must proceed in a catalytic cycle and fundamentally, that makes the catalyst 
recoverable which further improves the cost efficiency.  
 
 
2.1.4. Catalytic Enantioselective Additions Yielding Amines 
 
Catalytic enantioselective reactions27  is a term used for a class of reactions where 
the chirality in a large quantity of prochiral compound (substrate) is induced by a small 
amount of chiral source (chiral catalyst). This by itself is very efficient route for the 
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synthesis of chiral compounds and it can be used for a vast selection of substrates, 
particular interest lies on carbonyl compounds and their analogues (vide infra).  
 
Usually, catalytic enantioselective reactions performed with this type of compounds 
(aldehydes, ketones, ald-, ketimines) are divided according to the way of setting up the 
new stereogenic centre into two main groups which can be sorted further:  
 
1.  Transformations without carbon-carbon bond formation:  
- reductive amination of ketones,  
- reduction of imines, including (transfer) hydrogenation of imines.  
 
2.  Nucleophilic attack resulting in the formation of a new carbon-carbon bond.28 This 
group can be sorted according to the type of attacking nucleophile:  
- alkylmetals and cyanides,  
- Diels-Alder dienes for aza-Diels-Alder, and 
- enol ethers in Mannich-type reactions.  
 
However, other way of classification of catalytic enantioselective reactions may be 
applied, based on the choice of the chiral source in the used catalyst; the primary carrier 
of chirality – fundamentally, the catalyst can have either Lewis-acidic or basic character: 
 
1. Reactions catalysed by metal complexes:  
- “classical” transition metals – rhodium, ruthenium, 
- more recently utilised – iridium, titanium, cobalt, rhenium, copper. 
 
2. Reactions catalysed by metal-free catalysts – organocatalytic reactions:  
- aminoacids as chiral source, 
- carbohydrates as chiral source, and other types.  
 
In the specific case of preparation of amines from ketones (reductive amination) or 
ketimines (reduction), there is also an option to classify these reactions according to the 
chosen reducing agent:  
 
1.  Hydrogenation with H2 gas – high pressure (> 10 atm) or low pressure of H2 gas.  
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2.  Transfer of a hydride which is formed from:  
- formic acid,  
- silanes and boranes,  
-  metal hydrides and others. 
 
Apparently, there are many combinations and in this thesis I will pay attention to 
reduction of imines / reductive aminations of ketones and particularly their organocatalytic 
enantioselective versions. 
 
 
 
2.2.  Highlights of Metal-catalysed Asymmetric Reductions4a,28,29 
 
2.2.1. Rhodium Catalysis 
 
The first report on enatioselective reduction of imines was from Kagan et al. in 
1973.18 The reducing reagent was diphenylsilane and the source of chirality was chiral 
ligand 15 (DIOP) coordinated to a rhodium metal (Table 2.1, entry 1; Scheme 2.7). The 
catalyst loading was incredibly low (only 1 mol %) considering this was a pioneering 
reaction. Although the moderate enantioselectivity (50 % ee) was satisfying for the 
novelty, it was not enough for practical applications and it encouraged further research in 
this field.  
 
Ph
NBn
Ph
NHBn
18 Ph2SiH2
[RhCl(C2H4)2]2 (1 %)
15 (2 %)
(S)-19 (50 % ee)
 
 
Scheme 2.7. First Enantioselective Reduction of Imines 
 
However, it took ten years to improve the enantioselectivities of reductions by 
using transitions metals and new diphosphine ligands in high-pressure hydrogenations. 
Examples of the ligand structure optimisation were reported by Bakos et al.,30 who 
developed a procedure for the reduction of benzylimine 18 with ligand 20 coordinated to 
rhodium with up to 83 % ee (Table 2.1, entries 2 and 3; Scheme 2.8).  
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NHBn
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[Rh(nbd)Cl]2 (0.5 %)
22 (1 %), KI
22
(R)-19 (73-83 % ee)
(S)-23 (84-91 % ee)
 
 
Scheme 2.8. Enantioselective Reduction with Rh catalysts 
 
Another useful diphosphine ligand for the Rh-catalysed hydrogenation was the 
cyclohexyl derivative 22,31 which brought high enantioslectivity (up to 91 %, depending on 
the substrate) at very low loading (only 0.5 mol %). Potassium iodide was used as an 
additive to improve the enantioselectivity (Table 2.1, entries 4 and 5; Scheme 2.8).  
 
Table 2.1. Hydrogenations Catalysed by Rh Complexes 
 
Entry Imine Red. Reagent /  
 Additive 
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 18 Ph2SiH2 / - 15 / 1.0 ambient 99 / 50 (S) 
2 18 H2 / Et3N 20 / 1.0 ambient 96 / 73 (R) 
3 18 H2 / Et3N 20 / 1.0 0 99 / 83 (R) 
4 21 H2 / KI 22 / 0.5 ambient 99 / 84 (S) 
5 21 H2 / KI 22 / 0.5 –25 99 / 91 (S) 
6 18 H2 / - 24, s = 1.65 / 0.5 ambient 94 / 96 (R) 
7 18 H2 / - 24, s = 3.75 / 0.5 ambient 55 / 19 (R) 
8 18 H2 / - 26 / 0.1 ambient 99 / 95 (S) 
9 ketone 28 H2 / - 30 / 1.0 ambient 99 / 98 (S) 
10 ketone 29 H2 / - 30 / 1.0 ambient 99 / 90 (S) 
 
Bakos and Sinou continued their research on optimisation of the diphosphine and 
brought about the idea of biphasic hydrogenation systems32 (ethyl acetate – water) and 
water-soluble sulfonated ligand (sodium salt) 24, also at very low loading. The trick was in 
different degree of sulfonation which influenced the enantioselectivity, optimum was 
found at s = (m + n) = 1.4 to 1.7 (Table 2.1, entries 6 and 7; Scheme 2.9).  
 
Burk’s group33 exploited the beneficial effect of an additional binding nitrogen 
atom in hydrazones, which were successfully reduced with rhodium and (R,R)-Et-DuPHOS 
ligand 26, while the N-N bond in the product was cleaved with SmI2. Aromatic hydrazone 
substrates afforded the highest ee’s (up to 97 %; Table 2.1, entry 8; Scheme 2.9).  
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Scheme 2.9. More Examples of Rh-catalysed Reductions 
 
Kadyrov and Börner34 showed that Rh catalysis can be applied also to reductive 
aminations. They chose α-keto acids and benzylamine as substrates relevant to industrial 
production of N-benzyl-protected α-amino acids. However, the yields and 
enantioselectivities were varying, the best N-benzyl-phenylalanine 31 was obtained in high 
98 % ee (Table 2.1, entries 9 and 10; Scheme 2.10).  
 
R
O
COOH R
NHBn
COOHH2 (59 atm)
30: (R,R)-DeguPHOS
[Rh(cod)30]BF4 (1 %)
BnNH2
(S)-31 (98 % ee)
(S)-32 (90 % ee)
BnN
PPh2
PPh2
28: R = Bn
29: R = i-Bu
 
 
Scheme 2.10. Enantioselective Reductive Amination with Rh catalyst 
 
Rhodium catalysis exhibits several general trends:  
-  many reactions with Rh-diphosphine catalysts afford amines only in moderate ee’s,  
-  often, high hydrogen pressure needed and/or low catalyst TOF/TON, 
-  halide ions may have positive effects on enantioselectivity,  
-  best results obtained in biphasic systems with sulfonated ligands. 
 
 
2.2.2. Iridium Catalysis 
 
Chiral iridium complexes were also used in enantioselective hydrogenations, 
mainly in the late 1990s. High enantioselectivities were achieved by Pfaltz35 (Table 2.2, 
entry 1; Scheme 2.11) and later Zhang36 (Table 2.2, entries 2-4; Scheme 2.11). Pfaltz, 
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using his phosphine-oxazoline ligand 34, provided the aromatic amine 35 in 89 % ee, 
Zhang with his ferrocene-binaphane 37 obtained even better result, 99 % ee.  
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36: Ar = 2,6-diMePh
 
 
Scheme 2.11. Hydrogenation Using Ir Catalysts 
  
Besides hydrogenations of imines, Zhang also developed Ir-catalysed reductive 
aminations of aromatic ketones36 with up to 94 % ee (Table 2.2, entry 5; Scheme 2.12).  
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O
39
Ph
NHPMP
[Ir(cod)Cl]2/37 (1.0 %), 
I2, Ti(Oi-Pr)4
p-anisidine
H2 (68 atm) (R)-40 (<94 % ee)
 
 
Scheme 2.12. Ir-catalysed Reductive Amination 
 
A very simple monodenate phosphinoxide ligand 41 was used by de Vries37 (Table 
2.2, entry 6; Scheme 2.13). Its advantage was the simplicity of its preparation in two steps 
and one pot, and that it did not racemise easily. The best achieved enantioselectivity with 
this ligand for aromatic imines was 83 % ee.  
 
Another highly active iridium complex with ligand 42 for hydrogenation of 
aromatic imines by Andersson’s group38 was derived from 2-azanorbornane-oxazoline 
structure and promoted reduction of imines to amines with up to 90 % ee (Table 2.2, entry 
7; Scheme 2.13).  
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Scheme 2.13. Hydrogenation Using Ir Catalysts 
 
Iridium catalysis has been developed more recently complementing the previous 
methods of Rh and Ru catalysis:  
-  more effective Ir analogues of Rh catalysts,  
-  more easily deactivated by external factors, but having high TOF/TON,  
-  halide ions may have positive effects on enantioselectivity, acid often needed, too. 
 
Table 2.2. Hydrogenations Catalysed by Ir Complexes 
 
Entry Imine Red. Reagent /  
Additives  
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 33 H2 / - 34 / 0.1 ambient 99 / 89 (R) 
2 33 H2 / - 37 / 1.0 ambient 99 / 84  
3 33 H2 / I2 37 / 1.0 –5 99 / 94  
4 36 H2 / - 37 / 1.0 ambient 77 / 99  
5 ketone 39 H2 / I2, Ti(Oi-Pr)4 37 / 1.0 ambient 99 / 94 (R) 
6 18 H2 / pyridine 41 / 10 ambient 99 / 78 (S) 
7 33 H2 / - 42 / 0.5 ambient 98 / 90 (R) 
 
 
 
2.2.3. Ruthenium Catalysis 
 
The ruthenium complex 44 was employed in transfer hydrogenation protocol,14 
developed to avoid the use high-pressure hydrogen gas. Formic acid served as the hydride 
donor as other H-transfer sources (e.g. propan-2-ol) would require more active catalyst or 
harsher conditions. However, this method was relying on the rigidity of the structure 
containing the imine double bond, and in the case of cyclic imines, e.g. 43, very high 
enantioselectivity was achieved (up to 97 %; Table 2.3, entry 1; Scheme 2.14).  
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Scheme 2.14. Hydrogenations Using Ru Catalysts 
 
Cobley and Henschke39 chose a ligand system for Ru consisting of diphosphine and 
diamine, and the best combination proved to be (R,R)-Et-DuPHOS 26 and either of 
diamines 46a,b facilitating the reduction of the aromatic imine 33 with enantioselectivity 
of 91 % and 92 %, respectively (Table 2.3, entries 2 and 3; Scheme 2.14). Several cyclic 
imines of Noyori’s type, e.g. 43, were reduced with up to 79 % ee (at 0.1 mol % catalyst 
loading).  
 
Table 2.3. Hydrogenations Catalysed by Ru complexes 
 
Entry Imine Reducing Reagent /  
Additives 
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 43 HCOOH / Et3N 44 / 0.1 ambient 97 / 94 (R) 
2 33 H2 / - 26, 46a / 0.1 65 99 / 91 (S) 
3 33 H2 / - 26, 46b / 0.1 65 92 / 92 (S) 
4 Ketone 39 HCOOH / Et3N / NH3 47 / 1.0 60 92 / 95 (R) 
 
An interesting procedure for reductive amination of aromatic ketones, based on 
transfer hydrogenation with formic acid and (R)-BINAP-derived ligand 47, was developed 
by Kadyrov and Riermeier,40 who prepared primary amines of up to 95 % ee (Table 2.3, 
entry 4; Scheme 2.15).  
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Scheme 2.15. Ru-catalysed Reductive Amination 
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The appearance of Kadyrov-Riermeier’s and Zhang’s reductive amination protocols 
is even more remarkable considering the generality of the methods in spite of all the 
intermediates possibly present in the reaction mixture – heminaminals, N,O-acetals, 
aminals, imines and enamines and each of them requires specific hydrogenation 
conditions.41 
 
Ruthenium catalysis has provided several excellent methods for hydrogenations of 
ketones and transfer hydrogenation of imines (which is C=N chemoselective).  
 
 
2.2.4. Titanium, Cobalt, Rhenium and Copper Catalysis 
 
Several other metals were used for asymmetric hydrogenations. Titanium was 
introduced by Buchwald et al.42 in the early 1990s (Table 2.4, entries 1-4; Scheme 2.16). 
Testing reactions with titanocene catalysts 49a,b showed the best results with aromatic 
imines affording corresponding amines in 85-98 % ee.  
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Scheme 2.16. Hydrogenation with Ti Catalysts 
 
High pressure of hydrogen can be avoided by using Buchwald’s protocol of PhSiH3 
(treated with pyrrolidine and methanol) or polymethylhydrosiloxane (PHMS) as reducing 
reagents.43 Exceptionally, several alkylimines as 50 or 51 were reduced with very high 
enantioselectivity (up to 99 % ee). 
 
Mukaiyama et al.44 introduced the cobalt complex 55 which induced highly 
enantioselective reduction of N-diphenylphosphinyl imines, e.g. 54, with a modified 
borohydride reducing reagent (Table 2.4, entry 5; Scheme 2.17).  
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Table 2.4. Hydrogenations Catalysed by Other Metals 
 
Entry Imine Red. Reagent /  
Additives 
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 18 H2 / - 49a / 2.0 ambient 93 / 85 (R) 
2 18 PHMS / i-BuNH2 49b / 0.5 ambient 95 / 98 (S) 
3 50 PHMS / i-BuNH2 49b / 2.0 60  63 / 99 (S) 
4 51 PHMS / i-BuNH2 49b / 2.0 60 70 / 88 (S) 
5 54 Borohydride / - 55 / 1.0 ambient 97 / 90 (S) 
6 57 DMPS-H / - 60 / 3.0 ambient 76 / 99 (R) 
7 58 DMPS-H / - 60 / 3.0 ambient 89 / 95 (R) 
8 59 DMPS-H / - 60 / 3.0 ambient 83 / 99 (S) 
9 64 DMPS-H / - 65 / 6.0 ambient 89 / 96 (R) 
10 67 TMDS / t-BuOH 65 / 6.0 ambient 93 / 98 (R) 
11 54 propan-2-ol 70 / 120 60 85 / 96 (R) 
12 69 propan-2-ol 70 / 120 60 85 / 93 (R) 
 
Recently, an oxorhenium complex 60 appeared as a catalyst for reduction of N-
diphenylphosphinyl imines 57-59 with dimethylphenylsilane or diphenylmethylsilane. This 
reaction proceeded under mild conditions and without the need of exclusion of air or 
moisture45 – aromatic imines, α-iminoesters and conjugated imines were reduced smoothly 
and in almost exclusive enantioselectivity (Table 2.4, entries 6-8; Scheme 2.17).  
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Scheme 2.17. Hydrogenation of Diphenylphosphinyl Imines Catalysed by Co and Re complexes. 
 
One of the non-precious metals used recently in imine reductions was copper by 
Lipshutz and Shimizu46 (Table 2.4, entries 9 and 10;  
Scheme 2.18). They presumed the copper hydride as the actual reducing agent 
(preformed from CuCl), a chiral diphosphine ligand 65 and tetramethyldisiloxane (TMDS). 
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The standard amount of this catalyst is 6 mol %, by using only 1 mol % the ee’s decreased 
by 1 %.  
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Scheme 2.18. Cu-catalysed Hydrogenation 
 
An interesting protocol of Meerwein-Ponndorf-Verley-type aluminium-mediated 
transfer hydrogenation has been developed by Nguyen.47  It reduces aromatic and aliphatic 
imines; however, it is stoichiometric in aluminium and (S)-BINOL (Table 2.4, entries 11 
and 12; Scheme 2.19).  
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Scheme 2.19. Al-mediated Transfer Hydrogenation 
 
Less traditional catalysis with Ti, Co, Re or Cu has brought several remarkable 
protocols for reduction of different derivatives, often N-diphenylphosphinyl imines. These 
methods vary in reaction conditions or reducing agent according to the metal used. 
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2.3. Hydroboration of C=N Bonds  
 
2.3.1. History of Hydroboration and Early Mechanistic Views  
 
The word hydroboration is linked tightly to its discoverer and major developer H. 
C. Brown (Herbert Brovarnik), the 1979 Nobel Prize winner “for the development of the 
use of boron-containing compounds”.48 His interest in boron chemistry and mechanism of 
reductions with diborane goes back to his early career. The initial studies49 (1930s) on 
reactivity of diborane were carried out on carbonyl compounds. It was known that diborane 
reduced certain carbonyl compounds, but it was not clear why and how. With the 
development of the techniques for the preparation of diborane itself, its availability 
increased and the practical applications could have been improved, too50 (Scheme 2.20). 
Even if the term hydroboration is generic for addition of boranes to multiple bonds, 
nowadays, it is commonly used for the first step of preparation of alcohols from alkenes, 
this reaction is out of the scope of this thesis. 
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Scheme 2.20. Reduction of Carbonyl Compounds with Diborane 
 
For the reduction of carbonyl compounds to occur (Scheme 2.20), it was suggested 
that borane interacts with the carbonyl group on Lewis acid-base basis. Simple carbonyl 
compounds (aldehydes, ketones) have sufficient electron density on the carbonyl oxygen 
atom (a) and coordinate borane rapidly. The coordination process is followed by a hydride 
transfer (b) and formation monoalkoxyborane (c) which is able to act as LA, as well. In a 
similar fashion as before, it can coordinate to another carbonyl molecule which is the new 
hydride acceptor. The resulting dialkoxyborane (d) is hydrolysed upon work-up to alcohol 
(e) and a borate salt. Clearly, the initial coordination step (and the overall reactivity) is 
dependent on the Lewis basicity of the carbonyl oxygen, i.e. substituents on the carbonyl 
or α-carbon. In the case of esters, a significant slowing down the reaction rate was 
observed because the carbonyl and the ether oxygen atoms compete for coordination of 
borane.  However, the carbonyl-O is more probable to coordinate the boron thanks to 
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resonance stabilisation provided by the adjacent non-coordianted ether oxygen, even 
though the ester carbonyl-O has decreased electron density because of the same resonance 
stabilisation (in comparison to ketones). On the other hand, acids are readily reduced as 
they react through acylborane intermediates, which are stabilised through oxygen-boron 
resonance and the reactivity of the carbonyl then resembles that of ketones.  
 
 
2.3.2. Enantioselective Hydride Reductions and Hydroborations of C=N Bonds 
 
The research on enantioselective reduction of imines with boranes and hydrides 
begun to develop in mid-1970s and intensively continued in the 1980s. Naturally, the 
pioneering examples were carried out with ketones, readily available and stable 
compounds and preliminary success with them motivated researchers to explore also 
analogical reductions for C=N compounds. Among these, oximes were utilised as model 
compounds for they are more stable that imines, despite the fact they suffer more from the 
impact of the C=N bond geometry on stereochemistry of the product.  
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Scheme 2.21. Reduction with LiAlH4-Glucofuranose Complex 
 
First enantioselective reduction was published by Landor in 1974.51 The publication 
has provided several studies on reduction of ketones and their nitrogen analogues with 
lithium aluminium hydride-glucofuranose complex 72. They expected a kinetically 
controlled hydride transfer in the sterically least hindered transition state. However, this 
was quite a vague statement and their experiments only suggested that the transfer was 
intermolecular and two molecules of the reducing reagent were needed.  
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Table 2.5. Reductions with Modified Hydrides  
 
Entry Imine /  
Oxime 
Reducing Reagent (equiv.) /  
Additives (ambient temp.) 
Yield (%) /  
ee (%)  
1 33 LiAlH4.D-Glf (72) / 1.0 82 / 24 (S) 
2 73 LiAlH4.D-Glf (72) / 1.0 >70 / 11 (S) 
3 74 LiAlH4.D-Glf (72) / 1.0 >70 / 56 (S) 
4 76 NaBH4.L-Pro (77a) / 2.5 90 / 86 (S) 
5 76 NaBH4.L-Leu (77b) / 1.2 76 / 70 (S) 
6 76 NaBH4.L-Leu (77b) / 1.2 / ZnCl2  72 / 78 (S) 
7 76 NaBH4.L-Leu (77b) / 1.2 / Al2O3 81 / 95 (S) 
 
The best obtained level of enantioselectivity was around 25 % ee for imines and up 
to 56 % ee for oximes (Table 2.5, entries 1-3; Scheme 2.21). Somewhat better results (40-
50 % ee for several aliphatic oximes) were achieved using cyclohexyl-protected 
glucofuranose instead of the benzyl-protected one (as in complex 72).52  
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Scheme 2.22. Reductions with NaBH4-Amino Acids Complexes 
 
In early 1980s, Iwakuma brought the idea of modifying sodium borohydride by an 
amino acid (L-proline) and he investigated reduction of imines with the novel chiral 
triacyloxyborohydride 77a.53 The substrates of choice were 3,4-dihydropapaverine 
derivatives as 76. Under the optimised conditions natural product (S)-(–)-norcryptostyline 
78 was obtained in 86 % ee (Table 2.5, entry 4; Scheme 2.22). The same target molecule 
was synthesised also by Hajipour and Hantehzadeh using L-leucine-derived 
acylborohydride 77b and the effect of ZnCl2 additive was investigated (Table 2.5, entries 
5-7; Scheme 2.22).54 More interestingly, alumina-supported solvent-free synthesis 
provided the alkaloid 78 in excellent 95 % ee.  
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Figure 2.1. Isolated Complex from Imine 43 and NaBH(OCOCF3)3 
 
The authors53,54 speculated about the mechanism and proposed the formation of an 
imine-diacyloxyborane intermediate followed by an intramolecular hydride transfer. The 
idea was supported by isolation of 79 – a bis(trifluoroacetoxy)borohydride-43 complex 
(Figure 2.1). 
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Scheme 2.23. Itsuno’s Reductions with Borane and Borohydride Complex 
 
Based on previous scattered attempts of modifying the hydride reducing agents and 
fairly successful reduction of oxime ethers containing chiral auxiliary with BH3.THF or 
LiAlH4 (up to 44 % ee),55 Itsuno’s group developed a reduction protocol with BH3.THF 
complex in the presence of a chiral borane.56 The reduction of oxime ethers using this 
complex was efficient only in stoichiometric loading of the chiral source – an amino 
alcohol. Although the chiral borane, e.g. 82 did show some catalytic behaviour, attempts to 
decrease the loading to truly catalytic amounts failed and semicatalytic version (25 mol %) 
afforded the free amine 48 in 90 % ee (Table 2.6, entries 1-5; Scheme 2.23). The scope of 
oxime benzylethers effectively reduced with Itsuno’s reagent was broadened by Fontaine.57 
Products of all tested substrates were obtained in >97 % ee and >60 % yield.  
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Table 2.6. Reductions of Oximes with Borane and Sodium Borohydride 
 
Entry Oxime Reducing Reagent Ligand (mol 
%) 
Temp. (°C) Yield (%) /  
ee (%)  
1 73 BH3.THF 82 / 120 30 99 / 0 
2 80 BH3.THF 82 / 120 30 99 / 99 (S) 
3 81 BH3.THF 82 / 120 30 99 / 95 (S) 
4 81 BH3.THF 82 / 25 30 99 / 90 (S) 
5 81 BH3.THF 82 / 10 30 99 / 52 (S) 
6 80 NaBH4.ZrCl4 83 / 150 ambient 96 / 92 (S) 
7 80 NaBH4.ZrCl4 83 / 120 ambient 96 / 81 (S) 
8 80 NaBH4.ZrCl4 83 / 100 ambient 95 / 58 (S) 
 
Mechanistic studies have shown that the reduction of oxime ethers with 82 and 
BH3.THF exhibited the following characteristics:  
 
-  reduction with the BH3.THF complex was accelerated in the presence of complex 
82 (severe competition of the background reaction with catalyst loading below 25 
mol %),  
-  the complex 82 itself could not reduce oxime ethers,  
-  asymmetric induction was caused by the complex 82,  
-  only marginal change in level of asymmetric induction was observed with the 
polymer-supported 82.58  
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Scheme 2.24. Reductions of Diphenylphosphinyl Imines 
 
In effort to improve this technique, more convenient NaBH4 was revisited.59 
Sodium borohydride could be activated by a Lewis acid so that it reacted with an amino 
alcohol only in presence of a LA to form the desired chiral borohydride reductant (Table 
2.6, entries 6-8; Scheme 2.23); however, the structure of the active complex was not 
investigated. Optimised conditions afforded the free amine 48 in up to 92 % ee, the 
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enantioselectivity was dependent particularly on the ratio of the reagents. Unfortunately, 
neither this protocol could be made catalytic as any sub-stoichiometric amount of the chiral 
source (the amino alcohol) severely eroded the enantioselectivity and even when a 
transition metal Lewis acid was used.  
 
Table 2.7. Reductions of Imines with Modified 9-BBN and LiAlH4 
 
Entry Imine Reducing Reagent  
(equiv.) 
Temp. (°C) Yield (%) /  
ee (%)  
1 54 LiAlH4.70 / 1.2 25 35 / 77 (S) 
2 54 LiAlH4.70 / 1.2 –78 84 / 13 (S) 
3 84 LiAlH4.70 / 1.2 25 16 / 98 (S) 
4 84 LiAlH4.70 / 1.2 –78 66 / 7 (S) 
5 85 LiAlH4.70 / 1.2 25 38 / 93 (S) 
6 85 LiAlH4.70 / 1.2 –40 63 / 40 (S) 
7 85 89 / 1.2 –78 58 / 61 (R) 
8 88 89 / 1.2 –78 95 / 84 (R) 
 
Hutchins also screened several known combinations of chirally modified hydride 
reductant and found two of them quite successful: BINOL-LiAlH4 (BINAL, Noyori’s 
reagent) and glucofuranosyl-9-BBNH (89, Glucoride K, Brown’s reagent).60 Reduction of 
aromatic imines was more successful with BINAL system, achieving enantioselectivity up 
to 98 % ee (Table 2.7, entries 1-6; Scheme 2.24).  
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Scheme 2.25. Reductions with (–)-Norephedrine-Borane Complex 
 
Interestingly, at lower temperatures and shorter reaction times, the yields were high 
and enantioselectivity low; whereas at ambient temperature the product was obtained in 
low yield and high ee. Reductions with complex 89 were carried out at low temperatures 
and afforded N-diphenylphosphinyl amines in moderate to good yields and ee’s (Table 2.7, 
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entries 7 and 8; Scheme 2.24). Although some of the stated results gave almost enantiopure 
products, their unreliability made these experiments of little practical value.   
 
Table 2.8. Reductions of Oximes with Borane Complexes 
 
Entry Oxime Reducing Reagent Ligand (mol 
%) 
Temp. (°C) Yield (%) /  
ee (%)  
1 (E)-91 BH3.THF 93 / 200 20 64 / 92 (S) 
2 (Z)-91 BH3.THF 93 / 200 20 58 / 92 (R) 
3 (E)-92 BH3.THF 93 / 200 20 65 / 80 (S) 
4 (Z)-92 BH3.THF 93 / 200 20 45 / 79 (R) 
5 96 BH3.THF 93 / 130 ambient 52 / 99 (S) 
6 (E)-98  BH3.SMe2 99 / 10 ambient 68 / 50 (S) 
7 (Z)-98 BH3.SMe2 99 / 10 ambient n.a. / 55 (R) 
8 101 BH3.SMe2 99 / 10 ambient 45 / 72 (R) 
9 102 BH3.SMe2 99 / 10 ambient 65 / 70 (R) 
10 102 BH3.SMe2 99 / 5 ambient n.a. / 65 (R) 
11 102 BH3.SMe2 99 / 100 ambient 65 / 72 (R) 
 
The influence of oxime geometrical isomerism on the reduction with (1R,2S)-(–)-
norephedrine-borane complex 93 was tested by Sakito and Suzukamo.61 Their results 
clearly showed that the absolute configuration on the amine was dependent not only on the 
configuration of the catalyst but also on the C=N geometry: (E)-91 gave (S)-, and (Z)-91 
gave (R)-configuration of the resulting amine, maintaining the enantioselectivity (Table 
2.8, entries 1-4; Scheme 2.25). Complex 93 was also utilised for a commercial synthesis of 
the key intermediate 97 of a potent and selective 5-lipoxygenase inhibitor and it was 
obtained virtually enantiopure, in low yield though62 (Table 2.8, entry 5; Scheme 2.25).  
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Scheme 2.26. Sense of Asymmetric Induction vs. Geometry of Oxime 
 
Later on, Bolm has shown a similar trend with his sulfoximine catalyst 9963 (Table 
2.8, entries 6 and 7; Scheme 2.26). The enantioselectivity up to 72 % ee was obtained with 
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α-substituted oximes, e.g. 101 or 102. Despite the moderate levels of enantioselectivity, the 
reaction proceeded in truly catalytic manner and increasing the catalyst loading up to 1 
equivalent improved the ee’s only marginally (Table 2.8, entries 8-11; Scheme 2.26).  
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Figure 2.2. Chiral Modifiers for Asymmetric Reductions with Boranes 
 
At the begining of the 1990s, Cho and Chun tested the known methods for 
reduction of open-chain imines.64 Among the less successful were glucofuranosyl-9-BBNH 
89 or Chirald 105-BH3 complex (Mosher’s reagent; Figure 2.2) previously tested by 
Hutchins.60 On the other hand, oxazaborolidines 82 (Itsuno’s reagent) and 107 (Corey’s 
reagent) or sulfoxamide 106 (Sharpless’ reagent)-BH3 complex exhibited good reactivity 
and enantioselectivity for a model compound propiophenone phenyl imine 108 (Table 2.9, 
entries 1-5; Scheme 2.27).  
 
Table 2.9. Reductions of Imines with Oxazaborolidines and Dialkoxyborane 
 
Entry Imine Reducing Reagent Ligand  
(mol %) 
Temp. 
(°C) 
Yield (%) /  
ee (%)  
1 108 BH3.THF 106 / 100 30 60 / 66 (R) 
2 108 BH3.THF 82 / 100 30 98 / 87 (R) 
3 108 BH3.THF 82 / 10 30 95 / 66 (R) 
4 108 BH3.THF 107 / 100 25 96 / 78 (R) 
5 108  BH3.THF 107 / 10 25 92 / 70 (R) 
6 33 BH3.THF 82 / 100 30 98 / 73 (R) 
7 110 BH3.THF 82 / 100 30 90 / 80 (R) 
8 31 112 / 500 0 89 / 56 (R) 
9 18 112 / 500 0 70 / 72 (R) 
10 31 BH3.SMe2 113 / 10 110 59 / 63 (R) 
11 18 BH3.SMe2 113 / 10 110 65 / 60 (R) 
 
Further experiments have shown that catalyst loading of 10 mol % decreased the 
ee’s, the least dramatically for oxazaborolidine 107 (from 78 to 70 % ee). Several aromatic 
imines were reduced in high yields and good enantioselectivity (Table 2.9, entries 6 and 7, 
Scheme 2.27). By contrast, aliphatic imines afforded the corresponding amines in low ee’s.  
 
    44
Ph
NPh
Ph
NHPh
108
a., b. or c. a. 106 / BH3.THF (1.0 eq)        (R)-109 (66 % ee)b. 82 (1.0 eq)        (R)-109 (87 % ee)
c. 107 (1.0 eq)        (R)-109 (78 % ee)
d. 112 (5.0 eq)        (S)-109 (73 % ee)
Ph
NR
Ph
NHR82 (1.0 eq)
33: R = Ph
110: R = t-Bu
(R)-35 (73 % ee)
(R)-111 (80 % ee)
109
THF
THF
 
 
Scheme 2.27. Model Reduction of Imines with Various Reductants 
 
Nakagawa and Hino have reported on reduction of imines with chiral 
dialkoxyboranes,65 such as 112, and showed that diols could serve as useful chiral sources 
alongside amino alcohols. Arylimines 33 and 18 were reduced with good yields and 
moderate enantioselectivities up to 73 % for model imine (Table 2.9, entries 8 and 9; 
Scheme 2.28).  
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Scheme 2.28. Reduction of Imines with Other Types of Ligands 
 
Brunel and Buono have investigated the possibility of reduction of imines with a 
novel oxazaphospholidine 113 in analogy to oxazaborolidines.66 The reaction proceeded 
smoothly at the optimum loading 10 mol % and higher temperature (110 °C), only 
moderate enantioselectivities were achieved (60-63 % ee; Table 2.9, entries 10 and 11; 
Scheme 2.28).  
 
    45
Ph
NPMP
Ph
NHPMP116 (0.5 %)
115 (R,R)-117 (99 % ee)
116
BH3.THF (3 eq)
THF
Ph
NPMP
Ph
NHPMP
TBDMSO OH
Me
NH2
PhPh
Ph
NOTMS
Ph
NH293 (1.0 eq)
(S)-48 (90 % ee)
BH3.THF (1.0 eq)
THF114
 
 
Scheme 2.29. Reduction of Various Substrates with L-Thr-Borane Complex 
 
Cho et al. also reported reduction of TMS-protected ketoximes;67 however, high 
enantioselectiviy was observed only on the case of oxime 114 derived from acetophenone 
using (–)-norephedrine-derived oxazaborolidine 93 (Table 2.10, entry 8; Scheme 2.29). 
One of the few protocols where the chiral source is used in very low catalytic amounts was 
developed by Fujisawa for a stereoselective synthesis of 1,2-diphenylenediamines.68 The 
reaction was enantiospecific when 1 equivalent of the chiral ligand 116 was used. 
However, loading to 0.5 mol % (!) still provided the diamine in 99 % ee and 95:5 
stereocontrol (Table 2.10, entries 2 and 3; Scheme 2.29). Examples of diastereoselective 
reduction of 1-oxo-2-ketoximes using ligand 116 were provided, too.69  
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Scheme 2.30. Reduction of Bifunctional Substrates with Borane Complexes 
 
In bifunctional molecules, such as 1-oxo-2-ketoximes, the oxo-functionality is 
reduced preferentially and determines the configuration on the forming amino group from 
the 1-ol-2-ketoxime intermediate,70 the major product being the cyclic cis-amino alcohol 
with up to 80 % de and 93 % ee71  (Table 2.10, entry 4; Scheme 2.30) or non-cyclic anti-
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amino alcohol with up to 70 % de and 99 % ee72 (Table 2.10, entries 5 and 6; Scheme 
2.30). The enantioselectivity in this protocol was dependent on the steric bulk of the oxime 
ether group.  
 
Table 2.10. Reductions of Bifunctional Substrates with Boranes 
 
Entry Imine Reducing Reagent Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 114 BH3.THF 93 / 100 ambient 96 / 90 (S) 
2 115 BH3.THF 116 / 0.5 ambient 90 / 99 (R,R) 
3 115 BH3.THF 116 / 100 ambient 90 / >99 (R,R) 
4 118 BH3. SMe2 107 / 10 –20 to 25 78 / 91 (1S,2R) 
5 119 BH3. SMe2 120 / 10 ambient 91 / 90 (1S,2R) 
6 123 BH3. SMe2 120 / 10 ambient 93 / 91 (1S,2R) 
 
In the last decade, several variations of substrates, procedures, or oxazaborolidines 
have been reported. Aromatic and aliphatic imines, such as 125 or 126, were reduced with 
Corey’s reagent 107; however, only in moderate yields and enatioselectivities73 (Table 
2.11, entries 1 and 2; Scheme 2.31).  
 
Table 2.11. Miscellaneous Reductions with Boranes 
 
Entry Imine Reducing Reagent Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 125 BH3.THF 107 / 100 0 60 / 74 (S) 
2 126 BH3.THF 107 / 100 0 79 / 60 
3 129 BH3.THF 82 / 200 ambient 77 / 61 (S) 
4 129 BH3.THF 82 / 25 ambient 60 / 37 (S) 
5 131  Catecholborane
 
133 / 5 –15 87 / 86 (R) 
6 132 Catecholborane 133 / 5 –15 86 / 75 (R) 
7 136 Catecholborane 107 / 10 25 94 / 63 (R) 
8 18 BH3.THF 138a / 100 50 39 / 4 (S) 
9 80 BH3.THF 138a / 100 50 61 / 84 (S) 
10 80 BH3.THF 138b / 223 50 56 / 72 (R) 
11 80 BH3.THF 138c / 223 0 70 / 99 (R) 
 
Novel α-fluoro74 129 and α-trifluoromethyl NH-imines 131, 13275 or imino ester 
13676 were also successfully reduced with Itsuno’s reagent 82 or Corey’s oxazaborolidines 
107 and 133, to afford the corresponding α-fluoroamines, α-trifluoromethyl-arylamines, 
and α-amino-α-trifluoromethylcarboxylates, respectively (Table 2.11, entries 3-7, Scheme 
2.32). Unlike the majority of the previous applications, these methods were catalytic. 
Another interesting application of the reducing system 107-catecholborane was the 
reduction of α-trifluoromethyl-C-phosphorylated NH-imines77 in analogy to the previous 
NH-imines and esters. The α-amino-α-trifluoromethylphosphonates were obtained in 
moderate ee, up to 70 %.  
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Scheme 2.31. Novel Substrates for Reduction with Oxazaborolidines 
 
Itsuno has continued his research on enantioselective reductions of ketones, imines 
or oximes and he has developed a new piperazinemethanol-sulfonamide ligand 138a.78 
Ketones were reduced catalytically (20 mol %), oximes stoichiometrically, both in 
moderate ee’s (up to 84 % ee) and imines afforded only racemic products (Table 2.11, 
entries 8-11; Scheme 2.33).  
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Scheme 2.32. Novel Substrates for Catalytic Reduction with Oxazaborolidines 
 
The monomeric 138a was anchored to a polystyrene framework and the 
dependency of enantioselectivity on the composition of the polymer was investigated. It 
was found that the optimal molar fraction of the ligand monomer was 20 mol %. The co-
polymer 138c afforded free amine 48 in 99 % ee (opposite configuration than when using 
138a) and could be reused 6 times with no loss of enantioselectivity. This was a rare case 
when the polymeric catalyst exhibited better enantioselectivity than the homogenous 
monomer. 
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Scheme 2.33. Polymer-supported Ligand for Reduction with Borane  
 
A newer type of catalysts which form active reducing species with borane are 
spiroborate esters. The first protocol utilising the (R)-BINOL-proline-based spiroborate 
139a afforded free amines in high level of enantioselectivity (up to 98 % ee) only in 
stoichiometric amounts79 (Table 2.12, entry 1; Scheme 2.34).  
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Scheme 2.34. Reduction of Oxime Ethers with Spiroborates 
 
An improvement of this method came with the amino alcohol-ethyleneglycol 
catalyst 139b which reduced the oximes in the presence of (unusual) 4 equivalents of 
borane to free amines in very high enantioselectivity (typically 95-98 % ee).80 The 
reduction was also stereoselective, i.e. the (E)-oxime was reduced to (S)-amine, 
exclusively. The interesting fact was that a variety of heterocycles were tolerated in the 
place of the aryl group, except pyridin-2-yl substrates, which were reduced by borane in an 
uncatalysed (racemic) fashion.   
 
Table 2.12. Reductions with Spiroborates 
 
Entry Oxime Reducing Reagent Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 80 BH3.THF 139a / 100 0 76 / 98 (S) 
2 81 BH3.THF 139b / 10 25 83 / 89 (S) 
3 81 BH3.THF 139b / 10 0 77 / 97 (S) 
4 140 BH3.THF 139b / 10 0 38 / 98 (S) 
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2.3.3. Mechanistic Considerations of Reductions with Oxazaborolidines 
 
The oxazaborolidines (OABs) play the role of Lewis acid-Lewis base bifunctional 
asymmetric inducers for activation of the carbonyl and the borane81 (shown for Itsuno’s (b) 
and Corey’s (d) OAB, Scheme 2.35):  
 
-  the Lewis-basic nitrogen site of the OAB (b, d) coordinates a molecule of borane, 
forming a cis-fused oxazaborolidine-BH3 complex (c, e), activating the borane,  
-  thus, the Lewis acidity of the OAB boron atom is increased and it can bind the 
carbonyl compound (f, g) – simultaneous activation of both reacting species 
towards the intramolecular hydride transfer (g, h),  
-  the substrate approaches the OAB with the larger substituent (RL) cis towards the 
vicinal BH3 so that the hydride is transferred to re-face of the substrate (providing 
CIP priority is also RL > RS),   
-  the catalytic cycle is maintained by excess of the reducing borane (BHR2, BH2R, 
BH3) (i, j, k).   
 
Ph
Ph
OHH2N N
B
OH
R
Ph
Ph
N
B
OH
R
Ph
Ph
H3B
BH3BHR2
N
B O
Ph
Ph
R
N
B O
Ph
Ph
R
H3B
BH3
BH3
RL RS
O
RL RS
OBH2H
H2O
RL
OH
RS
(R)-product
(k)
(S)-OABs
N
B
OH
R
Ph
Ph
H3B
N B
O
Ph
Ph O RS
RL
H2B H
N B
O
Ph
Ph O RS
RL
B
H H
R
R
N B
O
Ph
Ph O RS
RL
H2B
H
R
H BH2
(a) (b) (c)
(d) (e)
(f) (g)
(h)(i)
(j)
 
 
Scheme 2.35. Proposed Mechanism for Reduction of Ketones with Oxazaborolidines 
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Tight organisation in the transition state secures that the chiral relay is 
unambiguous and the (S)-OAB is translated into (R)-configuration of the product. The 
optimal temperature was found to be 20-30 °C.82  
 
From the previous overview of examples and methods for reduction of imines (and 
oximes) with boranes or hydrides, it is clear that severe lack of reliability persists. Only 
very few protocols have been made catalytic, whereas the opposite is true for reduction of 
ketones with oxazaborolidines.83 Numerous examples of this have been documented in the 
literature, posing a question of why this system does not work for imines. It could be due 
to lower electrophilicity of the imine carbon and rapid equlibration between (E)- and (Z)-
isomers. Often enough, Lewis acidic boron is deactivated by the basic imine/amine 
nitrogen of the substrate or the product as discussed in Chapter 2.1.2.  
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Scheme 2.36. Proposed Mechanism for Reduction of Imines with Oxazaborolidines 
 
Another problem is the rate of the uncatalysed (background) reduction, which is – 
in the case of ketones – considerably slower than the catalysed reaction (using BH3.THF) 
or it does not proceed at all (using catecholborane). However, for imines, the background 
reaction affords the racemic product in high yield for both reducing reagents84 (Scheme 
2.36). If an (E)-imine is taken as substrate, the organisation of the transition state can differ 
according to the used reductant:  
 
-  using a sterically less demanding BH3, it is likely that the approach of the imine 
towards the OAB happens in similar fashion as in the case of ketones, as in (c) (RL 
~ Ph, RS ~ Me), resulting in formation of an (R)-amine (d),  
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-  if a sterically more demanding borane is used (e.g. catecholborane), it is likely that 
the less crowded conformation would be the opposite one (e), affording an (S)-
amine (f).  
 
Thus, the research of reductions of carbonyls with boranes has brought considerable 
achievements only for ketonic substrates. An alternative reducing reagent – virtually 
inactive on its own and activated by catalyst – had yet to be developed.  
 
 
 
2.4. Hydrosilylations of Imines  
 
2.4.1. History of Hydrosilylations and Early Mechanistic Views 
 
The reductive properties of trichlorosilane were extensively studied since the 1950s 
and resulted in reductive silylation of several classes of compounds, such as alkenes and 
alkynes (HSiCl3 only); aldehydes, ketones and imines, acids and their derivatives (HSiCl3 
with a tertiary amine).85 Though, it was not until the 1980s that the mechanistic 
understanding allowed development of new methods, synthetically truly useful.  
 
R3N  +  HSiCl3
R3N SiCl3
H
+  SiCl3R3N H
(a) (b) (c)
 
 
Scheme 2.37. First Proposed Mechanism for Formation of Trichlorosilyl Anion 
 
Mixtures of trichlorosilane and a Lewis base (pyridine, tertiary amine) were known 
to form isolable (but not very stable) adducts containing two equivalents of the base, prone 
to disproportionation to tetrachlorosilane and silane.86 The early mechanistic NMR 
experiments were targeted to propose and prove the structure of the trichlorosilane-tertiary 
amine complex (Scheme 2.37) – 1H NMR showed a new signal at δ 11.03 assigned as of 
protonated base (c);87 therefore creating trichlorosilyl anion available to act as the reactive 
nucleophile. Another proof of this species was the amine-catalysed deuterium exchange of 
1H-trichlorosilane with a tertiary amine-deuteriochloride salt where the formation of the 
new complex was the rate-determining step.88 The silicon-bonded hydrogen would gain 
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a substantial hydride character (see also Chapter 3.2). Another support for the theory is 
gained from the properties of pyridine-trichlorosilane adducts.89  It has been shown that the 
Si-Cl and Si-N bonds are predominantly ionic; however, the latter bond also featured 
donor-acceptor character, and the Si-H bond was categorised as polar-covalent. The natural 
charges on atoms were shifted to more extreme values upon coordination, i.e. the ligands 
became more negatively charged and silicon more positively.  
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Scheme 2.38. Proposed Mechanism for Formation of Trichlorosilyl-Imine Intermediate 
 
The first reduction of imines was successful with the standard trichlorosilane-
tertiary amine mixture, but also without the addition of a tertiary amine (Scheme 2.38). 
Both methods afforded the corresponding amine and not expected hydrocarbon as did 
carbonyls. An NMR study suggested that the actual product of the reaction was 
trichlorosilylamine (c) which was hydrolysed easily on work-up to the free amine (d). 
Supposedly inactive trichlorosilane reduced the imine double bond with no amine catalyst, 
suggestinng that the imine nitrogen is sufficiently Lewis basic to form an adduct with 
trichlorosilane, where the silicon atom is penta- or hexacoordinate (Chapter 3.2.2), similar 
to the species formed with a tertiary amine. The hydride transfer could then occur in an 
intramolecular fashion to the highly electrophilic carbon atom85b in (b) (Scheme 2.38).      
 
BF3
R1
R2
N
R3 R1
R2
N
R3
BF3
R1
R2 N
R3
SiCl3
H2OHSiCl3
H
R1
N
R3
HR
2
H- BF3
(a) (b) (c) (d)
 
 
Scheme 2.39. Proposed Mechanism for BF3-catalysed Trichlorosilylation 
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The attraction of the simple reduction method was spoilt by the harsh conditions – 
reflux in acetonitrile. A modification with milder conditions was developed in 1991,90 the 
use of catalytic amounts of a strong Lewis acid as BF3 facilitated the reaction at room 
temperature (Scheme 2.39). Authors claimed that BF3 and HSiCl3 did not react with each 
other and therefore the imine (a) would preferentially form a complex with BF3 (b) which 
then could be hydrosilylated (c) and hydrolysed to the amine product (d). Another 
possibility was to use more potent reductant dichlorosilane, without BF3 catalysis.  
 
Ph OH Ph OH+
Ph OH
145 (87 %)
Ph NHPh
144 (98 %)
Ph O Ph O+ (98 : 2)
Ph OPh NPh
a. HSiCl3, CH2Cl2/DMF (4:1), 0 °C, 4h
b. HSiCl3, CH2Cl2/DMF (4:1), −20 °C, 4h
or or
a.
b.
142 143
146 39 147 148
 
 
Scheme 2.40. Examples of DMF-catalysed Trichlorosilylation 
  
Five years later, another method was developed by Kobayashi, where 
trichlorosilane was activated with DMF.91 This method was a real breakthrough – simple, 
reliable, high-yielding and chemoselective! Aldehydes were reduced at –20 °C, aldimines 
at 0 °C in 4 hours, and ketones at room temperature and with longer reaction times 
(Scheme 2.40). Moreover, conjugated multiple bonds were not reduced, the reduction was 
entirely 1,2-selective. A 29Si NMR study identified the hypervalent silicates.   
 
DMF is a Lewis base capable of coordinating trichlorosilane to produce penta- or 
hexacoordinate silicates (b) that are strong Lewis acids highly electrophilic towards the 
carbonyl. The hydrogen bonded to silicon gains hydride character and once the carbonyl 
compound is in proximity of the silicon (c), an intramolecular hydride transfer can occur to 
produce trichlorosilylalcohol (e) which affords alcohol (f) upon hydrolysis (Scheme 2.41).  
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Scheme 2.41. Proposed Mechanism of DMF-catalysed Trichlorosilylation 
 
 
 
2.4.2. Enantioselective Hydrosilylations of Imines  
 
The variability of the Lewis basic component opened the door for asymmetric 
applications by using chiral Lewis bases.  The first enantioselective reduction of imines 
with trichlorosilane was reported in 2001 by Matsumura.92 His protocol was based on the 
Lewis base activation of trichlorosilane. In the presence of the proline-derived formamides 
149a,b, ee’s up to 66 % and high imine chemoselectivity were achieved (Table 2.13, 
entries 1-3; Scheme 2.42).  
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Scheme 2.42. First Enantioselective Reduction of Imines with Trichlorosilane 
 
For the same model reaction with imine 33, the valine derived formamide catalyst 
152a exhibited better results, aryl imines were reduced with high enantioselectivity up to 
92 % ee.93 Imines derived from aliphatic amines afforded racemic (or close) products 
(Table 2.13, entries 5-8; Scheme 2.43).  
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Table 2.13. Model Reductions of Imines with Trichlorosilane 
 
Entry Imine Catalyst (mol 
%) 
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 33 149a / 10 CH2Cl2  ambient 91 / 55 (R) 
2 33 149b / 10 CH2Cl2   ambient 52 / 66 (R) 
3 18 149a / 10 CH2Cl2 ambient 97 / 55 (R) 
4 31 152a / 10 CH2Cl2  ambient 68 / 79 (S) 
5 31 152a / 10 CHCl3 ambient 79 / 86 (S) 
6 31 152a / 10 CHCl3 –20 49 / 92 (S) 
7 18 152a / 10 CHCl3 ambient 46 / 8 
8 150 152a / 10 CHCl3 ambient 50 / 5  
 
Interestingly, the same configuration on the amino acid scaffold afforded opposite 
configuration of the amine indicating different mechanism of enantiodifferentiation. 
Second generation analogue, catalyst 152b performed even better and it was used for 
screening of its activity towards electronically modified substrates 151 to 156 (Table 2.14, 
entries 1-5; Scheme 2.43).93  
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Scheme 2.43. Enantioselective Reduction of Imines with Trichlorosilane and Valine Catalyst 
 
Optimisation of the reaction conditions included variation of solvent (CH2Cl2, 
CHCl3, MeCN, toluene), temperature, catalyst loading, and reaction time. Their 
combination has led to several practical conclusions:  
 
-  toluene as solvent increased the enantioselectivity from 79 % (CH2Cl2) to 92 % ee,  
-  lower temperature increased the enantioselectivity (mainly in case of aliphatic 
imines by slowing down the background reaction significantly), but decreased 
yields and the optimum temperature was determined to be room temperature,  
-  the background reaction for aromatic imines is slow and low-yielding,  
-  the catalyst loading could be as low as 1 mol %, the convenient optimum was 
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determined to be 5 mol %,  
-  the reaction time for full conversion was up to 24 h,  
-  linear relationship between the enantiopurity of the catalyst and the product; no 
non-linear effects were observed.   
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Figure 2.3. Catalyst 152 and Imine Structure Effects 
 
From preliminary experiments it was clear that the imine must be derived from an 
aromatic amine (Figure 2.3, position I), ideally p-methoxyaniline which then can be 
oxidatively removed. The reduction proceeds with practical enantioselectivities only if it is 
derived from an aryl-alkyl ketone (positions J and K). The catalyst structure was also 
varied, virtually on every position (Figure 2.3, A to E):  
 
-  A = H, the formamide moiety is crucial for the reactivity and enantioselectivity – 
the carbonyl group must be sufficiently Lewis basic and small,  
-  B = Me, the N-methyl group is important for enantioselectivity but not reactivity,  
-  C = i-Pr, the particular amino acid used determines not only the enantioselectivity 
of the reduction, but also the absolute configuration of the product, the continuum 
of enantioselectivity from highly enriched (S)-configured amine with valine-
derived catalyst through phenylglycine-derived catalyst affording racemic product 
to moderately (R)-enantioenriched amine obtained with alanine-derived catalyst: 
  
(S)-product ee ← i-Pr ~ Cy > t-Bu > Bn > i-Bu > Ph (racemic) < Me → (R)-product ee 
 
-  D = H, E = aryl, it is desirable that the catalyst is a secondary anilide derivative; a 
tertiary anilide or an aliphatic amide are unreactive,  
-  R group, the enantioselectivity of the reduction increases as: H < Me < i-Pr < t-Bu.  
 
The first organocatalyst catalysing reduction of imines and ketones was a pyridyl-
oxazoline 157 from the same group.94 It showed appreciable results for reduction of imines 
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(Table 2.14, entries 6 and 7; Scheme 2.44), up to 87 % ee, though it performed better in 
reduction of aromatic ketones. From mechanistic views, trichlorosilane coordinates both 
heterocyclic nitrogens and the reaction exhibits long-ranging chiral induction.  
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Scheme 2.44. Enantioselective Reduction of Imines with Trichlorosilane and Non-formamides 
 
Another non-formamide catalyst was a picolinic acid derivative 160 where the 
silicon atom is coordinated to the picolinyl nitrogen and carbonyl group,95 and the 
transition state might be additionally stabilised by the alcohol group. The highest 
enantioselectivity achieved with this catalyst was 80 % ee for imine 18 (Table 2.14, entries 
8 and 9; Scheme 2.44).  
 
Table 2.14. Other Organocatalyst for Reduction of Imines with Trichlorosilane 
 
Entry Imine Catalyst (mol 
%) 
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 33 152b / 10 CHCl3  ambient 70 / 89 (S) 
2 33 152b / 10 toluene ambient 81 / 92 (S) 
3 151 152b / 10 toluene  ambient 85 / 91 (S) 
4 155 152b / 10 toluene  ambient 86 / 85 (S) 
5 156 152b / 10 toluene  ambient 86 / 89 (S) 
6 155 157 / 20 CHCl3  –20 51 / 87 (R) 
7 156 157 / 20 CHCl3 –20 65 / 87 (R) 
8 33 160 / 10 CH2Cl2 ambient 86 / 73 (S) 
9 18 160 / 10 CH2Cl2  ambient 67 / 80 (S) 
 
Sun’s group published several organocatalysts for reduction of imines with 
trichlorosilane in a period of two years. The earlier work was represented by formamides 
based on the idea of replacing the 5-membered proline heterocycle of Matsumura’s catalyst 
149 with its six-membered analogue96 (pipecolinic acid) 161 and further modification to 
piperazin-2-carboxylic acid97 162 (Figure 2.4).  
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Figure 2.4. Most Successful Sun’s Organocatalysts for Reduction of Imines with Trichlorosilane 
 
Catalysts derived from pipecolinic acid, i.e. 161a and 161b exhibited good catalytic 
properties and high enantioselectivities for most of the aryl-methyl imines (up to 95 % ee; 
Table 2.15, entries 1 and 2; Scheme 2.45) and good enantioselectivity was reached also in 
the case of alkyl-methyl imines (up to 86 % ee). However, longer alkyl chain was not 
tolerated (Table 2.15, entry 3; Scheme 2.45). Both these catalysts showed similar reactivity 
in reduction of imines, the latter one 161b however, performed much better in reduction of 
ketones, when enantioselectivity of 161a dropped to ~75 % ee. Another structural feature 
important for reduction of ketones (but not imines) was the configuration at carbon C-2’. 
Removal of this stereogenic centre or reversing its absolute configuration [(S) → (R)] has 
led to a drop of enantioselectiviy (for ketones only) to ~70-80 % ee. This fact pointed to a 
possibility of different transition states for reduction of ketones and imines. On the other 
hand, (S)-configuration at C-1’ was distinctively preferred. The change of C-2’-acetoxy for 
C-2’-methoxy group increased the catalyst reactivity (cooling to –20 °C needed) and 
toluene was determined as an optimal solvent (instead of typical CH2Cl2, Table 2.15, 
entries 4 and 5).  
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Scheme 2.45. Enantioselective Reduction of Imines with Trichlorosilane and Formamides 
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The second generation of formamide catalysts 162a and 162b, derived from 
piperazine-2-carboxylic acid performed better with aryl-alkyl imines (typically 92 %, up to 
97 % ee; Table 2.15, entry 8; Scheme 2.45), while maintaining the selectivity for classical 
aryl-methyl and alkyl-methyl imines (Table 2.15, entries 6 and 7; Scheme 2.45). Imines 
with a substituted N-phenyl group were reduced only in moderate ee’s, though. 
Interestingly, variation at position N-4 from sulfonamide to carboxamide influenced the 
enantioselectivity only marginally, but improved its reactivity (reaction carried out at 0 °C 
instead of at –20 °C; Table 2.15, entry 9). It seemed plausible that group X (SO2 or CO in 
structure 162) provided the right steric shielding.  
 
Table 2.15. Other Organocatalyst for Reduction of Imines with Trichlorosilane 
 
Entry Imine Catalyst (mol 
%) 
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 33 161a / 10 CH2Cl2 0 97 / 95 (R) 
2 150 161a / 10 CH2Cl2  0 81 / 95 (R) 
3 166 161a / 10 CH2Cl2 0 n.a. / 29 (R) 
4 33 161b / 10 toluene –20 94 / 93 (R) 
5 150 161b / 10 toluene –20 93 / 92 (R) 
6 33 162a / 10 CH2Cl2  –20 95 / 89 (R) 
7 150 162a / 10 CH2Cl2  –20 86 / 82 (R) 
8 166 162a / 10 CH2Cl2 –20 84 / 89 (R) 
9 33 162b / 10 CH2Cl2 0 87 / 87 (R) 
 
A different class of sulfinamide catalysts was also developed by Sun. The 
preliminary success of commercial (R)-tert-butylsulfinamide 168 which exhibited catalytic 
activity with 21 % ee, has brought catalyst 163.98 An important feature of this catalyst was 
the phenolic group, whose position influenced the reactivity rather than the 
enantioselectivity. An additional electron-withdrawing group caused significant increase of 
enantioslectivity, indicating its role as a Brønsted acid and not a coordination site for 
trichlorosilane. Together with non-linear effects, it seemed probable that this phenolic 
hydroxyl facilitated assembly of two molecules of 163, chelating trichlorosilane with their 
sulfinamide groups. New, improved catalyst 164 resulted from attempts to incorporate 
chemically the two sulfinamide groups in one molecule, linked together with an 
appropriate spacer.99 The catalyst 164 exhibited linear dependence of product’s ee on 
catalyst’s enantiopurity and loading of 10 mol % ensured enantioenriched amines with the 
same levels as 20 mol % of 163 (Table 2.16, entries 2-7; Scheme 2.46), enantioselectivities 
up to 96 % ee for aromatic and 78 % ee for aliphatic imines. The authors also described 
beneficial effect of 0.3 equiv of 2,6-lutidine on enantioselectivity (Table 2.16, entry 8).   
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Scheme 2.46. Enantioselective Reduction of Imines with Trichlorosilane and Sulfinamides 
 
Table 2.16. Other Organocatalyst for Reduction of Imines with Trichlorosilane 
 
Entry Imine Ligand (mol %) /  
Additive (mol %) 
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 33 168 / 20 / - CH2Cl2 0 60 / 21 (S) 
2 33 163 / 20 / - CH2Cl2 –20 92 / 92 (S) 
3 150 163 / 20 / - CH2Cl2  –20 78 / 74 (S) 
4 166 163 / 20 / - CH2Cl2 –20 94 / 93 (S) 
5 33 164 / 10 / 2,6-lutidine / 30 CH2Cl2 –20 91 / 96 (S) 
6 150 164 / 10 / 2,6-lutidine / 30 CH2Cl2 –20 84 / 75 (S) 
7 166 164 / 10 / 2,6-lutidine / 30 CH2Cl2 –20 89 / 91 (S) 
8 33 164 / 10 / - CH2Cl2 –20 93 / 91 (S) 
9 18 165 / 10 / - toluene 0 98 / 96 (R) 
10 169 165 / 10 / - toluene 0 82 / 92 (R) 
11 170 165 / 10 / - toluene 0 67 / 66 (R) 
12 173 165 / 10 / - toluene 0 80 / 99.6 (R) 
 
Revisiting the existing catalysts for reduction of imines with trichlorosilane offered 
the idea of combining structural features of formamides (an amino acid as a source of 
chirality) and an extra chelating sulfinamide group, such a hybrid catalyst proved very 
efficient.100 Catalyst 165 exhibited deviation from the other catalysts, e.g. typical solvent 
CH2Cl2 and chloroform caused dramatic drop of enantioslelctivity (down to ~20-30 % ee), 
and interestingly, CCl4 was an excellent solvent alongside with toluene. The yields were 
comparable in both solvents and the enantioslectivity was complementary (Scheme 2.47). 
First virtually enantiopure amine (99.6 % ee) was prepared by this method (Table 2.16, 
entry 12; Scheme 2.47) and various unusual N-aryl and N-alkyl 169, 170 and 173 imines 
were reduced with very high levels of enantioselectivity (typically 96 % ee; Table 2.16, 
entries 9-11; Scheme 2.47).  
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Scheme 2.47. Enantioselective Reduction of Imines with Trichlorosilane and Sulfinamide 
 
After a thorough analysis of structural features of the valine-derived catalyst 152, it 
was recognised that introducing more bulky R groups (i-Pr or t-Bu) into the 3,5-positions 
of the anilide moiety (Figure 2.5) may cause further increase of the enantioselectivity in 
comparison to its unsubstituted 152a or methyl-substituted 152b predecessors (Figure 2.3).  
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Figure 2.5. Variations on Valine-derived Catalyst 152 
 
This assumption was proved correct by synthesising catalysts 152c and 152d.101 
With the increasing bulk of the 3,5-substituents, the enantioselectivity of reduction of 
model imine 151 was enhanced up to 94 % ee (Table 2.17, entry 1; Scheme 2.48; compare 
to Table 2.14, entry 3; from 91 % ee with 10 mol% of catalyst 152b in toluene). This 
beneficial role of the bulk at the anilide moiety was even more obvious for aliphatic and 
conjugated imines as 50, 178 and 179 (1,2-reduction) which were reduced to the 
corresponding amines with 85, 62 and 81 % ee, respectively (Table 2.17, entries 5-7; 
Scheme 2.48). Furthermore, the catalytic activity was improved and the loading of 152d 
could be decreased to 1 mol % while maintaining the same level of enantioselectivity 
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(Table 2.17, entries 1-4; Scheme 2.48). For convenience, though, 5 mol % of catalyst 152d 
was recognised as an optimal loading, for the reaction carried out in toluene at ambient 
temperature for 18 hours.  
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                             (S)-180 (62 % ee)
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Scheme 2.48. Enantioselective Reduction of Imines with Sigamide 
 
Investigation of the valine-derived catalyst 152 was extended also on the practical 
points of the methodology. The purification procedure was simplified by attaching a 
perfluoroalkoxy chain or polymer support to the N-arylamide (Figure 2.5). From previous 
results, it was clear that 4-methoxy anilide derivative was well tolerated and therefore there 
would be a possibility of derivatisation at this site.  
 
Table 2.17. Reductions with Modified Valine-derived Catalysts  
 
Entry Imine Ligand  
(mol %)  
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 151 152c / 10  toluene ambient 99 / 94 (S) 
2 151 152c / 5  toluene ambient 95 / 93 (S) 
3 151 152d / 5  toluene ambient 95 / 94 (S) 
4 151 152d / 1 toluene ambient 92 / 93 (S) 
5 50 152d / 5  toluene ambient 86 / 85 (S) 
6 178 152d / 5  toluene ambient 83 / 62 (S) 
7 179 152d / 5  toluene ambient 94 / 81 (S) 
 
Catalyst with an attached perfluoroalkoxy chain 175a exhibited high 
enantioselectivity101 (89 % ee; Table 2.18, entries 1 and 2; Scheme 2.49) as well as its n-
octyl congener 175b which proved no interference with the fluorous tag. The advantage 
was simple purification by filtration through a pad of fluorous silica gel, the amine eluted 
with a methanol – water mixture and the catalyst was released with pure methanol 
afterwards. Recycling the catalyst up to five times caused ~5 % loss of enantioselectivity, 
mainly because the catalyst recovery was not quantitative and the loading successively 
decreased.  
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Scheme 2.49. Enantioselective Reduction of Imines with Recoverable Catalysts 
 
The polymer supported series of catalysts 176 exhibited approximately 10 % ee 
lower enantioselectivity than their monomer-catalysed version.102 This was attributed to 
the heterogenous character of the reaction and the background reducing activity of the 
polymer support. Another major difference was that toluene proved unsuitable for the 
polymeric catalysts as the background (polymer-catalysed) reaction was even faster. 
Typically, the first run afforded amines with 5 % lower ee’s (73-76 % ee; Table 2.18, 
entries 3-5; Scheme 2.49) than the 2nd to 6th run (77-82 % ee, respectively; Scheme 2.49). 
It was hypothesised that formation of a small amount of gel by quenching of trichlorosilane 
during the first work-up would “condition” the polymer.  
 
Table 2.18. Reductions with Recoverable Valine-derived Catalysts  
 
Entry Imine Ligand  
(mol %)  
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 151 175a / 10  toluene ambient 98 / 89 (S) 
2 151 175b / 10  toluene ambient 98 / 90 (S) 
3 151 176a / 25  CHCl3 25 80 / 76 (S) 
4 151 176b / 15  CHCl3 25 87 / 77 (S) 
5 151 176c / 20  CHCl3 25 83 / 73 (S) 
6 151 177a / 20  toluene 20 90 / 84 (S) 
7 151 177b / 20  toluene 20 86 / 79 (S) 
 
The catalyst surface-immobilised on gold nanoparticles (Figure 2.5) was another 
option for constructing a homogenous recoverable catalyst.103 The standard ether linker 
was used in 177b; furthermore, lipoic ester linkage was tolerated well in 177a (Table 2.18, 
entries 6 and 7; Scheme 2.49). The coating level in the first case was approximately 10 % 
of the available sulfide functions, in the latter one around 5 %. The enantioselectivity was 
comparable with the polymer-supported catalyst (up to 84 % ee); however, the gold-coated 
catalyst failed to keep it after 3rd run, probably due to washing off the catalyst from the 
gold support or aggregation of the nanoparticles and change to heterogenous system.  
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Scheme 2.50. Enantioselective Reduction of α-Chloro Imines with Sigamide 
 
Besides the reduction of simple imines, α-chloro imines were reduced with 
Sigamide 152d and trichlorosilane104 (Method (A); Table 2.19, entry 1). This innovation 
offered shorter synthetic access to enantioenriched 1,2-disubstituted (terminal) aziridines 
than the known cyclisation of vicinal amino alcohols. Reactivity of α-chloro ketones with 
aliphatic amines, which would undergo substitution of the chlorine rather than to form the 
imine, was not an issue as the reduction protocol is effective only for less nucleophilic N-
aromatic imines. α-Chloro imines which were not isolable were generated in situ in the 
presence of an excess of the ketone (Method (B); Table 2.19, entries 2-4; Scheme 2.50), 
affording the chloro amines with up to 96 % ee (typically 89-93 % ee). Aziridine ring 
closure proceeded smoothly with t-BuOK in THF maintaining the enantiopurity.  
 
Table 2.19. Novel Application of Sigamide in Reductions with Trichlorosilane 
 
Entry Imine Ligand (mol %) / 
Additive (equiv.)  
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 182 (A) 152d / 5 / -  toluene ambient 98 / 96 (R) 
2 182 (B) 152d / 5 / -  toluene ambient 94 / 89 (R) 
3 183 (B) 152d / 5 / -  toluene ambient 86 / 91 (R) 
4 184 (B) 152d / 5 / -  toluene ambient 88 / 84 (R) 
5 191 152d / 5 / AcOH / 1 toluene ambient 98 / 89 (2S,3S) 
6 192 152d / 5 / AcOH / 1 toluene ambient 75 / 87 (2S,3S) 
7 193 152d / 10 / AcOH / 1 toluene ambient 84 / 76 (2S,3S) 
8 194 152d / 10 / AcOH / 1 toluene ambient 46 / 83 (2S,3S) 
9 195 152d / 10 / AcOH / 1 toluene ambient 84 / 76 (2S,3S) 
 
In the case of enamine esters or enamine nitriles,105 a clear drop of reactivity was 
observed. It is likely that equilibration between (E)- and (Z)-forms (promoted by the 
presence of an acid) proceeds through the imine form which is the actual substrate for 
reduction (also see Chapter 2.1.2); however, acid catalyses also the non-selective 
background reduction.  
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Scheme 2.51. Enantioselective Reduction of Enamines with Sigamide 
 
An optimal compromise between the enantioselectivity and the reactivity was 
found to be with 1 equivalent of acetic acid and reaction time 48 hours. The desired β-
amino esters were obtained in 87-89 % ee (Table 2.19, entries 5 and 6; Scheme 2.51). The 
α-substituted β-amino esters were obtained in high diastereoselectivity (>95:5) and good 
enantioslelctivity (typically 76 % ee; Table 2.19, entries 7 and 9; Scheme 2.51). The 
corresponding nitriles exhibited lower reactivity, but slightly higher ee’s (entry 8). 
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Figure 2.6. Novel Catalysts for Enantioselective Reduction of Imines with Trichlorosilane 
 
Two main research groups (Sun and Kočovský/Malkov) have demonstrated 
sufficiently the utility of the reduction of imines with a system of an organocatalyst and 
trichlorosilane. Another Chinese group (Zheng) prepared a series of new catalysts 201, 
based on those previously published by Matsumura and Sun (Figure 2.6).  
 
Table 2.20. Novel Catalysts for Reductions with Trichlorosilane 
 
Entry Imine Ligand (mol %)  Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 18 201a / 20  CHCl3 –10 85 / 80 (R) 
2 33 201a / 20  CHCl3 –10 88 / 92 (R) 
3 204 201a / 20  CHCl3 –10 70 / 67 (R) 
4 206 201a / 20  CHCl3 –10 85 / 95 (R) 
5 208 201b / 10  CHCl3 –30 82 / 95 (S) 
6 209 201b / 10  CHCl3 –30 96 / 95 (S) 
7 212 203 / 10  CH2Cl2 ambient 68 / 74 (R) 
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Screening of several diastereoisomers of the catalyst derived from picolinic acid 
and 1,2-disubstituted aminoethanol has lead to structure 201a which exhibited the desired 
levels of reactivity and enantioselectivity.106 Catalyst 201a performed well with a variety 
of N-benzyl (80 % ee; Table 2.20, entry 1; Scheme 2.52) and N-aryl imines (Table 2.20, 
entries 2-4; Scheme 2.52). Aryl-methyl imines were reduced with up to 92 % ee, tetralone-
derived imine with excellent 95 % ee and aliphatic imines with up to 67 % ee. However, 
the required catalyst loading was 20 mol %.  
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Scheme 2.52. Enantioselective Reduction of Imines with Trichlorosilane and Novel Catalysts 
 
Catalyst 201a gave unsatisfactory results for enantioselective reduction of 
enamines, whereas the opposite was true for catalyst 201b.107 A series of enamino esters as 
208 and 209 derived from aromatic β-keto esters and aromatic amines afforded β-amino 
esters with 92-96 % ee (Table 2.20, entries 5 and 6; Scheme 2.53).  
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Scheme 2.53. Enantioselective Reduction of Enamino Substrates with Trichlorosilane 
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Reductive cyclisation of N-acylated β-amino enones108 to 4H-1,3-oxazines was an 
elegant method utilising trichlorosilane and a phosphineoxides as catalysts. The best result 
was obtained with (S)-BINAPO 203, the desired product 213 was formed in moderate 
enantioselectivity (74 % ee; Table 2.20, entry 7; Scheme 2.53) and the acyclic by-product 
was found to be in low enantioselectivity.  
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Figure 2.7. More Novel Catalysts for Enantioselective Reduction of Imines with Trichlorosilane 
 
Several other modifications of the already existing catalysts have been published 
recently (Figure 2.7). Among these is formamide 215 containing an additional stereogenic 
centre in the amide part, designed for allylation of imines and along that, it was tested also 
for reduction with trichlorosilane.109 However, the best results were achieved with addition 
of HMPA and even then the enantioselectivity was only up to 74 % ee (Table 2.21, entries 
1 and 2; Scheme 2.54). Better results were obtained with picolinamide catalysts 216a,b, 
carrying a chiral cyclic diamine or binaphtyl moiety; particularly when considering the 
simplicity of their preparation (in 1 or 2 steps).110 They exhibited very high reactivity and 
good enantioselectivity up to 83 % ee (Table 2.21, entries 3 and 4; Scheme 2.54).  
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Scheme 2.54. Enantioselective Reduction of Imines with Trichlorosilane and Novel Catalysts 
 
The latter of the above-shown novel catalysts, catalyst 217 used imidazole moiety 
instead of the previously used pyridines (imidazole version of Mastsumura’s catalyst.111 Its 
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extraordinary catalytic activity enabled loading only 1 mol % (!) and yet, keeping the 
enantioselectivity at high level for aryl-alkyl N-aryl imines affording corresponding amines 
in 83-87 % ee (Table 2.21, entries 5-7; Scheme 2.54).  
 
Table 2.21. Novel Catalysts for Reductions with Trichlorosilane 
 
Entry Imine Ligand (mol %) /  
Additive (mol %)  
Solvent  Temp.  
(°C) 
Yield (%) /  
ee (%)  
1 33 215 / 30 / - CH2Cl2 ambient 52 / 67 (S) 
2 33 215 / 30 / HMPA / 30 CH2Cl2 ambient 64 / 74 (S) 
3 33 216a / 10 / - CH2Cl2 25 99 / 69 (S) 
4 33 216b / 10 / - CH2Cl2 0 98 / 83 (S) 
5 33 217 / 1 / - CH2Cl2 0 82 / 85 (S) 
6 151 217 / 1 / - CH2Cl2 0 96 / 87 (S) 
7 108 217 / 1 / - CH2Cl2 0 95 / 83 (S) 
8 33 202 / 10 / - CH2Cl2 0 85 / 63 (R) 
 
A series of secondary amides of N-formyl proline were synthesised for the 
mechanism-structural studies,112 adamantylamide 202 used for the most of the 
experiments. The enantioselectivity was comparable with the Matsumura’s catalyst 149, 63 
% ee (Table 2.21, entry 8; Scheme 2.54).  
 
 
2.4.3. Mechanistic Considerations of the Reduction with Trichlorosilane 
 
The mechanistic study112 provides calculations for the mode of coordination of 
trichlorosilane to the catalyst’s formamide moiety and the transition state upon interaction 
with the imine (Scheme 2.55). It is known that formamides are present in the solution as 
two isomers, the trans (a) being the major one, possibly thanks to hyperconjugation of the 
non-bonding electrons and intra-molecular hydrogen bonding. The cis-isomer (b) is, 
however, the more reactive species and can coordinate trichlorosilane while its 
conformation changes, too (c). Interestingly, a strong interaction between the formamide 
carbon and a chloride ligand is predicted (d) and that is how the authors reason the 
importance of the formamide group. Then the imine substrate (e) approaches the complex 
and interacts with the catalyst’s secondary amide hydrogen while hydride is transferred (f). 
These calculations have a drawback – they do not include the effect of Brønsted acid 
present in the solution and the model catalyst is a primary amide.  
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Scheme 2.55. Model Transition State with a Representative Proline Catalyst 
 
 
 
 
2.5. Transfer Hydrogenation with Hantzsch Dihydropyridines  
 
2.5.1. Hantzsch and Other Dihydropyridines (DHP)  
 
The term Hantzsch pyridine and dihydropyridine are reserved for 3,5-
bis(ethylcarboxy)-2,6-dimethyl-pyridine 222 and its 1,4(2H)-dihydro-analogue 221, 
respectively, first synthesised by A. Hantzsch in late nineteenth century113 (Scheme 2.56).  
He also demonstrated the ease of oxidation of dihydropyridines to their pyridine analogues. 
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Scheme 2.56. Hantzsch Synthesis of Pyridines 
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Later on, the concurrent reduction process became a spot of interest, particularly as 
a reduction method for organic substrates. The early experiments on reduction with 
dihydropyridines were inspired by the biochemical co-factor NADH and proved that its 
synthetic analogues showed similar activity. This character of 1,4-dihydropyridines was 
studied systematically by Westheimer in mid-twentieth century,114 the first model substrate 
was malachite green dye 223 reduced to its leuco base 226 with N-benzyl-1,4-
dihydronicotinamide 224 (Scheme 2.57).  
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Scheme 2.57. Early Experiments on Reductions with Dihydropyridines 
 
A series of experiments with different substrates and deuterium labelling showed 
that only the 1,4- and not the 1,2- or 1,6-dihydropyridines carried useful reduction 
potential. The kinetic studies with 4-deuterio-1-hydropyridines have suggested a hydride 
ion transfer mechanism because of:  
 
-  the presence of common radical traps did not affect the reduction,  
-  the reaction proceeded faster in polar solvents,  
-  high kinetic isotopic effect (kH/kD ~ 4-5).  
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Scheme 2.58. Two Proposed Mechanisms for Hydride Transfer from DHP 
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However, the order of the kinetic isotopic effect would point to the reaction 
pathway through discrete intermediates.115a Later, it was shown that the existence of 
radical intermediates from productive and/or unproductive side reactions could explain this 
discrepancy. Furthermore, it would be difficult to distinguish kinetically an electron-
transfer driven process from a synchronous hydride transfer (Scheme 2.58).  
 
Nucleophilic reactivity 
of a hydride donor 
(order of magnitude)3 5 7 9 11 13 151
HSiPh3 HSiEt3
221
224
H3B.NEt3
NaBH3CN
NaBH4
 
 
Figure 2.8. Reactivity of Common Reductants 
 
The reactivity of different dihydropyridines and borohydride anions towards 
benzhydrilium ions such as 223 was studied only recently.116 It was found that Hantzsch 
ester 221 was around three times more reactive than dihydronicotinamide 224 (used in 
reduction of malachite green). The reaction was fast in acetonitrile (in agreement with 
previous observations of reactivity in polar solvents) and addition of water had beneficial 
effect on the reaction rate. An interesting conclusion of the study was the order of 
reactivity of some common reductants (Figure 2.8). It was shown that dihydropyridines are 
much more potent hydride donors than silanes, but less potent than borohydrides.  
 
 
2.5.2. Enantioselective Reductions with Hantzsch Dihydropyridines  
 
An elegant utilisation of Hantzsch dihydropyridine 221 in asymmetric synthesis 
was published in 1989 by Singh and Batra.117 It was quite a unique concept at that time 
studying enantioselective reduction of imines in the presence of an amino acid as the chiral 
inducer (Table 2.22, entry 1; Scheme 2.59).  
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Scheme 2.59. First Enantioselective Reduction of Imines with DHP 
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It was only fifteen years later, an extensive research on enantioselective reduction 
of imines was triggered by a publication of Rueping, who demonstrated that aromatic 
imines or quinolines were reduced easily an cleanly to afford the corresponding amines 
with DHP in the presence of various Brønsted acid catalysts118 (10 mol % of CSA, HCl, 
TFA, HBF4 or DPP).  
 
Table 2.22. Reductions of Imines with DHP 221 and BINOL Catalysts  
 
Entry Imine Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 33 229 / n.a. reflux 55 / 62 (S) 
2 33 (R)-230a / 20 60 71 / 72 (R) 
3 151 (R)-230a / 20 60 76 / 74 (R) 
4 231 (R)-230a / 20 60 82 / 84 (R) 
5 151 (S)-230b / 1 35 96 / 88 (S) 
6 178 (S)-230b / 1 35 95 / 85 (S) 
7 231 (S)-2301b / 1 35 80 / 90 (S) 
8 Ketone 39 (R)-230c / 10 45 87 / 94 (R) 
9 Ketone 233 (R)-230c / 10 45 49 / 86 (R) 
10 Ketone 234 (R)-230c / 10 45 60 / 83 (R) 
11 Ketone 235 (R)-230c / 10 45 71 / 83 (R) 
12 237 (R)-230c / 10 40 82 / 97 (R) 
 
The catalysis by diphenyl phosphate (DPP) was shown to be the most successful 
regarding yields and the reaction rate; moreover, it could be easily modified to a chiral 
version which was published later.119 Several BINOL-derived phosphates were tested and 
the best results were obtained with catalyst 230a affording the aromatic amines such as 33, 
151 or 231 in good yields and enantioselectivity (typically 72-84 % ee; Table 2.22, entries 
2-4; Scheme 2.60); however, relatively high catalyst loading was required (20 mol %). 
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Figure 2.9. BINOL-derived Catalysts for Enantioselective Reduction with DHP 
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The method represented a novel example of BINOL utility, followed by 
improvements in the catalyst structure (Figure 2.9). In the course of two following years, 
the family of BINOL-derived ortho sterically congested phosphoric acid catalysts 
expanded to having five successful members – the first one substituted with 3,5-
bis(trifluoromethyl)phenyl 230a, 2,4,6-tris(iso-propyl)phenyl 230b, triphenylsilyl 230c, 
and two derivatives containing bulkier aromatics as 9-phenanthryl 230d or 9-anthryl 230e 
analogues.  
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NHR
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151: R = PMP
(R)-35 (72 % ee)
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benzene
NPMP
F
NHPMP
F
231 (R)-232 (84 % ee)
230a (20 %)
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Scheme 2.60. Enantioselective Reduction of Imines with DHP and Catalyst 230a 
 
Very shortly after the Rueping’s report, List published an improved procedure120 
and catalyst with bulkier aryl substituent on the BINOL-core, catalyst 230b (Table 2.22, 
entries 5-7, Scheme 2.61). His method provided better yields (however, with reaction times 
three times longer) and also better ee’s (up to 92 %) with much lower catalyst loading (1 
mol %).  
 
R
NPMP
R
NHPMP
151: R = Ph
178: R = i-Pr
(S)-154 (88 % ee)
(S)-180 (90 % ee)
230b (1 %)
221 (1.4 eq)
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NHPMP
F
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Scheme 2.61. Enantioselective Reduction of Imines with DHP and Catalyst 230b 
 
MacMillan’s protocol for reductive amination121 introduced even bulkier catalyst 
230c, affording the aromatic and aliphatic amines in good yields and enantioselectivity up 
to 95 % ee, typically ~85 % ee (Table 2.22, entries 8-10; Scheme 2.62). The more 
interesting outcome of this protocol was the high selectivity for reductive amination of 
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methylketones over other homologues, e.g. methyl-ethyl ketone 235 was reductively 
aminated to produce (R)-amine 236 (Table 2.22, entry 11; Scheme 2.62). The cyclic imine 
237 was reduced with high enantioselectivity (Table 2.22, entry 12) affording a useful 
alanine precursor. 
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Scheme 2.62. Enantioselective Reductive Amination of Ketones with DHP and Catalyst 230c. 
 
Catalyst 230b was also successful in the reductive amination of aldehydes,122  e.g. 
239-241, via dynamic kinetic resolution (DKR; Table 2.23, entries 1-3; Scheme 2.63). The 
fact of easy racemisation of α-branched carbonyl compounds has rendered them suitable 
for DKR and the corresponding amines were obtained in excellent ee’s up to 98 %.  
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Scheme 2.63. Enantioselective Reductive Amination of a-Branched Aldehydes. 
 
The latter reaction required efficient removal of water to attain the optimal 
enantioselectivity and oxygen-free conditions to prevent the cleavage of the enamine 
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intermediate (b) to ketone and N-formyl-p-anisidine. The optimisation of reaction 
conditions also included the use of a different DHP; the mixed methyl-tert-butyl ester 242 
provided a good compromise between reactivity and enantioseletivity. 
 
Table 2.23. Reductive Amination and Reduction of heterocycles with DHP  
 
Entry Imine Reducing 
DHP  
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 239 242 (R)-230b / 5 6 87 / 96 (R) 
2 240 242 (R)-230b / 5 6 92 / 98 (R) 
3 241 242 (R)-230b / 5 6 77 / 80 (R) 
4 246 221 (R)-230d / 2 60 92 / 97 (S) 
5 247 221 (R)-230d / 2 60 93 / >99 (S) 
6 248 221 (R)-230d / 1 60 91 / 88 (S) 
7 252 221 (R)-230d / 2 60 54 / 83 (R) 
8 253 221 (R)-230d / 5 60 43 / 99 (R,R) and 
 
 
 
 
 29 / n.a. (R,S) 
 
Rueping has adopted the strategy of employing his methodology on wide selection 
of substrates formally containing C=N bond,123 such as quinolines, benzoxazin(on)es or 
activated pyridines. The best enantioselectivities were obtained with catalysts 230d,e 
containing bulky aromatics.   
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Scheme 2.64. Enantioselective Reduction of Quinolines with DHP 
 
The quinoline substrates123a were easily reduced to tetrahydroquinolines by a 
cascade hydrogenation (Table 2.23, entries 4-6; Scheme 2.64). Even if only 1.2 equivalents 
of DHP were used, no 1,4- or 3,4-dihydroquinoline was formed. Thus, it was suggested 
that 1,4-hydride addition (as rate determining step) was followed by acid-catalysed 
isomerisation to 3,4-dihydroquinolinium and second hydride addition in a 1,2-fashion. 
Excellent yields and enantioselectivities (typically 97-99 % ee), and tolerance of functional 
groups (e.g. substrate 248; Table 2.23, entry 6) was shown. The tetrahydriquinoline motive 
is found in numerous alkaloids and enantioselective syntheses (90-91 % ee) of three such 
examples (Cuspareine, Galipinine, Angustureine) were provided.   
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Scheme 2.65. Enantioselective Reduction of Phenanthrolines with DHP 
 
In addition to reduction of quinolines, 2-substituted or 2,9-disubstituted 
phenanthrolines were reduced,124 as well, by another group (Table 2.23, entries 7 and 8; 
Scheme 2.65). The enantioselectivity and yields were lower, though. Disubstituted 
substrates produced along the expected (R,R)-octahydrophenanthroline also (R,S)-meso, 
which was probably formed from the minor (S)-tetrahydrophenanthroline after partial 
reduction of one ring and thus helped to increase the enantiopurity of the (R,R)-isomer.  
 
N
X
Ar
256: Ar = Ph, X = O
257: Ar = 4-Br-Ph, X = O
258: Ar = 4-Br-Ph, X = S
N
H
X
Ar
(S)-259 (98 % ee)
(S)-260 (>99 % ee)
(S)-261 (>99 % ee)
230d (0.1-1 %)
221 (1.25 eq)
CHCl3
HN
XR
 
 
Scheme 2.66. Enantioselective Reduction of Benzoxazines and Benzthiazines  with DHP 
 
Another remarkable employment of the method was in reduction of benzoxazines 
and benzthiazines123b (Table 2.24, entries 1-3, Scheme 2.66) or benzoxazinones123b (vide 
infra). Unlike the previous quinoline reduction, chloroform was found to be the optimal 
solvent for benzoxazines, e.g 256 and 257. Unusually low catalyst loading, only 0.1 mol % 
(!) was sufficient to drive the reaction to completion at room temperature overnight, 
maintaining the high yields and enatioselectivities (93-99 % ee). The sulfur analogues, 
such as 258, were reduced at the same level of enantioselectivity but with 1 mol % catalyst 
loading (Table 2.24, entry 3).  
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Table 2.24. Reductions of Heterocycles with DHP 221 and BINOL Catalysts.  
 
Entry Imine Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 256 (R)-230d / 0.1 ambient 95 / 98 (S) 
2 257 (R)-230d / 0.1 ambient 93 / >99 (S) 
3 258 (R)-230d / 1 ambient 87 / >99 (S) 
4 262 (R)-230d / 1 ambient 85 / 98 (S) 
5 263 (R)-230d / 1 ambient 92 / >99 (S) 
6 268 (R)-230d / 5 60 n.a. / 82 (R) 
7 268 (R)-230e / 5 60 66 / 92 (R) 
8 269 (R)-230e / 5 50 72 / 91 (R) 
9 270 (R)-230e / 5 50 47 / 86 (R) 
10 271 (R)-230e / 5 50 73 / 90 (R) 
 
The reduction of 3-aryl benzoxazinones like 262 and 263 (Table 2.24, entries 4 and 
5; Scheme 2.67) was investigated in order to open the dihydrobenzoxazinones with a 
primary amine (in the presence of 2-pyridone to prevent the racemisation) to afford the 
arylglycine amides 266 and 267 retaining its enantiopurity in around 90 % yield over two 
steps (Scheme 2.67).  
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Scheme 2.67. Enantioselective Reduction of Benzoxazinones with DHP 
 
Another important nitrogen-containing heterocycle that was reduced successfully 
by the Rueping method was substituted pyridine.123c For the reaction to work in terms of 
rate and enantioselectivity, position-3 of the substrate must be a carbonyl or equivalent. A 
series of trisubstituted pyridines 268 to 271 was investigated (Table 2.24, entries 6-10;) 
and their reduction was found to proceed in moderate yields and good enantioselectivities 
(86-92 % ee). The reaction conditions were similar to those employed for the reduction of 
quinolines; however, better enantiomeric excess of the reduced species was obtained with 
catalyst 230e (Table 2.24, entry 6 vs. 7; Scheme 2.68). The diethyl DHP ester 221 was 
found to be the optimal reductant. Tetrahydropyridine or piperidine is also an abundant 
moiety in alkaloids.  
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Scheme 2.68. Enantioselective Reduction of Pyridines with DHP 
 
Acyclic α-imino esters proved suitable substrates125 for reduction with DHP (Table 
2.25, entries 1-3; Scheme 2.69). The screening of several BINOL and other biaryls showed 
that 4,4’-dihydroxy-3,3’-biphenanthrene (VAPOL 279, compare to 230e, Table 2.25, entry 
1 vs. 2) was the most successful catalyst yielding the α-aryl (or alkyl) α-amino esters in 
high ee’s (95-99 %). The arylglycinates, e.g. 280, were of (R)-configuration, while 
alaninate 281 was obtained as (S)-isomer. Reductive amination version provided the amino 
acids in lower yields (10-20 %) but maintained the enantioselectivity.  
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Scheme 2.69. Enantioselective Reduction of α-Imino Esters with DHP. 
 
Another group investigated the same substrates with catalyst 230e126  (Table 2.25, 
entries 4 and 5; Scheme 2.69) and found that substrates with bulky ester groups (t-Bu, i-Pr) 
were reduced with higher enantioselectivity (up to 97 % ee); in particular, methyl ester was 
obtained in only 33 % ee. The ester group on DHP did not affect the enantioselectivity 
much; however, it did influence the reaction rate and 221 was found to be the optimum. 
The reaction was carried out in ether, unlike the previous ones.  
 
    79
NPMP
COOt-Bu
Ph
a. to d.
a. 230c (5 %), 221 (2.2 eq), ether        (R)-284 (85 % ee)
b. 230e (5 %), 221 (2.2 eq), ether        (S)-284 (90 % ee)
c. 230e (1 %), 221 (2.2 eq), toluene        (S)-284 (92 % ee)
d. 230e (1 %), 242 (2.2 eq), toluene        (S)-284 (86 % ee)
NHPMP
COOt-Bu
283
Ph
284
 
 
Scheme 2.70. Enantioselective Reduction of β,γ-Alkynyl-α-imino Esters with DHP. 
 
Reduction of α-imino esters as 283 containing β,γ-triple bond gave rise to (E)-
alkenyl-α-amino esters127 (Table 2.25, entries 6 and 7; Scheme 2.70). The influence of the 
ester group of the reductant (Scheme 2.70) and the substrate was screened. The bulkier 
esters in substrate (t-Bu vs. Et) improved the conversion but influenced the 
enantioselectivity only marginally; similar effects were observed with the change in the 
reductant’s ester group (Table 2.25, entry 8). The (E)-alkenyl-α-amino esters were not 
reduced further under these conditions and it was proposed that the triple bond was 
reduced much faster than the imino bond.  
 
Table 2.25. Reductions of Imino Esters with DHP and BINOL Catalysts  
 
Entry Imino  
Ester 
Reducing 
DHP  
Ligand  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%)  
1 276 221 (S)-230e / 5 50 77 / 80 (R) 
2 276 221 (S)-280 / 5 50 93 / 96 (R) 
8 277 221 (S)-280 / 5 50 88 / 99 (S) 
4 276 221 (S)-230e / 1  ambient 88 / 92 (S) 
5 278 221 (S)-230e / 1  ambient 87 / 97 (S) 
6 283 221 (S)-230e / 1 ambient 34 / 92 (S) 
7 283 221 (S)-230e / 1 ambient 58 / 94 (S) 
8 283 242 (S)-230e / 1 ambient n.a. / 86 (S) 
 
Polymer-supported Hantzsch ester was also developed; however, it was used only 
for the 1,4-reduction of unsaturated aldehydes and reductive amination of aldehydes.128  
 
 
2.5.3. Mechanistic Considerations   
 
The proposed catalytic cycle (Scheme 2.71, (A)) of the reduction of imines with 
DHP involves the LUMO-lowering activation of the imine (b) by protonation with the 
chiral (S)-Brønsted acid (a) generating the highly organised iminium ion pair (c) (plausible 
transition structure from acid 230d and 2-methylquinoline is shown at Scheme 2.71, (B)). 
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The nucleophilic DHP (d) can then approach the complex (c) from the less hindered face 
and transfer the hydride ion which in turn affords amine (e) and pyridinium salt (f). Proton 
transfer recycles the acid (a) and releases the free pyridine (g). 
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Scheme 2.71. Proposed Mechanism (A) and Transition Structure (B) 
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3. Lewis Base Organocatalysis  
 
3.1. Organocatalysis129    
 
3.1.1. What is Organocatalysis?129 
 
Organocatalysis is a younger brother of metal catalysis, a group of reactions that 
are promoted by small organic molecule catalyst, metal-free catalysis. The well-established 
metal-catalysed synthesis has been built on the advantageous properties of metal 
complexes:  
 
-  diversity in the metallocentre and the ligands,  
-  possible “tailoring” the complex structure and reactivity,  
-  usually high TON/TOF and low catalyst loading (<1 mol %).  
 
However, as every method, metal catalysis has certain disadvantages and 
drawbacks, which calls for the development of new methods because of:  
 
-  price of the metal and the ligand, complicated access to it,  
-  toxicity and pollution issues,  
-  product contamination with metal residues.   
 
On the other hand, organocatalysis can be considered as a relative of enzyme 
catalysis. Organocatalytic reactions show some of the features of bioorganic reactions – the 
catalyst can get saturated, the kinetics often follows the Michaelis-Menten equation 
describing the reversible formation of a catalyst (enzyme)-substrate complex. 
Organocatalysts, however, are not exclusively substrate-specific and they are able to 
catalyse a vast area of organic reactions. The main focus is inherently on asymmetric 
reactions and application of the well known, simple chiral small molecules for catalysing a 
growing number of reactions. These can be sorted according to the mechanism pathways:  
 
1.  Activation via covalent transition complexes – nucleophilic:  
- aldol condensations, α-amination, α-aminooxylation, Mannich reaction,  
-  nucleophilic epoxide opening,  
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-  conjugate additions to α,β-unsaturated carbonyls,  
-  Morita-Baylis-Hillman reaction,  
-  cycloadditions ([4+2] Diels-Alder, [2+2] of ketenes, [3+2] of allenes),  
-  SN2 alkylation, α-halogenation of carbonyls,  
-  hydrocyanations, acylations, and  
-  benzoin condensation and Stetter reaction (heteroazolium catalysts).  
 
2.  Activation via covalent transition complexes – electrophilic:  
-  1,4-additions, cycloadditions ([4+2], [3+2], [4+3]),  
-  epoxidations, Baeyer-Villiger reaction.   
 
3.  Activation via reactive intermediates – non-covalent activation:  
- allylation reactions,  hydride reductions, 
-  epoxidations, oxidation of sulfides to sulfoxides, 
- desymmetrisation of vicinal diols by oxidation, benzylic oxidations, and  
-  ylide reactions (epoxidation, cyclopropanation, aziridination).  
 
4. Phase-transfer catalysis:  
- alkylations, protonations, reductions,  
- Michael additions and 1,2-additions, aldol condensations 
-  Horner-Wadsworth-Emmons olefination,  
-  oxidations (epoxidation, ox. of sulfides), and Darzen reaction.  
 
5. Chiral-cavity-accelerated transformations:  
- hydrocyanations, reductions, transaminations of α-ketoacids (with cyclodextrins 
and calixarenes),  
- ester hydrolysis (template imprinting).  
 
Several catalysts have an amazingly broad spectrum of catalytic activity, whereas 
others are very specific for certain types of reactions or substrates. Overall, it is possible to 
define several groups of catalysts that are used most commonly and assign the typical 
reactions catalysed by them:   
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1. Cinchona alkaloids catalysts:  
- aldol reactions,  
-  acyl transfer reactions, desymmetrisation of cyclic anhydrides,  
- kinetic resolution of secondary alcohols,  
-  phase-transfer catalysis.  
 
2. Oligopeptides – aldol reactions, phosphorylations, and hydrocyanations.  
 
3.  Lewis base activation – aldol reactions, allylations, and reductions.  
 
4.  Catalysis with enamine intermediates – proline analogues:  
- aldol condansations, α-amination, α-aminooxylation, Mannich reaction,  
-  Michael additions, Morita-Baylis-Hillman reaction,  
-  cycloadditions ([4+2] Diels-Alder, [2+2] of ketenes, [3+2] of allenes),  
-  SN2 alkylation and acylations.  
 
5.  Carbene catalysts – benzoin condensation and Stetter reaction.  
 
Organocatalysis has become a well accepted part of organic synthesis and the 
understanding of the reaction mechanisms is improving with its current rapid development. 
This is a good foundation for novel, more efficient methods to grow.  
 
 
3.1.2. Highlights of Organocatalytic Reactions129  
 
Organocatalysis is a relatively new term, only used since 2001 when it was coined 
by MacMillan. However, if looked thoroughly into the numerous methodologies in organic 
chemistry, it can be dated back to beginning of 20th century when Rosenthaler and Bredig 
studied hydrocyanations of benzaldehyde in the presence of quinine 285a (Table 3.1, entry 
1; Scheme 3.1). The milestones of asymmetric catalysis are also depicted in Chapter 1.1.2. 
As the first highly enantioselective organocatalytic reaction can be considered Pracejus’ 
ketene methanolysis130 catalysed with O-acetylquinine 286b achieveing remarkable 74 % 
ee of the methyl ester (Table 3.1, entry 3; Scheme 3.1).  
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Table 3.1. Highlights of Organocatalysis 
 
Entry Substrates Catalyst  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%) 
1 146 285a / n.a.  n.a. / < 10  
2 146 286 / 2 35  40 / 90 (R) 
3 288  285b / 1 –111 90 / 74 (R) 
3 290 291 / 3 20   84 / 93 (R) 
4 146, 294 291 / 30 ambient 62 / 60 (R) 
5 293, 294 291 / 30 ambient 97 / 96 (R) 
6 297, 298  299 / 10 –78 73 / 74 (endo) 
7 301, 302 303 / 10  –40 90 / 10 (endo), 5 / n.a. (exo) 
8 143, 305 306 / 5 23  43 / 93 (endo), 56 / 93 (exo)  
9 308 309a / 100 0 65 / 94 (R,R) 
10 308 309b / 10 0 95 / 90 (R,R) 
 
The hydrocyanation reaction was revisited in late 1970s by Inoue131 and later by 
others. He developed a dipeptide catalyst 286 that afforded cyanohydrin 287 in 
enantioselectivity as high as 90 % ee at low conversion (Table 3.1, entry 2; Scheme 3.1). 
Unfortunately, racemisation occurred under the reaction conditions, lowering the ee to 69 
% at 80 % conversion.  
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Scheme 3.1. Organocatalytic Enantioselective Hydrocyanation and Ketene Methanolysis  
 
In early 1970s, Hajos and co-workers published a remarkably simple 
organocatalytic intramolecular aldol reaction132 using 3 mol % of proline as the catalyst 
(Table 3.1, entry 2; Scheme 3.2). The enantiomeric excess of the Wieland-Miescher ketone 
292 was 93 %! This method was already known in stoichiometric version leading up to 84 
% ee.133 After this sporadic report, proline was forgotten for the following 30 years, not 
only for aldol reaction – it proved difficult to develop a highly enantioselective 
intermolecular version, due to self-condenstaion by-products, as one can expect.134 The 
successful protocol is inspired by aldolase I-catalysed biochemical reactions via enamine 
formation. The yields and enantioselectivities for aromatic aldehydes were moderate; 
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however, isobutyraldehyde gave the aldol product 296 in excellent 97 % yield and 96 % ee 
(Table 3.1, entries 4 and 5; Scheme 3.2).  
 
OO
O
Me O
O
Me
N
H
COOH
290
291: L-Proline
292: Wieland-Miescher ketone (93 % ee)
291 (3 %)
DMF
R
O
146: R = Ph
293: R = i-Pr
291 (30 %)
DMSO
O
294
R
OH O
(R)-295 (60 % ee)
(R)-296 (96 % ee)
+
1.
2. HCl
 
 
Scheme 3.2. Organocatalytic Enantioselective Aldol Condensation 
 
In 1989, a report on the first Diels-Alder (DA) addition catalysed by a chiral boron-
based Lewis acid 299 appeared.135 In analogy to the traditional metallic Lewis acids 
catalysing this reaction, lowering of the LUMO-energy was assumed. The 
enantioselectivity was around 70 % ee for a range of dienes and dienophiles (Table 3.1, 
entry 6; Scheme 3.3).  
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Scheme 3.3. Organocatalytic Enantioselective Diels-Alder Addition 
 
The first DA reaction catalysed by a silicon-based Lewis acidic catalyst136 
containing covalently bonded chiral backbone to the silicon atom and upon treatment of 
the hydrosilane precursor with a base (e.g. trityl cation), the silylium cationic catalyst 303 
was obtained (Table 3.1, entry 7; Scheme 3.3). As initial results, the reaction proceeded in 
low enantioselectivity (10 % ee) which only triggered an extensive research in this field.  
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Scheme 3.4. Organocatalytic Enantioselective Diels-Alder Addition 
 
The reversible iminium ion formation from imidazolidin-4-one catalyst 306 can be 
considered as the first truly organocatalytic, showing also characteristics of Lewis acid 
catalysis.137 Addition of α,β-unsaturated aldehyde to cyclopentadiene was achieved with 
excellent 93 % ee, even though a mixture of isomeric cyclo-adducts was obtained (Table 
3.1, entry 8; Scheme 3.4).  
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Scheme 3.5. Organocatalytic Enantioselective Epoxidation 
 
Oxidations proved more difficult to realise in an organocatalytic fashion. The first 
report on enantioselective organocatalytic epoxidation exploied the idea of chiral dioxirane 
oxidant – the chiral ketone precursors are very versatile an easy to access, e.g. from sugars. 
The first catalyst was the fructose-based ketone 309a and its dioxirane epoxidised (E)-
alkenes in very high ee (typically 95 %); however, only in stoichiometric amounts (Table 
3.1, entry 9).138 System 309b/Oxone mediated epoxidation of a large number of (E)- and 
trisubstituted alkenes (Table 3.1, entry 10; Scheme 3.5) and optimisation of the reaction 
conditions extended the substrates scope to cis-alkenes, dienes, enynes, 2,2-disubstituted 
vinylsilanes, enol silylethers and esters and the process became catalytic.139  
 
 
 
 
 
 
 
 
    87
3.2. Lewis Base Catalysis140   
 
3.2.1. Lewis Bases in Organic Synthesis and Catalysis140  
 
Definition of acid and base by G. N. Lewis (1923) has changed the view of the 
chemical society on acid-base interactions. It elegantly unified the earlier theories and 
simply explained chemical behaviour by electron sharing phenomenon – a base is an 
electron pair donor and an acid is an electron pair acceptor. Over the many years of 
studying the Lewis acid-base behaviour and reactivity, they have found a firm place in 
organic synthesis, Lewis acids, in particular. Lewis-base-catalysis is less common, because 
of a lack of Lewis acidic sites in common organic molecules (substrates) and limited 
possibilities of valence expansion on carbon centres. However, it can be well used to 
interact with a reagent of the desired Lewis acidic properties.  
 
XnD AYn XnD AYn
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XnD AYn-1
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Scheme 3.6. Formation of an Acid (Acceptor) - Base (Donor) Adduct 
 
An acid-base adduct as the product of neutralisation is commonly expected to have 
increased thermodynamic stability and decreased reactivity. The binding of a Lewis base 
(a) to an acid (b) does increase the overall electron density at the Lewis acid centre 
(Scheme 3.6); however, it is more important to consider where the electrons are localised 
and how they are distributed in the molecule. This can result in either quenching each-
other’s reactivity (c) or the opposite – the acidity (electrophilicity) of the Lewis acid is 
enhanced (d,e)!  
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Figure 3.1. LB-LA Adduct and the Change of Bond Lengths 
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It is the enhancement of the electrophilicity of the Lewis acid centre that is 
synthetically useful. Even though the net electron transfer is from the donor towards the 
acceptor, in polyatomic species the accepted electrons are redistributed over the 
peripheral ligands Y which results in a net decrease of the electron density at the acceptor 
central atom (Scheme 3.6). The donor (D) – acceptor (A) adducts exhibit characteristics 
formulated by Gutmann rules (an example examined by X-ray crystallography on Figure 
3.1):141  
 
-  the smaller the distance between the donor and the acceptor, the smaller the 
polarisation of D-A bond and the longer the peripheral bonds (D-X or A-Y) 
-  the higher the coordination number, the longer the peripheral bonds on this centre,  
-  the peripheral bonds compensate (by elongation or contraction) the changes of 
electron density at D and A.  
 
For example, the Mulliken charges at the silicon atom in SiF4, (SiF5)- and (SiF6)2-  
are +1.19, +1.14 and +2.12 or in series of SiCl4, (SiCl5)- and (SiCl6)2-  are +0.178, +0.279 
and +0.539,140c,142 respectively, even if an additional anionic ligand (Cl-) coordinates! The 
synthetic consequence of this phenomenon is that the Lewis acidic (acceptor) centre 
becomes more acidic and electrophilic while its ligands become more nucleophilic.   
 
HOMO - nonbonding
LUMO - antibonding
SiCl Cl
bonding
 
 
Figure 3.2. Three-centre Four-electron Bond in Hypervalent Silicates 
 
Silicon Lewis acids are among the most common non-metallic acids that are used 
in organic synthesis. Silicon’s ability to coordinate beyond the octet rule was originally 
explained by the availability of 3d orbitals in analogy to transition metals. Later, these 
orbitals were shown to be too diffuse to provide bonding and theory of three-centre four-
electron bond of 3p orbitals formed instead. Thus, the expanded pentavalent silicon atom is 
formally sp2-hybridised and of trigonal bipyramid geometry the hexavalent species is sp-
hybridised octahedral (bond lengths in SiF4 are 1.560 Å, (SiF5)-: ax 1.660 Å, eq 1.622 Å 
and (SiF6)2-: 1.685 Å).142 The hypervalent bonds are electron-rich at the ligands and 
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electron-deficient at the central silicon atom. Two n-orbitals of the donor and one silicon σ-
orbital create three molecular orbitals (Figure 3.2), whose HOMO has a node at the silicon 
atom and concentrate the electron density at the ligands. As the strength of the donor 
increases, the energy gap between the HOMO and LUMO can be sufficiently large to 
cause ionisation of the A-Y bond (Scheme 3.6). This molecular orbital theory is in 
agreement with the empirical Gutmann analysis.  
 
Lewis base-catalysed reactions cover a broad range of reactions, with or without 
the formation of a new stereogenic centre (room for enantioselective modifications). Any 
of the three types of interactions might be significant for the catalytic process:   
 
1. Reactions occurring via n-π* interactions – nucleophilic additions:  
- electrophilic acylations, nucleophilic reactions of acylated LB,  
-  reactions of ketenes, cycloadditions, 
- Morita-Baylis-Hillman reaction (alkenoates, alkynoates),  
-  amine organocatalysis.  
 
2. Reactions via n-σ* interactions – polarised or ionised intermediates:  
- allylations, alkylations, epoxide ring-opening 
-  aldol condensations, Mannich reaction, Michael additions,  
-  trifluoromethylation, silylcyanation, Strecker reaction,  
-  reductions of carbonyls.  
 
3.  Reactions via n-n* interactions – boron:  
-  reductions of carbonyls, allylations.  
 
4.  Bifunctional catalysis:  
- n-σ* Lewis base / Lewis acid catalysis –  
alkylations with diethylzinc, silylcyanation, fluoride-catalysed reactions,  
-  n-π * Lewis base / Brønsted acid catalysis –  
Morita-Baylis-Hillman, amino-acid-catalysed reactions,  
-  dual activation – carbene catalysts.  
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3.2.2. Hypervalent Silicates143  
 
Reduction potential of silanes has been studied along with their other properties 
since the 1950s. Over the following decades, it was reported that their reducing activity 
could be enhanced with acids, fluorides, alkoxides, or transition metal complexes. Silicon 
complexes activated by fluoride anion – pentavalent fluorosilicates – were the first group 
of hypercoordinate silicon reagents that were not only studied structurally, but also used in 
organic synthesis for reduction of carbonyl compounds144 or allylation reactions.145 They 
became particularly popular in late 1970s when soluble fluoride sources (e.g. TBAF)145a 
were introduced to replace the insoluble inorganic salts (such as KF or CsF),144 which 
triggered a major expansion of their synthetic applicability. The bond energies146 shed 
some light onto the activation of silicon with fluorides:  
 
-  very high Si-F bond energy (in average 143 kcal.mol-1 ~ 599 kJ.mol-1; for 
comparison, the Si-Cl is 71 kcal.mol-1 ~ 297 kJ.mol-1),  
-  relatively low energy of the newly formed C-C (83 kcal.mol-1 ~ 348 kJ.mol-1) or C-
H bond (99 kcal.mol-1 ~ 414 kJ.mol-1).  
 
It was noticed that not only fluorides but also neutral strong nucleophiles, such as 
HMPA, DMSO and DMF can activate silicon and this process is entropy-controlled.144c  
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Scheme 3.7. Proposed Mechanism of Fluoride and/or a Neutral LB-catalysed Reduction of Carbonyls. 
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The mechanism of silicon-activation with fluorides (Scheme 3.7) was based on fast 
bonding of fluoride to silicon, generating a pentacoordinate fluorosilicate (c) which is 
assumed to be the active hydride donor.147 However, in the presence of a Lewis basic 
solvent (e.g. HMPA), this species (c) can coordinate another molecule of Lewis base to 
form a hexacoordinate silicate (d). Intermolecular hydride transfer from (d) to carbonyl 
compound (e) is then followed by immediate trapping of the alkoxide by the solvent-
coordinated fluorosilane. The resulting hexacoordinated complex (f) dissociates to produce 
silylated alcohol (g) and two molecules of Lewis bases (F- and HMPA).  
 
Table 3.2. Selected Lewis-Base-catalysed Reactions Involving Hypervalent Silicates  
 
Entry Substrates Catalyst  
(mol %) 
Temp. (°C) Yield (%) /  
ee (%) 
1 39 311 / 0.4 ambient 89 / 52 (R) 
2 146, 312 313a / 100 –78 85 / 63 (R) 
3 146, 312 313a / 10 –78 40 / 53 (R) 
4 146, 315 313b / 10 –78 93 / 93 (anti), 2 / n.a. (syn) 
5 146, 312 317 / 7 –60  72 / 98 (S) 
6 318, 312 17 / 300  –78 80 / 98 (S) 
7 146, 320  321 / 5 –78 99 / 81 (syn) or 99 / 59 (anti) 
8 146, 323  321 / 5 –78 95 / 98 (S) 
 
Similar catalytic process was observed in reduction and allylation reactions with 
alkyl-, aryl-, alkoxy- or mixed silanes because they exhibit the desired nucleophilic 
character under Lewis base activation. Polyalkoxy- and chlorosilanes are naturally 
(weakly) electrophilic, in contrary to polyalkyl- or arylsilanes, and can attain nucleophilic 
character solely under LB activation (vide infra). The understanding that alkyl- and 
alkoxysilanes can perform analogous reactions and that inherently more versatile alkoxides 
can be conveniently used for activation of the silane caused rapid development of the 
alkoxide activation.148,149 
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Scheme 3.8. Organocatalytic Enantioselective Reduction of Acetophenone. 
 
The first organocatalytic (Li is not mechanistically involved) enantioselective 
version of reduction of ketones with activated alkoxysilanes appeared only 2 years after the 
discovery of its racemic parent.148 The trimethoxysilane was activated and desymmetrised 
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by dilithium salt of prolinol 311.150 This catalyst mediated extremely efficient cycle in only 
0.4 % (!) loading and the product was obtained in remarkable 52 % ee (Table 3.2, entry 1; 
Scheme 3.8).  
 
The realisation that neutral Lewis bases can activate silanes as efficiently as 
anions,151 set the scene for developing mild catalytic methods and new opportunities in 
enantioselective modifications. Even milder conditions could be achieved by using 
chlorosilanes instead of alkylsilanes because the nucleophilicity of the dialkylchlorosilane 
is approximately 1000 times lower than the trialkylsilane – i.e. electrophilicity of the 
hypervalent centre increases ~300 times with the first methyl-for-chloride substitution, and 
up to 105 times for all three methyl-for-chloride substitutions on silicon!152 Furthermore, 
halosilanes gain greater nucleophilic character at the halogen (or carbon) ligands and 
greater electrophilic character at the silicon atom. That provides a binding site for 
substrates as carbonyls, in other words – dual activation for both reactants – the substrate 
and the reagent. The choice of an appropriate activator (fluoride, alkoxide, neutral LB) and 
the silane (from polyalkyl- to polyhalosilanes) and their right combination shows how the 
reactivity can be tailored according to the needs.   
 
Ph
O
313a (10 %)
146
Ph
OH
(R)-314 (53 % ee)
Cl3Si
Ph
O
146
+
312
OSiCl3
315
anti-316 (93 % ee)
313b (10 %)
+ Ph
OH O
CH2Cl2
CH2Cl2
R
R
N
Me
P
Me
N O
N
313a: R = -(CH2)3-
313b: R = Ph
 
 
Scheme 3.9. Organocatalytic Enantioselective Allylation and Aldol Reaction. 
 
Lewis acidic silicon reagents activated by a Lewis base were used as very potent 
hydride and allyl donors from the 1990s when enantioselective allylation153 attracted much 
attention. The first addition of allyltrichlorosilane 312 to benzaldehyde 146 was carried out 
with 10 mol % of phosphoramide catalyst 313a and afforded the homoallylic alcohol in 
moderate yield and 53 % enantioselectivity154 (Table 3.2, entries 2 and 3; Scheme 3.9). 
Analogous catalyst 313b was more successful in catalysing the addition of enol 
silylethers155 (Table 3.2, entry 4; Scheme 3.9), which was known to proceed uncatalysed. 
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However, it was significantly accelerated by the addition of a Lewis base. The product was 
almost exclusively of anti-configuration (>95:5) and high enantiopurity (95 % ee). This 
was a breakthrough in the reactions of Lewis-base-activated Lewis acids as it demonstrated 
its applicability in enantioselective (organo)catalysis. Other Lewis bases used in analogous 
reactions were chiral formamides, N-oxides and sulfoxides (vide infra).  
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Figure 3.3. Proposed Transition Structure for Addition of Enol Silylethers (A) and Allylation (B) 
 
The diastereoconvergency of the enol silylether addition [(E)-enol → anti, (Z)-enol 
→ syn] and allylation [crotylation: (E)-alkene → anti, (Z)-alkene → syn] indicates that the 
reaction proceeds through a cyclic, chair-like transition state organised around the 
hypervalent (hexavalent) silicon (Figure 3.3). Among the best performing catalysts were 
the mono-N-oxide 317 for allylation of aldehydes affording the homoallylic alcohol in very 
high yields and enantioselectivity156 (both 98 %; Table 3.2, entry 5; Scheme 3.10). 
Interestingly, the allylation reaction of nitrogen analogues of carbonyls has not been very 
successful. One exception, yet only in stoichiometric amounts (3 equivalents!) of sulfoxide 
activator 17 performed well in allylation of hydrazones157 with ee up to 98 % (Table 3.2, 
entry 6; Scheme 3.10).  
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Scheme 3.10. Organocatalytic Enantioselective Allylation. 
 
Aldol reactions are commonly catalysed by Lewis acids, thus they can be suitable 
model reactions for catalysis by a chiral Lewis acid or a Lewis acid activated by a chiral 
Lewis base (Scheme 3.9, Scheme 3.11). Various bis(phosphoramides) were tested as 
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potential catalysts for aldol reactions and the best results were achieved with binaphtyl-
derived catalyst 321 – particularly for the addition of enol silylethers. The mechanism of 
addition of enol silylethers158 as 320 to aldehydes (Table 3.2, entry 7; Scheme 3.11) was 
expected to be similar to the allylation mechanism (six-membered chair-like TS; Figure 
3.3), producing the alcohol in high diastereoselectivity. The enantioselectivity was higher 
in the case of (E)-enols (up to 90 %). Exo-enols also reacted with aldehydes in the presence 
of the catalyst 321 affording β-hydroxy ketones in excellent enantioselectivity159 (Table 
3.2, entry 8; Scheme 3.11).  
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Scheme 3.11. Organocatalytic Enantioselective Aldol Reactions 
 
Formamide and sulfinamide catalysts became very popular for the reductions of 
imines with silanes, as described in detail in Chapter 2.4. 
 
A generalised mechanistic picture can be drawn for the described reaction as they 
all have common features of LB-activated LA-catalysis:  
 
-  a Lewis acidic silicon reagent is used as a carrier of a carbon fragment or a hydride,  
-  the silicon atom in the reagent is activated by a (chiral) Lewis base,  
-  the LB-activated hypervalent silicon species is the true intermediate.  
 
The example of trichlorosilane and a neutral Lewis basic activator (Scheme 3.12) is 
the most common combination used up-to-date. The coordination of a Lewis base (a) to 
silicon forms the pentavalent silicate (c) in which the silicon is more electrophilic and the 
chlorides are more nucleophilic than in the original weakly Lewis acidic tetravalent 
trichlorosilane (b). The highly Lewis acidic silicon in (c) can now bind another Lewis 
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basic molecule – either another catalyst or a substrate (typically carbonyl) to form a 
hexavalent species (e). Depending on the character of the LB-catalyst, a ligand (chloride) 
may dissociate from either of these hypervalent silicates (c) or (e) to form a pair of 
hyperreactive electrophiles (d) or (f) and nucleophile (Cl-).  
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Scheme 3.12. Activation of Trichlorosilane (Lewis Acid) with a Lewis Base 
 
While many metal centres are often good Lewis acids, many known organic 
catalysts tend to react as heteroatom N(O)-, P(O)- and S(O)-centred Lewis bases. Side by 
side with enamine catalysis which also does exhibit features of Lewis acid catalysis, these 
methods of catalysis are complementary.  
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Part B:  
 
Results and Discussion  
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Aims  
 
The field of enantioselective organocatalysis became very competitive in the new 
millennium. The enantioselective organocatalytic reduction of imines with trichlorosilane 
became quickly one of the research targets in Kočovský / Malkov group, where it has been 
in development since 2004.II  
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Scheme A3. Scope of Enantioselective Reduction of Imines with HSiCl3 and Sigamide
 
 
My contributions to the advancements in understandings of the methodology are 
based on investigating the scope and synthetic utility of the new methodology using the 
improved catalyst Sigamide (Scheme A3). The synthesis of Sigamide has already been 
established (see Chapter 2.4.2). The choice of substrates of interest is based on their 
possible practical use as synthetic intermediates or in synthesis of natural products. A 
diverse substrate scope has to be explored to gain pieces of information for the mechanistic 
proposal. Thus, imines derived from acetylheteroaromatics containing nitrogen, sulfur or 
oxygen are of importance for they prove the (in)tolerance towards different heteroatoms. 
On the other hand, aromatic or aliphatic imines with varied groups in the proximity of the 
C=N bond may demonstrate the impact of setric and electronic variations in the substrate 
structure and tolerance to functional groups.   
 
The experimental results gathered from a library of prepared enantioenriched 
amines will be assessed and a mechanistical picture will be drawn concluding the scope 
and limitations of the methodology. The practical use of the method in a short total 
synthesis will be demonstared, as well.  
 
 
II. (a) Malkov, A. V.; Mariani, A.; MacDougall, K. N.; Kočovský, P. Org. Lett. 2004, 6, 2253; (b) Malkov, 
A. V.; Stončius, S.; MacDougall, K. N.; Mariani, A.; McGeoch, G. D.; Kočovský, P. Tetrahedron 2006, 
62, 264; (c) Malkov, A. V.; Stončius, S.; Kočovský, P. Angew. Chem. Int. Ed. 2007, 46, 3722; (d) Malkov, 
A. V.; Figlus, M; Stončius, S. Kočovský, P. J. Org. Chem. 2007, 72, 1315.  
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4. Preparation of Imines   
 
4.1. Synthesis of Ketones  
 
A majority of the ketones used in this study were either commercially available or 
synthesised according to the literature procedures, without optimisation. For future 
reference, I will keep sorting according to the type of group in the side chain:  
 
-  N- (pyridines); N,S- (thiazoles) or S-heterocyclic (thiophene),  
-  O-heterocyclic (furan) and O- or N-bicyclic (benzo[b]furan, indole),  
-  aryl-alkyl chain with functional groups or increasing bulk, and 
-  miscellaneous.  
  
4.1.1. Ketones containing N-; N, S-; S- and O-heterocycles  
 
The only prepared ketone from the pyridine series was the bulky 2,6-di-iso-propyl-
analogue of 4-acetylpyridine (Scheme 4.1). Elevated temperature and acidic conditions 
were required for the formation and propagation of the radical chain.160 On the other hand, 
the presence of radicals and the harsh condition might have been also the reason why the 
yield was so poor (7 %).  
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Scheme 4.1. Derivatisation of 4-Acetylpyridine 
 
Precursors for 2-acetyl-4-alkylthiazoles, the 4-alkylthiazoles, were constructed 
from the corresponding α-bromo ketones and thioformamide (Scheme 4.2). Bromination of 
simple ketones161 afforded essentially pure α-bromo ketones which were cyclised with 
formamide in the presence of phosphorus pentasulfide as the source of sulfur.162 
Distillation of the crude mixtures yielded the 4-alkylthiazoles.  
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Scheme 4.2. Synthesis of 4-Alkylthiazoles 
 
Acetylation of 4-alkylthiazoles was carried out in two different ways (Scheme 4.3). 
Ethyl acetate acted as a potent acetylating reagent and the 2-lithiated intermediate was 
acetylated in at least 75 %.163 However, approximately a third of the product 334A thus 
formed over-reacted with n-butyllithium to produce the corresponding alcohol 334B. 
Using less base only caused decreased conversion and yields. Hence, N-acetylmorpholine, 
an acetyl-transfer reagent, was used to diminish the risk of over-reacting while the amount 
of the base was decreased to 1.05 equivalents.164  
 
N
S O
N
S OH
n-BuAcOEt (2 eq)
Et2O, −80 °C to r.t.
n-BuLi (1.3 eq),  
Et2O, −80 °C, 1 h1.
2.
N
S
332
N
S O
334A (49 %) 334B (28 %)
(1.3 eq)
−80 °C to r.t.
n-BuLi (1.05 eq),  
THF, −80 °C, 1 h1.
2. O N
O
333
N
S
+
335 (53 %)
 
 
Scheme 4.3. Acetylation of 4-Alkylthiazoles 
 
Another acetylthiazole derivative was prepared by derivatisation of 2,4-
dibromothiazole 336, starting by acetylation at the most reactive position-2. This step 
proved rather tricky as extensive decomposition of the material occurred easily.165 Metal-
halogen exchange with iso-propylmagensium chloride or ethylmagnesium bromide at 
temperatures varying from –20 ºC to room temperature and subsequent quenching with 
acetonitrile or ethyl acetate,166 afforded only a mixture of unreacted dibromo-compound, 
the desired 2-acetylated compound 337A and 2-debrominated species 337B in 1:1:2 ratio 
and combined maximum 60 % yield (Scheme 4.4). This only showed that the electrophile 
was not sufficiently reactive. 
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N
S O
Br N
S
Br
+ (1:2:1)
336
a. 1. i-PrMgCl (1 eq), THF, 0 °C, 1 h
    2. MeCN (1.5 eq), THF, r.t., 1 h 
b. 1. n-BuLi (1.1 eq), THF, −80 °C, 30 min
O N
O
2.               (1.4 eq), THF, −80 °C to r.t.
a.
337A (14 %) 337B (29 %)
336 (15 %)
b.
337A (56 %)
 
 
Scheme 4.4. Acetylation of 2,4-Dibromothiazole 
 
Alternatively, metal-halogen exchange with n-butyllithium at low temperature (–80 
ºC) and 4-acetylmorpholine as acetylating agent were utilised instead164 and this method 
resulted in clean conversion to 2-acetylated thiazole in 56 % yield (Scheme 4.4).  
Before further derivatisation at the position-4 was carried out, the carbonyl group 
was protected as a ketal167 (Scheme 4.5) in excellent 98 % yield of 339. For comparison, 
analogous furan derivative 340 was obtained in low 37 % yield, possibly due to the higher 
volatility of the product and co-evaporation with toluene during the work-up. These 
protected acetyl-heterocycles were metallated and reacted with an electrophile, such as 
trimethylsilyl chloride or carbon dioxide.  
 
O
340 (37 %) a. HOCH2CH2OH (4 eq), p-TsOH (0.1 eq)
b. HOCH2CH2OH (3.6 eq), p-TsOH (1 %) 
both: toluene, Dean-Stark trap, reflux, 10 h
a.b.
Ar
O
337A: Ar =
338: Ar =
N
S
Br
O
N
S
339 (98 %)
Br
O
O
O
O
 
 
Scheme 4.5. Protection of the Carbonyl Group 
 
Even if the reaction of 339 with n-butyllithium was quantitative, the yield of the 
desired 5-trimethylsilylated thiazole 341A was low (49 %). The relatively similar acidity 
of the positions 4 and 5 in thiazole ring could explain why the expected metal-halogen 
exchange at position-5 was accompanied by concurrent undesired deprotonation at 
position-4, despite the cooling (Scheme 4.6). This resulted in the formation of a mixture of 
two major products 5-TMS 341A, 5-bromo-4-TMS 341B; moreover, double lithiation 
yielded the 4,5-di-TMS 341C. This is in contrast to clean silylation167 of furan derivative 
340 in 77 % yield (Scheme 4.6), where the positional reactivity is clearly differentiated.  
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TMSCl (1.8 eq)
−80 °C to r.t.
n-BuLi (1.2 eq)  
THF, −80 °C, 30 min1.
2.
N
S
N
S
N
STMSTMS
TMS TMSBr
+ +
339
341A (49 %) 341B (43 %) 341C (7 %)
340
TMSCl (2 eq)
−80 °C to r.t., 2 h
n-BuLi (1.5 eq)  
THF, −80 °C, 30 min1.
2.
O
342 (77 %)
O
O
O
O
O
O
O
O
TMS
 
 
Scheme 4.6.  Silylation of Protected 2-Acetylthiazole and 2-Acetylfuran  
 
Reactivity of both heterocycles was very different also in the ketal-deprotection 
step. The furan-derived dioxolane 342 was deprotected in 3 hours while the thiazole 
analogue 341A was quite resistant to the acid catalysed transketalisation with acetone and 
the reaction mixture had to be refluxed for 4 days (Scheme 4.7). However, the deprotection 
step was not optimised because enough of material was obtained.   
 
O O
344 (88 %)
a. Py.p-TsOH (0.15 eq), acetone/H2O, reflux, 4 d
b. Py.p-TsOH (1 %), acetone/H2O, reflux, 3 h
a.b. 341A: Ar =
342: Ar =
N
S
TMS N
S O
343 (66 %)
TMS
Ar
O
O
TMS
OTMS
 
 
Scheme 4.7. Deprotection of the Carbonyl 
 
The 5-lithiated protected 2-acetylfuran167 was also carboxylated using dry ice. It 
turned out that during the acid-base work-up of the crude acid, the dioxolane moiety was 
cleaved and produced the intermediate keto acid 345. From practical reasons, the crude 
acid was transformed into ethyl ester 346 using the mixed anhydride method with ethyl 
chloroformate.168 
 
340
CO2 (excess)
−80 °C to r.t.
n-BuLi (1.5 eq)  
THF, −80 °C, 2 h1.
2.
O
345
O O O
346 (38 %)
CH2Cl2
0 °C to r.t., 2 h
ClCOOEt (1 eq)
HOOC EtOOC
 
 
Scheme 4.8. Carboxylation of Protected 2-Acetylfuran 
 
For the group of Grignard addition reactions, only one aldehyde was synthesised, 
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the others were commercially available. The Vilsmeier-Haack formylation of 
benzo[b]furan produced selectively the 3-formyl isomer 348, even if it was in only 36 % 
yield (Scheme 4.9).  
 
O
POCl3 (8 eq)
DMF (8 eq)
80 °C, 24 h
O
O
347 348 (36 %)
N
H
MeI (6 eq)
NaH (4 eq)
DMF 
r.t., 24 h
N
Me
349 350
COOH COOH
MeLi (4 eq)
THF
0 °C to reflux., 4 h
N
Me
351 (18 %)
O
 
 
Scheme 4.9. Vilsmeier-Haack Formylation of Benzofuran and Preparation of 2-Acetylindole 
 
N-Methylated 2-acetylindole was prepared by a two-step procedure from the NH-
free acid 349 (Scheme 4.9). The mixture of N-methyl and/or O-methyl compounds 
resulting from the methylation of the acid 349 was unified by facile basic hydrolysis of the 
methyl ester. Addition of methyllithium to the N-methyl acid intermediate 350 afforded the 
2-acetyl derivative 351 in 18 % overall yield.   
  
 
4.1.2. Grignard Additions and Concomitant Oxidations  
 
The addition of an appropriate Grignard reagent was the most common way for the 
preparation of the desired alcohols that were oxidised to the corresponding ketones.169 The 
reactions were reliable and high-yielding (65-97 %). The oxidation with pyridinium 
chlorochromate169 (PCC) was the method of choice for alcohols whose side chains were 
not sensitive to the acidic oxidative conditions. Thus, the furan-derived alcohols were 
oxidised preferentially with pyridinium dichromate170 (PDC) which is less acidic.  
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O R2MgX (1.5 eq)
ether or THF
0 °C to r.t
3 h to 16 h
R1
OH
R2 R1
O
R2
a. PCC (1.5 eq), Celite, CH2Cl2, r.t., 2-3 h
b. PDC (1.4-1.75 eq), DMF, 3 h
a. or b.
O
OH
O
OH
O
OH
O
OH
O
OH OH OH
MeO
O
O
O
O O O
MeOO
O
O
O
352a
73 %
352b
89 %
352c
90 %
352d
69 %
352e
94 %
352f
65 %
352g
97 %
353a
32 %
353b
23 %
353f
84 %
353g
72 %
353e
40 %
353d
60 %
 
 
Scheme 4.10. Grignard Additions and Concomitant Oxidations 
 
Remarkably, furaldehydes did not undergo Grignard addition with silylether-
protected 3-bromopropanol,171 although this protocol was described in the literature.172 
Reaction conditions were varied:  
 
-  reaction temperatures – from cooling to heating,  
-  dilution – to prevent undesired reactions of the initially formed magnesio-species,  
-  activation with iodine or 1,2-dibromoethane was expected to promote the formation 
of the Grignard reagent.  
 
O
O
PGO OPG
+
O
O
Br OTBDMSBr OTMS Br OH
a.b.
a. TBDMSCl (1.2 eq), Et3N (1.3 eq), DMAP (5 %), THF, 0 °C to r.t., 16 h
b. TMSCl (1.2 eq), 2,4-lutidine (1.2 eq), CCl4, 0 °C to r.t., 3 h
354455b (54 %) 455a (95 %)
456
a. Mg/455 (1.5 eq), ether or THF, 0 °C to reflux, 3 h
b. 455 (1 eq), SmI2 (2 eq), HMPA (7 eq), THF, r.t., 2 h
c. 455 (3 eq), Sm (3 eq), I2 (5 %), THF, r.t., 16 h
a., b. or c.
 
 
Scheme 4.11. Protection of Bromoalcohol and Its Attempted Grignard Addition 
 
However, none to these attempts produced the desired alcohol; instead, only Wurtz 
coupling occurred and the silylated hexanediol was isolated in high yields (~80 %), 
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presumably because the Grignard magnesiohalide was not formed. The Grignard addition 
of an O-protected 3-bromoalcohol was problematic also with other protecting group 
(tetrahydropyranyl).173 Another possible way for the preparation of the Grignard reagent 
was metal-halogen exchange with iso-propylmagnesium chloride174 followed by standard 
addition of the aldehyde. However, this method provided only the products of i-PrMgCl 
addition to the aldehyde (30 %) and reduction of the aldehyde to a primary alcohol (50 %). 
The attempt to promote the formation of the correct magnesio-species by performing 
Barbier-version175 with SmI2 or Sm/I2 afforded similar Wurtz-type product, if any (Scheme 
4.11).  
 
Ph
O
COOH Ph
O
COOMe
COOMe
Ph
O
+
146457 458459 (57-96 %)
a. H2SO4 (cat.), MeOH, reflux, 3 h
b. [(PPh3)3Rh]Cl (5 %), PhCOOH (0.2 eq),                (0.4 eq), toluene, 130 °C, 2 hN
Me
NH2
a. b.
 
 
Scheme 4.12. Synthesis of γ-Keto Ester 
 
Previously attempted synthesis of β,γ-functionalised ketones led us to an alternative 
γ-keto ester (Scheme 4.12) which could be reduced to alcohol for further applications. 
Besides the simple high-yielding esterification of the corresponding acid 457, a Rh-
catalysed addition of benzaldehyde to methyl acrylate176 afforded the ester (57 % yield).  
 
 
4.1.3. Aryl-alkyl or dialkyl ketones   
 
Two model substrates were examined before embarking on the synthesis of 
colchinol (Chapter 7.2). Chalcone 460 was hydrogenated at an atmospheric pressure over 
palladium on charcoal (Scheme 4.13). This heterogenous hydrogenation provided selective 
reduction of the α,β-double bond, whereas its selectivity failed in the colchinol 
intermediate 562 and homogenous protocol was used (Scheme 7.19). Free-OH group was 
expected to have deleterious effect on the reduction of the corresponding imine, hence a 
silylether protecting group171 was utilised for 3-hydroxyacetophenone (Scheme 4.13). 
Structurally analogous protected hydroxyl ketone 563 was applied in the synthesis of 
colchinol (Scheme 7.19).  
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O
Ph Ph
O
Ph
10 % Pd/C, H2
AcOEt
460 461 (94 %)
HO
O
TBDMSO
OTBDMSCl (1.2 eq)Et3N (1.3 eq)
DMAP (5 %)
THF
0 °C to r.t., 16 h462 463 (96 %)
 
 
Scheme 4.13. Hydrogenation of Chalcone and Silylation of 3-Acetylphenol 
 
Three α,β-unsaturated conjugated ketones were synthesised for investigating the 
effect of an extended conjugation on the reduction step. The easiest to prepare proved to be 
the (E)-3-methyl-4-phenylbut-3-en-2-one 464 (Scheme 4.14). Acid-catalysed aldol 
condensation177 favoured the reaction of benzaldehyde with the thermodynamically more 
stable trisubstituted-enol (derived from 235) and give rise to 464.  
 
O
O
O
+
H2SO4 (1 eq)
AcOH
235 146 464 (62 %)
 
 
Scheme 4.14. Synthesis of 3-Methyl-4-phenylbut-3-en-2-one 
 
By contrast, the synthesis of the 2-methyl analogue 466A proved tricky. Careful 
addition of phenylmagnesium bromide to acetylacetone178 yielded a mixture of (at least) 
five products 466 in low yields (Scheme 4.15).  
 
Ph
O
Ph
O OH
Ph Ph
HO OHO O PhMgBr (1.5 eq)
Et2O,
0 °C to reflux
+ +
465 (E)-466A (12 %)
(Z)-466A (6 %)
466B (7 %) 466C (6 %)
 
 
Scheme 4.15. Reaction of Acetylacetone with Phenylmagnesium Bromide 
 
Hence, a three-step approach, lengthy but selective, was chosen179 (Scheme 4.16). 
Horner-Wadsworth-Emmons reaction of acetophenone with triethyl phosphonoacetate 
afforded the (E)- and (Z)-α,β-unsaturated ester 467 in moderate yield and good 9:1 
selectivity. These two isomers were separable by column chromatography and the starting 
material was also recovered. The (E)-ester was transformed into the Weinreb amide 468 
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and subjected to the addition of methylmagnesium bromide to provide the desired 4-
methyl-4-phenylbut-3-en-2-one 466 in 10 % overall yield. According to the literature,179 
the two latter reactions should have been almost quantitative.  
 
Ph COOEt
Ph
O
N
OMe
Ph O
THF, r.t., 24 h
i-PrMgCl (4.5 eq)
MeNH-OMe.HCl (2 eq)
THF, r.t., 1 h
MeMgBr (1.3 eq)
THF,
−30 °C to r.t.
Ph
O
P(OEt)2
O
EtOOC (1.3 eq)
NaH (1.4 eq)
39 (E)-467 (46 %)
(Z)-467 (5 %)
468 (E)-466 (31 %)
468 (69 %)
 
 
Scheme 4.16. Synthesis of 4-Methyl-4-phenylbut-3-en-2-one 
 
4,4-Diphenyl analogue was prepared by condensation of dilithium salt of 
acetonoxime 469 and benzophenone180 in nearly quantitative yield with no purification 
required (Scheme 4.17). Not surprisingly, the following oxime deprotection181 and 
dehydration in concentrated HCl was non-selective and accompanied by closure of 
isoxazoline ring 471b.  
 
NOHO
EtOH/H2O
80 °C, 1 h
NH2OH.HCl (1.3 eq)
NaOH (1.4 eq)
Ph
PhNHO
OH
n-BuLi (2 eq)  
THF, 0 °C, 1 h
THF, −80 °C to r.t.
1.
2.
HCl (conc.) Ph
PhONPh
PhO
+
Ph Ph
O
(1 eq)294 469 (48 %) 470 (99 %)
470
471A (31 %) 471B (36 %)
 
 
Scheme 4.17. Synthesis of 4,4-Diphenylbut-3-en-2-one 
 
The p,p’-disubstituted benzophenone was synthesised by Friedel-Crafts acylation 
of anisole by the appropriate acid 472 (Scheme 4.18). Crystallisation of the product 474 
from the solution was induced by addition of methanol.  
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COOH
F3C OMe
(excess)
TFAA (2 equiv)
80 °C, 1 h
Tf2O (5 %)
90 °C, 2 h
1.
2.
+
472 473 474 (61 %)
O
F3C OMe
 
 
Scheme 4.18. Synthesis of Substituted Benzophenone 
 
 
 
 
4.2. Formation of Imines  
 
Four methods were used for the preparation of a library of imines and enamines, 
which differ in the way the reaction water is removed.  
 
4.2.1. Prepared Imines   
 
The first two methods required elevated temperatures. The first of them used 4Å 
molecular sieves as the water scavenger (Method A, Scheme 4.19.). The advantage of this 
method was that the imine solution was obtained by simple filtration from the sieves and, 
in general, it provided imines in good isolated yields.  
 
R1
O
R2 R1
N
R2
OMe
toluene, 4A sieves
reflux, 16 h
475a
95 %
N
NPMP NPMP
S
N475d
95 %
NPMP
O
475l
74 %
Si
475k
74 %
O
NPMP
475m
72 %
EtOOC O
NPMP
475p
40 %
O
NPMP
475o
31 %
OMeH2N
NPMP
O
475q
74 %
476k
69 %
NPMP
476a
48 %
NPMP
NPMP
O
476n
16 %
NPMP
476u
39 %
NPMP
(1.5 eq)
 
 
Scheme 4.19. Imines Synthesised by Method A 
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However, in the cases where only small amounts of the ketone were available, the 
reaction became quite sensitive to the traces of water in the apparatus, the reaction 
components and the activity of the sieves. This rendered it inconvenient and unsuitable for 
imination of precious ketones.  
 
R1
O
R2 R1
N
R2
OMe
Dean-Stark trap
benzene, reflux, 16 h
p-TsOH (0.1 eq)
N
NPMP
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96 %
N
NPMP
475c
~ 57 %
NPMP
S
475i
41 %
NPMP
O
475j
78%
S
N
475f
73 %
NPMP
S
N
475h
91 %
NPMP
Si
NPMP
O
475n
~ 10 %
OMeH2N
N
NPMP
475t
38 %
NPMP
476b
29 %
COOMe
476m
67 %
NPMP
476q
72 %
NPMP
MeO
476p
38 %
NPMP
MeO
NPMP
TBDMSO
476w
87 %
476v
27 %
NPMP
Fe
NPMP
476t
~ 32 %
S
N
475g
76 %
NPMP
S
N
475e
65 %
NPMP
N
NPMP
475s
56 %
O
475r
57 %
NPMP
476o
40 %
NPMP
Cl
NPMP
476l
66 %
(1.1 eq)
 
 
Scheme 4.20. Imines Synthesised by Method B 
 
An alternative method used a Brønsted acid catalyst (p-toluenesulfonic acid) and a 
solvent that forms azeotropic mixtures with water, e.g., benzene or toluene (Method B, 
Scheme 4.20.). This method was efficient even for small quantities of ketones, provided a 
Dean-Stark trap of an adequate size was used. However, for obtaining pure imines, the 
removal the (p-TsOH)-(p-anisidine) salt and other polar components (e.g., residues of 
unreacted p-anisidine) by filtration on the triethylamine-treated silica proved beneficial, 
followed by crystallisation (typically from hexane).  
 
Generally, either of the previously mentioned methods A or B was suitable for 
imines from methyl or other non-hindered ketones. However, when steric bulk was built 
around the carbonyl, conversion to imines became low (e.g. imines 475n, 476b). A third 
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method was chosen, a Lewis-acid-mediated imination182 where the Lewis acidic titanium 
tetrachloride also served as a powerful dehydrating agent (Method C, Scheme 4.21.). This 
method proved to be the most efficient and was also used when the other methods failed or 
when a sensitive imine was formed (e.g., imine 476s). This method required anhydrous 
conditions and large excess of the aniline (3 equiv.), but the imine was obtained essentially 
pure (in particular, containing no p-anisidine residues) by simple filtration from the 
precipitate.  
 
476f
68 %
NPMPNPMP
476e
53 %
476c
52 %
476d
63 %
NPMP NPMP
476i
75 %
NPMP
R1
O
R2 R1
N
R2
OMe
Et2O, reflux, 12 h
OMeH2N
TiCl4 (1 eq)
NPMP
476s
22 %
NPMP
F3C OMe476j
69 %
(3 eq)
 
 
Scheme 4.21. Imines Synthesised by Method C 
 
As revealed by 1H NMR spectroscopy, the configuration at the imine double bond 
was predominantly (E)-, typically in 7:1-10:1 ratio when R2 ≠ Me; otherwise, the imine 
adopted (E)-form exclusively. When the R2 group became very bulky, in particular for 
476c-f, 5:2-5:3 mixtures of (E/Z)-isomers were isolated, whereas 476j was a 3:2 mixture. 
However, this did not influence the enantioselectivity of the reduction, as shown later.  
 
 
4.2.2. Attempted Syntheses of Imines    
 
It is pertinent to note that some ketones did not produce the corresponding imines. 
One of these was the β,γ-unsaturated ketone 353b, as it underwent isomerisation followed 
by Michael addition (Scheme 4.22). The standard imination is unsuitable for β,γ-
unsaturated ketones;  thus, other ways were tried. 
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O O
353b
Imination
Method B
O O
477
NHPMP
Ph
OH
OMeRHN2.
1. a., b., c. or d.
a. MsCl/Py, CH2Cl2, 0 °C
b. Tf2O/Py, CH2Cl2, 0 °C
c. Tf2O/Et3N, CH2Cl2, 0 °C
d. PPh3/DEAD, THF, r.t., overnight, R = Ts
Ph
NR-PMP
R = H
Ph
NPMP
314 478
 
 
Scheme 4.22. Michael Addition under Imination Conditions and Proposed Alternative Route 
 
An easy-to-perform but lengthy approach would be the substitution-oxidation 
sequence (Scheme 4.22). A model homoallyl alcohol 314, activated as mesylate,183 triflate, 
tosylate, or via Mitsunobu conditions,184 was subjected to nucleophilic substitution with p-
anisidine. None of these reactions led to any reasonable product and this type of substrate 
was erased from the list.  
 
Interestingly, the α,β-unsaturated-β,β-disubstituted ketones were not suitable 
substrates for imination by any of the above-mentioned methods, including reductive 
amination. The only imine prepared was the α,β-disubstituted 476s, the other two β,β-
disubstituted analogues failed even if three alternative routes were investigated.  
 
MeO NH2 MeO N3
NaN3 (1.2 eq), H2O
r.t., 2 h
NaNO2 (1 eq), HCl
H2O, 0 °C, 30 min
1.
2.
THF, reflux, 20 h
480 (47 %)
MeO N
PPh3480 (1.5 eq)
PPh3 (1.5 eq)
Ph
O
Ph
NPMP
481
479
466A
 
 
Scheme 4.23. Attempted Aza-Wittig reaction 
 
The first non-traditional method for introducing the imino group was an aza-Wittig 
reaction with the corresponding ketone, performed with p-azidoanisole 480 (Scheme 4.23) 
as the source of nitrogen. This method afforded only recovered starting ketone and N-
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triphenylphosphino-p-anisidine adduct. This method was reported for β,γ-usaturated-α-
imino esters127 which are much more reactive than α,β-unsaturated ketones.  
 
PhPh
O
482 (E)-483 (52 %)
(Z)-483 (8 %)
Ph
NPMP
(E)-483
484 (98 %.)
a. POCl3 (1 eq), DMF (4 eq), 80 °C, 1.5 h
b. p-anisidine (1.05 eq), p-TsOH (5 %), MgSO4, CH2Cl2, r.t., 1.5 h
a. b.
 
 
Scheme 4.24. Vilsmeier-Haack Formylation of Styrene and Imination of The Aldehyde 
 
In parallel to the β,γ-unsaturated ketones, an alternative way was based on the idea 
of oxidation of the corresponding racemic amine. The synthesis of the amine started by 
Vilsmeier-Haack formylation of α-methylstyrene 482 which produced (E)- and (Z)-
isomeric β-methylcinnamaldehyde 483 in good selectivity and moderate yield (Scheme 
4.24). Separation by column chromatography afforded the (E)-α,β-unsaturated aldehyde in 
52 % yield.  
 
Ph
NHPMP
THF,
0 °C, 30 min
MeLi (1 eq)
a. DDQ (1.2 equiv), benzene, r.t., 2 h (no reaction)
b. DDQ (1.1 equiv), benzene, r.t., overnight (tar)
c. DDQ (1.8 equiv), benzene, r.t., 2 h (tar)
d. MnO2, toluene, reflux, 2 h (no reaction)
e. MnO2, toluene, reflux, overnight (tar)
a. to e.
484
485 (24 %)
481
 
 
Scheme 4.25. Addition of MeLi on Aldimine to Produce Amine 485 and Attempts to Oxidise It 
 
The aldehyde (E)-483 was iminated in virtually quantitative yield and the product 
484 was used for the addition of methyllithium to produce the racemic amine 485 in poor 
24 % yield (Scheme 4.25). However, that was enough to carry out the following oxidation 
reactions and no optimisation was attempted. The oxidation was performed with DDQ185 
and freshly prepared manganese dioxide;186 though, no success was achieved. Production 
of tar material or occasional isolation of acetophenone pointed at the instability of the 
possibly-formed imine.  
 
    112
Ph
N OH
Ph
N O
O F
F
F
F
F
Ph
O
MeOH
reflux, 1.5 h
NH2OH.HCl (4 eq)
pyridine (5 eq)
486a (97 %)
Cl
O F
F
F
F
F                                         487a (76 %)
a.                   (1.2 eq), Et3N (2 eq), CH2Cl2, 0 °C, 2 h
b.                              (1.2 eq), Cu(OAc)2, DMF, 0 °C, 3 h
a.
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Scheme 4.26. Copper(II)-catalysed Coupling Reaction 
 
Much milder method of preparation of imine was needed. The nitrogen atom could 
be introduced in the form of oxime 486a, because this is not an equilibrium reaction and 
coupling with an appropriate boronic acid would provide the imine. The final coupling 
precursor pentafluorobenzoate-O-oxime ester187 487a (Scheme 4.26) was formed from the 
corresponding oxime in 76 % yield. Copper(II)-catalysed coupling of 487a with 4-
methoxyphenylboronic acid (Scheme 4.26) afforded only the ketone 466A (41 % yield), 
which might have been a result of hydrolysis of imine 481 by traces of reaction water 
produced from the boronic acid. 
 
Ph
N OH
Ph
N O
O
F
F
F
F
F
486b 487b
Ph
O
464
Ph
N PMP
476t
 
 
Figure 4.1. Reference Intermediates for Cu-catalysed Imine Formation 
 
The whole synthesis was carried out in parallel (Figure 4.1) with 3-methyl-4-
phenylbut-3-en-2-one 464 whose imine 476s was prepared by imination Method C in 22 % 
yield. In this case, the coupling yielded a 1:1 mixture of the desired imine and the 
corresponding ketone (26 % each). It became apparent that the imine 481 would not be 
stable enough to bring it through to the next step. It is likely that the imine of ketone 471A 
would be even less stable.  
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5. Reduction of Imines188  
 
5.1. Preparation of Enantioenriched Amines  
 
The reduction of all imines was carried out under our standard conditions at 0.2 
mmol scale with 2 equivalents of trichlorosilane, 5 mol % of the catalyst Sigamide in 
toluene at ambient temperature for 18 hours under an argon atmosphere (Scheme 5.1). In 
some cases an additive was used to improve the reaction rate.  
 
R1
N
R2
OMe
R1 ∗
HN
R2
OMe
toluene
r.t., 18 h
N
O
N
H
O
cat*
Sigamide
HSiCl3 (2 eq)
cat* (5 %)
 
 
Scheme 5.1. Enantioselective Reduction of Imines 
 
All enantioenriched amines were were also synthesised in their racemic forms 
(Scheme 5.2), either by reduction with sodium borohydride in methanol at ambient 
temperature or by a way analogous to the enantioselective one using DMF as the activator.  
 
R1
N
R2
OMe
R1
HN
R2
OMe
a. or b.
a. NaBH4 (4 eq)
    MeOH, r.t., 2-16 h
b. HSiCl3 (2 eq), DMF (1 eq)
    toluene, r.t., 18 h
 
 
Scheme 5.2. Racemic Reduction of Imines 
 
The typical isolated yields of the racemic amines were 65-95 %. These were 
prepared at 0.3 mmol scale to be used for characterisation and calibration of the HPLC 
conditions.  
 
In the following text, only the formation of enantioenriched amines will be 
discussed, they are colour-coded: yields are in blue, enantiomeric excess in red.  
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5.1.1. Amines Containing N-; N,S- and S-heterocycles  
 
In the previous study,93,101-105 the method showed a good substrate generality, 
however only considering the electronically modified aromatic imines. Introduction of a 
heteroatom into the aromatic system of the model compounds was a natural step towards 
broader applicability in the view of the role of heterocyclic compounds in the 
pharmaceutical industry. At first, substrates containing an N- or S-heterocycle were 
investigated (Figure 5.1, Figure 5.2).  
 
The pyridin-2-yl and pyridin-4-yl derivatives 488a,b were reduced cleanly only 
with the addition of 1 equivalent of acetic acid (Figure 5.1); without it, these substrates 
reacted sluggishly. However, the products turned out to be almost racemic (7 and 21 % ee, 
respectively). In another study, it was shown that the pyridine nitrogen is capable of 
coordinating the silicon of trichlorosilane.89,94 Hence, the lack of enantioselection can be 
attributed to this type of coordination, which is stoichiometric and non-chiral and can 
compete with the coordination to the chiral catalyst, which is present in only 5 mol %. To 
support this theory of the undesired coordination, steric bulk was built around the nitrogen 
of the substrate, as in the 2,6-di-iso-propyl analogue 488c which was reduced with good 
enantioselectivity (78 % ee).  
 
488a
70 % (AcOH)
7 % ee
N
NHPMP
N
NHPMP
488b
72 % (AcOH)
21 % ee
N
NHPMP
488c
68 %
78 % ee
NHPMP
S
488i
77 %
89 % ee
 
 
Figure 5.1. Amines Containing Pyridine and Thiophene Heterocycles 
 
Thiazole is another heterocycle favoured in many pharmaceuticals (Figure 5.2). 
However, in its character it is similar to the pyridine nitrogen and its coordinating 
properties can account for the low observed enantioselectivity (13 %) of the amine 488d. 
Introduction of increased bulk next to the nitrogen as Me < i-Pr < t-Bu improved the 
enantioselectivity in this series (31, 34, and 41 % ee, respectively); though, not as 
efficiently as in the case of pyridine. A drop of enantioselectivity (to 6 % ee) was caused 
by even bulkier, but more electron-donating 4-TMS group in derivative 488h. The longer 
C-Si bond also might have caused overall smaller steric hindrance of the nitrogen.  
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NHPMP
N
S 488d
83 %
13 % ee
NHPMP
S
N
488f
71 %
34 % ee
NHPMP
S
N
488e
30 %
31 % ee
NHPMP
S
N
488g
58 %
41 % ee
NHPMP
S
N
TMS
488h
91 %
6 % ee
 
 
Figure 5.2. Amines Containing Thiazole Heterocycle 
 
Sulfur as a heteroatom is free of negative effects, as shown by the thiophen-2-yl 
derivative 488i (Figure 5.1), where the enantioselectivity (89 % ee) was close to that 
observed for the acetophenone-derived imines (91-94 % ee). 
 
∗
NHPMP
S
∗
N
PG
S
O O
PMP
Diels-Alder
-SO2
R1 R2
∗
N
R1
R2
PG PMP
ox.
 
 
Scheme 5.3. Possible Use of Enantioenriched Thiophene-derived Amine 
 
Thiophene in form of its 1,2-dioxide is known to be a good substrate for Diels-
Alder reaction.189 First attempt of oxidation of thiophene 488i to thiophene-1,1-dioxide 
was performed with Oxone/acetone mixture190 forming 3,3-dimethyldioxirane in situ. This 
produced thiophene-1-oxide 489 undesirably oxidised also at the C-N bond destroying the 
stereogenic centre previously formed (Scheme 5.4).  
 
NHPMP
S S
NPMPOOxone (1.35 eq)
EDTA, NaHCO3
Acetone/H2O
r.t., 2-16 h488i 489 (72 %)
 
 
Scheme 5.4. Oxidation of Thiophene with Oxone 
 
When Oxone was used with the imine 475i, partial hydrolysis occurred (Scheme 
5.5). Thus, more experiments were carried out with the corresponding ketone 490. The 
mild oxidant as m-chloroperoxybenzoic acid191 proved inefficient and the starting ketone 
was recovered. Stronger oxidising reagent potassium peroxydisulfate or aqueous hydrogen 
peroxide in trifluoroacetic acid was utilised, but again with no success. In the latter case, it 
is plausible that Baeyer-Villiger product was formed instead of the 1,1-dioxide.192 Urea-
hydrogen peroxide adduct193 or catalytic methyltrioxorhenium with stoichiometric 
hydrogen peroxide194 were reported to oxidise α,β-unsaturated ketones to lactones or 
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pyridines to their N-oxides, respectively, however they provided no product (at no 
conversion).  
 
NPMP
S
no reaction
a. Oxone (1.35 eq), EDTA, NaHCO3, acetone/H2O, r.t., 2-16 h
b. K2S2O8 (5 eq), DCM/H2O, r.t., 16 h
c. m-CPBA (5 eq), DCM, r.t., 16 h
d. H2O2 (3 eq), TFA, r.t, 3 days
e. UHP (10 eq), Na2HPO4 (9 eq), TFAA (4 eq), CH2Cl2, 20 d
f. MeReO3 (0.5 %), H2O2 (2 eq), CH2Cl2, 2 d
a. to c., e., f.a.
O
S
OS O
491 + tar
475i 490 + tar
d.
 
 
Scheme 5.5. Attempted Oxidation of Thiophene to Its 1,1-Dioxide 
 
It was reported that in the cases where the common oxidants (Scheme 5.5) failed in 
oxidations of sulfides to sulfones, anhydrous conditions were found to be helpful. The 
literature192 also describes how to avoid the Baeyer-Villiger reaction by using extremely 
strong oxidant as 95 % hydrogen peroxide in TFA; however this was not attempted for 
safety concerns. 
 
 
5.1.2. Amines Containing O-heterocycles and N- or O-bicyclics  
 
From the oxygen-containing heterocycles, furan is particularly interesting as it can 
be oxidatively opened to substituted 1,4-dicarbonyls and then further reactions can be 
performed (Scheme 5.6). Several furan-derived imines were prepared to study a library of 
substituted furans which then could undergo other transformations.   
 
∗
NHPMP
O
R
∗
HN O
RR
O O ∗
NHPMP
 
 
Scheme 5.6. Possible Trasformations of Furan 
 
Furan-derived imines 488j-n were found to be reduced with the efficiency laying 
between that of the sulfur and nitrogen heterocycles (45-77 % ee; Figure 5.3). Oxygen in 
the furan ring might also interact with trichlorosilane, which would explain the drop of 
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enantioselectivity in comparison with its thiophene analogue (from 89 to 56 % ee, structure 
488j). Decreased temperature helped to improve the enantioselectivity only marginally, to 
62 % ee at –20 °C and at the expense of reactivity. The substitution in position-5 also 
influenced the enantioselectiviy, however, the results were rather confusing.  
 
NHPMP
O
488l
62 % (AcOH)
63 % ee
TMS
NHPMP
O
488k
86 %
45 % ee
NHPMP
O
488j
62 % (r.t.)
56 % ee 
57 % (−20 °C)
62 % ee
O
NHPMP
488m
62 %
70 % ee
EtOOC
NHPMP
O
488n
75 %
85 % ee
 
Figure 5.3. Amines Containing 2-Substituted Furan 
 
Bulk at the position-5 caused drop or rise of enantioselectivity – the 5-methyl 488k 
(drop to 45 % ee) and 5-TMS 488l (increase to 63 % ee) analogues exhibited the opposite 
trend in comparison to the members of thiazole series (Figure 5.2). Trimethylsilyl group 
can be considered not only as a sterically hindering substituent, but also an electron-
donating one. The effect of an electron-withdrawing group was shown on amine 488m. 
Unfortunately, only marginal change of enantioselectivity was observed (62 %). Good 
enantioselectivity was achieved for the furyl-iso-propyl derivative 488n (85 % ee). The 
effect of the bulk around the prochiral centre of the imine is discussed in Chapter 5.1.3.  
 
O
NHPMP
488p
90 %
91 % ee
O
NHPMP
488o
60 %
77 % ee
 
 
Figure 5.4. Amines Containing 3-Substituted Furan 
 
The results obtained with the furan-2-yl series were slightly disappointing, 
therefore no further synthetic application of these substrates was provided. On the other 
hand, the furan-3-yl derivatives (Figure 5.4) exhibited a significantly higher level of 
asymmetric induction, the 488o (77 % ee) than its 2-isomers 488h (56 % ee). In their case, 
increasing the steric bulk in position-5 had clearly a positive effect, as documented by the 
2,5-dimethyl derivative 488p (91 % ee).  
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NHPMP
O
488q
79 %
70 % ee
Me
N
NHPMP
488s
77 %
91 % ee
MeN
NHPMP
488t
0 %
n.a.
O
NHPMP
488r
84 %
65 % ee
 
 
Figure 5.5. Amines Containing Benzo[b]furan and Indole Heterocycles 
 
The benzo[b]furans 488q (70 % ee) and 488r (65 % ee) followed similar trends as 
the furans (Figure 5.5). N-Methylindol can be viewed as the benzo[b]furan nitrogen 
congener with a non-coordinating (protected) nitrogen atom (Figure 5.5). In contrast to the 
indol-2-yl 488s, which was reduced in good yield and high enantioselectivity (91 % ee), 
the indol-3-yl analogue 488t did not react at all, even with the addition of acetic acid or at 
elevated temperature (50 °C).  
 
 
5.1.3. Aryl-alkyl Chain with Increasing Bulk or Functional Groups  
 
The imines investigated so far were all derived from either electronically modified 
acetophenone or heteroaryl methyl ketones. Naturally, to present a complete study, it was 
of interest to vary the methyl group (Figure 5.6).  
 
NHPMP
492b
98 %
97 % ee
492a
81 %
92 % ee
NHPMP NHPMP
492e
83 %
76 % ee
NHPMP
492f
18 %
10 % ee
46 % (AcOH)
10 % ee
NHPMP
492d
75 % 
94 % ee
NHPMP
492c
87 %
95 % ee
 
Figure 5.6. Aryl-alkyl Amines with Increasing Bulk 
 
The ethyl analogue 492a (92 % ee) turned out to behave in the same way as the 
acetophenone-derived counterpart. Branching in the R2 group, as in the isopropyl 492b, 
had a positive effect, in fact it was the “best-fitting” substrate (97 % ee). The structurally 
similar, but more rigid cyclopropyl 492c and the cyclobutyl derivative 492d were obtained 
in high enantiopurity (95 and 94 % ee, respectively). Moving to the bulkier cyclohexyl 
derivative 492e, a drop of enantioselectivity was observed (76 % ee). Even more sterically 
congested tert-butyl substrate was reduced to 492f in very sluggish and close-to-racemic 
fashion (10 % ee). 
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NHPMP
492j
79 %
6 % ee
MeO CF3
NHPMP
492i
63 %
39 % ee
92 % (AcOH)
38 % ee
NHPMP
492g
83 %
62 % ee
NHPMP
492h
86 %
85 % ee
 
 
Figure 5.7. Dialkyl or Diaryl Amines 
 
The dialkyl imines 492g-i (Figure 5.7) showed a similar pattern as the phenyl-alkyl 
congeners. Good fit of the cyclo-hexyl group in substrate 492h (85 % ee), but drop of 
enantioselectiviy in 492j raised a question of what is the role of the aromatic moiety or the 
bulk of the group. As expected, the iso-propyl substrate was reduced in moderate (62 % ee) 
and tert-butyl-methyl in low enantioselectivity (38 % ee). Hydrolysis occurred partially 
when no additive (e.g. acetic acid) was used, similar to the case of 492f. However, the 
yield was better as 492i has at least one sterically non-hindered site. Furthermore, an imine 
with two electronically opposite aromatic groups was prepared to investigate the 
importance of the electronics in either of sterically identical sides (Figure 5.7). The 
corresponding amine 492j was obtained readily but almost racemic (6 % ee). These results 
show that the electronics in the imine plays a negligible role during the reduction compared 
to the steric effects. 
 
HN
O
O
HN
O
264
91 %
41 % ee
260
69 %
26 % ee
Br
492k
89 %
0 % ee
NHPMP NHPMP
492l
0 %
n.a.
 
 
Figure 5.8. Cyclic Amines 
 
Reduction of the cyclic exo-imines to amines 492k,l (Figure 5.8) was briefly 
investigated. The tetralone-derived imine, which could be viewed as a cyclic analogue of 
492a, was reduced readily, but in a racemic fashion. On the other hand, the isophorone-
derived imine was not reduced at all. The reduction to amines 264 and 260 carrying 
familiar structural features – N-aryl, N-C-phenyl group (R1) and a functionalised carbon 
chain (R2), also proceeded smoothly but in low enantioselectivities (41 and 26 % ee); 
noteworthy, in opposite configuration to each other. These results suggest that a highly 
    120
enantioselective reduction occurs in a conformation that is attainable by the non-cyclic 
imines but not available for the rigid cyclic structures (discussion in Chapter 5.2).  
 
492n
64 %
84 % ee
NHPMP
492m
38 %
88 % ee
NHPMP
COOMe
492o
62 %
82 % ee
NHPMP
Cl
NHPMP
MeO
n
492p: n = 2;  492q: n = 1
98 %         99 %
90 % ee     95 % ee
 
 
Figure 5.9. Aryl-alkyl Amines with Functionalised Side Chain 
 
Further interest lied in functionalised side chain that would be available for 
synthetic transformations. Extension of the R2-alkyl chain to a functionalised one with a 
double bond or a carboxylic acid was also successful in terms of yields and 
enantioselectivity (Figure 5.9). γ-Imino ester was reduced to 492m in comparable 
enantioselectivity as the enamino ester 191105 (88 % ee). Terminal double bond was also 
tolerated well in 492n-p (82-90 % ee) and proved very profitable in the reduction to amine 
492q (95 % ee).  
 
NHPMP
492s
62 %
84 % ee
Fe
NHPMP
492t
0 %
n.a.
NHPMP
492r
94 %
81 % ee
 
 
Figure 5.10. Cinnamyl-methyl and Ferrocene-derived Amines 
 
Extended conjugation and distance between the aromatic nucleus and the imine 
moiety caused a minor decrease of the enantioselectivity (81 and 84 % ee) for the cinnamyl 
derivative 492r and its more hindered α-methyl analogue 492s, respectively (Figure 5.10). 
The ferrocene-based imine was not reduced under our reaction conditions.  
 
NHPMP
TBDMSO
492w
72 %
93 % ee
492v
95 %
95 % ee
NHPMP
492u
0 %
n.a.
NHPMP
 
 
Figure 5.11. Targeting Colchinol 
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Amine 492v containing the 1,3-diphenyl core was obtained in one of the highest 
enantioselectivities (95 % ee) which was exploited in the synthesis of the natural product 
N-acetylcolchinol (Chapter 7.2). Its conjugated analogue 492u was not formed under our 
conditions, possibly because of the extensive conjugation of the imine 476u. A silylether 
protecting group was also tolerated and the amine 492w was prepared in high yield and 
enantiopurity (93 % ee); no desilylation occurred. It is noteworthy to say that the free 
phenol obstructed the reduction and a protecting group must be used.  
 
 
 
5.2. Proposed Mechanism    
  
5.2.1. The Impact of a Brønsted Acid and the Imine (E/Z)-isomerism 
 
Bulkier imines were obtained in mixtures of (E/Z)-isomers, e.g., the phenyl-alkyl 
imines 492b-d existed as up to 5:3 (E:Z) mixtures of isomers. However, the 
enantioselectivity of the Lewis base-catalysed imine reduction with trichlorosilane does not 
seem to be affected by the isomeric non-homogenity of the starting imines as the above-
mentioned imines were reduced to the corresponding amines with 94-97 % ee.  
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Scheme 5.7. Brønsted-acid-catalysed Isomerisation of Imines 
 
The Brønsted-acid-catalysed isomerisation of compounds containing C=N bonds is 
a well-known process (Scheme 5.7; also described in Chapter 2.1.2). The generally 
accepted mechanism involves the initial protonation of the imine nitrogen, generating trace 
amounts of the iminium ion (b), followed by rotation around the C-N bond in the 
mesomeric carbocation (c,d) and loss of the proton. Alternatively, addition of the acid 
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counter-anion to the iminium (b) produces the corresponding tetrahedral intermediate (e) 
which also undergoes rotation to (f) and elimination of a molecule of acid yields the other 
isomer (g). 
 
Traces of hydrochloric acid, naturally present in the moisture-sensitive HSiCl3, 
trigger an (E/Z)-equilibration of imines, which must be faster than the reduction. 
Apparently, the (E)-isomer is the more stable imine species and it is reduced from the re-
face to give the (S)-amine. However, the absence of steric preference for (E)- or (Z)-isomer 
may account for the loss of enantioselectivity and formation of a racemic product in the 
case of imine 492j (Figure 5.7).  
However, protonation does not only catalyse the isomerisation process, but may 
also contribute to the non-selective background reaction by enhancing the electrophilicity 
of the imines in the form of iminium ions. To shed more light on the effect of the solution 
acidity on the rate and enantioselectivity of the reduction catalysed by Sigamide 152d, a 
few common acidic and basic additives were briefly investigated (Table 5.1).  
Reduction of imine 151 in the presence of triflic acid (0.1 equiv) led to a minor 
decrease of enantioselectivity (91 % ee; Table 5.1, entry 1; compare with 93 % ee, Table 
2.17, entry 2 in Chapter 2.4.2). Addition of methanol caused partial hydrolysis of 
trichlorosilane producing HCl and the enantioselectivity of the reduction dropped to 84 % 
ee (Table 5.1, entry 2). In the case of enamino ester 191, the addition of acetic acid was 
found to have a beneficial effect on reactivity at the slight expense of enantioselectivity, 
affording the β-amino ester 196 in 85-89 % ee (Table 5.1, entries 3 and 4). Reduction 
carried out in the presence of the stronger trifluoroacetic acid, afforded a racemic mixture 
of amine 154 (Table 5.1, entry 5).  
 
Table 5.1. Reduction of Imines with Trochlorosilane in the Presence of Additives 
 
Entry Imine  Additive (equiv) Yield (%) / ee (%) 
1 151 CF3SO3H (0.1 equiv) 90 / 91  
2 151 MeOH (1.0 equiv)  90 / 84  
3 191 AcOH (1.5 equiv) 95 / 85  
4 191 AcOH (1.0 equiv)  98 / 89  
5 191 TFA (1.0 equiv)  89 / 0  
6 151 i-Pr2EtN (1.0 equiv)  trace / 0  
7 151 Proton Sponge (1.0 equiv)  0 / n.a.  
8 151 2,6-Lutidine (0.3 equiv)  73 / 92  
9 151 Proton Sponge (1.0 equiv) +  
After 10 min AcOH (1.5 equiv)   
92 / 87  
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By contrast, stoichiometric amounts of proton scavengers, such as i-Pr2EtN 
(Hünig’s base) or 1,8-bis(dimethylamino)naphthalene (proton sponge), were found to slow 
down the reaction dramatically and to ruin the enantioselectivity (Table 5.1, entries 6 and 
7). An analogous effect of a stoichiometric amount of 2,6-lutidine has also been 
observed.99 On the other hand, the reported beneficial effect of sub-stoichiometric amounts 
of this base on enantioselectivity,99 was not noticed with our model imine (Table 5.1, entry 
8; compare with Table 2.16, entries 5-8 in Chapter 2.4.2). The complete loss of reactivity 
in the presence of stoichiometric amounts of bases implies that the Brønsted acid is 
involved in the catalytic cycle. This hypothesis is supported by the observation that the 
addition of acetic acid (1.5 equiv) to the reaction mixture, first deactivated with proton 
sponge (1.0 equiv), restored the reactivity providing the amine in high yield and 87 % ee 
(Table 5.1, entry 9).  
 
 
5.2.2. Impact of the Spatial Organisation    
 
The key importance of low concentrations of H+ for the reaction to occur suggests 
that protonated imines (the iminium ions), might be the actual species undergoing the 
reduction by trichlorosilane (Figure 5.12). It can be speculated that the protonated iminium 
interacts with the catalyst’s secondary anilide carbonyl via hydrogen bonding and 
trichlorosilane is activated by coordination to the formamide carbonyl group to form a 
pentacoordinated silicon species (Figure 5.12, (B)). However, increasing the concentration 
of Brønsted acid in the reaction mixture leads to an erosion of enantioselectivity due to the 
competing non-selective background reduction (Figure 5.12, (C)). 
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Figure 5.12. Proposed Calculated (A) and Our (B) Transition Structure and Non-selective Reduction (C) 
 
A recent mechanistic and computational study on the reduction of imines with 
HSiCl3, catalysed by a series of secondary amides,112 suggests that the catalyst not only 
coordinates to the reagent (in hexacoordinate fashion), but also acts as a proton donor to 
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the imine in the transition structure [Figure 5.12, (A)]. However, the calculated structure 
does not take into account the role of the present Brønsted acid. Moreover, the calculations 
are performed with a model catalyst containing primary amide moiety instead of the 
secondary amides that were used experimentally.  
Based on the experimental results, it is likely that the enantioselective reduction of 
imines proceeds smoothly only in cases when there is enough flexibility in the imine 
structure (Scheme 5.8). Aromatic imines usually attain conformation in which the aromatic 
ring (R1 substituent) is coplanar with the C=N bond to maintain the conjugation, as in (a). 
However, it is not rare that bulkier aromatic groups (or substituted phenyl rings) rotate to 
minimise the steric hindrance (also see Scheme 2.4, Chapter 2.1.2). Thus, it is expected 
that the steric bulk is even greater in the protonated form (b) and more prone to adopt a 
non-coplanar position of the R1 aryl moiety in (c), defined by dihedral angle θ (Scheme 
5.8). The N-aryl group is typically close to perpendicular with respect to the C=N-H plane.  
 
N
OMe
HH N
OMe
HN
OMe
H+
θ
(a) (b) (c)
 
 
Scheme 5.8. Stereochemistry of a Model Imine and Its Protonated Iminium Form 
 
The cases of cyclic imines strongly support the theory that highly enantioselective 
reduction occurs in a conformation attainable by the non-cyclic imines but not available for 
the rigid cyclic structures [Figure 5.13, (A)]. In the cyclic imines 476k and 257/262, the 
aromatic R1 group is locked in coplanar arrangement and the steric congestion around the 
C=N bond prevents the catalyst from coordination and the background racemic reaction is 
the only feasible. Furthermore, the reduced conformational mobility of the N-aryl moiety, 
which is nearly coplanar with the C=N bond in imines 257 and 262 [Figure 5.13, (A)], has 
a similar effect; i.e. the reduction proceeds with much lower enantioselectivities than those 
observed for the acyclic imines.  
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Figure 5.13. Problematic Substrates with: (A) Rigid Conformations and (B) Extreme Bulk 
 
The effect of the steric hindrance is even more obvious in imines containing 
extremely bulky tert-butyl group, which impedes the protonation and/or coordination to the 
catalyst, resulting in low reactivity and enantioselectivity (Figure 5.13, (B)).   
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Figure 5.14. Dihedral Angle in Crystals of Selected Catalysts  
 
It is pertinent to note that the proline-derived catalyst 149b, which has the same 
absolute configuration as Sigamide 152c, induced the formation of (R)-35, i.e. the opposite 
enantiomer to that produced by our catalysts 152a-d. This result suggests that the two 
catalysts assume a different conformation on coordination of the silicon. This is partially 
supported by single crystal X-ray analysis of Kenamide 152a and the acetamide 493, an 
analogue of 149 which significantly differ in the dihedral angle of the CHn-N-C*-alkyl 
fragment188 (n = 2 or 3; Figure 5.14). Note also that the L-alanine-derived (alkyl = Me) 
analogue of 152b also affords (R)-configured amines (see Chapter 2.4.2). The flexibility of 
the valine-derived catalyst combined with the N-methyl moiety of the catalyst is crucial for 
the enantioselectivity, presumably by controlling the spatial orientation of the formamide 
group and relaying the stereochemical information from the chiral centre93 and allow an 
optimal conformation in the transition state. 
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5.2.3. Conclusions    
 
Trichlorosilane is a main building block of silicon industry (chips, solar cells), thus 
it is a cheap reducing agent, easily handled when techniques for moderately moisture-
sensitive compounds are taken into account. Toluene as solvent represents lower 
environmental risk than the commonly used chlorinated solvents and aqueous work-up 
only produces non-toxic inorganic materials (NaCl and silica). Catalyst 152d is a bench-
stable compound synthesised in four steps from N-BOC-valine.93b Its reaction reliability 
and wide spectrum of substrates made it a suitable for commercial sale. It appeared under 
name Sigamide in the Aldrich catalogue from year 2008 (₤120 per 100 mg). 
 
A broad scope of the reduction of imines with trichlorosilane catalysed by the 
Lewis-basic Sigamide 152d was demonstrated in this thesis. Current limitations are 
relatively few:  
 
-  the reaction exhibits very low enantioselectivity with imines derived from pyridine 
(containing a coordinating nitrogen atom), but a remedy to this flaw was found in 
the shape of steric bulk around the heteroatom,  
-  reduction of imines derived from diaryl ketones gives practically racemic products 
even if the two aryl groups differ in their electronics,  
-  the current system only works efficiently with imines derived from aromatic 
amines (e.g., aniline and anisidine), nevertheless, the anisidine-derived amines can 
be oxidatively deprotected to produce primary amines,  
-  imines derived from cyclic ketones exhibit low enantioselectivity.  
 
Excluding the difficult types of substrates, high enantioselectivity (typically up to 
90 % ee) was observed across the spectrum of aromatic, heteroaromatic, and aliphatic 
substrates, which may contain additional functional groups (protected hydroxyl, carboxyl 
or double bonds). The reaction proceeds in toluene at room temperature overnight with 5 
mol % of the catalyst. Hence, our protocol compares competitively with its alternatives, 
such as catalytic hydrogenation, reduction with Hantzsch dihydropyridines catalysed by 
chiral acids or reduction with boranes. 
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6. Experimental Part 
 
6.1. General    
 
6.1.1. General Methods 
 
Melting points were determined on a Kofler block and are uncorrected. Optical 
rotations were recorded in CHCl3 unless otherwise indicated, with an error of ≤(±0.1), the 
[α]D values are given in 10-1 deg.cm3.g-1. The NMR spectra were recorded in CDCl3, 1H at 
400.0 MHz and 13C at 100.6 MHz with chloroform-d1 (δ 7.26, 1H; δ 77.0, 13C) or TMS as 
internal standard unless otherwise indicated. Various 2D-techniques and DEPT 
experiments were used to establish the structures and to assign the signals. The IR spectra 
were recorded for a thin film of CHCl3 solutions between NaCl plates unless otherwise 
stated. The mass spectra (EI and/or CI) were measured on a dual sector mass spectrometer 
using direct inlet and the lowest temperature enabling evaporation. The enantiomeric 
excess values (ee) were determined by HPLC equipped with diode array detector and were 
calibrated with the corresponding racemic mixtures. The identity of the products prepared 
by different methods was checked by comparison of their NMR, IR, and MS data and by 
the TLC behaviour.  Yields are given for isolated products showing one spot on a TLC 
plate and no impurities detectable in the NMR spectrum. 
 
 
6.1.2. Materials  
 
Some reactions, when needed, were performed under an atmosphere of dry, 
oxygen-free argon in oven-dried glassware three times evacuated and filled with the argon. 
Solvents and solutions were transferred by syringe-septum or cannula technique. Solvents 
for the anhydrous reactions were of reagent grade and were distilled immediately before 
use as follows: tetrahydrofuran (THF) from sodium/benzophenone; dichloromethane and 
triethylamine from calcium hydride, benzene was distilled from sodium and stored over 4Å 
molecular sieves and under argon, methanol (MeOH) was distilled from magnesium / 
magnesium methoxide, absolute ethanol (EtOH) from magnesium / magnesium ethoxide 
and stored over 4Å molecular sieves and under argon. Alternatively, THF, toluene and 
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dichloromethane were obtained from Pure-Solv™ Solvent Purification System (Innovative 
Technology). Aniline and p-anisidine were distilled prior to use. All other chemicals 
needed were used as received unless otherwise stated. Petroleum ether (PE) refers to the 
fraction boiling in the range of 40-60 ºC, AcOEt refers to ethyl acetate, AcOH refers to 
acetic acid, TsOH refers to p-toluenesulfonic acid and Py refers to pyridine. Saturated 
solutions of NaHCO3 or NH4Cl refer to aqueous solutions unless otherwise stated.  
 
 
 
6.2. Precursors and Ketones    
 
4-Acetyl-2,6-di-iso-propylpyridine (327), C13H19NO, FW = 205.33 
N
O
327
 
Neat tert-butylhydroperoxide (11.3 mL, 61.9 mmol, 2.5 equiv) was added to a solution of 
4-acetylpyridine (2.74 mL, 24.8 mmol, 1 equiv), iso-propyl iodide (3.42 mL, 99.0 mmol, 4 
equiv), trifluoroacetic acid (1.84 mL, 24.8 mmol, 1 equiv) and ferric acetate (29 mg, 1.24 
mmol, 5 mol %v) in acetic acid (250 mL) and the mixture was refluxed overnight. The 
reaction was quenched with NaOH (2.0 M, 600 mL) and the aqueous layer was extracted 
with CH2Cl2 (3 × 150 mL). The combined organic layers were dried over MgSO4 and 
evaporated. The residue was purified on a silica gel column (75 mL) with a petroleum 
ether – ethyl acetate mixture (92:8) to afford 327 (355 mg, 1.73 mmol, 7 %): colourless 
liquid; 1H NMR (400 MHz, CDCl3) δ 1.28 (d, J = 6.9 Hz, 12H), 2.58 (s, 3H), 3.08 (sept, J 
= 6.9 Hz, 2H), 7.37 (s, 2H); 13C NMR δ 22.49 (4 × CH3), 26.74 (2 × CH), 36.39 (CH3), 
115.17 (2 × CH), 143.83 (C), 167.83 (2 × C), 198.40 (C); IR ν 2964, 2929, 2871, 1697, 
1564, 1468, 1409, 1359, 1283, 1202 cm-1; MS (CI/isobutane) m/z (%) 206 [(M+H)+, 100], 
205 (33), 204 (90), 202 (33), 143 (10); HRMS (CI/isobutane) 206.1546 (C13H20NO 
requires 206.1545). 
 
α-Bromination of Ketones:195  
Neat bromine (5.12 mL, 16.0 g, 100 mmol, 1 equiv) was added drop-wise to a cooled (–30 
ºC) solution of ketone (100 mmol, 1 equiv, see Table 6.1) in methanol (50 mL) over a 
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period of 30 min. The reaction mixture was allowed to warm to room temperature, at 
which time the solution became colourless and was immediately quenched with cold 
saturated NaHCO3 (1 mL). After 5 min, water was added (50 mL) and extracted with 
petroleum ether (3 × 50 mL). The combined organic layers were dried over MgSO4 and 
evaporated to afford crude liquid product (strong lachrymatory!) which was used without 
further purification.  
 
Table 6.1. Preparation of α-Bromoketones  
 
Ketone α-Bromoketone product 
3-methylbutan-2-one (10.7 mL, 8.61 g) 330 (10.5 g, 64 mmol, 64 %) 
3,3-dimethylbutan-2-one (12.5 mL, 10.2 g) 331 (17.4 g, 97.2 mmol, 97 %) 
 
1-Bromo-3-methyl-butan-2-one (330),196 C5H9OBr, FW = 165.04: greyish 
liquid; 1H NMR (400 MHz, CDCl3) δ 1.10 (d, J = 6.9 Hz, 6H), 2.92 (sept d, J = 
6.9, 0.7 Hz, 1H), 3.96 (br s, 2H). 
 
1-Bromo-3,3-dimethyl-butan-2-one (331),195 C6H11OBr, FW = 179.07: 
colourless liquid; 1H NMR (400 MHz, CDCl3) δ 1.21 (s, 9H), 4.16 (s, 2H). 
 
Cyclisation of Thiazoles:162  
Solid diphosphorus pentasulfide (0.2 equiv) was added to a stirred mixture of α-ketone (1 
equiv) and formamide (2 equiv) pre-cooled to 0 ºC (Table 6.2). The reaction mixture was 
allowed to warm to room temperature (highly exothermic reaction occurred when the 
temperature reached 5 ºC) and the slurry was heated to 90 ºC for 1 h. Then it was diluted 
with water (50 mL), basified with saturated aqueous ammonia and extracted with ethyl 
acetate. The combined organic layers were washed with brine (60 mL), dried over MgSO4 
and evaporated. Distillation of the crude mixture afforded pale yellow liquid of thiazole 
(stench!).  
 
Table 6.2. Preparation of Thiazoles   
 
α-Bromoketone  Formamide P2S5  Alkylthiazole 
330  
(10.5 g, 64.0 mmol) 
5.05 mL, 5.73 g, 
127 mmol 
5.65 g,  
12.7 mmol 
332  
(2.78 g, 21.9 mmol, 34 %) 
331  
(17.0 g, 94.9 mmol) 
7.5 mL, 8.6 g, 189 
mmol 
8.44 g,  
19.0 mmol 
333  
(3.49 g, 24.7 mmol, 26 %) 
 
 
O
Br
O
Br
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4-iso-Propylthiazole (332), C6H9NS, FW = 127.22: pale yellow liquid; bp 25 
ºC (18 mbar); 1H NMR (400 MHz, CDCl3) δ 1.29 (d, J = 6.9 Hz, 6H), 3.12 
(sept d, J = 6.9, 0.7 Hz, 1H), 6.88 (dd, J = 2.0, 0.9 Hz, 1H), 8.71 (d, J = 2.0 Hz, 
1H); 13C NMR δ 22.32 (2 × CH3), 30.63 (CH), 110.69 (CH), 152.11 (CH), 164.30 (C); IR 
ν 3116, 3083, 2964, 2928, 2873, 1702, 1508, 1409, 1280 cm-1.  
 
4-tert-Butylthiazole (333),162 C7H11NS, FW = 141.25: pale yellow liquid; bp 
55 ºC (60 mbar); 1H NMR (400 MHz, CDCl3) δ 1.37 (s, 9H), 6.95 (d, J = 2.0 
Hz, 1H), 8.75 (d, J = 2.0 Hz, 1H); 13C NMR δ 30.13 (3 × CH3), 34.67 (C), 
110.14 (CH), 152.09 (CH), 167.42 (C).  
 
Acetylation of 4-iso-propylthiazole:163   
A solution of thiazole 332 (2.00 g, 15.7 mmol, 1 equiv) in anhydrous ether (0.2M, 79 mL) 
was added drop-wise to a solution of n-butyllithium (1.6M in pentane, 12.8 mL, 20.4 
mmol, 1.3 equiv) in ether (13 mL) at –80 ºC and let to stir. After 1 h, a solution of ethyl 
acetate (3.08 mL, 2.77 g, 31.4 mmol, 2 equiv) in ether (0.2 M, 157 mL) was added drop-
wise at –80 ºC. The mixture was let to stir at –80 ºC for 10 min and then let to warm to 
room temperature. Then it was quenched with saturated NaHCO3 (100 mL) and extracted 
with ether (2 × 30 mL). The combined organic layers were washed with brine (30 mL), 
dried over MgSO4 and evaporated. The crude product was purified on a silica gel column 
(60 mL) with a gradient of petroleum ether to petroleum ether – ethyl acetate mixture 
(95:5) to afford the desired acetylthiazole 334A and over-reacted alcohol 334B.  
 
 2-Acetyl-4-iso-propylthiazole (334A), C8H11NOS, FW = 169.26 (1.30 
g, 7.65 mmol, 49 %): pale yellow liquid; 1H NMR (400 MHz, CDCl3) δ 
1.31 (d, J = 6.9 Hz, 6H), 2.67 (s, 3H), 3.13 (sept d, J = 6.9, 0.7 Hz, 1H), 
7.22 (d, J = 0.8 Hz, 1H); 13C NMR δ 22.38 (2 × CH3), 26.03 (CH3), 31.00 (CH), 119.01 
(CH), 166.08 (C), 166.15 (C), 191.93 (C); IR ν 3358, 3105, 2966, 2928, 2871, 1691, 1499, 
1430, 1360, 1274 cm-1; MS (EI) m/z (%) 169 (M˙+, 38), 154 (50), 112 (35); HRMS (EI) 
169.0558 (C8H11NOS requires 169.0561).  
 
2-(2’-Hydroxy-hex-2’-yl)-4-iso-propylthiazole (334B), 
C12H21NOS, FW = 227.39 (992 mg, 4.38 mmol, 28 %): yellow 
liquid; 1H NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.2 Hz, 3H), 1.10-
N
S
N
S
N
S OA
N
S OHB
n-Bu
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1.41 (m, 4H), 1.27 (dd, J = 6.9, 0.6 Hz, 6H), 1.59 (s, 3H), 1.83-1.85 (m, 2H), 3.04 (sept d, 
J = 6.9, 0.9 Hz, 1H), 3.50 (br s, 1H), 6.76 (d, J = 0.9 Hz, 1H); 13C NMR δ 13.94 (CH3), 
22.17 (CH3), 22.24 (CH3), 22.77 (CH2), 25.76 (CH2), 29.48 (CH3), 30.75 (CH), 43.56 
(CH2), 75.13 (C), 110.54 (CH), 162.80 (C), 177.44 (C); IR ν 33426, 3113, 2960, 2932, 
2871, 1519, 1462, 1381, 1165 cm-1; MS (CI/isobutane) m/z (%) 228 [(M+H)+, 100], 210 
(42), 170 (20); HRMS (CI/isobutane) 228.1416 (C12H22NOS requires 228.1422).  
 
2-Acetyl-4-tert-butylthiazole (335), C9H13NOS, FW = 183.29 
N
S O335
 
n-Butyllithium (7.43 mL, 2.0M in pentane, 14.9 mmol, 1.05 equiv) was added drop-wise to 
a solution of thiazole 333 (2.00 g, 14.2 mmol, 1 equiv) in anhydrous THF (30 mL, 0.2 M) 
under an argon atmosphere at –80 ºC.164 After 1 h at this temperature, neat N-acetyl 
morpholine (2.13 mL, 2.38 g, 18.4 mmol, 1.3 equiv) was added drop-wise and the mixture 
was let to warm up to room temperature. The reaction mixture was diluted with ether (50 
mL) and washed with a saturated NaHCO3 solution (20 mL), dried over MgSO4 and 
concentrated. The residue was purified on a  silica gel column (120 mL) with a gradient of 
petroleum ether to petroleum ether – ethyl acetate mixture (97:3) to afford the desired 
acetylthiazole 335 (1.37 g, 7.47 mmol, 53 %): pale yellow liquid which solidified upon 
standing; mp 26-27 ºC; 1H NMR (400 MHz, CDCl3) δ 1.38 (s, 9H), 2.70 (s, 3H), 7.25 (s, 
1H); 13C NMR δ 25.96 (CH3), 30.06 (3 × CH3), 35.02 (C), 118.17 (CH), 165.98 (C), 
168.99 (C), 192.16 (C); IR (ATR) ν 3099, 2955, 1679, 1493, 1417, 1355, 1276, 1245 cm-1; 
MS (EI) m/z (%) 183 (M˙+, 30), 168 (100), 141 (15), 126 (55); HRMS (EI) 183.0721 
(C9H13NOS requires 183.0718).  
 
Acetylation of 2,4-Dibromothiazole:  
Method A:166a A solution of iso-propylmagnesium chloride (2.06 mL, 4.12 mmol, 2.0 M in 
THF, 1 equiv) was added drop-wise to a solution of 2,4-dibromothiazole (1.00 g, 4.12 
mmol, 1.0 equiv) in anhydrous THF (10 mL) at 0 ºC and let to stir for 1 h. Then neat 
acetonitrile (323 µL, 254 mg, 6.18 mmol, 1.5 equiv) was added drop-wise. The mixture 
was let to warm to room temperature and stirred additional 1 h after which it was quenched 
with water (10 mL) and extracted with ether (3 × 15 mL). The combined organic layers 
were washed with brine (20 mL), dried over MgSO4 and concentrated in vacuo. The crude 
product was purified on a silica gel column (25 mL) with a petroleum ether – ethyl acetate 
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mixture (95:5) to afford the desired acetylthiazole 337A, debrominated product 337B 
resulting from the quenched unreacted 2-magnesiothiazole chloride and recovered starting 
material (151 mg).  
 
2-Acetyl-4-bromothiazole (337A),197 C5H4NOSBr, FW = 206.04 (122 
mg, 0.592 mmol, 14 %): white crystals; mp 65-66 ºC (hexane, with 
sublimation); 1H NMR (400 MHz, CDCl3) δ 2.69 (s, 3H), 7.78 (s, 1H); 13C 
NMR δ 25.82 (CH3), 125.03 (CH), 126.85 (C), 166.82 (C), 190.36 (C); IR ν 3080, 3019, 
1691, 1458, 1386, 1274 cm-1; MS (EI) m/z (%) 207 (M˙+, 10), 205 (M˙+, 10), 179 (10), 177 
(10); HRMS (EI) 204.9196 (C5H4NOS79Br requires 204.9197), 206.9183 (C5H4NOS81Br 
requires 206.9176). 
 
4-Bromothiazole (337B),198 C3H2NSBr, FW = 206.04 (197 mg, 01.20 mmol, 
29 %): yellowish liquid; 1H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 2.3 Hz, 
1H), 8.74 (d, J = 2.2 Hz, 1H).   
 
Method B:164 n-Butyllithium (6.80 mL, 2.0 M in pentane, 13.58 mmol, 1.1 equiv) was 
added drop-wise to a solution of 2,4-dibromothiazole (3.00 g, 12.35 mmol, 1.0 equiv) in 
THF (14 mL) under an argon atmosphere at –80 ºC. After 30 min at this temperature, neat 
N-acetyl morpholine (2.00 mL, 2.23 g, 17.29 mmol, 1.4 equiv) was added drop-wise and 
the mixture was stirred for 2 h at –80 ºC. The reaction mixture was diluted with ether (50 
mL) and washed with a saturated NaHCO3 solution (20 mL), dried over MgSO4 and 
concentrated. The residue was purified on a  silica gel column (60 mL) with a petroleum 
ether – ethyl acetate mixture (95:5) to afford the desired acetylthiazole 337B (1.43 g, 6.94 
mmol, 56 %). 
 
2-Methyl-2-(4’-bromothiazol-2’-yl)-1,3-dioxolane (339), C7H8NO2SBr, FW = 250.12 
N
S O
O
Br
339
 
A solution of 337B (1.55 g, 7.52 mmol, 1 equiv), ethyleneglycol (1.31 mL, 1.87 g, 30.1 
mmol, 4 equiv) and p-tolueneulfonic acid (142 mg, 0.752 mmol, 10 mol %) in toluene was 
refluxed in a Dean-Stark apparatus for 10 hours.167 The reaction mixture was cooled to 
room temperature, concentrated, loaded on a silica gel column (40 mL) and eluted with a 
petroleum ether – ethyl acetate mixture (99:1 to 90:10) to afford the dioxolane 339 (1.84 g, 
N
S
Br
C
N
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Br
B
    133
7.36 mmol, 98 %): pale yellow liquid; 1H NMR (400 MHz, CDCl3) δ 1.81 (s, 3H), 3.97-
4.13 (m, 4H), 7.19 (s, 1H); 13C NMR δ 25.25 (CH3), 65.57 (2 × CH2), 106.75 (C), 117.87 
(CH), 125.46 (C), 173.31 (C); IR ν 3115, 2992, 2890, 1476, 1423, 1373, 1254, 1196 cm-1; 
MS (EI) m/z (%) 251 (M˙+, 10), 249 (M˙+, 10), 236 (32), 234 (32), 208 (20), 206 (20), 192 
(18), 190 (18), 87 (100); HRMS (EI) 250.9436 (C7H8NO281Br requires 250.9438), 
248.9460 (C7H8NO279Br requires 248.9459); 
 
Silylation of Bromothiazole:167  
n-Butyllithium (4.30 mL, 2.0 M in pentane, 8.64 mmol, 1.2 equiv) was added drop-wise to 
a solution of 339 (1.80 g, 7.20 mmol, 1.0 equiv) in THF (14 mL) under an argon 
atmosphere at –80 ºC and the mixture was stirred at this temperature for 30 min. Then neat 
trimethylsilyl chloride (1.66 mL, 1.41 g, 13.0 mmol, 1.8 equiv) was added drop-wise to the 
resulting red slurry and it was stirred at this temperature for 1 h. The solution was then let 
to warm to room temperature and quenched with water (20 mL). The aqueous layer was 
extracted with ether (2 × 15 mL), the combined organic layers were dried over Na2SO4 and 
evaporated. The residue was purified on a silica gel column (60 mL) with a solvent 
gradient from petroleum ether to a mixture of petroleum ether – ethyl acetate (90:10) 
affording three products.   
 
2-Methyl-2-(4’-trimethylsilylthiazol-2’-yl)-1,3-dioxolane (341A), 
C10H17NO2SSi, FW = 243.43 (882 mg, 3.62 mmol, 49 %): pale yellow 
liquid; 1H NMR (400 MHz, CDCl3) δ 0.32 (s, 9H), 1.83 (s, 3H), 3.97-
4.15 (m, 4H), 7.75 (s, 1H); 13C NMR δ –0.11 (3 × CH3), 25.50 (CH3), 65.37 (2 × CH2), 
107.23 (C), 133.50 (C), 148.91 (CH), 176.72 (C); IR ν 2991, 2956, 2894, 1498, 1372, 
1252, 1201 cm-1; MS (CI/isobutane) 244 [(M+H)+, 100], 113 (20), 85 (38); HRMS 
(CI/isobutane) 244.0832 (C10H18NO2SSi requires 244.0828).  
 
2-Methyl-2-(4’-bromo-5’-trimethylsilylthiazol-2’-yl)-1,3-dioxolane 
(341B), C10H16NO2SBrSi, FW = 322.32 (1.03 g, 3.18 mmol, 43 %): 
thick pale yellow oil which solidified upon standing; mp 55-56 ºC 
(hexane); 1H NMR (400 MHz, CDCl3) δ 0.39 (s, 9H), 1.81 (s, 3H), 4.00-4.12 (m, 4H); 13C 
NMR δ –0.84 (3 × CH3), 25.27 (CH3), 65.48 (2 × CH2), 106.82 (C), 129.35 (C), 131.05 
(C), 175.98 (C); IR ν 2991, 2957, 2895, 1473, 1403, 1372, 1253, 1203 cm-1; MS (EI) m/z 
(%) 323 (M˙+, 18), 321 (M˙+, 18), 308 (70), 306 (70), 280 (80), 278 (80), 264 (10), 262 
N
S O
O
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(10), 87 (100); HRMS (EI) 322.9832 (C10H16NO2S81BrSi requires 322.9834), 320.9850 
(C7H8NO2S79BrSi requires 320.9854).  
 
2-Methyl-2-[4’,5’-bis(trimethylsilyl)thiazol-2’-yl]-1,3-dioxolane 
(341C), C13H25NO2SSi2, FW = 315.63 (181 mg, 0.573 mmol, 7 %): 
pale yellow oil; 1H NMR (400 MHz, CDCl3) δ 0.36 (s, 9H), 0.38 (s, 
9H), 1.86 (s, 3H), 4.10 (s, 4H). 
 
2-Acetyl-4-trimethylsilylthiazole (343), C8H13NOSSi, FW = 199.37 
N
S O
Si
343
 
A solution of 341A (730 mg, 3.00 mmol, 1 equiv) and pyridinium tosylate (113 mg, 0.450 
mmol, 15 mol %) in an acetone (17 mL) / water (3 mL) mixture was refluxed for 4 days.199 
The reaction mixture was concentrated in vacuo, the residue was dissolved in ether, and the 
resulting solution was washed with water (2 × 30 mL) and evaporated. The residue was 
purified by flash chromatography on a silica gel column (30 mL) with a petroleum ether – 
ethyl acetate mixture (98:2) to afford 343 (394 mg, 1.98 mmol, 66 %): colourless liquid; 
1H NMR (400 MHz, CDCl3) δ 0.37 (s, 9H), 2.72 (s, 3H), 4.01-4.14 (m, 4H), 7.97 (s, 1H); 
13C NMR δ –0.26 (3 × CH3), 26.33 (CH3), 142.04 (C), 149.85 (CH), 171.08 (C), 191.46 
(C); IR ν 2958, 1688, 1479, 1387, 1358, 1267, 1254 cm-1; MS (EI) m/z (%) 199 (M˙+, 45), 
184 (90), 142 (38), 115 (50); HRMS (EI) 199.0489 (C8H13NOSSi requires 199.0487).  
 
2-(Furan-2’-yl)-2-methyl-1,3-dioxolane (340), C8H10O3, FW = 154.18 
O
O O
340
 
A solution of 2-acetylfuran (2.20 g, 20.0 mmol, 1 equiv), ethyleneglycol (3.13 mL, 4.47 g, 
72.0 mmol, 3.6 equiv) and p-toluenesulfonic acid (38 mg, 0.200 mmol, 1 mol %) in 
toluene was refluxed in a Dean-Stark apparatus for 10 hours.167 The reaction mixture was 
cooled to room temperature and washed with a saturated NaHCO3 solution (50 mL), water 
(2 × 50 mL) and concentrated in vacuo. The residue was filtered through a short silica gel 
column (35 mL) with petroleum ether to obtain 340 (1.13 g, 7.33 mmol, 37 %): colourless 
liquid; 1H NMR (400 MHz, CDCl3) δ 1.72 (s, 3H), 3.96-4.06 (m, 4H), 6.29 (dd, J = 3.2, 
1.7 Hz, 1H), 6.30 (dd, J = 3.2, 1.0 Hz, 1H), 7.35 (dd, J = 1.7, 1.0 Hz, 1H); 13C NMR δ 
N
S O
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24.33 (CH3), 65.12 (2 × CH2), 104.71 (C), 106.49 (CH), 109.86 (CH), 142.35 (CH), 154.44 
(C); IR ν 3121, 2993, 2891, 1373, 1258, 1199, 1039 cm-1; MS (CI/isobutane) m/z (%) 155 
[(M+H)+, 100], 139 (30), 111 (12), 109 (11), 87 (14); HRMS (CI/isobutane) 155.0710 
(C8H11O3 requires 155.0708).  
 
2-Methyl-2-(5’-Trimethylsilylfuran-2’-yl)-1,3-dioxolane (342), C11H18O3Si, FW = 
226.38  
O
Si
O O
342
 
n-Butyllithium (1.6 M in hexane, 3.04 mL, 4.87 mmol, 1.5 equiv) was added to a solution 
of 340 (500 mg, 3.24 mmol, 1 equiv) in THF (3 mL) under an argon atmosphere at –80 ºC 
and the mixture was stirred at this temperature for 2 h.167 Then trimethylsilyl chloride (829 
µL, 705 mg, 6.49 mmol, 2 equiv) was added drop-wise to the resulting red solution and the 
solution was let to warm to room temperature and to stir for 3 h. Then the mixture was 
diluted with CH2Cl2 (2 mL) and quenched with water (3 mL). The aqueous layer was 
extracted with CH2Cl2 (2 × 5 mL), the combined organic layers were dried over Na2SO4 
and evaporated. The residue was purified by flash chromatography on a silica gel column 
(25 mL) with petroleum ether to afford 342 (562 mg, 2.48 mmol, 77 %): colourless liquid; 
1H NMR (400 MHz, CDCl3) δ 0.25 (s, 9H), 1.74 (s, 3H), 3.98-4.06 (m, 4H), 6.28 (d, J = 
3.2 Hz, 1H), 6.52 (d, J = 3.2 Hz, 1H); 13C NMR δ –1.71 (3 × CH3), 24.15 (CH3), 64.99 (2 
× CH2), 104.72 (C), 106.25 (CH), 119.65 (CH), 158.60 (C), 160.21 (C); IR ν 2960, 2896, 
1374, 1251, 1185, 1040 cm-1; MS (EI) m/z (%) 226 (M˙+, 20), 212 (38), 211 (100), 167 
(82), 87 (32); HRMS (EI) 226.1026 (C11H18O3Si requires 226.1025). 
 
2-Acetyl-5-trimethylsilylfuran (344), C9H14O2Si, FW = 182.32  
O
Si
O344
 
A solution of 342 (500 mg, 2.21 mmol, 1 equiv) and pyridinium tosylate (83 mg, 0.330 
mmol, 15 mol %) in an acetone (13 mL) – water (2 mL) mixture was refluxed for 3 h and 
then stirred overnight at room temperature overnight.199 The reaction mixture was 
concentrated in vacuo, the residue was dissolved in ether, and the resulting solution was 
washed with water (2 × 20 mL) and evaporated. The residue was purified on a silica gel 
column (25 mL) with a petroleum ether – ethyl acetate mixture (99:1) to afford 344200  
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(355 mg, 1.94 mmol, 88 %): colourless liquid; 1H NMR (400 MHz, CDCl3) δ 0.30 (s, 9H), 
2.47 (s, 3H), 6.68 (d, J = 3.5 Hz, 1H), 7.14 (d, J = 3.5 Hz, 1H); 13C NMR δ –1.96 (3 × 
CH3), 26.14 (CH3), 117.00 (CH), 121.24 (CH), 156.45 (C), 166.45 (C), 189.97 (C); IR ν 
2960, 1689, 1563, 1453, 1360, 1252, 1118 cm-1; MS (EI) m/z (%) 182 (M˙+, 44), 167 
(100), 151 (23); HRMS (EI) 182.0767 (C9H14O2Si requires 182.0763).  
 
Two-step Procedure for Preparation of Ethyl 5-acetylfuran-2-carboxylate:  
n-Butyllithium (1.6 M in hexane, 4.30 mL, 6.81 mmol, 1.5 equiv) was added to a solution 
of 340 (700 mg, 4.54 mmol, 1 equiv) in THF (3.5 mL) under an argon atmosphere at –80 
ºC and the mixture was stirred at this temperature for 2 h.167 The resulting red solution was 
transferred by cannula technique onto a large excess of dry ice continuously cooled to –80 
ºC. After 3 h (or when all the dry ice was consumed) the suspension was dissolved in water 
(15 mL) and extracted with ether (3 × 20 mL). Then the aqueous layer was acidified to pH 
3 and extracted with ether (3 × 20 mL); the combined organic layers (of the latter 
extraction) were washed with water, dried over MgSO4 and evaporated. The crude acid 
345 thus obtained was considered pure enough to be used directly in the next step.  
 
Triethylamine (484 µL, 308 mg, 3.20 mmol, 1.05 equiv) was added to a solution of the 
crude acid (470 mg, approximated as 3.05 mmol, 1 equiv) in CH2Cl2 (14 mL).168 The 
mixture was cooled to 0 ºC and ethyl chloroformate (310 µL, 316 mg, 3.05 mmol, 1 equiv) 
was added dropwise. The mixture was let to warm to room temperature, then refluxed for 2 
h and let to stir at room temperature overnight. The reaction was quenched with water (10 
mL), the aqueous layer was extracted with CH2Cl2 (2 × 10 mL), the organic layers were 
combined, dried over MgSO4, and evaporated. The residue was purified by 
chromatography on a silica gel column (60 mL) with a petroleum ether – ethyl acetate 
mixture (85:15) to obtain white crystalline solid 346 (317 mg, 1.74 mmol, 38 % over two 
steps).  
 
Ethyl 5-acetylfuran-2-carboxylate (346), C9H10O4, FW = 182.19 
O
O346
EtO
O
 
346:201 white crystals; mp 69-70 ºC (hexane/CH2Cl2), [lit.201 gives 77 ºC (EtOH)]; 1H 
NMR (400 MHz, CDCl3) δ 1.38 (t, J = 7.1 Hz, 3H), 2.55 (s, 3H), 4.39 (q, J = 7.1 Hz, 2H), 
7.18 (d, J = 3.7 Hz, 1H), 7.20 (d, J = 3.7 Hz, 1H); 13C NMR δ 14.29 (CH3), 26.41 (CH3), 
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61.71 (CH2), 116.69 (CH), 118.63 (CH), 146.55 (C), 154.16 (C), 158.21 (C), 187.65 (C); 
IR ν 3020, 1725, 1686, 1575, 1298, 1263, 1217 cm-1; MS (EI) m/z (%) 182 (M˙+, 54), 169 
(82), 154 (32), 139 (100), 137 (50), 95 (52), 86 (40), 84 (61); HRMS (EI) 182.0582 
(C9H10O4 requires 182.0579). 
 
Benzo[b]furan-3-carbaldehyde (348), C9H6O2, FW = 146.15 
O
O
348
 
Freshly distilled phosphous oxytrichloride (12.6 mL, 20.8 g, 135 mmol, 8 equiv) was 
added drop-wise to a stirred solution of benzofuran (1.87 mL, 2.00 g, 16.9 mmol, 1 equiv) 
in anhydrous DMF (10.5 mL, 9.90 g, 135 mmol, 8 equiv) at 80 ºC and the to stir for 24 h at 
this temperature.202 After cooling to room temperature, the reaction was quenched with 
water (150 mL) and extracted with ethyl acetate (3 × 30 mL). The combined organic layers 
were washed with brine (20 mL), dried over MgSO4 and evaporated. The crude product 
was purified on a silica column (30 mL) with a gradient of petroleum ether to petroleum 
ether – ethyl acetate mixture (95:5) to furnish yellowish liquid aldehyde 348202 (897 mg, 
6.14 mmol, 36 %): yellowish liquid; 1H NMR (400 MHz, CDCl3) δ 7.32 (ddd, J = 7.9, 7.1, 
1.0 Hz, 1H), 7.50 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H), 7.55 (d, J = 1.0 Hz, 1H), 7.58 (ddd, J = 
8.5, 1.7, 0.9 Hz, 1H), 7.73 (ddd, J = 7.9, 1.2, 0.8 Hz, 1H), 9.85 (s, 1H); 13C NMR δ 112.56 
(CH), 117.82 (CH), 123.56 (CH), 124.10 (CH), 126.53 (C), 129.12 (CH), 152.55 (C), 
156.15 (C), 179.65 (CH); IR ν 3123, 3092, 2835, 1685, 1611, 1557, 1448, 1328, 1289 
cm-1; MS (EI) m/z (%) 116 (M˙+, 100), 145 (90), 118 (17), 89 (70); HRMS (EI) 146.0369 
(C9H6O2 requires 146.0368). 
 
General Procedure for Grignard Addition:169  
Grignard reagents were commercial solutions (methylmagnesium bromide, iso-
propylmagnesium chloride) or freshly prepared from the corresponding alkyl halogenide 
(methyl iodide, allyl bromide, 5-bromopent-1-ene) and magnesium (1:1 equiv) as follows:  
 
The alkyl halogenide was added drop-wise to magnesium turnings in ether in a three-
necked flask under an argon atmosphere and the reaction mixture was heated to maintain 
the reflux. When all the magnesium was consumed, the mixture was cooled to 0 ºC and 
neat aldehyde (1 equiv for 1.5 equiv of the Grignard reagent; Table 6.3) was added drop-
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wise. The reaction was monitored by TLC and when complete, it was quenched with a 
saturated aqueous NH4Cl solution and the aqueous layer was extracted with ether (2 × one 
fold volume). The combined organic layers were dried over MgSO4 and evaporated. The 
residue was used without further purification or distilled on Kugelrohr apparatus at 5 mbar 
(3.75 mmHg, temperature in Table 6.3) to obtain pure alcohols as colourless oils.  
 
Table 6.3. Addition of Grignard Reagents onto Aldehydes 
 
Alkylhalogenide or 
Grignard reagent 
Aldehyde /   
Reaction time 
Purif. Alcohol  
MeI (467 µL, 1.07 g, 
7.50 mmol),  
ether 10 mL  
3-Furaldehyde (433 µL, 481 
mg, 5.00 mmol) / 1 h 
- 352a (500 mg,  
4.46 mmol, 89 %) 
AllylBr (1.04 mL, 1.45 
g, 12.0 mmol),  
ether 20 mL  
3-Furaldehyde (692 µL, 769 
mg, 8.00 mmol) / 2 h 
dist. 
60 °C 
352b (996 mg,  
7.21 mmol, 90 %) 
AllylBr (2.60 mL, 3.63 
g, 30.0 mmol),  
ether 50 mL  
2-Furaldehyde (1.66 mL, 
1.92 g, 20.0 mmol) / 4 h 
dist. 
75 °C 
352c (1.92 g,  
13.89 mmol, 69 %) 
MeMgBr (3.0 M in 
ether, 3.04 mL, 9.13 
mmol), ether 24 mL 
Benzo[b]furan-3-
carbaldehyde (890 mg, 6.09 
mmol, 1 equiv) / 3 h 
20 mL SiO2, PE 
– EA (90:10) 
352d (927 mg, 5.72 
mmol, 94 %). 
i-PrMgCl (2.0 M in 
THF, 13 mL, 25.0 
mmol),  
THF 10 mL 
2-Furaldehyde (1.66 mL, 
1.93 g, 20.0 mmol) / 18 h 
- 352e (2.04 g, 14.6 mmol, 
73 %) 
i-PrMgCl (2.0 M in 
THF, 4.06 mL, 40.0 
mmol),  
THF 20 mL 
Benzaldehyde (4.06 mL, 40.0 
mmol) / 18 h 
75 mL SiO2, PE 
– EA (95:5) 
352f (3.88 g, 25.8 mmol, 
65 %) 
5-Bromopent-1-ene  
(3.55 mL, 4.47 g, 30.0 
mmol), ether 50 mL 
3-Methoxybenzaldehyde  
(2.43 mL, 2.72 g, 20.0 mmol) / 
2.5 h  
- 352g (4.03 g, 19.5 mmol, 
97 %) 
 
1-(Furan-3’-yl)ethanol, 3-(1’-hydroxyethyl)furan (352a), C6H8O2, FW = 112.14 
O OH
352a
 
352a:203 colourless liquid: 1H NMR (400 MHz, CDCl3) δ 1.49 (d, J = 6.4 Hz, 3H), 1.71 (br 
s, 1H), 4.87 (q, J = 6.3 Hz, 1H), 6.42 (dd, J = 1.4, 1.2 Hz, 1H), 7.38 (s, 1H), 7.39 (s, 1H); 
13C NMR δ 22.97 (CH3), 62.02 (CH), 107.48 (CH), 129.28 (C), 137.50 (CH), 142.35 
(CH); IR ν 3357, 2975, 1503, 1371, 1160 cm-1; MS (CI/isobutane) m/z (%) 112 (M˙+, 14), 
95 (100). 
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1-(Furan-3’-yl)but-3-en-1-ol, 3-(1’-Hydroxybut-3’-en-1’-yl)furan (352b), C8H10O2, 
FW = 138.18 
O OH
352b
 
352b:169c colourless liquid: 1H NMR (400 MHz, CDCl3) δ 2.45-2.49 (m, 2H), 2.52 (br s, 
1H), 4.66 (t, J = 6.4 Hz, 1H), 5.09-5.12 (m, 1H), 5.13 (ddd, J = 17.1, 3.3, 1.4 Hz, 1H), 5.78 
(ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 6.38 (dd, J = 1.4, 0.9 Hz, 1H), 7.34-7.35 (m, 1H), 7.36 
(dd, J = 3.4, 1.6 Hz, 1H); 13C NMR δ 42.41 (CH2), 66.10 (CH), 108.63 (CH), 118.38 
(CH2), 128.51 (C), 134.22 (CH), 139.08 (CH), 143.27 (CH); IR ν 3375, 3077, 2908, 1642, 
1502, 1160 cm-1; MS (EI) m/z (%) 138 (M˙+, 10), 97 (100), 95 (12); HRMS (EI) 138.0679 
(C8H10O2 requires 138.0681).  
 
1-(Furan-2’-yl)but-3-en-1-ol, 2-(1’-Hydroxybut-3’-en-1’-yl)furan (352c), C8H8O2, FW 
= 138.18 
O
352c OH
 
352c:204 colourless liquid: 1H NMR (400 MHz, CDCl3) δ 2.54-2.64 (m, 2H), 3.02 (br s, 
1H), 4.68-4.71 (m, 1H), 5.09-5.17 (m, 2H), 5.78 (ddt, J = 17.1, 10.1, 7.1 Hz, 1H), 6.22-23 
(m, 1H), 6.32 (dd, J = 3.1, 1.7 Hz, 1H), 7.36-7.37 (m, 1H); 13C NMR δ 40.03 (CH2), 66.92 
(CH), 106.13 (CH), 110.14 (CH), 118.19 (CH2), 133.90 (CH), 141.88 (CH), 156.19 (C); 
IR ν 3375, 3078, 2912, 1642, 1505, 1149 cm-1; MS (EI) m/z (%) 138 (M˙+, 5), 97 (100); 
HRMS (EI) 138.0680 (C8H10O2 requires 138.0681). 
 
1-(Benzo[b]furan-3’-yl)ethanol, 3-(1’-Hydroxyethyl)benzo[b]furan (352d), C10H10O2, 
FW = 162.20 
O
OH
352d
 
352d:205 yellowish oil which solidified upon standing; mp 36-37 ºC; 1H NMR (400 MHz, 
CDCl3) δ 1.50 (d, J = 6.6 Hz, 3H), 2.56 (br s, 1H), 4.88 (q, J = 6.6 Hz, 1H), 6.47 (s, 1H), 
7.10 (ddd, J = 7.4, 7.4, 0.9 Hz, 1H), 7.16 (ddd, J = 7.8, 7.3, 1.3 Hz, 1H), 7.34 (d, J = 8.2 
Hz, 1H), 7.42 (dd, J = 7.0, 1.2 Hz, 1H); 13C NMR δ 21.30 (CH3), 64.01 (CH), 101.69 
(CH), 111.10 (CH), 120.97 (CH), 122.66 (CH), 124.05 (CH), 128.04 (C), 154.64 (C), 
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160.13 (C); IR ν 3347, 3066, 2981, 2928, 1454, 1254 cm-1; MS (EI) m/z (%) 162 (M˙+, 
42), 147 (100), 145 (20), 91 (47); HRMS (EI) 162.0682 (C10H10O2 requires 162.0681).  
 
1-(Furan-2’-yl)-2-methylpropan-1-ol (352e), C8H12O2, FW = 140.20 
O
352e OH
 
352e:206 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 0.83 (d, J = 6.8 Hz, 3H), 1.00 (d, 
J = 6.7 Hz, 3H), 2.08 (oct, J = 6.8 Hz, 1H), 2.40 (br s, 1H), 4.34 (br d, J = 6.9 Hz, 1H), 
6.20 (dd, J = 3.2, 0.5 Hz, 1H), 6.31 (dd, J = 3.2, 1.8 Hz, 1H), 7.34 (dd, J = 1.8, 0.8 Hz, 
1H); 13C NMR δ 18.26 (CH3), 18.68 (CH3), 33.32 (CH), 73.43 (CH), 106.43 (CH), 110.02 
(CH), 141.60 (CH), 156.25 (C); IR ν 3389, 2962, 2873, 1505, 1468, 1386, 1150 cm-1; MS 
(CI/isobutane) m/z (%) 141 [(M+H)+, 10], 123 (100), 97 (20); HRMS (CI/isobutane) 
141.0923 (C8H13O2 requires 141.0916).  
 
2-Methyl-1-phenylpropan-1-ol (352f), C10H14O, FW = 150.24 
OH352f
 
352f:207 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 0.79 (d, J = 6.8 Hz, 3H), 1.00 (d, 
J = 6.7 Hz, 3H), 1.94 (octet, J = 6.8 Hz, 1H), 2.47 (br s, 1H), 4.31 (br d, J = 6.9 Hz, 1H), 
7.25-7.36 (m, 5H); 13C NMR δ 18.12 (CH3), 18.73 (CH3), 34.97 (CH), 79.68 (CH), 126.38 
(2 × CH), 127.08 (CH), 127.87 (2 × CH), 143.43 (C); IR ν 3388, 2959, 2872, 1453, 1383 
cm-1; MS (EI) m/z (%) 150 (M˙+, 12), 107 (100); HRMS (EI) 150.1046 (C10H14O requires 
150.1045).  
 
1-(3’-Methoxyphenyl)hex-5-en-1-ol (352g), C13H18O2, FW = 206.31 
352g OH
MeO
 
352g:208 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 1.21-1.35 (m, 1H), 1.35-1.48 (m, 
1H), 1.55-1.73 (m, 2H), 1.97 (tdt, J = 7.3, 6.8, 1.3 Hz, 2H), 2.19 (br s, 1H), 3.70 (s, 3H), 
4.51 (dd, J = 7.1, 6.1 Hz, 1H), 4.85 (ddt, J = 10.2, 2.2, 1.2 Hz, 1H), 4.90 (ddt, J = 17.1, 3.6, 
1.6 Hz, 1H), 5.69 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 6.71 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 
6.79-6.81 (m, 2H), 7.15 (dd, J = 8.2, 8.0 Hz, 1H); 13C NMR δ 25.09 (CH2), 33.63 (CH2), 
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38.67 (CH2), 55.22 (CH3), 74.38 (CH), 111.40 (CH), 112.89 (CH), 114.22 (CH2), 118.27 
(CH), 129.46 (CH), 138.64 (CH), 146.67 (C), 159.71 (C); IR ν 3392, 3075, 2937, 2837, 
1640, 1602, 1488, 1457, 1436, 1318, 1259, 1156 cm-1; MS (EI) m/z (%) 206 (M˙+, 80), 163 
(90), 150 (81), 138 (80), 137 (100), 135 (60), 134 (44), 109 (100), 94 (93); HRMS (EI) 
206.1306 (C13H18O2 requires 206.1307). 
 
General Procedures for Oxidation of Alcohols to the Corresponding Ketones:  
 
Method A: A mixture of pyridinium chlorochromate (PCC, 1.5 equiv) and Celite (1:1 
w/w) was added in several portions to a solution of alcohol (1 equiv) in CH2Cl2.169 The 
reaction was monitored by TLC. When no starting material was observed (approximately 2 
h), the mixture was diluted with ether (one fold volume) and let to stir for 15 min. Then the 
suspension was filtered through a pad of silica gel, washed with ether, and the filtrate was 
evaporated. The crude ketone was filtered on a silica gel column (10 fold weight of the 
crude) with a petroleum ether – ethyl acetate mixture (95:5) (Table 6.4).  
 
Table 6.4. Oxidation of Alcohols the Corresponding Ketones with PCC 
 
Alcohol / CH2Cl2 PCC Ketone 
352a (500 mg, 4.50 mmol) /  
20 mL 
1.50 g, 6.75 mmol 353a (161 mg, 1.46 mmol, 32 %) 
352b (700 mg, 5.07 mmol) /  
14 mL 
1.64 g, 7.60 mmol 353b (157 mg, 1.15 mmol, 23 %) 
352e (1.65 g, 8.00 mmol) /  
30 mL 
2.59 g,12.0 mmol 353e (1.37 g, 6.71 mmol, 84 %) 
352f (2.50 g, 16.6 mmol) /  
75 mL 
5.38 g, 25.0 mmol 353f (1.78 g, 12.0 mmol, 72 %) 
 
 
Method B:170 A solution of pyridinium dichromate (PDC, 1.4 to 1.75 equiv) in anhydrous 
DMF was added drop-wise to the neat alcohol (1 equiv) and the reaction was let to stir 
overnight at room temperature for 3 h. The mixture was diluted with ether (60 mL) and 
quenched with water (300 mL). The layers were separated and the aqueous layer was 
extracted with ether (3 × 60 mL). The combined organic layers were washed with brine (60 
mL), dried over MgSO4 and evaporated in vacuo. The crude ketone was purified on a silica 
gel column with a petroleum ether – ethyl acetate mixture (Table 6.5).  
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Table 6.5. Oxidation of Alcohols the Corresponding Ketones with PDC 
 
Alcohol / DMF PDC  SiO2  
PE – EA 
Ketone 
352d (900 mg,  
5.55 mmol) / 6 mL 
2.92 g, 7.78 mmol, 1.4 
equiv 
20 mL, 98:2 353d (534 mg, 3.33 
mmol, 60 %) 
352g (800 mg,  
5.70 mmol) / 7.5 mL 
9.98 mmol, 3.75 g, 1.75 
equiv  
35 mL, 97:3 353g (319 mg, 3.31 
mmol, 40 % ) 
 
3-Acetylfuran (353a), C6H6O2, FW = 110.12 
O O
353a
 
353a:209 white crystals: mp 47-48 ºC (hexane) [lit. 48.5-49.5 ºC (pentane)]; 1H NMR (400 
MHz, CDCl3) δ 2.37 (d, J = 0.9 Hz, 3H), 6.69-6.70 (m, 1H), 7.36-7.37 (m, 1H), 7.95-7.96 
(m, 1H); 13C NMR δ 27.85 (CH3), 108.59 (CH), 128.12 (C), 144.32 (CH), 147.59 (CH), 
192.49 (C); IR ν 3122, 1658, 1562, 1311, 1161 cm-1; MS (CI/isobutane) m/z (%) 111 
[(M+H)+, 100]; HRMS (CI/isobutane) 111.0442 (C6H7O2 requires 111.0446). 
 
1-(Furan-3’-yl)but-3-en-1-one, 3-(1’-Oxobut-3’-en-1’-yl)furan (353b), C8H8O2, FW = 
136.16 
O O
353b
 
353b: colourless liquid: 1H NMR (400 MHz, CDCl3) δ 3.51 (dt, J = 6.8, 1.4 Hz, 2H), 5.16-
5.22 (m, 2H), 6.01 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H), 6.76 (dd, J = 1.9, 0.8 Hz, 1H), 7.42 
(dd, J = 1.8, 1.5 Hz, 1H), 8.04 (dd, J = 1.4, 0.8 Hz, 1H); 13C NMR δ 20.99 (CH3), 46.34 
(CH2), 46.97 (CH), 108.54 (CH), 114.84 (CH2), 127.27 (C), 130.71 (CH), 144.25 (CH), 
147.46 (CH), 192.66 (C); IR ν 3134, 1678, 1562, 1511, 1390, 1333, 1157 cm-1; MS 
(CI/isobutane) m/z (%) 137 [(M+H)+, 100], 95 (55); HRMS (CI/isobutane) 137.0601 
(C8H9O2 requires 137.0603). 
 
3-Acetyl-benzo[b]furan (353d), C10H8O2, FW = 160.18 
O O
353d
 
353d:205 off-white crystals; mp 58-59 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.60 (s, 
3H), 7.30 (ddd, J = 7.8, 7.2, 0.8 Hz, 1H), 7.47 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.49 (d, J = 
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0.9 Hz, 1H), 7.57 (ddd, J = 8.4, 1.8, 0.9 Hz, 1H), 7.70 (dd, J = 7.9, 1.1, 0.8 Hz, 1H); 13C 
NMR δ 26.47 (CH3), 112.49 (CH), 113.05 (CH), 123.31 (CH), 123.93 (CH), 127.08 (C), 
128.29 (CH), 152.67 (C), 155.69 (C), 188.64 (C); IR ν 3121, 3086, 3019, 1678, 1613, 
1556, 1362, 1295 cm-1; MS (EI) m/z (%) 160 (M˙+, 52), 144 (100), 89 (27), 86 (32), 84 
(48); HRMS (EI) 160.0526 (C10H8O2 requires 160.0524). 
 
1-(Furan-2’-yl)-2-methylpropan-1-one (353e), C8H10O2, FW = 138.18 
O
353e O
 
353e: colourless liquid; 1H NMR (400 MHz, CDCl3) δ 1.21 (d, J = 6.9 Hz, 6H), 3.33 (sept, 
J = 6.9 Hz, 1H), 6.52 (dd, J = 3.5, 1.7 Hz, 1H), 7.18 (dd, J = 3.5, 0.6 Hz, 1H), 7.57 (dd, J = 
1.6, 0.7 Hz, 1H); 13C NMR δ 18.80 (2 × CH3), 36.25 (CH), 112.11 (CH), 117.15 (CH), 
146.24 (CH), 152.13 (C), 193.69 (C); IR ν 3131, 2973, 2935, 2875, 1671, 1567, 1468, 
1396, 1255 cm-1; MS (EI) m/z (%) 138 (M˙+, 10), 95 (30), 86 (62), 84 (100); HRMS (EI) 
138.0679 (C8H10O2 requires 138.0681). 
 
2-Methyl-1-phenylpropan-1-one (353f), C10H12O, FW = 148.22 
O353f
 
353f:210 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 1.11 (d, J = 6.9 Hz, 6H), 3.44 
(sept, J = 6.8 Hz, 1H), 7.32-7.36 (m, 2H), 7.43 (dddd, J = 8.2, 6.5, 1.3, 1.3 Hz, 1H), 7.84-
7.87 (m, 2H); 13C NMR δ 18.98 (2 × CH3), 35.14 (CH), 128.12 (2 × CH), 128.43 (2 × 
CH), 132.62 (CH), 135.98 (C), 204.45 (C); IR ν 2972, 2933, 2873, 1682, 1597, 1465, 
1384, 1224 cm-1; MS (EI) m/z (%) 148 (M˙+, 16), 147 (10), 105 (100); HRMS (EI) 
148.0889 (C10H12O requires 148.0888). 
 
1-(3’-Methoxyphenyl)hex-5-en-1-one (353g), C13H16O2, FW = 204.29 
353g O
MeO
 
353g:208 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 1.81 (tt, J = 7.5, 7.2 Hz, 2H), 
2.12 (ddt, J = 7.3, 6.8, 1.2 Hz, 2H), 2.92 (t, J = 7.3 Hz, 2H), 3.80 (s, 3H), 4.97 (ddt, J = 
10.2, 2.1, 1.2 Hz, 1H), 5.02 (ddt, J = 17.1, 3.6, 1.6 Hz, 1H), 5.79 (ddt, J = 17.1, 10.3, 6.8 
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Hz, 1H), 7.05 (ddd, J = 8.2, 2.7, 0.9 Hz, 1H), 7.32 (dd, J = 8.0, 7.9 Hz, 1H), 7.45 (dd, J = 
2.6, 1.5 Hz, 1H), 7.49 (ddd, J = 7.6, 1.4, 1.0 Hz, 1H); 13C NMR δ 23.33 (CH2), 33.19 
(CH2), 37.79 (CH2), 55.36 (CH3), 112.31 (CH), 115.29 (CH2), 119.26 (CH), 120.65 (CH), 
129.54 (CH), 138.05 (CH), 138.39 (C), 159.80 (C), 199.93 (C); IR ν 3076, 2940, 2837, 
1685, 1640, 1598, 1583, 1486, 1452, 1431, 1260 cm-1; MS (EI) m/z (%) 204 (M˙+, 45), 150 
(100), 135 (96), 122 (18), 107 (68), 92 (40); HRMS (EI) 204.1152 (C13H16O2 requires 
204.1150). 
 
3-Bromo-1-(tert-butyldimethylsilyloxy)propane (455a), C9H21OSiBr, FW = 253.29 
Br OTBDMS
455a
 
3-Bromopropan-1-ol (2.71 mL, 4.17 g, 30.0 mmol) was added to a solution of 
t-butyldimethylsilyl chloride (5.44 g, 36.0 mmol, 1.2 equiv), triethylamine (5.90 mL, 3.75 
g, 39.0 mmol, 1.3 equiv) and 4-(N,N-dimethylamino)pyridine (183 mg, 1.50 mmol, 5 mol 
%) in THF (45 mL) at 0 °C.171 The mixture was let to warm to room temperature and to 
stir overnight. The reaction was quenched with a saturated aqueous NH4Cl solution (50 
mL) and the aqueous layer was extracted with CH2Cl2 (2 × 40 mL). The combined organic 
layers were dried over MgSO4 and evaporated to afford a colourless oil 455a171 (7.24 g, 
28.57 mmol, 95 %). The residue was used in the next step without further purification: 
colourless liquid; 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 6H), 0.89 (s, 9H), 2.02 (tt, J = 
6.2, 5.9 Hz, 2H), 3.50 (t, J = 6.4 Hz, 2H), 3.73 (t, J = 5.7 Hz, 2H); 13C NMR δ -6.53 (2 × 
CH3), 17.14 (C), 24.76 (3 × CH3), 29.48 (CH2), 34.39 (CH2), 59.22 (CH2); IR ν 3360, 
2961, 2832, 1670, 1511, 1155 cm-1; MS (FAB/NOBA) m/z (%), 221 (21), 207 (19), 148 
(56), 75 (100). 
 
3-Bromo-1-(trimethylsilyloxy)propanol (455b), C6H15OSiBr, FW = 211.20 
Br OTMS
455b
 
Trimethylsilyl chloride (8.18 mL, 7.82 g, 72 mmol, 1.2 equiv) was added to a solution of 
3-bromopropan-1-ol (5.43 mL, 8.34 g, 60 mmol) and 2,6-lutidine (8.39 mL, 7.72 g, 72 
mmol, 1.2 equiv) in CCl4 (60 mL) at 0 °C.171 The mixture was let to warm to room 
temperature and to stir for 3 h. The resulting suspension was filtered and the solvent was 
distilled off at atmospheric pressure. The residue was distilled at 5 mbar (3.75 mmHg) at 
70 °C to afford 455b as a colourless oil (6.87 g, 32.50 mmol, 54%): colourless liquid; 1H 
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NMR (400 MHz, CDCl3) δ 0.12 (s, 9H), 2.04 (tt, J = 6.2, 6.0 Hz, 2H), 3.50 (t, J = 6.4 Hz, 
2H), 3.70 (t, J = 5.7 Hz, 2H); 13C NMR δ -0.62 (3 × CH3), 31.11 (CH2), 35.89 (CH2), 
60.83 (CH2); IR ν 2957, 1251, 1100 cm-1; MS (CI/isobutane) m/z (%) 213 [(M+H)+, 100], 
211 [(M+H)+, 100], 197 (15), 195 (15), 167 (15), 85 (24); HRMS (CI/isobutane) 211.0144 
(C6H16Osi79Br requires 211.0154), 213.0114 (C6H16Osi81Br requires 213.0133). 
 
Two-step Procedure for Preparation of 2-Acetyl-1-methyl-1H-indol:  
A solution of 1H-indol-2-carboxylic acid (2.42 g, 15 mmol, 1 equiv) in anhydrous DMF 
(24 mL) was added drop-wise to a suspension of sodium hydride (neat, 1.44 g, 60 mmol, 4 
equiv) in THF (12 mL) at 0 ºC and the mixture was let to stir for 1 h. Then methyl iodide 
(5.61 mL, 12.8 g, 90.0 mmol, 6 eq) was added and the reaction was left overnight at room 
temperature. The reaction was quenched with ethyl acetate (10 mL) and water (100 mL) 
and extracted with ether (3 × 50 mL). The combined organic layers were washed with 
brine (20 mL), dried over MgSO4 and evaporated. The crude contained mixture of 
compounds and was subjected to hydrolysis of the residual methyl ester as follows: a 
solution of potassium hydroxide (30 %, 30 mL) was added to a suspension of the crude 
material in toluene (30 mL) and refluxed for 2 h. The cooled mixture was diluted with 
water (100 mL) and the basic aqueous layer was extracted with ether (3 × 40 mL). Then 
the aqueous layer was acidified to pH = 1 and extracted with ether (3 × 50 mL). The 
second etheric extracts were combined, washed with brine (20 mL), dried over MgSO4 and 
evaporated. The crude after hydrolysis (1.57 g) was used for the next step without further 
purification.   
 
A solution of methyllithium (1.6 M in ether, 11.2 mL, 18.0 mmol, 2 equiv) was added 
drop-wise to a cooled solution (0 ºC) of crude acid (1.57 g, approximated as 9.00 mmol, 1 
equiv).211 The solution was let to warm to room temperature and stir for 1 h, then another 
portion of methyllithium was added (1.6 M in ether, 11.2 mL, 18.0 mmol, 2 equiv) and the 
mixture was refluxed for 4 h. After cooling to 0 ºC, the reaction was quenched with water 
(20 mL) and extracted with ether (3 × 30 mL). The combined organic layers were washed 
with brine, dried over MgSO4 and evaporated. The crude mixture was purified on a silica 
gel column (75 mL) in a petroleum ether – ethyl acetate mixture (85:15) to obtain white 
crystalline solid of ketone 352 (469 mg, 2.71 mmol, 18 % from 1H-indol-2-carboxylic 
acid).  
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2-Acetyl-1-methyl-1H-indol (352), C11H11NO, FW = 173.23 
N O
352
 
352:211 off-white crystals; mp 54-55 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.62 (s, 
3H), 4.08 (s, 3H), 7.16 (ddd, J = 8.0, 4.4, 3.5 Hz, 1H), 7.29 (s, 1H), 7.38-7.39 (m, 2H), 
7.70 (ddd, J = 8.0, 0.9, 0.9 Hz, 1H); 13C NMR δ 27.90 (CH3), 32.10 (CH3), 110.31 (CH), 
111.91 (CH), 120.63 (CH), 122.81 (CH), 125.72 (C), 125.84 (CH), 134.85 (C), 140.02 (C), 
191.56 (C); IR ν 3017, 2935, 1656, 1513, 1465, 1392, 1352, 1219 cm-1; MS (CI/isobutane) 
m/z (%) 174 [(M+H)+, 100], 173 (15), 85 (27); HRMS (CI/isobutane) 174.0918 
(C11H12NO requires 174.0919). 
  
Procedures for Preparation of Methyl 4-oxo-4-phenylbutanoate:  
Method A: A Schlenk flask loaded with a solution of benzaldehyde (105 mg, 100 µL, 1.00 
mmol, 1 equiv), methyl acrylate (172 mg, 180 µL, 2.00 mmol, 2 equiv), Wilkinson catalyst 
(48.4 mg, 0.050 mmol, 5 mol %), 2-amino-3-picoline (43 mg, 40 µL, 0.400 mmol, 0.4 
equiv) and benzoic acid (24 mg, 0.200 mmol, 0.2 equiv) in anhydrous toluene (0.4 mL) 
under an inert atmosphere was put into an oil bath preheated to 130 ºC and was let to stir at 
this temperature for 2 h.176 After cooling down, the reaction was diluted with ether and 
washed with water (3 × 5 mL). The combined organic layers were washed with brine (5 
mL), dried over MgSO4 and evaporated. The crude product was purified on a silica gel 
column (40 mL) in a petroleum ether – ethyl actetate mixture (95:5) to obtain the γ-keto 
ester 167 (110 mg, 0.572 mmol, 57 %).  
 
Method B: A solution of 4-oxo-4-phenylbutanoic acid (5 g, 28.1 mmol) and concentrated 
sulphuric acid (3 drops from Pasteur pipette) was was refluxed in methanol (50 mL) for 3 h 
after which the mixture was let to cool down and concentrated in vacuo. The residue was 
then dissolved in ether (50 mL) and washed with saturated NaHCO3 (2 × 50 mL), water 
(50 mL), brine (50 mL), dried over MgSO4 and evaporated. The crude methyl ester 459 
(5.20 g, 27.1 mmol, 96 %) was used without further purification.  
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Methyl 4-oxo-4-phenylbutanoate (459), C11H12O3, FW = 192.23 
O
COOMe
459
 
459:176 colourless liquid; 1H NMR (400 MHz, CDCl3) δ 2.73 (t, J = 6.6 Hz, 2H), 3.29 (t, J 
= 6.6 Hz, 2H), 3.67 (s, 3H), 7.43 (dd, J = 7.8, 7.4, 2H), 7.53 (dd, J = 7.4, 7.1, 1H), 7.95 
(dd, J = 7.8, 0.5, 2H); 13C NMR δ 23.88 (CH2), 27.99 (CH2), 51.84 (CH3), 128.04 (2 × 
CH), 128.63 (2 × CH), 133.27 (CH), 136.48 (C), 173.39 (C), 198.07 (C); IR ν 3061, 1737, 
1686, 1597, 1449, 1438, 1221 cm-1; MS (EI) m/z (%) 192 (M˙+, 10), 161 (14), 105 (100); 
HRMS (EI) 192.0785 (C11H12O3 requires 192.0786). 
 
1,3-Diphenylpropan-1-one (461), C15H14O, FW = 210.29 
461 O
 
A suspension of 10 % palladium on carbon (514 mg) and chalcone 460 (4.17 g, 20.0 
mmol) in ethyl acetate was placed under an atmosphere of H2 (balloon). The reaction was 
monitored by TLC and when the starting material was consumed (ca. 60 h), the suspension 
was filtered through a Celite pad and the adsorbent was washed with ethyl acetate. The 
filtrate was evaporated to afford 461212 as a crystalline residue (3.95 g, 18.8 mmol, 94 %), 
which was used without further purification: white crystals; mp 70-71 ºC (hexane); 1H 
NMR (400 MHz, CDCl3) δ 3.00 (dd, J = 8.0, 7.4 Hz, 2H), 3.23 (dd, J = 8.0, 7.4 Hz, 2H), 
7.14 (dddd, J = 7.1, 7.0, 1.8, 1.5 Hz, 1H), 7.18-7.25 (m, 4 H), 7.38 (dd, J = 8.5, 7.5 Hz, 
2H), 7.45 (ddd, J = 8.0, 1.3, 1.3 Hz, 1H), 7.89 (ddd, J = 8.2, 1.7, 1.1 Hz, 2H); 13C NMR δ 
30.15 (CH2), 40.51 (CH2), 126.18 (CH), 128.08 (2 × CH), 128.48 (2 × CH), 128.58 (2 × 
CH), 128.65 (2 × CH), 133.13 (CH), 136.85 (C), 141.33 (C), 199.28 (C); MS (EI) m/z (%) 
210 (M˙+, 42), 105 (92), 87 (38), 85 (100); HRMS (EI) 210.1046 (C15H14O requires 
210.1045).  
 
3’-(tert-Butyldimethylsilyloxy)acetophenone (463), C14H22O2Si, FW = 250.45 
O
TBDMSO
463
 
A solution of tert-butyldimethylsilyl chloride (907 mg, 6.00 mmol, 1.2 equiv) in anhydrous 
THF (2.5 mL) was added to a mixture of 3-hydroxyacetophenone (681 mg, 5.00 mmol), 
    148
triethylamine (983 µL, 625 mg, 6.50 mmol, 1.3 equiv) and 4-(N,N-dimethylamino)pyridine 
(31 mg, 0.250 mmol, 5 mol %) in THF (5 mL) at 0 ºC.171 The mixture was let to warm to 
room temperature and to stir overnight. Then it was quenched with a saturated aqueous 
NH4Cl solution (50 mL) and the aqueous layer was extracted with ether (2 × 40 mL). The 
combined organic layers were dried over MgSO4 and evaporated to afford 463 (1.20 g, 
4.79 mmol, 96 %) as a colourless oil, which was used in the next step without further 
purification: colourless liquid; 1H NMR (400 MHz, CDCl3) δ 0.21 (s, 6H), 0.99 (s, 9H), 
2.57 (s, 3H), 7.04 (ddd, J = 8.1, 2.5, 1.0 Hz, 1H), 7.31 (dd, J = 7.9, 7.8 Hz, 1H), 7.41 (dd, J 
= 2.2, 1.8 Hz, 1H), 7.54 (ddd, J = 7.7, 1.6, 1.0 Hz, 1H); 13C NMR δ –4.40 (2 × CH3), 18.22 
(C), 25.67 (3 × CH3), 26.78 (CH3), 119.49 (CH), 121.59 (CH), 125.00 (CH), 129.58 (CH), 
138.60 (C), 155.98 (C), 197.96 (C); IR ν 2956, 2931, 2859, 1687, 1582, 1483, 1436, 1359, 
1283 cm-1; MS (CI/isobutane) m/z (%) 251 [(M+H)+, 100], 193 (5), 137 (5); HRMS 
(CI/isobutane) 251.1462 (C14H23O2Si requires 251.1467). 
 
Reaction of acetylacetone with phenylmagnesium bromide:178 
Freshly prepared etheral solution of phenylmagnesium bromide [3.0 M, prepared from 
bromobenzene (15.8 mL, 23.6 g, 150 mmol, 1.5 equiv) and magnesium turnings (3.45 g, 
150 mmol, 1.5 equiv) in ether (50 mL), see general procedure stated previously] was added 
drop-wise (ca 30 min) to a solution of freshly distilled acetylacetone (10.3 mL, 10.0 g, 100 
mmol, 1 equiv) in anhydrous ether (100 mL) at 0 ºC. The resulting suspension was let to 
warm to room temperature, to stir for 1 h at this temperature and refluxed for an additional 
1 h. The mixture was the cooled to 0 ºC and quenched with saturated NH4Cl (100 mL). The 
aqueous layer was extracted with ether (3 × 60 mL), washed with brine (40 mL), dried over 
MgSO4 and concentrated in vacuo. The residue was purified on a silica gel column (200 
mL) with gradient of petroleum ether to a petroleum ether – ethyl acetate mixture (80:20) 
to obtain five distinguished fractions. 
 
4-Phenylpent-3-en-2-one (466A), C11H12O, FW = 160.23   
O
A
 
(E)-466A (1.94 g, 12.1 mmol, 12 %):179 yellowish oil; 1H NMR (400 MHz, CDCl3) δ 2.20 
(s, 3H), 2.45 (d, J = 1.2 Hz, 3H), 6.42 (q, J = 0.9 Hz, 1H), 7.27-7.30 (m, 3H), 7.38-7.40 (m, 
2H); (Z)-466A (883 mg, 5.51 mmol, 5.5 %):213 yellowish oil; 1H NMR (400 MHz, CDCl3) 
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δ 1.81 (s, 3H), 2.20 (d, J = 1.4 Hz, 3H), 6.13 (q, J = 1.3 Hz, 1H), 7.19-7.22 (m, 2H), 7.35-
7.44 (m, 3H). 
 
4-Hydroxy-4-phenylpentan-2-one (466B),214 C11H14O2, FW = 178.25, 
(1.28 g, 7.18 mmol, 7 %); yellowish oil; 1H NMR (400 MHz, CDCl3) δ 
1.52 (s, 3H), 2.08 (s, 3H), 2.85 (d, J = 17.1 Hz, 1H), 3.20 (d, J = 17.1 Hz, 
1H), 4.53 (s, 1H), 7.21-7.25 (m, 1H), 7.31-7.35 (m, 2H), 7.41-7.43 (m, 2H). 
 
2,4-Diphenylpentan-2,4-diol (466C),215 C17H20O2, FW = 256.37, 
(1.62 g, 6.32 mmol, 6 %); yellowish oil; 1H NMR (400 MHz, 
CDCl3) δ 1.26 (s, 6H), 2.40 (s, 2H), 3.77-3.79 (m, 2H), 7.23-7.27 
(m, 2H), 7.34-7.38 (m, 4H), 7.47-7.49 (m, 4H).  
 
Biphenyl (466D), C12H10, FW = 154.22, (775 mg, 5.03 mmol, 5 %); white crystals; 1H 
NMR (400 MHz, CDCl3) δ 7.33-7.38 (m, 2H), 7.43-7.47 (m, 4H), 7.59-7.62 (m, 2H).  
 
Three-step Procedure for Clean Preparation of (E)-alkene 466A:179  
 
(E)-Ethyl 3-phenylbut-2-enoate (467), C12H14O2, FW = 190.26 
COOEt
467
 
A solution of triethyl phosphonoacetate (10.7 mL, 12.1 g, 54.1 mmol, 1.3 equiv) in 
anhydrous THF (10 mL) was added drop-wise to a suspension of NaH (neat, 1.4 g, 58.2 
mmol, 1.4 equiv) in anhydrous THF (10 mL) cooled to 0 ºC and the mixture was let to stir 
at room temperature for 30 min. Then, acetophenone (4.85 mL, 5.0 g, 41.6 mmol, 1 equiv) 
was added at 0 ºC, and the mixture was let to stir at room temperature for 24 h. The 
reaction was quenched with saturated NaHCO3 (50 mL) and extracted with ethyl acetate (3 
× 50 mL). The combined organic layers were washed with brine (40 mL), dried over 
MgSO4 and concentrated in vacuo. The residue was purified on a silica gel column (300 
mL) with a petroleum ether – ethyl acetate mixture (96:4) to give (E)-ester 467 (3.63 g, 
19.1 mmol, 46 %): colourless oil; 1H NMR (400 MHz, CDCl3) δ 1.32 (t, J = 7.1 Hz, 3H), 
2.58 (d, J = 1.3 Hz, 3H), 4.22 (q, J = 7.1 Hz, 2H), 6.13 (q, J = 1.3 Hz, 1H), 7.35-7.40 (m, 
3H), 7.47-7.49 (m, 2H). 
 
O
B
OH
HO OH
C
    150
(E)-N-methoxy-N-methyl-3-phenylbut-2-enamide (468), C12H15NO2, FW = 205.28 
468
O
N
OMe
 
A solution of iso-propylmagnesium chloride (2.0M in THF, 36.0 mL, 72 mmol, 4.5 equiv) 
was added drop-wise at 0 ºC to a solution of (E)-467 (3.04 g, 16.0 mmol, 1 equiv) and 
N,O-dimethylhydroxylamine hydrochloride (3.12 g, 32.0 mmol, 2 equiv) in anhydrous 
THF (40 mL). The mixture was let to stir for 1h at room temperature, after which the 
reaction was quenched with saturated NH4Cl (40 mL) and the mixture was extracted with 
ethyl acetate (3 × 50 mL). The combined organic layers were washed with brine (40 mL), 
dried over MgSO4 and evaporated. The residue was purified on a silica gel column (80 
mL) with a petroleum ether – ethyl acetate mixture (70:30) to afford the Weinreb amide 
468 (2.25 g, 11.0 mmol, 69 %): 1H NMR (400 MHz, CDCl3) δ 2.53 (d, J = 1.2 Hz, 3H), 
3.27 (s, 3H), 3.71 (s, 3H), 6.57 (br s, 1H), 7.34-7.40 (m, 3H), 7.46-7.49 (m, 2H). 
 
(E)-4-Phenylpent-3-en-2-one (466A), C11H12O, FW = 160.23 
O
466A
 
A solution of methylmagnesium bromide (3.0 M in ether, 4.80 mL, 14.3 mmol, 1.3 equiv) 
was added drop-wise to a solution of amide 468 (2.25 g, 11.0 mmol, 1 equiv) in anhydrous 
THF (20 mL) at –30 ºC and was let to warm to room temperature. Then the reaction was 
quenched with saturated NH4Cl (40 mL) and extracted with ether (3 × 50 mL). The 
combined organic layers were washed with brine (40 mL), dried over MgSO4 and 
evaporated. The residue was purified on a silica gel column (30 mL) with a petroleum 
ether – ethyl acetate mixture (95:5) to obtain title (E)-alkene 466A179 (1.74 g, 11.0 mmol, 
99 %) in overall 31 % yield over three steps: yellowish oil; 1H NMR (400 MHz, CDCl3) δ 
2.20 (s, 3H), 2.45 (d, J = 1.2 Hz, 3H), 6.42 (q, J = 0.9 Hz, 1H), 7.27-7.30 (m, 3H), 7.38-
7.40 (m, 2H); 13C NMR δ 18.39 (CH3), 32.31 (CH3), 124.54 (CH), 126.51 (2 × CH), 
128.61 (2 × CH), 129.14 (CH), 142.52 (C), 153.93 (C), 198.96 (C); IR ν 3058, 3026, 1681, 
1600, 1446, 1356, 1266, 1182 cm-1; MS (CI/isobutane) m/z (%) 161 [(M+H)+, 100], 89 
(100); HRMS (CI/isobutane) 161.0965 (C11H13O requires 161.0966). 
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 (E)-3-Methyl-4-phenylbut-3-en-2-one (464), C11H12O, FW = 160.23 
O
464
 
Concentrated sulphuric acid (5.33 ml, 9.81 g, 100 mmol, 1 equiv) was added slowly to a 
solution of butanone (17.9 mL, 14.4 g, 200 mmol, 2 equiv) and benzaldehyde (10.1 mL, 
10.5 g, 100 mmol, 1 equiv) in glacial acetic acid (100 mL).177 The solution was let to stir 
for 20 h at room temperature. Then the reaction was diluted with water and quenched with 
aqueous solution of NaOH (25 %, 50 mL). The aqueous layer was extracted with ether (3 × 
100 mL), washed with brine (40 mL), dried over MgSO4 and concentrated in vacuo. The 
residue was purified on a silica gel column (120 mL) with a petroleum ether – ethyl acetate 
mixture (95:5) to obtain the desired alkene as yellowish oil which solidified upon standing 
464177 (9.94 g, 62.0 mmol, 62 %): yellowish oil which solidified upon standing; mp 29-30 
ºC; 1H NMR (400 MHz, CDCl3) δ 2.06 (d, J = 1.4 Hz, 3H), 2.46 (s, 3H), 7.31-7.36 (m, 
1H), 7.37-7.41 (m, 4H), 7.52 (q, J = 1.3 Hz, 1H); 13C NMR δ 12.96 (CH3), 25.89 (CH3), 
128.35 (2 × CH), 128.60 (CH), 129.74 (2 × CH), 135.92 (C), 139.73 (C), 142.22 (CH), 
200.34 (C); IR ν 3057, 3026, 2963, 2924, 1665, 1625, 1445, 1365, 1244 cm-1; MS (EI) m/z 
(%) 160 (M˙+, 88), 159 (62), 145 (40), 117 (100), 115 (70), 91 (32), 86 (32), 85 (30), 84 
(48), 83 (63); HRMS (EI) 160.0887 (C11H12O requires 160.0888). 
 
Propan-2-oxime (469), C3H7NO, FW = 73.11  
NHO
469
 
Sodium hydroxide (5.6 g, 140 mmol, 1.4 equiv) was added to a solution of acetone (7.34 
mL, 5.81 g, 100 mmol, 1 equiv) and hydroxylamine hydrochloride (9.03 g, 130 mmol, 1.3 
equiv) in an ethanol (30 mL) – water mixture (10 mL) and the mixture was heated to 80 ºC 
for 1 h.180 Then the solvent was removed in vacuo, re-dissolved in ethyl acetate, filtered 
and concentrated to afford the crude oxime 469 (3.49 g, 47.7 mmol, 48 %) which was used 
without further purification: white crystals; mp 59-59.5 ºC (EtOH, with sublimation); 1H 
NMR (400 MHz, CDCl3) δ 1.89 (s, 3H), 1.90 (s, 3H), 8.15 (br s, 1H). 
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4,4-Diphenyl-4-hydroxybutan-2-oxime (470), C16H17NO2, FW = 255.34 
NHO
470
HO
 
n-Butyllithium (2.0 M in pentane, 27.4 mL, 54.8 mmol, 2 equiv) was added drop-wise to a 
solution of oxime 469 (2.0 g, 27.4 mmol, 1 equiv) in anhydrous THF (35 mL) at 0 ºC and 
the mixture was let to stir for 30 min (to gain homogenous yellow solution) after which 
time it was cooled to –80 ºC and a solution of benzophenone (4.99 g, 27.4 mmol, 1 equiv) 
in THF (15 mL) was added drop-wise.180 The solution was stirred for 10 min at this 
temperature, then allowed to warm to room temperature and quenched with brine (50 mL). 
The aqueous layer was extracted with an ether – acetone mixture (2:1, 4 × 30 mL). The 
combined organic layers were dried over MgSO4 and evaporated. The crude oxime 470 
was used without further purification: white crystals; 1H NMR (400 MHz, CDCl3) δ 1.22 
(s, 3H), 3.35 (s, 2H), 3.64 (t, J = 6.6 Hz, 1H), 4.99 (br s, 2H), 7.15-7.19 (m, 2H), 7.22-7.26 
(m, 4H), 7.39-7.41 (m, 4H).  
 
Deprotection of Oxime 470:  
A suspension of oxime 470 (6.90 g, 27.0 mmol) in HCl (15 % aq, 50 mL) was refluxed for 
1 h after which time it was let to cool to room temperature and extracted with ether (3 × 30 
mL).181 The combined organic layers were dried over MgSO4 and evaporated. The residue 
spontaneously crystallised from ether to afford crystalline 471B and mother liquor which 
was purified on a silica gel column (40 mL) with a gradient of petroleum ether to 
petroleum ether – ethyl acetate mixture (90:10). The main fraction proved to be the desired 
alkene 471A.  
 
4,4-Diphenylbut-3-en-2-one (471A),216 C16H14O, FW = 222.30 (1.88 g, 
8.46 mmol, 31 %): yellowish oil; 1H NMR (400 MHz, CDCl3) δ 1.89 (s, 
3H), 6.60 (s, 1H), 7.22-7.24 (m, 2H), 7.29-7.44 (m, 8H); 13C NMR δ 
30.40 (CH3), 127.75 (CH), 128.46 (4 × CH), 128.85 (2 × CH), 129.52 (2 × 
CH), 129.66 (2 × CH), 139.00 (C), 140.80 (C), 154.02 (C), 200.27 (C); IR ν 3058, 3027, 
1958, 1895, 1812, 1660, 1590, 1491, 1445, 1354, 1257, 1177 cm-1; MS (CI/isobutane) m/z 
(%) 223 [(M+H)+, 100]; HRMS (CI/isobutane) 223.1126 (C16H15O requires 223.1123). 
 
O
A
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5,5-Diphenyl-3-methylisoxazoline (471B), C16H15NO, FW = 237.32 
(2.32 g, 9.83 mmol, 36 %): white crystals; mp 111-112 ºC (ether); 1H 
NMR (400 MHz, CDCl3) δ 2.00 (s, 3H), 3.56 (d, J = 0.7 Hz, 2H), 7.24-
7.28 (m, 2H), 7.31-7.35 (m, 4H), 7.40-7.42 (m, 4H); 13C NMR δ 13.50 
(CH3), 51.79 (CH2), 126.06 (4 × CH), 127.54 (2 × CH), 128.41 (4 × CH), 144.39 (2 × C), 
155.21 (C); IR ν 3059, 3023, 2985, 2921, 1957, 1881, 1807, 1596, 1490, 1445, 1387, 
1329, 1217 cm-1; MS (CI/isobutane) m/z (%) 238 [(M+H)+, 100], 89 (35); HRMS 
(CI/isobutane) 238.1233 (C16H16NO requires 238.1232). 
 
4-Methoxy-4’-trifluoromethylbenzophenone (474), C15H11O2F3, FW = 280.2 
O
F3C OMe
474
 
Trifluoroacetic anhydride (2.19 mL, 3.31 g, 15.8 mmol, 2 equiv) was added to a solution of 
p-trifluoromethylbenzoic acid (1.50 g, 7.89 mmol, 1 equiv) in anisole (solvent, 7.5 mL) 
and the mixture was heated to 80 ºC.217 After 1h, trifluoromethanesulfonic acid (35 µL, 59 
mg, 0.395 mmol, 5 mol %) was added and the mixture was stirred 2 h at 90 ºC. After this 
period, methanol (7 mL) was added and the product 474 crystallised overnight at 0 ºC 
(1.35 g, 4.82 mmol, 61 %): pinkish crystals; mp 100-101 ºC (MeOH/anisole); 1H NMR 
(400 MHz, CDCl3) δ 3.88 (s, 3H), 6.95-6.99 (m, 2H), 7.72-7.74 (m, 2H), 7.77.7-83 (m, 
2H), 7.81-7.84 (m, 2H); 13C NMR δ 55.52 (CH3), 113.81 (2 × CH), 123.76 (q, J = 272.6 
Hz, CF3), 125.24 (q, J = 3.7 Hz, 2 × CH), 129.33 (C), 129.78 (2 × CH), 132.62 (2 × CH), 
138.22 (q, J = 32.6 Hz, C), 141.52 (C), 163.74 (C), 194.23 (C); 19F NMR δ –62.92; IR ν 
3019, 2971, 2845, 1645, 1601, 1326, 1264, 1216, 1134 cm-1; MS (EI) m/z (%) 280 (M˙+, 
37), 145 (15), 135 (100), 92 (13); HRMS (EI) 280.0707 (C15H11O2F3 requires 280.0711). 
 
Vilsmeier-Haack formylation of α-methyl styrene: 218   
Phosphorus oxytrichloride (9.32 mL, 15.3 g, 100 mmol, 1 equiv) was added drop-wise 
with stirring and cooling to dimethylformamide (31.0 mL, 29.2 g, 0.40 mol, 4 equiv) so 
that the temperature was kept under 20 ºC. Neat α-methyl styrene (13.0 mL, 11.8 g, 100 
mmol, 1 equiv) was added drop-wise and the solution was heated to 50 ºC when an 
exotermic reaction occurred and cooling was necessary to maintain this temperature. After 
the exotermic reaction subsided, the mixture was heated to 80 ºC for 1.5 hour. Then the 
mixture was cooled to 0 ºC, 200 mL of 30 % aqueous sodium acetate was added slowly (at 
B
ON
    154
first, then rapidly) and the mixture was reheated to 80 ºC for 15 min. The aqueous layer 
was then extracted with ether (3 × 100 mL) and the combined organic layers were washed 
with water (100 mL), brine (100 mL), dried over MgSO4 and evaporated. The crude 
material was purified on a silica gel column (200 mL) with a solvent gradient from 
petroleum ether to a mixture of petroleum ether – ethyl acetate (95:5) to afford (Z)- and 
(E)-isomers as yellow oils.   
 
3-Phenybut-2-enal (483), C10H10O, FW = 146.20 
O
483
 
(Z)-483 (1.33 g, 7.79 mmol, 8 %):219 more soluble in petroleoum ether; yellow liquid; 1H 
NMR (400 MHz, CDCl3) δ 2.57 (d, J = 1.2 Hz, 3H), 6.39 (dq, J = 7.9, 1.2 Hz, 1H), 7.41-
7.43 (m, 3H), 7.53-7.56 (m, 2H), 10.18 (d, J = 7.8 Hz, 1H); (E)-483 (7.65 g, 52.3 mmol, 52 
%):220 yellow liquid; 1H NMR (400 MHz, CDCl3) δ 2.32 (d, J = 1.4 Hz, 3H), 6.13 (dq, J = 
8.3, 1.4 Hz, 1H), 7.29-7.31 (m, 2H), 7.39-7.43 (m, 3H), 9.47 (d, J = 8.1 Hz, 1H).  
 
(E)-4-Methoxy-N-(3’-phenylbut-2’-en-1’-ylidene)aniline (484), C17H17NO, FW = 
251.35  
N
484
OMe
 
A solution of p-anisidine (3.88 g, 31.5 mmol, 1.05 euiqv) in anhydrous CH2Cl2 (10 mL) 
was added to a solution of aldehyde (E)-483 (4.39 g, 30.0 mmol, 1 equiv), p-toluensulfonic 
acid (284 mg, 1.5 mmol, 5 mol %) and anhydrous MgSO4 (6.0 g) in CH2Cl2 (20 mL) under 
an inert atmosphere. The mixture was let stir at room temperature for 1.5 h and then 
concentrated in vacuo to obtain the crude aldimine 484 (7.79 g, 31.0 mmol, 98 %), which 
was used without further purification: yellow solid; 1H NMR (400 MHz, CDCl3) δ 2.43 (d, 
J = 1.3 Hz, 3H), 3.83 (s, 3H), 6.83 (dq, J = 9.5, 1.3 Hz, 1H), 6.91-6.95 (m, 2H), 7.19-7.23 
(m, 2H), 7.33-7.42 (m, 3H), 7.56-7.59 (m, 2H), 8.62 (d, J = 9.5 Hz, 1H).  
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4-Azidoanisole (480), C7H7N3O, FW = 149.17  
OMeN3
480
 
Solid sodium nitrite (8.40 g, 122 mmol, 1 equiv) was added to a cooled (0 ºC) solution of 
p-anisidine (15.0 g, 122 mmol, 1 equiv) in 12 % aqueous HCl (150 mL).221 After stirring 
for 30 min at this temperature, sodium azide (9.52 g, 146 mmol, 1.2 equiv) in water (50 
mL) was added and the mixture was let stir for 2 h at room temperature. The aqueous layer 
was extracted with ethyl acetate (3 × 70 mL) and the combined organic layers were washed 
with brine (100 mL), dried over MgSO4 and evaporated. The crude azide 480221 (8.53 g, 
57.2 mmol, 47 %) was used without further purification: grey solid; 1H NMR (400 MHz, 
CDCl3) δ 3.80 (s, 3H), 6.87-6.91 (m, 2H), 6.94-6.98 (m, 2H).  
 
Procedure for Preparation of Oximes:187  
Pyridine (753 µL, 740 mg, 9.36 mmol, 5 equiv) was added to a solution of ketone 466A or 
464 (300 mg, 1.87 mmol, 1 equiv), hydroxylamine hydrochloride (520 mg, 7.49 mmol, 4 
equiv) in methanol (7.5 mL) and the mixture was refluxed for 1.5 h. Then the mixture was 
concentrated, dissolved in a 1:1 mixture of ethyl acetate and hexane (20 mL) and washed 
with diluted HCl (20 mL). The aqueous layer was extracted with the same solvent mixture 
(2 × 20 mL), washed with water (20 mL), brine (20 mL) and evaporated. The oximes were 
used without further purification (319 mg, 1.82 mmol, 97 %).  
 
(2E,3E)-4-phenylpent-3-en-2-one oxime (486a), C11H13NO, FW = 
175.25: white solid; 1H NMR (400 MHz, CDCl3) δ 2.08 (s, 3H), 2.32 (d, 
J = 1.4 Hz, 3H), 6.1 (q, J = 1.3 Hz, 1H), 7.29-7.37 (m, 3H), 7.43-7.45 
(m, 2H).  
 
(2E,3E)-3-methyl-4-phenylbut-3-en-2-one oxime (486b), C11H13NO, 
FW = 175.25: yellowish solid; 1H NMR (400 MHz, CDCl3) δ 2.08 (d, J 
= 1.2 Hz, 3H), 2.17 (s, 3H), 6.92 (d, J = 0.4 Hz, 1H), 7.28-7.39 (m, 5H).   
 
Preparation of Pentafluorobenzoates of Oximes:187 
Pentafluorobenzoyl chloride (166 µL, 277 mg, 1.20 mmol, 1.2 equiv) was added drop-wise 
to a cooled (0 ºC) solution of oxime 486 (175 mg, 1.00 mmol, 1 equiv) and triethylamine 
(279 µL, 202 mg, 2.00 mmol, 2 equiv) in anhydrous CH2Cl2 (3 mL) and the mixture was 
N
486a OH
N
486b OH
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stirred at this temperature for 2 h. The reaction was quenched with saturated NaHCO3 (20 
mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic layers were 
washed with water (20 mL), brine (20 mL), dried over MgSO4 and concentrated in vacuo. 
The residue after evaporation was purified on a silica gel column (40 mL) with a petroleum 
ether – ethyl acetate mixture (85:15) to obtain white crystalline solid 487a or the 
evaporation residue of 487b was used crude.  
 
(2E,3E)-4-phenylpent-3-en-2-one pentafluorobenzoyl-O-
oxime ester (487a), C18H12NO2F5 , FW = 369.31 (269 mg, 
0.763 mmol, 76 %): white crystals; mp 121-122 ºC (visible 
softening and sublimation, hexane/AcOEt); 1H NMR (400 
MHz, CDCl3) δ 2.23 (s, 3H), 2.46 (d, J = 1.3 Hz, 3H), 6.15 (d, J = 1.3 Hz, 1H), 7.33-7.40 
(m, 3H), 7.45-7.47 (m, 2H); 13C NMR δ 19.14 (CH3), 19.44 (CH3), 120.80 (CH), 126.28 (2 
× CH), 128.45 (2 × CH), 128.48 (CH), 142.70 (C), 147.59 (C), 156.58 (C), 164.53 (C), 
136-147 (pentafluorophenyl); 19F NMR δ (–160.02)-(–159.87) (m, 2F), –147.92 (tt, J = 
20.8, 4.5 Hz, 1F), (–137.23)-(–137.12) (m, 2F); IR ν 1747, 1497, 1324, 1199 999, 987 
cm-1; MS (CI/isobutane) m/z (%) 370 [(M+H)+, 20], 350 (25), 214 (15), 160 (100), 158 
(45), 113 (22); HRMS (CI/isobutane) 370.0867 (C18H13NO2F5 requires 370.0866). 
 
(2E,3E)-3-methyl-4-phenylbut-3-en-2-one 
pentafluorobenzoyl-O-oxime ester (487b), C18H12NO2F5 , FW 
= 369.31 (327 mg, 0.926 mmol, 93 %): white crystals; mp 115-
117 ºC (visible softening and sublimation, hexane/AcOEt); 1H 
NMR (400 MHz, CDCl3) δ 2.20 (d, J = 1.2 Hz, 3H), 2.32 (s, 
3H), 7.13 (br s, 1H), 7.30-7.42 (m, 5H); 13C NMR δ 13.18 (CH3), 14.51 (CH3), 127.94 
(CH), 128.39 (2 × CH), 129.50 (2 × CH), 133.27 (C), 135.34 (CH), 136.24 (C), 156.58 (C), 
166.87, 134-150 (pentafluorophenyl); 19F NMR δ (–159.92)-(–159.77) (m, 2F), –147.72 
(tt, J = 20.9, 4.7 Hz, 1F), (–137.14)-(–137.02) (m, 2F); IR ν 1751, 1652, 1525, 1487, 1415, 
1376, 1322, 1189, 999, 986 cm-1; MS (CI/isobutane) m/z (%) 370 [(M+H)+, 25], 310 (20), 
308 (22), 160 (100); HRMS (CI/isobutane) 370.0869 (C18H13NO2F5 requires 370.0866).  
 
 
 
 
N
487a
O
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6.3. Imines  
 
General Procedures for Preparation of Imines:  
 
Method A. 5Ǻ Molecular sieves (6.25 g) were added to a solution of the corresponding 
ketone (5.00 mmol, 1 equiv) and p-anisidine (770 mg, 6.25 mmol, 1.25 equiv) in 
anhydrous toluene (25 mL) and the reaction mixture was heated under reflux for 5 h. The 
cooled reaction mixture was filtered from the sieves, the filtrate was evaporated and the 
residue was purified by flash chromatography on a silica gel column (5 g unless otherwise 
stated, pre-treated overnight with 10% triethylamine in petroleum ether) with a petroleum 
ether – ethyl acetate mobile phase, followed by recrystallisation.  
 
Method B. A solution of the corresponding ketone (5.00 mmol, 1 equiv), p-anisidine (647 
mg, 5.25 mmol, 1.05 equiv) and p-toluenesulfonic acid monohydrate (47 mg, 0.250 mmol, 
5 mol % equiv) in anhydrous benzene (25 mL) was heated under reflux with a Dean-Stark 
trap for 16 h, then cooled and evaporated to dryness. The residue was purified by flash 
chromatography on a silica gel column (25 g, treated overnight with 10 % triethylamine in 
petroleumether) with a petroleum ether – ethyl acetate mixture.  
 
Method C. A solution of titanium(IV) chloride (1.0 M in CH2Cl2 or toluene, 3.0 mL, 3.00 
mmol, 1 equiv) was added dropwise to a pre-cooled (0 ºC) solution of the ketone (3.00 
mmol, 1 equiv) and p-anisidine (1.11 g, 9.00 mmol, 3 equiv) in anhydrous ether. The 
reaction was let to reflux overnight and after cooling to room temperature it was filtered 
and the solids were washed with anhydrous ether. The filtrate was then washed with a 
KOH solution (2.0 M, 15 mL) and the aqueous layer was extracted with ether (3 × 10 mL). 
The combined organic layers were dried over K2CO3 and evaporated. The crude mixture 
was purified on a silica gel column (15 g, treated overnight with 10 % triethylamine in 
petroleumether) with a petroleoum ether – triethylamine (99:1).  
 
For yields and purification methods see Table 6.6, Table 6.7 and Table 6.8.  
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6.3.1. Imines with Heterocycles  
 
Table 6.6. Preparation of N,S-heterocyclic Imines from the Corresponding Ketones 
 
Method Ketone 
p-anisidine 
p-TsOH (mg) or TiCl4 (mL)  
SiO2  
PE – EA 
Imine 
A 561 µL, 606 mg, 5.00 mmol 
770 mg, 6.25 mmol 
25 mL 
95:5 
475a (1.03 g, 4.77 mmol, 95 %) 
B 658 µL, 721 mg, 5.95 mmol 
770 mg, 6.25 mmol 
57 mg, 0.300 mmol 
25 mL 
60:40 
475b (1.08 g, 4.82 mmol, 96 %) 
B 327 (250 mg, 1.22 mmol) 
165 mg, 1.34 mmol   
23 mg, 0.122 mmol 
20 mL 
100:0 
1475c (~ 214 mg, 0.69 mmol, 57 %) 
D 1.05 g, 4.00 mmol  
542 mg, 4.40 mmol  
76 mg, 0.400 mmol  
Cryst.  
MeOH/ether 
(1:1)  
475z (1.19 g, 3.23 mmol, 81 %)  
A 521 µL, 636 mg, 5.00 mmol 
770 mg, 6.25 mmol 
25 mL 
95:5 
475d (1.10 g, 4.74 mmol, 95 %) 
B 500 mg, 3.54 mmol  
480 mg, 3.90 mmol 
67 mg, 0.354 mmol 
20 mL 
97:3  
475e (564 mg, 2.29 mmol, 65 %) 
B 334A (1.48 g, 8.79 mmol) 
1.19 g, 9.67 mmol   
83 mg, 0.440 mmol 
40 mL 
99:1 
475f (1.76 g, 6.46 mmol, 73 %) 
B 335 (800 mg, 4.37 mmol) 
591 mg, 4.80 mmol  
83 mg, 0.437 mmol 
25 mL 
99:1  
(PE/Et3N)  
475g (964 mg, 3.34 mmol, 76 %)  
B 343 (349 mg, 1.75 mmol)  
253 mg, 2.06 mmol   
33 mg, 0.175 mmol 
15 mL 
99:1 → 97:3 
475h (486 mg, 1.60 mmol, 91 %) 
B 540 µL, 631 mg, 5.00 mmol 
647 mg, 5.25 mmol 
47 mg, 0.250 mmol 
25 mL 
100:0 
475i (475 mg, 2.05 mmol, 41 %) 
 
(E)-4-Methoxy-N-[1’-(pyridin-2”-yl)ethylidene]aniline (475a), C14H14N2O, FW = 
226.29 
475a
N N OMe
 
475a: yellow oil; 1H NMR (400 MHz, CDCl3) δ 2.38 (s, 3H), 3.82 (s, 3H), 6.78-6.82 (m, 
2H), 6.91-6.94 (m, 2H), 7.34 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H), 7.77 (ddd, J = 8.0, 7.5, 1.8 
Hz, 1H), 8.25 (ddd, J = 8.0, 1.0, 1.0 Hz, 1H), 8.65 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H); 13C 
NMR δ 16.38 (CH3), 55.50 (CH3), 114.25 (2 × CH), 120.85 (2 × CH), 121.36 (CH), 
124.66 (CH), 136.38 (CH), 144.32 (C), 148.52 (CH), 156.25 (C), 157.04 (C), 167.36 (C); 
IR ν 3001, 2952, 2834, 1636, 1504, 1241 cm-1; MS (EI) m/z (%) 226 (M˙+, 100), 211 (45), 
185 (14), 148 (80), 123 (15), 108 (23), 92 (28); HRMS (EI) 226.1104 (C14H14N2O requires 
226.1106). 
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(E)-4-Methoxy-N-[1’-(pyridin-4”-yl)ethylidene]aniline (475b), C14H14N2O, FW = 
226.29 
N
N OMe
475b
 
475b: yellow crystals; mp 112-113 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.27 (s, 
3H), 3.82 (s, 3H), 6.75-6.79 (m, 2H), 6.91-6.95 (m, 2H), 7.80 (dd, J = 4.6, 1.6 Hz, 2H), 
7.77 (ddd, J = 8.0, 7.5, 1.8 Hz, 1H), 8.25 (ddd, J = 8.0, 1.0, 1.0 Hz, 1H), 8.65 (ddd, J = 4.8, 
1.8, 0.9 Hz, 1H); 13C NMR δ 17.05 (CH3), 55.51 (CH3), 114.33 (2 × CH), 120.75 (2 × 
CH), 121.09 (2 × CH), 143.82 (C), 146.56 (C), 150.34 (2 × CH), 156.48 (C), 163.93 (C); 
IR ν 3019, 2965, 2837, 1634, 1597, 1504, 1216 cm-1; MS (EI) m/z (%) 226 (M˙+, 85), 211 
(100), 148 (32), 92 (24); HRMS (EI) 226.1104 (C14H14N2O requires 226.1106). 
 
(E)-N-[1’-(2”,6”-Di-iso-propylpyridin-4”-yl)ethylidene]-4-methoxyaniline (475c), 
C20H26N2O, FW = 310.48 
N
N
475c
OMe
 
475c: 1H NMR (400 MHz, CDCl3) δ 1.28 (d, J = 6.9 Hz, 12H), 2.58 (s, 3H), 3.08 (sept, J 
= 6.9 Hz, 2H), 6.67-6.67 (m, 2H), 6.82-6.85 (m, 2H), 7.37 (s, 2H). No further data 
provided as the imine was obtained only in a mixture with the corresponding ketone.  
 
(E)-4-Methoxy-N-[1’-(1”-methylpyridinium-4”-yl)ethylidene]aniline iodide (475z), 
C15H17N2OI, FW = 368.24 
N
N
I
475z
OMe
 
475z: brown crystals; mp 158-160 ºC (MeOH/Et2O); 1H NMR (400 MHz, CDCl3) δ 2.43 
(s, 3H), 3.85 (s, 3H), 4.63 (br s, 3H), 6.82-6.86 (m, 2H), 6.95-6.99 (m, 2H), 8.54 (d, J = 6.0 
Hz, 2H), 9.25 (d, J = 6.0 Hz, 2H); 1H NMR (400 MHz, DMSO-d6) δ 2.39 (s, 3H), 2.78 (s, 
3H), 4.39 (s, 3H), 6.91-6.95 (m, 2H), 7.00-7.04 (m, 2H), 8.54 (d, J = 6.4 Hz, 2H), 9.07 (d, 
J = 6.4 Hz, 2H); 13C NMR (DMSO-d6) δ 17.18 (CH3), 47.63 (CH3), 55.27 (CH3), 114.31 
(2 × CH), 121.55 (2 × CH), 124.83 (2 × CH), 142.23 (C), 145.91 (2 × CH), 152.60 (C), 
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156.78 (C), 161.79 (C); IR (ATR) ν 3038, 2996, 1628, 1504, 1445, 1283 cm-1; MS 
(FAB+/NOB) m/z (%) 241 (M˙+, 100), 157 (17); HRMS (FAB+/NOB) 241.1340 
(C15H17N2O requires 241.1341). 
 
(E)-4-Methoxy-N-[1’-(thiazol-2”-yl)ethylidene]aniline (475d), C12H12N2OS, FW = 
232.32 
N
S N
475d
OMe
 
475d: yellow crystals; mp 44-45 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.42 (s, 3H), 
3.82 (s, 3H), 6.83-6.87 (m, 2H), 6.90-6.94 (m, 2H), 7.45 (d, J = 3.2 Hz, 1H), 7.91 (d, J = 
3.2 Hz, 1H); 13C NMR δ 16.81 (CH3), 55.48 (CH3), 114.21 (2 × CH), 121.50 (2 × CH), 
122.86 (CH), 142.58 (C), 143.64 (CH), 156.77 (C), 161.30 (C), 170.92 (C); IR ν 3019, 
2954, 2833, 1629, 1505, 1243, 1215 cm-1; MS (EI) m/z (%) 232 (M˙+, 100), 217 (60), 148 
(53), 92 (38); HRMS (EI) 232.0668 (C12H12N2OS requires 232.0670). 
 
(E)-4-Methoxy-N-[1’-(4”-methythiazol-2”-yl)ethylidene]aniline (475e), C13H14N2OS, 
FW = 246.35 
N
S N
475e
OMe
 
475e: yellow oil; 1H NMR (400 MHz, CDCl3) δ 2.39 (s, 3H), 2.50 (s, 3H), 3.81 (s, 3H), 
6.81-6.84 (m, 2H), 6.89-6.92 (m, 2H), 6.99 (s, 1H); 13C NMR δ 16.88 (CH3), 17.37 (CH3), 
55.46 (CH3), 114.17 (2 × CH), 117.60 (CH), 121.48 (2 × CH), 142.75 (C), 153.81 (C), 
156.67 (C), 161.35 (C), 169.90 (C); IR ν 2954, 2923, 2834, 1626, 1504, 1455, 1365, 1244 
cm-1; MS (EI) m/z (%) 246 (M˙+, 55), 231 (37), 148 (30); HRMS (EI) 246.0828 
(C13H14N2OS requires 246.0827).  
 
(E)-4-Methoxy-N-[1’-(4”-iso-propylthiazol-2”-yl)ethylidene]aniline (475f), 
C14H18N2OS, FW = 274.41 
N
S N
475f
OMe
 
475f: yellow oil; mp 44-45 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.9 
Hz, 6H), 2.40 (s, 3H), 3.13 (sept d, J = 6.9, 0.8 Hz, 1H), 3.80 (s, 3H), 6.81-6.85 (m, 2H), 
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6.88-6.92 (m, 2H), 6.99 (d, J = 0.8 Hz, 1H); 13C NMR δ 16.76 (CH3), 22.30 (2 × CH3), 
30.94 (CH), 55.29 (CH3), 114.02 (2 × CH), 114.90 (CH), 121.32 (2 × CH), 142.71 (C), 
156.46 (C), 161.59 (C), 164.59 (C), 169.54 (C); IR ν 2962, 2929, 2869, 2834, 1627, 1505, 
1466, 1365, 1293, 1244 cm-1; MS (EI) m/z (%) 274 (M˙+, 100), 259 (52), 218 (15), 148 
(50), 92 (15); HRMS (EI) 274.1136 (C15H18N2OS requires 274.1140). 
 
(E)-N-[1’-(4”-tert-Butylhiazol-2”-yl)ethylidene]-4-methoxyaniline (475g), C16H20N2OS, 
FW = 288.44 
N
S N
475g
OMe
 
475g: yellow oil which solidified upon standing; mp 33-34 ºC; 1H NMR (400 MHz, 
CDCl3) δ 1.38 (s, 9H), 2.40 (s, 3H), 3.81 (s, 3H), 6.81-6.85 (m, 2H), 6.89-6.93 (m, 2H), 
7.01 (s, 1H); 13C NMR δ 16.83 (CH3), 30.05 (3 × CH3), 34.92 (C), 55.44 (CH3), 114.18 (2 
× CH), 114.23 (CH), 121.39 (2 × CH), 143.00 (C), 156.57 (C), 162.00 (C), 167.57 (C), 
169.33 (C); IR ν 2959, 1628, 1505, 1364, 1295, 1243 cm-1; MS (EI) m/z (%) 288 (M˙+, 
55), 273 (34), 148 (30); HRMS (EI) 288.1297 (C16H20N2OS requires 288.1296).  
 
(E)-4-Methoxy-N-[1’-(4”-trimetylsilylthiazol-2”-yl)ethylidene]aniline (475h), 
C15H20N2OSSi, FW = 304.52 
N
S N
Si
475h
OMe
 
475h: colourless oil which solidified upon standing; mp 54-55 ºC; 1H NMR (400 MHz, 
CDCl3) δ 0.35 (s, 9H), 2.41 (s, 3H), 3.80 (s, 3H), 6.81-6.85 (m, 2H), 6.89-6.92 (m, 2H), 
7.89 (s, 1H); 13C NMR δ –0.23 (3 × CH3), 16.95 (CH3), 55.37 (CH3), 114.10 (2 × CH), 
121.40 (2 × CH), 137.43 (C), 142.70 (C), 148.97 (CH), 156.64 (C), 161.28 (C), 174.85 (C); 
IR ν 3067, 2955, 2899, 2834, 1627, 1505, 1487, 1365, 1290, 1244 cm-1; MS (EI) m/z (%) 
304 (M˙+, 100), 303 (80), 148 (32); HRMS (EI) 304.1070 (C15H20N2OSSi requires 
304.1066).  
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(E)-4-Methoxy-N-[1’-(thiophen-2”-yl)ethylidene]aniline (475i), C13H13NOS, FW = 
231.33 
N OMeS
475i
 
475i: yellow crystals; mp 77-78 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.26 (s, 3H), 
3.81 (s, 3H), 6.76-6.80 (m, 2H), 6.88-6.91 (m, 2H), 7.09 (dd, J = 5.1, 3.7 Hz, 1H), 7.44 
(dd, J = 5.1, 1.1 Hz, 1H), 7.46 (dd, J = 3.7, 1.1 Hz, 1H); 13C NMR δ 17.39 (CH3), 55.49 
(CH3), 114.14 (2 × CH), 121.42 (2 × CH), 127.44 (CH), 128.26 (CH), 129.71 (CH), 143.71 
(C), 146.78 (C), 156.16 (C), 160.47 (C); IR ν 3009, 2961, 2837, 1617, 1502, 1428, 1239, 
1241, 1206 cm-1; MS (EI) m/z (%) 231 (M˙+, 95), 216 (100), 201 (20), 173 (20), 92 (25); 
HRMS (EI) 231.0717 (C13H13NOS requires 231.0718).  
 
Table 6.7. Preparation of O,N-heterocyclic Imines from the Corresponding Ketones 
 
Method Ketone 
p-anisidine 
p-TsOH (mg) or TiCl4 (mL) 
SiO2  
PE – EA 
Imine 
B 550 mg, 5.00 mmol 
647 mg, 5.25 mmol 
47 mg, 0.250 mmol 
25 mL 
98:2 
475j (838 mg, 3.89 mmol, 78%) 
A 349 µL, 373 mg, 3.00 mmol 
462 mg, 3.75 mmol 
25 mL 
98:2 
475k (507 mg, 2.211 mmol, 74 %) 
A 353b (150 mg, 1.10 mmol)  
170 mg, 1.38 mmol  
Heating to 50 ºC 
25 mL  
90:10  
Amino Ketone 477  
(217 mg, 0.837 mmol 76 %) 
A 344 (250 mg, 1.30 mmol) 
200 mg, 1.63 mmol  
25 mL 
98:2 
475l (275 mg, 0.566 mmol, 74 %) 
A 346 (182 mg, 1.00 mmol) 
154 mg, 1.25 mmol 
40 mL 
97:3 
475m (206 mg, 0.712 mmol, 72 %) 
B 300 mg, 2.17 mmol 
334 mg, 2.71 mmol 
21 mg, 0.109 mmol 
25 mL 
99:1  
(PE:Et3N) 
475n (~ 52 mg, 0.214 mmol, 10 %) 
A 353a (160 mg, 1.45 mmol) 
224 mg, 1.82 mmol 
10 mL 
85:15 
475o (97 mg, 0.451 mmol, 31 %) 
A 399 µL, 415 mg, 3.00 mmol 
462 mg, 3.75 mmol 
25 mL 
99:1 
475p (292 mg, 1.200 mmol, 40 %) 
A 481 mg, 3.00 mmol 
462 mg, 3.75 mmol 
25 mL 
90:10 
475q (590 mg, 2.224 mmol, 74 %) 
B 353d (300 mg,1.87 mmol) 
254 mg, 2.06 mmol 
18 mg, 0.094 mmol 
30 mL  
100:0 → 97:3 
475r (282 mg, 1.06 mmol, 57 %) 
B 352 (200 mg, 1.16 mmol) 
144 mg, 1.17 mmol 
22 mg, 0.116 mmol 
25 mL 
97:3 
475s (194 mg, 0.70 mmol, 56 %) 
B 866 mg, 5.00 mmol 
647 mg, 5.25 mmol  
47 mg, 0.250 mmol 
Cryst. DCM 475t (528 mg, 1.900 mmol, 38 %) 
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(E)-N-[1’-(Furan-2”-yl)ethylidene]-4-methoxyaniline (475j), C13H13NO2, FW = 215.26 
N OMeO
475j
 
475j: yellow crystals; mp 82-83 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.17 (s, 3H), 
3.81 (s, 3H), 6.51 (dd, J = 3.4, 1.7 Hz, 1H), 6.78-6.81 (m, 2H), 6.87-6.90 (m, 2H), 6.92 (d, 
J = 3.4 Hz, 1H), 7.55-7.56 (m, 1H); 13C NMR δ 14.62 (CH3), 55.56 (CH3), 109.82 (CH), 
111.01 (CH), 112.21 (2 × CH), 119.51 (2 × CH), 141.68 (C), 142.82 (CH), 151.86 (C), 
154.26 (C), 154.64 (C); IR ν 3019, 2964, 2837, 2400, 1625, 1504, 1482, 1239, 1214 cm-1; 
MS (EI) m/z (%) 215 (M˙+, 75), 200 (100); HRMS (EI) 215.0948 (C13H13NO2 requires 
215.0946). 
 
(E)-4-Methoxy-N-[1’-(5”-methylfuran-2”-yl)ethylidene]aniline (475k), C14H15NO2, 
FW = 229.30 
N
OMe
O
475k
 
475k: yellow oil; 1H NMR (400 MHz, CDCl3) δ 2.10 (s, 3H), 2.39-2.40 (m, 3H), 3.79 (s, 
3H), 6.10 (dq, J = 3.3, 0.9 Hz, 1H), 6.75-6.79 (m, 2H), 6.79 (br d, J = 3.4 Hz, 1H), 6.85-
6.89 (m, 2H); 13C NMR δ 14.09 (CH3), 16.37 (CH3), 55.43 (CH3), 108.15 (CH), 114.03 (2 
× CH), 114.86 (CH), 121.42 (2 × CH), 143.95 (C), 152.18 (C), 155.58 (C), 155.96 (C), 
156.35 (C); IR ν 2956, 1621, 1501, 1242, 1217 cm-1; MS (EI) m/z (%) 229 (M˙+, 76), 214 
(100), 186 (12); HRMS (EI) 229.1101 (C14H15NO2 requires 229.1103).  
 
1-(Furan-3’-yl)-3-(4”-methoxyanilino)butan-1-one (477), C15H17NO3, FW = 259.33 
O O
477
HN OMe
 
477 prepared according to imination Method A or B (224 mg, 0.864 mmol, 76 %): yellow 
oil; 1H NMR (400 MHz, CDCl3) δ 1.27 (d, J = 6.4 Hz, 3H), 2.77 (dd, J = 15.6, 7.4 Hz, 
1H), 3.05 (dd, J = 15.6, 4.5 Hz, 1H), 3.48 (br s, 1H), 3.99 (dqd, J = 13.7, 6.5, 4.6 Hz, 1H), 
6.59-6.63 (m, 2H), 7.76-7.80 (m, 2H), 6.75 (dd, J = 1.9, 0.8 Hz, 1H), 7.42 (dd, J = 1.8, 1.6 
Hz, 1H), 7.97 (dd, J = 1.3, 0.9 Hz, 1H); 13C NMR δ 45.39 (CH2), 108.72 (CH), 114.84 (2 × 
CH), 115.47 (2 × CH), 128.38 (C), 140.96 (C), 144.35 (CH), 147.44 (CH), 152.45 (CH), 
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194.03 (C); IR ν 3360, 2961, 2832, 1670, 1511, 1155 cm-1; MS (CI/isobutane) m/z (%) 260 
[(M+H)+, 100], 176 (21), 150 (70), 138 (26); HRMS (CI/isobutane) 260.1284 (C15H18NO3 
requires 260.1287).  
 
(E)-4-Methoxy-N-[1’-(5”-trimetylsilylfuran-2”-yl)ethylidene]aniline (475l), 
C16H21NO2Si, FW = 287.56 
N
OMe
O
475l
Si
 
475l: yellow crystals: mp 65-66 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 0.31 (s, 9H), 
2.18 (s, 3H), 3.81 (s, 3H), 6.71 (d, J = 3.4 Hz, 1H), 6.75-6.79 (m, 2H), 6.87-6.91 (m, 2H), 
6.97 (d, J = 3.4 Hz, 1H); 13C NMR δ –1.62 (3 × CH3), 16.74 (CH3), 55.41 (CH3), 112.09 
(CH), 114.05 (2 × CH), 121.25 (2 × CH), 121.46 (CH), 155.98 (C), 155.98 (C), 157.49 (C), 
158.04 (C), 163.44 (C); IR ν 3019, 2959, 1623, 1504, 1241, 1215 cm-1; MS (EI) m/z (%) 
287 (M˙+, 83), 272 (100), 170 (47); HRMS (EI) 287.1341 (C16H21NO2Si requires 
287.1342). 
 
Ethyl (E)-5-[1’-(4”-methoxyphenylimino)ethyl]furan-2-carboxylate (475m), 
C16H17NO4, FW = 287.34 
O
EtOOC
N
475m OMe
 
475m: yellow crystals; mp 69-70 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 1.36 (t, J = 
7.1 Hz, 3H), 2.23 (s, 3H), 3.78 (s, 3H), 4.36 (q, J = 7.1 Hz, 2H), 6.74-6.78 (m, 2H), 6.86-
6.90 (m, 2H), 7.04 (d, J = 3.6 Hz, 1H), 7.22 (d, J = 3.6 Hz, 1H); 13C NMR δ 13.30 (CH3), 
15.49 (CH3), 54.39 (CH3), 60.18 (CH2), 111.33 (CH), 113.17 (2 × CH), 118.09 (CH), 
120.24 (2 × CH), 142.09 (C), 144.28 (C), 155.49 (C), 155.85 (C), 155.92 (C), 157.53 (C); 
IR ν 3019, 1718, 1627, 1502, 1291, 1242, 1225 cm-1; MS (EI) m/z (%) 287 (M˙+, 100), 
272 (87), 244 (32), 199 (17), 148 (17), 92 (23), 86 (20), 84 (32); HRMS (EI) 287.1161 
(C16H17NO4 requires 287.1158). 
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N-[1’-(Furan-2”-yl)-2’-methylprop-1’-ylidene]-4-methoxyaniline (475n), C15H17NO2, 
FW = 243.33  
N
OMe
O
475n
 
475n: 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 11:5, the minor 
one is marked *) δ 1.27 (d, J = 6.9 Hz, 8.7H), 3.16* (sept, J = 7.1 Hz, 0.45H), 3.40 (sept, J 
= 6.8 Hz, 1H), 3.79 (s, 4.35H), 5.67 (dd, J = 3.6, 0.6 Hz, 1H), 6.21 (dd, J = 3.6, 1.7 Hz, 
1H), 6.49* (dd, J = 3.5, 1.8 Hz, 0.45H), 6.60-6.64 (m, 2H), 6.69-6.73* (m, 0.9H), 6.85-
6.89 (m, 2H), 7.32-7.36* (m, 0.9H), 6.99* (dd, J = 3.5, 0.7 Hz, 0.45H), 7.31 (dd, J = 1.7, 
0.6 Hz, 1H), 7.53* (dd, J = 1.8, 0.7 Hz, 0.45H). No further data provided as the imine was 
obtained only in a mixture with the corresponding ketone.  
 
(E)-N-[1’-(Furan-3”-yl)ethylidene]-4-methoxyaniline (475o), C13H13NO2, FW = 215.27  
O N
475o
OMe
 
475o: pale yellow crystals; mp 54-55 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.10 (s, 
3H), 3.79 (s, 3H), 6.72-6.76 (m, 2H), 6.87-6.91 (m, 2H), 6.92 (dd, J = 1.9, 0.8 Hz, 1H), 
7.44 (dd, J = 1.7, 1.7 Hz, 1H), 7.83 (dd, J = 1.4, 0.8 Hz, 1H); 13C NMR δ 16.90 (CH3), 
54.46 (CH3), 107.63 (CH), 113.17 (2 × CH), 119.97 (2 × CH), 128.11 (C), 142.73 (CH), 
142.80 (CH), 143.08 (C), 154.97 (C), 158.67 (C), 160.85 (C); IR ν 2961, 1629, 1501, 
1241, 1218 cm-1; MS (CI/isobutane) m/z (%) 216 [(M+H)+, 100], 85 (18); HRMS 
(CI/isobutane) 216.1026 (C13H14NO2 requires 216.1025). 
 
(E)-N-[1’-(2”,5”-Dimethylfuran-3”-yl)ethylidene]-4-methoxyaniline (475p), 
C15H17NO2, FW = 243.33 
O N
475p
OMe
 
475p: pale yellow crystals; mp 49-50 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.07 (s, 
3H), 2.27 (br s, 3H), 2.56 (s, 3H), 3.79 (s, 3H), 6.24 (br s, 1H), 6.69-6.73 (m, 2H), 6.86-
6.90 (m, 2H); 13C NMR δ 12.23 (CH3), 13.42 (CH3), 18.09 (CH3), 54.43 (CH3), 105.14 
(CH), 113.14 (2 × CH), 119.91 (2 × CH), 121.67 (C), 143.77 (C), 148.35 (C), 150.39 (C), 
154.65 (C), 160.85 (C); IR ν 3018, 1611, 1503, 1241, 1216 cm-1; MS (EI) m/z (%) 243 
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(M˙+, 26), 228 (25), 87 (27), 85 (100); HRMS (EI) 243.1256 (C15H17NO2 requires 
243.1259).  
 
(E)-N-[1’-(Benzofuran-2”-yl)ethylidene]-4-methoxyaniline (475q), C17H15NO2, FW = 
265.33 
N
OMe
O
475q
 
475q: yellow crystals; mp 119-120 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.28(s, 
3H), 3.80 (s, 3H), 6.82-6.86 (m, 2H), 6.90-6.94 (m, 2H), 7.25 (d, J = 0.9 Hz, 1H), 7.30 
(ddd, J = 7.8, 7.3, 1.0 Hz, 1H), 7.38 (ddd, J = 8.3, 7.3, 1.3 Hz, 1H), 7.60 (ddd, J = 8.3, 1.7, 
1.0 Hz, 1H), 7.64 (ddd, J = 7.8, 1.3, 0.7 Hz, 1H); 13C NMR δ 16.81 (CH3), 55.46 (CH3), 
109.49 (CH), 112.16 (CH), 114.14 (2 × CH), 121.39 (2 × CH), 122.05 (CH), 123.35 (CH), 
126.49 (CH), 127.94 (C), 143.45 (C), 154.78 (C), 155.53 (C), 156.40 (C), 157.20 (C); IR ν 
3019, 2982, 1619, 1503, 1244, 1215 cm-1; MS (EI) m/z (%) 265 (M˙+, 76), 250 (100), 181 
(10), 115 (13), 92 (12); HRMS (EI) 265.1105 (C17H15NO2 requires 265.1103). 
 
(E)-N-[1’-(Benzofuran-3”-yl)ethylidene]-4-methoxyaniline (475r), C17H15NO2, FW = 
265.33 
O N
475r OMe
 
475r: yellow crystals; mp 101-102 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.28 (s, 
3H), 3.82 (s, 3H), 6.82-6.86 (m, 2H), 6.90-6.94 (m, 2H), 7.25-7.29 (m, 2H), 7.38 (ddd, J = 
8.3, 7.2, 1.2 Hz, 1H), 7.60 (dd, J = 8.3, 0.7 Hz, 1H), 7.65 (br d, J = 7.7 Hz, 1H); 13C NMR 
δ 16.75 (CH3), 55.45 (CH3), 109.32 (CH), 112.12 (CH), 114.15 (2 × CH), 121.32 (2 × CH), 
122.00 (CH), 123.31 (CH), 126.42 (CH), 127.95 (C), 143.49 (C), 154.84 (C), 155.53 (C), 
156.41 (C), 157.16 (C); IR ν 3023, 2982, 2962, 1619, 1502, 1450, 1217 cm-1; MS (EI) m/z 
(%) 265 (M˙+, 80), 250 (100), 115 (15), 85 (53), 84 (28), 83 (82); HRMS (EI) 265.1101 
(C17H15NO2 requires 265.1103). 
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(E)-4-Methoxy-N-[1’-(1”-methyl-1H-indol-2”-yl)ethylidene]aniline (475s), C18H18N2O, 
FW = 278.38 
N N OMe
475s
 
475s: yellowish crystals; mp 143-144 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 2.29 (s, 
3H), 3.80 (s, 3H), 4.14 (s, 3H), 6.74-6.78 (m, 2H), 6.89-6.93 (m, 2H), 6.99 (d, J = 0.7 Hz, 
1H), 7.12 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 7.30 (ddd, J = 8.4, 6.9, 1.1 Hz, 1H), 7.37 (ddd, J 
= 8.4, 0.7 Hz, 1H), 7.64 (dd, J = 7.9, 0.8 Hz, 1H); 13C NMR δ 18.62 (CH3), 32.98 (CH3), 
55.56 (CH3), 107.37 (CH), 110.03 (CH), 114.31 (2 × CH), 120.02 (CH), 120.85 (2 × CH), 
121.57 (CH), 123.92 (CH), 126.49 (C), 137.70 (C), 140.01 (C), 144.28 (C), 156.02 (C), 
160.23 (C); IR ν 3019, 2945, 1621, 1500, 1465, 1391, 1240, 1217 cm-1; MS (EI) m/z (%) 
278 (M˙+, 50), 263 (12), 171 (10), 121 (54); HRMS (EI) 278.1417 (C18H18N2O requires 
278.1419). 
 
(E)-4-Methoxy-N-[1’-(1”-methyl-1H-indol-3”-yl)ethylidene]aniline (475t), C18H18N2O, 
FW = 278.38 
N N
475t OMe
 
475t: pale yellow crystals; mp 222-223 ºC (CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 2.27 
(s, 3H), 3.86 (s, 3H), 3.98 (s, 3H), 6.83-6.87 (m, 2H), 6.93-6.97 (m, 2H), 7.28 (ddd, J = 
7.9, 6.7, 1.4 Hz, 1H), 7.34 (ddd, J = 8.0, 6.7, 1.3 Hz, 1H), 7.37 (ddd, J = 8.0, 1.4, 0.8 Hz, 
1H), 7.53 (s, 1H), 8.61 (ddd, J = 7.8, 1.2, 0.8 Hz, 1H); 13C NMR δ 18.00 (CH3), 33.24 
(CH3), 55.56 (CH3), 109.21 (CH), 114.11 (2 × CH), 117.12 (C), 121.34 (2 × CH), 121.41 
(CH), 122.80 (CH), 123.41 (CH), 126.17 (C), 131.86 (CH), 137.78 (C), 145.47 (C), 155.43 
(C), 161.76 (C); IR ν 3019, 2927, 2830, 1658, 1602, 1535, 1498, 1466, 1372, 1216 cm-1; 
MS (EI) m/z (%) 278 (M˙+, 65), 263 (100), 220 (10), 85 (37), 83 (59); HRMS (EI) 
278.1417 (C18H18N2O requires 278.1419). 
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6.3.2. Imines without Heterocycles  
 
Table 6.8. Preparation of Aryl-alkyl and Dialkyl Imines  
 
 
Method Ketone 
p-anisidine 
p-TsOH (mg) or TiCl4 (mL) 
SiO2  
PE – EA 
Imine 
A 671 µL, 671 mg, 5.00 mmol 
770 mg, 6.25 mmol 
25 mL 
100:1 
476a (571 mg, 2.39 mmol, 48 %) 
B 353f (700 mg, 4.72 mmol) 
727 mg, 5.90 mmol  
89 mg, 0.472 mmol 
20 mL 
100:0 
476b (345 mg, 1.36 mmol, 29 %) 
C 500 mg, 3.42 mmol 
1.26 g, 10.26 mmol 
3.4 mL, 3.42 mmol 
30 mL 
100:0 
476c (448 mg, 1.78 mmol, 52 %) 
C 500 mg, 3.12 mmol 
1.15 g, 9.36 mmol 
3.1 mL, 3.12 mmol 
30 mL 
100:0 
476d (524 mg, 1.98 mmol, 63 %) 
C 395 mg, 2.10 mmol 
775 mg, 6.29 mmol 
2.1 mL, 2.10 mmol 
30 mL 
100:0 
476e (325 mg, 1.11 mmol, 53 %) 
C 517µL, 500 mg, 3.08 mmol 
1.19 g, 9.65 mmol 
3.1 mL, 3.08 mmol 
15 mL 
100:0 
476f (560 mg, 2.09 mmol, 68 %) 
C 1.04 mL, 832 mg, 8.27 mmol 
3.06 g, 24.8 mmol  
8.3 mL, 8.27 mmol 
25 mL 
100:0 
476i (1.28 g, 6.23 mmol, 75 %) 
C 474 (500 mg, 1.78 mmol) 
659 mg, 5.35 mmol   
1.8 mL, 1.78 mmol 
30 mL  
85:15 
(PE:DCM) 
476j (476 mg, 1.24 mmol, 69 %) 
A 400 µL, 439 mg, 3.00 mmol 
462 mg, 3.75 mmol 
40 mL 
98:2 
476k (517 mg, 2.057 mmol, 69 %) 
B  750 µL, 691 mg, 5.00 mmol 
677 mg, 5.50 mmol  
95 mg, 0.500 mmol 
30 mL 
99:1 → 95:5 
476l (809 mg, 3.32 mmol, 66 %) 
B 459 (1.00 g, 5.20 mmol) 
705 mg, 5.72 mmol   
49 mg, 0.260 mmol 
35 mL  
100:0 → 95:5 
476m (921 mg, 3.10 mmol, 60 %) 
A 630 mg, 3.62 mmol 
557 mg, 5.19 mmol 
25 mL 
98:2 
476n (157 mg, 0.562 mmol, 16 %) 
B 390 mg, 1.905 mmol  
246 mg, 2.000 mmol   
18 mg, 0.095 mmol 
60 mL 
100:0  
476o (237 mg, 0.761 mmol, 40 %) 
A 500 mg, 2.45 mmol 
377 mg, 3.06 mmol   
19 mg, 0.104 mmol 
40 mL 
100:0 
476p (287 mg, 0.93 mmol, 38 %) 
B 500 mg, 2.68 mmol 
340 mg, 2.76 mmol  
25 mg, 0.134 mmol 
25 mL 
100:0 
476q (573 mg, 1.940 mmol, 72 %) 
C 464 (500 mg, 3.12 mmol) 
1.15 g, 9.36 mmol 
3.1 mL, 3.12 mmol 
25 mL  
100:0 → 97:3 
476s (185 mg, 0.697 mmol, 22 %) 
B  430 mg, 1.89 mmol 
255 mg, 2.07 mmol  
18 mg, 0.0943 mmol 
20 mL  
85:15 
(PE:DCM) 
476t (~ 200 mg, 0.600 mmol, 32 %)  
A 521 mg, 2.50 mmol  
385 mg, 3.13 mmol  
 
40 mL 
90:10 
476u (306 mg, 0.976 mmol, 39 %) 
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Table 6.8. – Cont. Preparation of Aryl-alkyl and Dialkyl Imines  
 
Method Ketone 
p-anisidine 
p-TsOH (mg) or TiCl4 (mL) 
SiO2  
PE – EA 
Imine 
B 1.05 g, 5.00 mmol 
647 mg, 5.25 mmol   
47 mg, 0.250 mmol  
25 mL  
100:0  
 
476v (433 mg, 1.373 mmol, 27 %)  
B 463 (501 mg, 2.00 mmol) 
308 mg, 2.50 mmol  
19 mg, 0.104 mmol  
20 mL 
95:5 
 
476w (644 mg, 1.75 mmol, 87 %) 
 
(E)-4-Methoxy-N-(1’-phenylprop-1’-ylidene)aniline (476a), C16H17NO, FW = 239.33 
476a
N
OMe
 
476a:222 yellow crystals; mp 104-105 ºC (hexane) [lit.222 gives 101-102 ºC (MeOH)]; 1H 
NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ca. 10:1 ratio, the minor one is 
marked *) δ 1.09 (t, J = 7.7 Hz, 3H), 1.22* (t, J = 7.4 Hz, 0.3H), 2.69 (q, J = 7.7 Hz, 2H), 
2.78* (t, J = 7.4 Hz, 0.2H), 3.71* (s, 0.3H), 3.82 (s, 3H), 6.55-6.59* (m, 0.2H), 6.64-6.68* 
(m, 0.2H), 6.73-6.77 (m, 2H), 6.89-6.93 (m, 2H), 7.04-7.07* (m, 0.2H), 7.21-7.23* (m, 
0.3H), 7.44-7.46 (m, 3H), 7.90-7.93 (m, 2H); 13C NMR δ 11.01* (CH3), 12.92 (CH3), 
23.28 (CH2), 34.60* (CH2), 55.29* (CH3), 55.50 (CH3), 113.74* (2 × CH), 114.29 (2 × 
CH), 120.29 (2 × CH), 122.29* (2 × CH), 127.58 (2 × CH), 127.85* (2 × CH), 128.11* (2 
× CH), 128.21* (CH), 128.51 (2 × CH), 130.26 (CH), 138.08* (C), 138.29 (C), 144.10* 
(C), 144.86 (C), 155.58* (C), 155.77 (C), 171.37 (C), 173.06* (C); IR ν 3017, 2979, 2835, 
1626, 1503, 1240, 1216 cm-1; MS (EI) m/z (%) 239 (M˙+, 44), 210 (100), 195 (12), 167 
(13), 92 (18); HRMS (EI) 239.1307 (C16H17NO requires 239.1310). 
 
(E)-4-Methoxy-N-(2’-methyl-1’-phenylprop-1’-ylidene)aniline (476b), C17H19NO, FW 
= 253.37 
N
476b OMe
 
476b: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 7:1, 
the minor one is marked *) δ 1.07* (d, J = 7.1 Hz, 0.9H), 1.13 (d, J = 6.8 Hz, 6H), 2.93 
(sept, J = 6.8 Hz, 1H), 3.10* (sept, J = 7.1 Hz, 0.15H), 3.58 (s, 3H), 3.71* (s, 0.45), 6.43-
6.47 (m, 2H), 6.53-6.56 (m, 2H), 6.65-6.69* (m, 0.30H), 6.79-6.83* (m, 2H), 6.91-6.93 (m, 
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2H), 7.07-7.15 (m, 3H), 7.30-7.32 (m, 0.45H), 7.55-7.59 (m, 2H); 13C NMR δ 20.17 (2 × 
CH3), 20.88* (2 × CH3), 31.62* (CH), 38.45 (CH), 55.14 (CH3), 55.35* (CH3), 113.52 (2 × 
CH), 114.14* (2 × CH), 119.88* (2 × CH), 121.95 (2 × CH), 127.77 (3 × CH), 127.83 (4 × 
CH), 128.86* (3 × CH), 138.10 (C), 139.22* (C), 144.07* (C), 144.19 (C), 155.29 (C), 
155.56* (C), 176.59* (C), 176.64 (C); IR ν 3056, 2967, 2832, 2834, 1633, 1503, 1464, 
1442, 1290, 1241 cm-1; MS (EI) m/z (%) 253 (M˙+, 20), 210 (100), 167 (10), 106 (33), 91 
(54); HRMS (EI) 253.1464 (C17H19NO requires 253.1467). 
 
 (E)-N-[Cyclopropyl(phenyl)methylene]-4-methoxyaniline (476c), C17H17NO, FW = 
251.35 
N
OMe476c
 
476c:223 yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 
5:3, the minor one is marked *) δ 0.58* (ddd, J = 6.2, 5.8, 4.6 Hz, 1.2H), 0.82 (ddd, J = 
8.6, 6.6, 4.6 Hz, 2H), 0.98 (ddd, J = 8.1, 6.5, 3.6 Hz, 2H), 1.16* (ddd, J = 6.3, 4.8, 3.5 Hz, 
1.2H), 1.89* (tt, J = 8.6, 5.7 Hz, 0.6H), 1.99 (tt, J = 8.1, 4.8 Hz, 1H), 3.69 (s, 3H), 3.82* (s, 
1.8H), 6.52-6.55 (m, 2H), 6.63-6.67 (m, 2H), 6.89-6.93* (m, 1.2H), 6.94-6.97* (m, 1.2H), 
7.14-7.18 (m, 2H), 7.20-7.24 (m, 3H), 7.38-7.42* (m, 1.8H), 7.74-7.78 (m, 1.2H); 13C 
NMR δ 7.98 (2 × CH2), 79.36 (2 × CH2), 13.90* (CH), 20.19 (CH), 55.27 (CH3), 55.44* 
(CH3), 113.76 (2 × CH), 114.00* (2 × CH), 121.60* (2 × CH), 122.21* (2 × CH), 127.93* 
(2 × CH), 127.97 (2 × CH), 128.02* (2 × CH), 128.10 (2 × CH), 128.23 (CH), 129.25* 
(CH), 138.16 (C), 138.79* (C), 144.03* (C), 144.20 (C), 155.46 (C), 155.99* (C), 170.68 
(C), 172.58* (C); IR ν 3056, 3001, 2968, 2833, 1627, 1576, 1503, 1443, 1381, 1289, 1241 
cm-1; MS (EI) m/z (%) 251 (M˙+, 100), 250 (27), 236 (30), 212 (28), 210 (50), 174 (12), 
128 (15), 92 (15); HRMS (EI) 251.1307 (C17H17NO requires 251.1310). 
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(E)-N-[Cyclobutyl(phenyl)methylene]-4-methoxyaniline (476d), C18H19NO, FW = 
265.38 
N
OMe476d
 
476d: yellow crystals; mp 43-44 ºC (hexane); 1H NMR (400 MHz, CDCl3, a mixture of 
(E/Z) isomers in ratio ca. 5:3, the minor one is marked *) δ 1.48-1.56* (m, 0.6H), 1.67-
1.79* (m, 0.6H), 1.81-2.06 (m, 4.4H), 2.17-2.24 (m, 2H), 2.36-2.46 (m, 2H), 3.64 (ttd, J = 
8.2, 8.2, 1.0 Hz, 1H), 3.69 (s, 3H), 3.79 (s, 1.8H), 3.80-3.90* (m, 0.6H), 6.59-6.62 (m, 2H), 
6.65-6.69 (m, 2H), 6.79-6.83* (m, 1.2H), 6.85-6.89* (m, 1.2H), 7.00-7.05 (m, 2H), 7.17-
7.21 (m, 3H), 7.38-7.43* (m, 1.8H), 7.67-7.69* (m, 1.2H); 13C NMR δ 17.73 (CH2), 
18.34* (CH2), 26.55 (2 × CH2), 29.16* (2 × CH2), 39.44* (CH), 44.16 (CH), 55.23 (CH3), 
55.40* (CH3), 113.74 (2 × CH), 113.88* (2 × CH), 120.78* (2 × CH), 122.55 (2 × CH), 
127.50* (2 × CH), 127.78 (2 × CH), 128.01 (2 × CH), 128.05* (2 × CH), 128.08 (CH), 
129.17 (CH), 137.50 (C), 139.88* (C), 143.95* (C), 144.23 (C), 155.60 (C), 155.93* (C), 
172.97* (C), 173.47 (C); IR ν 3056, 2944, 2866, 2833, 1630, 1502, 1442, 1289, 1241 cm-1; 
MS (EI) m/z (%) 265 (M˙+, 59), 250 (15), 236 (12), 210 (100), 134 (12), 115 (15), 92 (20); 
HRMS (EI) 265.1464 (C18H19NO requires 265.1467). 
 
(E)-N-[Cyclohexyl(phenyl)methylene]-4-methoxyaniline (476e), C20H23NO, FW = 
293.44 
N
OMe476e
 
476e: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 10:1, 
the minor one is marked *) δ 0.98-1.10* (m, 0.3H), 1.12-1.27 (m, 3H), 1.34-1.42 (m, 2H), 
1.57-1.61 (m, 1H), 1.70-1.74 (m, 2H), 1.82-1.86 (m, 2H), 1.41-1.64* (m, 0.7H), 2.57 
(dddd, J = 11.4, 11.4, 3.3, 3.3 Hz, 1H), 2.75* (dddd, J = 12.2, 12.2, 3.1, 3.1 Hz, 0.1H), 
3.53 (s, 3H), 3.68* (s, 0.3H), 6.41-6.45 (m, 2H), 6.49-6.53 (m, 2H), 6.63-6.66* (m, 0.2H), 
6.77-6.80* (m, 0.2H), 6.69-6.91 (m, 2H), 7.04-7.10 (m, 3H), 7.26-7.28* (m, 0.3H), 7.48-
7.50* (m, 0.2H); 13C NMR δ 22.66* (2 × CH2), 25.97* (CH2), 26.01* (2 × CH2), 26.29 
(CH2), 26.31 (2 × CH2), 30.65 (2 × CH2), 30.92* (2 × CH2), 43.15* (CH), 48.52 (CH), 
55.18 (CH3), 55.38* (CH3), 113.63 (2 × CH), 114.20* (2 × CH), 120.05* (2 × CH), 121.95 
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(2 × CH), 127.75 (CH), 127.77 (4 × CH), 127.83 (4 × CH), 128.64* (CH), 138.44 (C), 
140.40* (C), 144.07* (C), 144.39 (C), 155.43 (C), 155.67* (C), 176.03 (C), 176.20* (C); 
IR ν 2930, 2852, 1635, 1503, 1445, 1290, 1241 cm-1; MS (EI) m/z (%) 293 (M˙+, 55), 292 
(25), 238 (48), 210 (100), 92 (26); HRMS (EI) 293.1778 (C20H23NO requires 293.1780). 
 
N-(2’,2’-Dimethyl-1’-phenylprop-1’-ylidene)-4-methoxyaniline (476f), C18H21NO, FW 
= 267.40 
N
OMe476f
 
476f:189 colourless crystals; mp 53-54 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 1.28 (s, 
9H), 3.64 (s, 3H), 6.46-6.50 (m, 2H), 6.57-6.60 (m, 2H), 6.90-6.93 (m, 1H), 7.11-7.20 (m, 
3H); 13C NMR δ 28.56 (3 × CH3), 40.45 (C), 55.20 (CH3), 113.41 (2 × CH), 121.49 (2 × 
CH), 127.16 (CH), 127.39 (2 × CH), 127.98 (2 × CH), 137.40 (C), 144.54 (C), 155.09 (C), 
180.15(C); IR ν 3046, 2955, 2930, 2905, 2867, 2833, 1640, 1503, 1461, 1390, 1361, 1291 
cm-1; MS (EI) m/z (%) 267 (M˙+, 20), 210 (100); HRMS (EI) 267.1621 (C18H21NO 
requires 267.1623).  
 
 (E)-N-(3’,3’-Dimethylbut-2’-ylidene)-4-methoxyaniline (476i), C13H19NO, FW =  
N
OMe476i
 
476i: colourless oil; 1H NMR (400 MHz, CDCl3) δ 1.19 (s, 9H), 1.72 (s, 3H), 3.74 (s, 3H), 
6.53-6.57 (m, 2H), 6.79-6.82 (m, 2H); 13C NMR δ 14.95 (CH3), 27.68 (3 × CH3), 40.05 
(C), 55.19 (CH3), 113.97 (2 × CH), 119.93 (2 × CH), 145.22 (C), 155.24 (C); IR ν 2966, 
2907, 2867, 2834, 1650, 1504, 1466, 1364, 1288, 1240 cm-1; MS (EI) m/z (%) 205 (M˙+, 
20), 148 (100), 92 (10); HRMS (EI) 205.1463 (C13H19NO requires 205.1467).  
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4-Methoxy-N-[(4’-methoxyphenyl)-(4”-trifluoromethylphenyl)methylene]aniline 
(476j), C21H18O2NF3, FW = 385.41  
N
F3C OMe
476j OMe
 
476j: yellow oil which solidified upon standing; mp 60-62 ºC; 1H NMR (400 MHz, 
CDCl3, a mixture of isomers in ratio ca. 3:2, the minor one is marked *) δ 3.71 (s, 3H), 
3.74* (s, 2H), 3.80* (s, 2H), 3.84 (s, 3H), 6.61-6.64* (m, 1.34H), 6.63-6.68 (m, 2H), 6.67-
6.70* (m, 1.34H), 6.71-6.73 (m, 2H), 6.79-6.83* (m, 1.34H), 6.89-6.93 (m, 2H), 7.03-
7.06* (m, 1.34H), 7.24-7.25 (dd, J = 7.9, 0.7 Hz, 2H), 7.54 (dd, J = 8.0, 0.6 Hz, 2H), 7.63-
7.65* (m, 1.34H), 7.64-7.67 (m, 2H), 7.82-7.85* (m, 1.34H); 13C NMR δ 55.21* (CH3), 
55.29 (CH3), 55.32* (CH3), 55.41* (CH3), 113.67* (2 × CH), 113.68 (2 × CH), 113.91 (2 × 
CH), 113.95* (2 × CH), 122.48 (2 × CH), 122.59* (2 × CH), 123.89 (q, J = 272.5 Hz, 
CF3), 124.09* (q, J = 272.2 Hz, CF3), 125.06 (q, J = 3.6 Hz, 2 × CH), 125.06* (q, J = 3.6 
Hz, 2 × CH), 127.96 (C), 129.80* (C), 129.60* (2 × CH), 129.89 (2 × CH), 130.74 (2 × 
CH), 131.31* (2 × CH), 130.31 (q, J = 32.6 Hz, C), 131.93* (q, J = 32.4 Hz, C), 131.95 
(C), 132.64* (C), 144.00 (C), 144.21* (C), 155.95 (C), 156.19* (C), 159.94* (C), 161.92 
(C), 165.60 (C), 166.03* (C); 19F NMR δ –62.67; IR ν 3006, 2957, 2837, 1605, 1502, 
1325, 1245, 1168 cm-1; MS (EI) m/z (%) 385 (M˙+, 100), 370 (44), 240 (35), 171 (15), 92 
(15); HRMS (EI) 385.1289 (C22H18NO2F3 requires 385.1290). 
 
(E)-N-(3’,4’-Dihydronaphthalen-1’(2H)-ylidene)-4-methoxyaniline (476k), C17H17NO, 
FW = 251.35 
476k
N
OMe
 
476k:224 yellow crystals; mp 116-117 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 1.88-
1.95 (m, 2H), 2.56 (dd, J = 6.6, 6.2 Hz, 2H), 2.90 (t, J = 6.1 Hz, 2H), 3.82 (s, 3H), 
6.74-6.78 (m, 2H), 6.89-6.92 (m, 2H), 7.20 (br d, J = 7.5 Hz, 1H), 7.29 (ddd, J = 7.9, 7.3, 
0.6 Hz, 1H), 7.64 (dd, J = 7.4, 1.4 Hz, 1H), 8.31 (dd, J = 7.9, 1.1 Hz, 1H); 13C NMR δ 
23.08 (CH2), 29.88 (CH2), 30.00 (CH2), 55.52 (CH3), 114.24 (2 × CH), 120.92 (2 × CH), 
126.29 (CH), 126.46 (CH), 128.77 (CH), 130.58 (CH), 134.09 (C), 141.24 (C), 144.68 (C), 
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155.82 (C), 166.00 (C); IR ν 3019, 2946, 1625, 1503, 1241, 1216 cm-1; MS (EI) m/z (%) 
251 (M˙+, 100), 236 (80), 223 (20), 208 (24), 180 (14), 129 (20), 128 (18), 84 (22); HRMS 
(EI) 251.1313 (C17H17NO requires 251.1310). 
 
4-Methoxy-N-(3’,5’,5’-trimethylcyclohex-2’-enylidene)aniline (476l), C16H21NO, FW = 
243.38 
N
476l
OMe
 
476l: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of isomers in ratio ca. 55:45, the 
minor one is marked *) δ 1.77* (d, J = 1.2 Hz, 2.4H), 1.90 (d, J = 1.1 Hz, 3H), 2.04 (br s, 
2H), 2.07* (d, J = 0.5 Hz, 1.6H), 2.09 (s, 2H), 2.34* (s, 1.6H), 3.796 (s, 3H), 3.799* (s, 
2.4H), 5.90* (q, J = 1.4 Hz, 0.8H), 6.12 (d, J = 1.4 Hz, 1H), 6.65-6.70 (m, 2H), 6.70-6.73* 
(m, 1.6H), 6.83-6.87 (m, 3.6H); 13C NMR δ 24.21 (CH3), 24.36* (CH3), 28.19* (CH3), 
28.25 (CH3), 32.09 (C), 32.41* (C), 41.02 (CH2), 45.16 (CH2), 45.72* (CH2), 47.99* 
(CH2), 55.41 (2 × CH3), 113.97 (2 × CH), 114.04 (2 × CH), 117.18* (CH), 121.10 (2 × 
CH), 121.75* (2 × CH), 126.02 (CH), 144.22* (C), 144.39 (C), 148.96* (C), 150.95 (C), 
155.66 (C), 155.73* (C), 166.40* (C), 167.80 (C); IR ν 2955, 2896, 2833, 1637, 1608, 
1502, 1466, 1287, 1241 cm-1; MS (EI) m/z (%) 243 (M˙+, 100), 228 (52), 187 (32), 91 (30); 
MS (CI/isobutane) m/z (%)  244 [(M+H)+, 100]. 
 
Methyl (E)-4-[N-(4’-methoxyphenyl)imino]-4-phenylbutanoate (476m), C18H19NO3, 
FW = 297.38 
N
476m OMe
COOMe
 
476m: yellow crystals; mp 62-63 ºC (hexane); 1H NMR (400 MHz, CDCl3, a mixture of 
(E/Z) isomers in ratio ca. 2.3:1, the minor one is marked *) δ 2.42-2.47 (m, 2H), 2.81* (dd, 
J = 7.0, 6.9 Hz, 0.86H), 3.00-3.07 (m, 2.86H), 3.60 (s, 3H), 3.698* (s, 1.29H), 3.701* (s, 
1.29H), 3.82 (s, 3H), 6.51-6.55* (m, 0.86H), 6.63-6.67* (m, 0.86H), 6.71-6.75 (M, 2H), 
6.89-6.92 (M, 2H), 7.98-7.12* (m, 0.86H), 7.20-7.24* (m, 1.29H), 7.42-7.47 (m, 3H), 
7.85-7.90 (m, 2H); 13C NMR δ 25.18 (CH2), 30.30* (CH2), 31.99 (CH2), 35.50* (CH2), 
51.67* (CH3), 51.86 (CH3), 55.28* (CH3), 55.47 (CH3), 113.77* (2 × CH), 114.45 (2 × 
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CH), 120.08 (2 × CH), 122.12* (2 × CH), 127.49 (2 × CH), 127.78* (2 × CH), 128.20* (2 
× CH), 128.47* (CH), 128.66 (2 × CH), 137.91 (C), 137.99* (C), 143.74* (C), 144.31 (C), 
155.69* (C), 156.00 (C), 168.29 (C), 169.20* (C), 172.40 (C), 173.80* (C); IR ν 3020, 
2951, 2834, 11735, 1630, 1503, 1439, 1287, 1241 cm-1; MS (CI/isobutane) m/z (%) 298 
[(M+H)+, 100]; HRMS (CI/isobutane) 298.1441 (C18H20NO3 requires 298.1443).  
 
(E)-4-Methoxy-N-(1”-phenylhex-5’-en-1’-ylidene)aniline, (476n), C19H21NO, FW = 
279.41 
476n
N
OMe
 
476n: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca 10:1, 
only the major one is given) δ 1.44-1.52 (m, 2H), 1.86-1.92 (m, 2H), 2.56-2.60 (m, 2H), 
3.73 (s, 3H), 4.81-4.65 (m, 2H), 5.57 (ddt, J = 17.7, 9.6, 6.6 Hz, 1H), 6.63-6.67 (m, 2H), 
6.80-6.84 (m, 2H), 7.33-7.37 (m, 3H), 7.79-7.81 (m, 2H); 13C NMR δ 26.73 (CH2), 29.54 
(CH2), 33.65 (CH2), 55.50 (CH3), 114.28 (2 × CH), 115.36 (CH2), 120.33 (2 × CH), 127.52 
(2 × CH), 128.61 (2 × CH), 130.25 (CH), 137.64 (CH), 138.66 (C), 144.76 (C), 155.79 (C), 
158.47 (C), 170.27 (C); IR ν 3018, 2936, 1627, 1503, 1242, 1216 cm-1; MS (CI/isobutane) 
m/z (%) 280 [(M+H)+, 20], 228 (100), 212 (31), 206 (30), 175 (70), 124 (31).   
 
(E)-N-[1’-(3”-Chlorophenyl)hex-5’-en-1’-ylidene]-4-methoxyaniline (476o), 
C19H20NOCl, FW = 313.85 
476o
N
OMe
Cl
 
476o: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 10:1, 
only the major one is given) δ 1.42-1.50 (m, 2H), 1.86-1.91 (m, 2H), 2.54-2.58 (m, 2H), 
3.73 (s, 3H), 4.81-4.87 (m, 2H), 5.57 (ddt, J = 17.7, 9.6, 6.6 Hz, 1H), 6.61-6.65 (m, 2H), 
6.80-6.84 (m, 2H), 7.27 (t, J = 7.7 Hz, 1H), 7.33 (ddd, J = 7.9, 2.0, 1.3 Hz, 1H), 7.64 (ddd, 
J = 7.6, 1.5, 1.3 Hz, 1H), 7.82 (dd, J = 1.8, 1.7 Hz, 1H); 13C NMR δ 25.56 (CH2), 27.11 
(CH2), 33.54 (CH2), 55.50 (CH3), 114.32 (2 × CH), 115.56 (CH2), 120.23 (2 × CH), 125.63 
(CH), 127.72 (CH), 129.72 (CH), 130.20 (CH), 134.25 (C), 137.43 (CH), 140.49 (C), 
144.26 (C), 156.00 (C), 168.95 (C); IR ν 3072, 2933, 1628, 1567, 1503, 1292, 1242, 1208 
    176
cm-1; MS (CI/isobutane) m/z (%) 316 [(M+H)+, 38], 314 [(M+H)˙+, 100], 259 (12); HRMS 
(CI/isobutane) 316.1287 (C19H21NO37Cl requires 316.1289), 314.1315 (C19H21NO35Cl 
requires 314.1312).  
 
(E)-4-Methoxy-N-[1’-(3”-methoxyphenyl)hex-5’-en-1’-ylidene]aniline (476p), 
C20H23NO2, FW = 309.44 
476p
N
OMe
MeO
 
476p: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 7:1, 
the minor one is marked *) δ 1.54-1.62 (m, 2H), 1.72-1.82* (m, 0.30H), 1.95-2.01 (m, 2H), 
1.15-1.21* (m, 0.30H), 2.66 (tq, J = 8.1, 5.3 Hz, 2H), 2.75-2.79* (m, 0.30H), 3.64* (s, 
0.45H), 3.70* (s, 0.45H), 3.82 (s. 3H), 3.86 (s, 3H), 4.90-4.96 (m, 2H), 4.98* (ddt, J = 
10.2, 2.2, 1.1 Hz, 0.15H), 5.04* (ddt, J = 17.1, 3.6, 1.6 Hz, 0.15H), 5.67 (ddt, J = 17.8, 
11.3, 6.7 Hz, 1H), 5.83* (ddt, J = 17.1, 10.2, 6.8 Hz, 0.15H), 6.57-6.61* (m, 0.45H), 6.65-
6.69* (m, 0.45H), 6.72-6.77 (m, 2.15H), 6.89-6.93 (m, 2H), 7.01 (ddd, J = 8.2, 2.6, 1.0 Hz, 
1H), 7.14* (dd, J = 8.0, 7.9 Hz, 1H), 7.34 (dd, J = 8.1, 7.8 Hz, 1H), 7.43 (ddd, J = 7.7, 1.6, 
1.1 Hz, 1H), 7.50 (dd, J = 2.6, 1.6 Hz, 1H); 13C NMR δ 25.72* (CH2), 27.32 (CH2), 29.65 
(CH2), 33.41* (CH2), 33.65 (CH2), 40.78* (CH2), 55.14* (CH3), 55.29* (CH3), 55.39 
(CH3), 55.48 (CH3), 112.38 (CH), 113.48* (CH), 113.80* (2 × CH), 113.89* (CH), 114.29 
(2 × CH), 115.03* (CH2), 115.36 (CH2), 116.43 (CH), 120.02 (CH), 120.23* (CH), 120.28 
(2 × CH), 122.08* (2 × CH), 129.25* (CH), 129.40 (CH), 137.62 (CH), 138.37* (CH), 
139.32* (C), 140.13 (C), 144.06* (C), 144.71 (C), 155.66* (C), 155.81 (C), 159.16* (C), 
159.81 (C), 170.04 (C), 171.69* (C); IR ν 3074, 2936, 2834, 1627, 1579, 1503, 1463, 
1285, 1241, 1208 cm-1; MS (EI) m/z (%) 309 (M˙+, 77), 268 (27), 256 (43), 255 (100), 254 
(92), 240 (90), 197 (38), 134 (80), 122 (92), 92 (52); HRMS (EI) 309.1728 (C20H23NO2 
requires 309.1729). 
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(E)-4-Methoxy-N-[1’-(3”-methoxyphenyl)pent-4’-en-1’-ylidene]aniline (476q), 
C19H21NO2, FW = 295.41 
476q
N
OMe
MeO
 
476q: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 6:1, 
the minor one is marked *) δ 2.11-2.17 (m, 2H), 2.31-2.37* (m, 0.28 H), 2.64-2.68 (m, 
2H), 2.75-2.78* (m, 0.28H), 3.56* (s, 0.42H), 3.62* (s, 0.42H), 3.73 (s, 3H), 3.73 (s, 3H), 
4.82 (ddd, J = 7.3, 3.0, 1.5, 1H), 4.86 (dd, J = 1.3, 1.2, 1H), 4.91-4.98* (m, 0.28H), 5.55 
(ddt, J = 17.5, 10.9, 6.6, 1H), 5.84* (ddt, J = 17.1, 10.3, 6.6, 0.14H), 6.48-6.52* (m, 
0.42H), 5.56-6.60* (m, 0.42H), 6.63-6.67 (m, 2H), 6.80-6.84 (m, 2H), 6.92 (ddd, J = 8.1, 
2.6, 1.0, 1H), 7.06* (t, J = 7.9, 0.14H), 7.27 (t, J = 7.9, 1H), 7.34 (ddd, J = 7.7, 1.4, 1.1, 
1H), 7.40 (dd, J = 2.4, 1.6, 1H); 13C NMR δ 29.507 (CH2), 30.59* (CH2), 32.02 (CH2), 
40.50* (CH2), 55.17* (CH3), 55.33* (CH3), 55.43 (CH3), 55.49 (CH3), 112.38 (CH), 
113.46* (CH), 113.80* (2 × CH), 113.97* (CH), 114.29 (2 × CH), 115.18* (CH2), 115.39 
(CH2), 116.48 (CH), 120.01 (CH), 120.29 (2 × CH), 122.08* (2 × CH), 129.27* (CH), 
129.44 (CH), 136.85 (CH), 137.67* (CH), 139.21* (C), 1140.03 (C), 143.97* (C), 144.57 
(C), 155.68* (C), 155.84 (C), 159.15* (C), 159.83 (C), 169.47 (C), 171.00* (C); IR ν 
3000, 2954, 2834, 1628, 1579, 1502, 1464, 1285, 1240, 1208 cm-1; MS (EI) m/z (%) 295 
(M˙+, 61), 294 (57), 280 (38), 240 (100), 197 (16), 174 (15), 135 (28), 123 (41), 92 (30); 
HRMS (EI) 295.1570 (C19H21NO2 requires 295.1572). 
 
(E)-4-Methoxy-N-[(E)-3’-methyl-4’-phenylbut-3’-en-2’-ylidene]aniline (476s), 
C18H19NO, FW = 265.38 
N
476s OMe
 
476s: yellow crystals; mp 72-73 ºC; 1H NMR (400 MHz, CDCl3) δ 2.12 (s, 3H), 2.22 (d, J 
= 1.2 Hz, 3H), 3.81 (s, 3H), 6.67-6.71 (m, 2H), 6.87-6.91 (m, 2H), 7.21 (q, J = 1.1 Hz, 
1H), 7.28-7.33 (m, 1H), 7.40-7.42 (m, 4H); 13C NMR δ 14.66 (CH3), 16.40 (CH3), 55.49 
(CH3), 114.19 (2 × CH), 120.56 (2 × CH), 127.36 (CH), 128.25 (2 × CH), 129.46 (2 × CH), 
133.75 (CH), 137.42 (C), 139.43 (C), 145.22 (CH), 155.80 (C), 167.91 (C); IR ν 3015, 
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2959, 2836, 1664, 1606, 1503, 1442, 1243, 1218 cm-1; MS (CI/isobutane) m/z (%) 266 
[(M+H)+, 45], 89 (100); HRMS (CI/isobutane) 266.1542 (C18H20NO requires 266.1545).  
 
(E)-N-[1’-(Ferrocen-1”-yl)ethylidene]-4-methoxyaniline (476t), C19H19NOFe, FW = 
333.24 
Fe
N OMe
476t
 
476t: orange oil; 1H NMR (400 MHz, CDCl3) δ 2.10 (s, 3H), 3.81 (s, 3H), 4.21 (s, 5H), 
4.41 (t, J = 1.9 Hz, 2H), 4.79 (t, J = 1.9 Hz, 2H), 6.69-6.73 (m, 2H), 6.86-6.90 (m, 2H). No 
further data provided as the imine was obtained only in a mixture with the corresponding 
ketone.  
 
(E,E)-N-(1’,3’-Diphenylallylidene)-4-methoxyaniline (476u), C22H19NO, FW = 313.42 
476u
N
OMe
 
476u: yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ca. 3:1 ratio, 
the minor one is marked *) δ 3.63* (s, 3H), 3.76 (s, 3H), 6.56-6.60* (m, 1.4H), 6.72* (d, J 
= 16.4 Hz, 0.4H), 6.81-6.88 (m, 6.2H), 7.05-7.07* (m, 0.8H), 7.18* (d, J = 5.2 Hz, 0.4H), 
7.20-7.28 (both isomers, m, 7.5H), 7.36-7.43 (both isomers, m, 3.9H), 7.63-7.66 (m, 2H); 
13C NMR δ 55.29* (CH3), 55.51 (CH3), 113.65* (2 × CH), 114.08 (2 × CH), 122.32 (CH), 
122.55 (2 × CH), 122.90* (2 × CH), 127.49 (2 × CH), 127.51* (2 × CH), 128.26* (2 × 
CH), 128.37 (2 × CH), 128.41* (CH), 128.82* (2 × CH), 128.85 (2 × CH), 129.05 (CH), 
129.18* (CH), 129.36* (2 × CH), 129.44 (2 × CH), 129.84 (CH), 132.05* (CH), 135.84 
(C), 135.87* (C), 135.94* (C), 139.71 (C), 140.79* (CH), 141.14 (CH), 143.64* (C), 
144.19 (C), 156.04* (C), 156.57 (C), 167.09 (C), 168.38* (C); IR ν 3019, 2962, 2836, 
2399, 1603, 1502, 1288 cm-1; MS (EI) m/z (%) 313 (M˙+, 100), 312 (95), 298 (13), 236 
(12), 210 (12), 191 (44); HRMS (EI) 313.1464 (C22H19NO requires 313.1467). 
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(E)-N-(1’,3’-Diphenylprop-1’-ylidene)-4-methoxyaniline (476v), C22H21NO, FW = 
315.44 
476v
N
OMe
 
476v: yellow crystals; mp 60-61 ºC (hexane); 1H NMR (400 MHz, CDCl3, a mixture of 
(E/Z) isomers in ratio ca. 10:1, only the major one is given) δ 2.68-2.72 (m, 2H), 2.87-2.91 
(m, 2H), 3.73 (s, 3H), 6.45-4.48 (m, 2H), 6.75-6.79 (m, 2H), 6.88-6.90 (m, 1H), 7.10-7.17 
(m, 4H), 7.37-7.41, (m, 3H), 7.84-7.87 (m, 2H); 13C NMR δ 32.07 (CH2), 33.98 (CH2), 
55.53 (CH3), 114.23 (2 × CH), 120.13 (2 × CH), 126.32 (CH), 127.61 (2 × CH), 128.29 (2 
× CH), 128.52 (2 × CH), 128.60 (2 × CH), 128.65 (2 × CH), 130.38 (CH), 138.52 (C), 
140.65 (C), 144.61 (C), 155.79 (C), 169.37 (C); IR ν 3027, 2946, 1629, 1502, 1454, 1241, 
1208 cm-1; MS (EI) m/z (%) 315 (M˙+, 100), 314 (37), 238 (24), 219 (84), 180 (16), 167 
(14), 121 (25), 91 (47); HRMS (EI) 315.1624 (C22H21NO requires 315.1623). 
 
(E)-N-{1’-[3”-(tert-Butyldimethylsilyloxy)phenyl]ethylidene}-4-methoxyaniline 
(476w), C21H29NO5Si, FW = 355.60 
N
TBDMSO
OMe
476w
 
476w: yellow oil; 1H NMR (400 MHz, CDCl3) δ 0.23 (s 6H), 1.00 (s, 9H), 2.22 (s, 3H), 
3.82 (s, 3H), 6.73-6.77 (m, 2H), 6.89-6.93 (m, 2H), 6.93 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 
7.29 (dd, J = 8.0, 7.9 Hz, 1H), 7.44 (dd, J = 2.0, 1.9 Hz, 1H), 7.55 (ddd, J = 7.8, 1.6, 1.0 
Hz, 1H); 13C NMR δ –4.34 (2 × CH3), 17.43 (CH3), 18.23 (C), 25.73 (3 × CH3), 55.49 
(CH3), 114.22 (2 × CH), 118.83 (CH), 120.24 (CH), 120.74 (2 × CH), 121.94 (CH), 129.23 
(CH), 141.35 (C), 144.84 (C), 155.74 (C), 155.91 (C), 165.44 (C); IR ν 2955, 2930, 2858, 
1631, 1580, 1503, 1434, 1352, 1285, 1241 cm-1; MS (CI/isobutane) m/z (%) 356 [(M+H)+, 
100], 298 (5), 186 (8); HRMS (CI/isobutane) 356.2043 (C21H30NO2Si requires 356.2046). 
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6.4. Amines  
 
 
General Procedure for Racemic Reduction of Imines:  
 
Method A: Sodium borohydride (46 mg, 1.20 mmol, 4 equiv) was added to a cooled 
solution (0 ºC) of the imine (0.300 mmol, 1 equiv, see Table 6.9) in anhydrous methanol (3 
mL) under an argon atmosphere. The reaction mixture was let to warm to room 
temperature and to stir for 16 h. Then the mixture was concentrated in vacuo, the residue 
was dissolved in ethyl acetate (5 mL) and washed with water (10 mL). The aqueous layer 
was extracted with ethyl acetate (2 × 5 mL); the combined organic layers were washed 
with brine (5 mL) dried over anhydrous Na2SO4 and evaporated. The residue was purified 
by flash chromatography on a silica gel column (25 mL) with a petroleum ether – ethyl 
acetate mixture (Table 6.9).  
 
Method B (marked *): Trichlorosilane (60 µL, 0.600 mmol, 2 equiv) was added dropwise 
to a cooled solution (0 ºC) of the imine (0.300 mmol, 1 equiv, see Table 6.9), 
dimethylformamide (21.9 mg, 23 µL, 0.300 mmol, 1 equiv) in anhydrous toluene (3 mL) 
under an argon atmosphere. The reaction mixture was let to stir at room temperature for 24 
h. Then the reaction mixture was diluted with ethyl acetate (5 mL), quenched with a 
saturated NaHCO3 solution (20 mL) and the layers were separated. The aqueous layer was 
extracted with ethyl acetate (2 × 5 mL) and washed with water (2 × 15 mL), brine (5 mL), 
dried over anhydrous MgSO4 and evaporated. The residue was purified by flash 
chromatography on a silica gel column (25 mL) with a petroleum ether – ethyl acetate 
mixture (Table 6.9, marked *, racemates only in Table 6.10).  
 
Table 6.9. Racemic reduction of Imines 
 
Imine PE – EA Amine 
475a (67 mg) 80:20 488a (50 mg, 0.219 mmol, 73 %) 
475b (67 mg) 60:40 488b (47 mg, 0.206 mmol, 69 %) 
475c (88 mg) 95:5 488c (50 mg, 0.160 mmol, 53 %) 
475z (110 mg)* Cryst., 50:50  
(EA:MeOH) 
488z (60 mg, 0.178 mmol, 59 %) 
475d (70 mg) 90:10 488d (38 mg, 0.162 mmol, 54 %) 
475e (734 mg) 95:5 488e (47 mg, 0.189 mmol, 63 %) 
475f (82 mg) 95:5 488f (78 mg, 0.283 mmol, 94 %) 
475g (87 mg) 97:3 488g (44 mg, 0.152 mmol, 50 %) 
475h (91 mg) 95:5 → 90:10 488h (42 mg, 0.137 mmol, 46 %) 
475i (69 mg) 95:5 488i (56 mg, 0.240 mmol, 80 %) 
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Table 6.9. – Cont. Racemic reduction of Imines 
 
Imine PE – EA Amine 
475j (65 mg) 95:5 488j (42 mg, 0.193 mmol, 64 %) 
475k (69 mg) 93:7 488k (65 mg, 0.281 mmol, 94 %) 
475l (86 mg) 95:5 488l (61 mg, 0.211 mmol, 70 %) 
475m (90 mg) 90:10 488m (63 mg, 0.218 mmol, 73 %) 
475n (73 mg) 95:5 488n (53 mg, 0.216 mmol, 72 %) 
475o (63 mg) 95:5 488o (45 mg, 0.214 mmol, 71 %) 
475p (78 mg) 97:3 488p (56 mg, 0.228 mmol, 76 %) 
475q (80 mg) 93:7 488q (74 mg, 0.277 mmol, 92 %) 
475r (80 mg) 96:4 488r (65 mg, 0.243 mmol, 81 %) 
475s (84 mg) 95:5 488s (83 mg, 0.296 mmol, 99 %) 
475t (84 mg) 80:20 488t (75 mg, 0.271 mmol, 90 %) 
476a (72 mg) 98:2 492a (64 mg, 0.265 mmol, 88 %) 
476b (76 mg) 98:2 492b (74 mg, 0.290 mmol, 96 %) 
476c (75 mg) 95:5 492c (74 mg, 0.292 mmol, 97 %) 
476d (80 mg) 95:5 492d (67 mg, 0.251 mmol, 84 %) 
476e (88 mg) 98:2 492e (87 mg, 0.295 mmol, 98 %) 
476f (80 mg) 98:2 492f (58 mg, 0.215 mmol, 72 %) 
476i (62 mg) 98:2 492i (60 mg, 0.289 mmol, 96 %) 
476j (116 mg) 96:4 492j (79 mg, 0.204 mmol, 68 %) 
476k (75 mg) 95:5 492k (53 mg, 0.209 mmol, 70 %) 
476l (73 mg) 97:3 492l (68 mg, 0.277 mmol, 92 %) 
476m (594 mg) * 93:7 492m (201 mg, 0.872 mmol, 44 %) 
262 (67 mg) 85:15 264 (49 mg, 0.218 mmol, 73 %) 
257 (86 mg) * 90:10  260 (76 mg, 0.262 mmol, 87 %) 
476n (94 mg) 97:3 492n (23 mg, 0.080 mmol, 27 %) 
476o (94 mg) 98:2 492o (34 mg, 0.108 mmol, 36 %) 
476p (93 mg) 95:5 492p (69 mg, 0.222 mmol, 74 %) 
476q (89 mg) 95:5 492q (88 mg, 0.299 mmol, 99 %) 
476s (80 mg) 97:3 492s (40 mg, 0.150 mmol, 50 %) 
476t (100 mg) 95:5 492t (71 mg, 0.209 mmol, 70 %) 
476u (94 mg) -  no reaction  
476v (93 mg) 95:5 492v (82 mg, 0.258 mmol, 86 %) 
476w (107 mg) 100:0 492w (90 mg, 0.244 mmol, 81 %) 
 
Table 6.10. Attempts of Enantioselective Reduction of Imines 
 
Imine / Additives Amine 
475t (56 mg) 1. AcOH (12 µL)  
                      2. 40 °C 
no reaction 
476l (49 mg) no reaction 
476t (67 mg) no reaction 
476u (63 mg) 1. AcOH (12 µL) 
                       2. 50 ºC 
no reaction 
 
 
General Procedure for Enantioselective Reduction of Imines: 
Trichlorosilane (40 µL, 0.400 mmol, 2 equiv) was added dropwise to a 
cooled solution (0 ºC) of the imine (0.200 mmol, 1 equiv, see Table 
6.11) catalyst cat* (3.46 mg, 0.010 mmol, 5 mol %) and a possible 
additive (0.2 mmol, 1 equiv, see Table 6.11) in anhydrous toluene (2 
mL) under an argon atmosphere. The reaction mixture was let to stir at 
N
O
N
H
O
cat*
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room temperature (unless otherwise stated) for 24 h. Then the reaction mixture was diluted 
with ethyl acetate (5 mL), quenched with a saturated NaHCO3 solution (20 mL) and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (2 × 5 mL) and 
washed with water (2 × 15 mL), brine (5 mL), dried over anhydrous MgSO4 and 
evaporated. The residue was purified by flash chromatography on a silica gel column (20 
mL) with a petroleum ether – ethyl acetate mixture (Table 6.11).  
 
Table 6.11. Enantioselective reduction of Imines 
 
Imine / Additives PE – EA Amine 
475a (45 mg) / AcOH (12 µL) 85:15 488a (32 mg, 0.140 mmol, 70 %) 
475b (45 mg) / AcOH (12 µL) 70:30 488b (33 mg, 0.145 mmol, 72 %) 
475c (59 mg) 95:5 488c (43 mg, 0.136 mmol, 68 %) 
475z (74 mg) 50:50 (EA:MeOH) 488z (36 mg, 0.097 mmol, 49 %) 
not pure, decomposition 
475d (47 mg) 90:10 488d (39 mg, 0.166 mmol, 83 %) 
475e (49 mg) 95:5 488e (15 mg, 0.060 mmol, 30 %) 
465f (55 mg) 95:5 488f (39 mg, 0.142 mmol, 71 %) 
475g (58 mg) 97:3 488g (34 mg, 0.117 mmol, 58 %) 
475h (61 mg) 95:5 → 90:10 488h (56 mg, 0.183 mmol, 91 %) 
475i (46 mg) 95:5 488i (36 mg, 0.154 mmol, 77 %) 
475j (43 mg) / - 
475j (43 mg) / –20 ºC 
95:5 488j (27 mg, 0.124 mmol, 62 %) 
488j (25 mg, 0.115 mmol, 57 %)  
475k (46 mg) 93:7 488k (40 mg, 0.173 mmol, 86 %) 
475l (57 mg) / AcOH (12 µL) 95:5 488l (36 mg, 0.124 mmol, 62 %) 
475m (61 mg) 93:7 488m (36 mg, 0.124 mmol, 62 %) 
475n (47 mg) 95:5 488n (37 mg, 0.150 mmol, 75 %) 
475o (43 mg) 94:6 488o (26 mg, 0.120 mmol, 60 %) 
475p (52 mg) 95:5 488p (44 mg, 0.180 mmol, 90 %) 
475q (53 mg) 95:5 488q (42 mg, 0.157 mmol, 79 %) 
475r (53 mg) 97:3 488r (45 mg, 0.168 mmol, 84 %) 
475t (56 mg) 95:5 488t (43 mg, 0.153 mmol, 77 %) 
476a (48 mg) 98:2 492a (39 mg, 0.162 mmol, 81 %) 
476b (51 mg) 98:2 492b (50 mg, 0.196 mmol, 98 %) 
476c (50 mg) 93:7 492c (44 mg, 0.174 mmol, 87 %) 
476d (53 mg) 93:7 492d (40 mg, 0.150 mmol, 75 %) 
476e (59 mg) 98:2 492e (49 mg, 0.166 mmol, 83 %) 
476f (54 mg) / - 
476f (54 mg) / AcOH (12 µL) 
99.5:0.5 492f (25 mg, 0.0366 mmol, 10 %) 
492f (25 mg, 0.0930 mmol, 46 %) 
476i (41 mg) / - 
476i (41 mg) / AcOH (12 µL) 
99.5:0.5 492i (10 mg, 0.125 mmol, 63 %) 
492i (38 mg, 0.183 mmol, 92 %) 
476j (77 mg) 97:3 492j (61 mg, 0.157 mmol, 79 %) 
476k (50 mg) 95:5 492k (45 mg, 0.178 mmol, 89 %) 
476m (60 mg) 93:7 492m (23 mg, 0.077 mmol, 38 %) 
262 (45 mg) 85:15 264 (41 mg, 0.182 mmol, 91 %) 
257 (58 mg) 90:10 260 (40 mg, 0.138 mmol, 69 %) 
476n (56 mg) 95:5 492n (36 mg, 0.128 mmol, 64 %) 
476o (63 mg) 98:2 492o (39 mg, 0.124 mmol, 62 %) 
476p (62 mg) 95:5 492p (61 mg, 0.196 mmol, 98 %) 
476q (59 mg) 95:5 492q (59 mg, 0.198 mmol, 99 %) 
476s (53 mg) 97:3 492s (33 mg, 0.123 mmol, 62 %) 
476v (63 mg) 95:5 492v (60 mg, 0.189 mmol, 95 %) 
476w (71 mg) 100:0 492w (53 mg, 0.143 mmol, 72 %) 
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6.4.1. Amines with Heterocycles  
 
N-(4-Methoxyphenyl)-N-[1’-(pyridin-2”-yl)ethyl]amine (488a), C14H16N2O, FW = 
228.31 
488a
N HN OMe
 
488a:225 yellowish oil; 1H NMR (400 MHz, CDCl3) δ 1.44 (d, J = 6.7 Hz, 3H), 3.56 (br s, 
1H), 3.60 (s, 3H), 4.46 (q, J = 6.7 Hz, 1H), 6.42-6.46 (m, 2H), 6.64-6.68 (m, 2H), 7.04 
(ddd, J = 7.4, 4.9, 1.1 Hz, 1H), 7.24 (br d, J = 7.9 Hz, 1H), 7.50 (ddd, J = 7.7, 7.7, 1.8 Hz, 
1H), 8.48 (ddd, J = 4.8, 1.6, 0.8 Hz, 1H); 13C NMR δ 23.33 (CH3), 55.72 (CH), 55.76 
(CH3), 114.76 (2 × CH), 114.81 (2 × CH), 120.40 (CH), 121.97 (CH), 136.85 (CH), 141.34 
(C), 149.32 (CH), 152.02 (C), 164.21 (C); HPLC analysis (Chiralcel OJ-H, hexane – 
propan-2-ol (80:20), 0.75 mL/min, t1 = 56.477 min, t2 = 63.686 min) showed 7 % ee. 
 
N-(4-Methoxyphenyl)-N-[1’-(pyridin-4”-yl)ethyl]amine (488b), C14H16N2O, FW = 
228.31 
N
HN OMe
488b
 
488b: yellowish oil; 1H NMR (400 MHz, CDCl3) δ 1.49 (d, J = 6.8 Hz, 3H), 3.69 (s, 3H), 
3.93 (br s, 1H), 4.38 (q, J = 6.8 Hz, 1H), 6.39-6.43 (m, 2H), 6.67-6.71 (m, 2H), 7.29 (dd, J 
= 4.6, 1.5 Hz, 1H), 8.53 (dd, J = 4.5, 1.6 Hz, 1H); 13C NMR δ 23.57 (CH3), 52.44 (CH), 
55.66 (CH3), 113.42 (2 × CH), 113.74 (2 × CH), 120.18 (2 × CH), 139.79 (C), 149.07 (2 × 
CH), 151.15 (C), 153.68 (C); IR ν 3424, 3015, 2969, 2834, 1600, 1512, 1237, 1216 cm-1; 
MS (EI) m/z (%) 228 (M˙+, 90), 213 (100), 150 (24), 122 (76), 106 (27); HRMS (EI) 
228.1265 (C14H16N2O requires 228.1263); HPLC analysis (Chiralcel OJ-H, hexane – 
propan-2-ol (80:20), 0.75 mL/min, tmajor = 27.009 min, tminor = 39.127 min) showed 21 % 
ee. 
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(–)-N-[1’-(2”,6”-Di-iso-propylpyridin-4’-yl)ethyl]-N-(4-methoxyphenyl)amine (488c), 
C20H28N2O, FW = 312.50 
N
HN
488c
OMe
 
488c: colourless oil; [α]D –12.7 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.26 (d, J = 
7.0 Hz, 3H), 1.28 (d, J = 7.0 Hz, 3H), 1.49 (d, J = 6.9 Hz, 3H), 3.01 (sept, J = 6.9 Hz, 2H), 
3.71 (s, 3H), 4.34 (q, J = 6.7 Hz, 1H, 6.44-6.48 (m, 2H), 6.69-6.73 (m, 2H), 6.96 (s, 2H); 
13C NMR δ 22.67 (2 × CH3), 22.71 (2 × CH3), 24.42 (CH3), 36.30 (CH), 54.04 (CH), 
55.66 (CH3), 114.60 (2 × CH), 114.68 (2 × CH), 114.73 (2 × CH), 141.31 (C), 152.05 (C), 
154.90 (C), 166.72 (2 × C); IR ν 3396, 2962, 2869, 1602, 1567, 1513, 1467, 1235 cm-1; 
MS (CI/isobutane) m/z (%) 313 [(M+H)+, 100], 312 (20), 192 (10), 93 (40); HRMS 
(CI/isobutane) 313.2282 (C20H29N2O requires 313.2280); HPLC analysis (Chiralpak IB, 
hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 12.73 min, tmajor = 17.31 min) showed 
78 % ee.  
 
N-(4-Methoxyphenyl)-N-[1’-(thiazol-2”-yl)ethyl]amine (488d), C12H14N2OS, FW = 
234.34 
HN OMe
S
N
488d
 
488d: yellowish oil; 1H NMR (400 MHz, CDCl3) δ 1.65 (d, J = 6.7 Hz, 3H), 3.71 (s, 3H), 
3.97 (br s, 1H), 4.80 (q, J = 6.7 Hz, 1H), 6.55-6.59 (m, 2H), 6.72-6.76 (m, 2H), 7.20 (d, J = 
3.3 Hz, 1H), 7.72 (d, J = 3.3 Hz, 1H); 13C NMR δ 23.57 (CH3), 53.31 (CH), 55.68 (CH3), 
114.82 (CH), 114.96 (CH), 118.71 (CH), 140.62 (C), 142.64 (CH), 152.73 (C), 177.68 (C); 
IR ν 3419, 3018, 2834, 1512, 1237, 1216 cm-1; MS (EI) m/z (%) 234 (M˙+, 100), 219 (78), 
150 (58), 134 (34), 122 (80), 112 (77), 108 (42), 86 (62); HRMS (EI) 234.0824 
(C12H14N2OS requires 234.0827); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(93:7), 0.75 mL/min, t1 = 16.48 min, t2 = 19.17 min) showed 13% ee.  
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(+)-N-(4-Methoxyphenyl)-N-[1’-(4”-methylthiazol-2”-yl)ethyl]amine (488e), 
C13H16N2OS, FW = 248.37 
N
S HN
488e
OMe
 
488e: colourless oil; [α]D +24 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.63 (d, J = 
6.7 Hz, 3H), 2.44 (s, 3H), 2.50 (s, 3H), 3.71 (s, 3H), 4.74 (q, J = 6.7 Hz, 1H), 6.56-6.60 (m, 
2H), 6.72-6.75 (m, 2H), 6.76 (s, 1H); 13C NMR δ 17.18 (CH3), 23.93 (CH3), 53.41 (CH), 
55.68 (CH3), 113.08 (CH), 114.79 (2 × CH), 115.08 (2 × CH), 140.43 (C), 152.63 (C), 
152.79 (C), 176.78 (C); IR (ATR) ν 3391, 2923, 2831, 1506, 1441, 1312, 1291, 1233 cm-1; 
MS (EI) m/z (%) 248 (M˙+, 100), 233 (64), 150 (25), 126 (75), 123 (40), 122 (50), 100 
(30); HRMS (EI) 248.0982 (C13H16N2OS requires 248.0983); HPLC analysis (Chiralpak 
IB, hexane – propan-2-ol (97:3), 0.75 mL/min, tminor = 18.63 min, tmajor = 21.18 min) 
showed 31 % ee. 
 
(+)-N-(4-Methoxyphenyl)-N-[1’-(4”-iso-propylthiazol-2”-yl)ethyl]amine (488f), 
C13H23NO, FW = 276.43 
N
S HN
488f
OMe
 
488f: yellow oil; [α]D +17.6 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.31 (dd, J = 
6.9, 1.7 Hz, 6H), 1.63 (d, J = 6.7 Hz, 3H), 3.09 (sept d, J = 6.9, 0.9 Hz, 1H), 3.71 (s, 3H), 
3.97 (br s, 1H), 4.74 (q, J = 6.7 Hz, 1H), 6.56-6.60 (m, 2H), 6.72 (d, J = 0.9 Hz, 1H), 6.72-
6.76 (m, 2H),); 13C NMR δ 22.21 (CH3), 22.31 (CH3), 23.72 (CH3), 30.91 (CH), 53.27 
(CH), 55.57 (CH3), 110.29 (CH), 114.65 (2 × CH), 114.76 (2 × CH), 140.70 (C), 152.46 
(C), 163.65 (C), 176.73 (C); IR ν 3385, 2963, 2929, 2869, 2831, 1512, 1462, 1314, 1237 
cm-1; MS (EI) m/z (%) 276 (M˙+, 85), 261 (60), 154 (100), 150 (30), 123 (55), 122 (37), 
108 (22); HRMS (EI) 276.1293 (C15H20N2OS requires 276.1296); HPLC analysis 
(Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 15.28 min, tmajor = 18.92 
min) showed 34 % ee. 
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(+)-N-[1’-(4”-t-Butylthiazol-2”-yl)ethyl]-N-(4-methoxyphenyl)amine (488g), 
C16H22N2OS, FW = 290.46 
N
S HN
488g
OMe
 
488g: white crystalline solid; mp 69-70 ºC; [α]D +31 (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 1.34 (s, 9H), 1.64 (d, J = 6.7 Hz, 3H), 3.72 (s, 3H), 4.76 (q, J = 6.7 Hz, 1H), 
6.59-6.63 (m, 2H), 6.72-6.75 (m, 2H), 6.76 (s, 1H); 13C NMR δ 23.58 (CH3), 29.99 (3 × 
CH3), 34.78 (C), 53.57 (CH), 55.68 (CH3), 109.76 (CH), 114.76 (2 × CH), 115.31 (2 × 
CH), 140.43 (C), 152.83 (C), 166.56 (C), 175.79 (C); IR (ATR) ν 3285, 3104, 2959, 2899, 
1507, 1313, 1238 cm-1; MS (EI) m/z (%) 290 (M˙+, 100), 275 (70), 168 (90), 150 (30), 123 
(55), 122 (30); HRMS (EI) 290.1452 (C16H22N2OS requires 290.1453); HPLC analysis 
(Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 12.63 min, tmajor = 16.41 
min) showed 41 % ee.  
 
N-(4-Methoxyphenyl)-N-[1’-(4”-trimethylsilylthiazol-2”-yl)ethyl]amine (488h), 
C15H22N2OSSi, FW = 306.54 
N
S HN
Si
488h
OMe
 
488h: yellowish crystals; mp 95-97 ºC (hexane);  1H NMR (400 MHz, CDCl3) δ 0.29 (s, 
9H), 1.64 (d, J = 6.7 Hz, 3H), 3.72 (s, 3H), 3.99 (br s, 1H), 4.82 (q, J = 6.5 Hz, 1H), 6.57-
6.61 (m, 2H), 6.73-6.77 (m, 2H), 7.72 (s, 1H); 13C NMR δ –0.30 (3 × CH3), 23.44 (CH3), 
52.97 (CH), 55.40 (CH3), 114.53 (2 × CH), 114.59 (2 × CH), 132.03 (C), 140.52 (C), 
148.10 (CH), 152.33 (C), 181.61 (C); IR ν 3417, 3018, 2959, 2834, 1512, 1250, 1235, 
1216 cm-1; MS (EI) m/z (%) 306 (M˙+, 100), 291 (55), 184 (95), 150 (30), 123 (33), 85 
(52), 83 (80); HRMS (EI) 306.1221 (C15H22N2OSSi requires 306.1222); HPLC analysis 
(Chiralpak IB, hexane – propan-2-ol (98:2), 0.75 mL/min, tminor = 13.865 min, tmajor = 
16.935 min) showed 6 % ee. 
  
 
 
 
 
    187
(–)-N-(4-Methoxyphenyl)-N-[1’-(thiophen-2”-yl)ethyl]amine (488i), C13H15NOS, FW = 
233.35 
HN OMeS
488i
 
488i: yellow oil; [α]D –9.0 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.61 (d, J = 6.6 
Hz, 3H), 3.73 (s, 3H), 4.74 (q, J = 6.6 Hz, 1H), 6.58-6.62 (m, 2H), 6.74-6.78 (m, 2H), 6.94 
(dd, J = 4.9, 3.5 Hz, 1H), 6.97 (ddd, J = 3.5, 1.2, 0.9 Hz, 1H), 7.14 (dd, J = 4.9, 1.4 Hz, 
1H); 13C NMR δ 24.81 (CH3), 50.54 (CH), 55.74 (CH3), 114.79 (2 × CH), 115.09 (2 × 
CH), 122.95 (CH), 123.63 (CH), 126.75 (CH), 141.15 (C), 150.62 (C), 152.39 (C); IR ν 
3417, 3017, 2835, 1510, 1239, 1216 cm-1; MS (EI) m/z (%) 233 (M˙+, 50), 123 (44), 111 
(100); HRMS (EI) 233.0869 (C13H15NOS requires 233.0874); HPLC analysis (Chiralcel 
OD-H, hexane – propan-2-ol (99:1), 0.70 mL/min, tminor = 27.44 min, tmajor = 30.94 min) 
showed 89% ee.  
 
 (–)-N-[1’-(Furan-2”-yl)ethyl]-N-(4-methoxyphenyl)amine (488j), C13H15NO2, FW = 
217.28 
HN OMeO
488j
 
488j:226,36b colourless oil; [α]D –48 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.54 (d, 
J = 6.7 Hz, 3H), 3.53 (br s, 1H), 3.74 (s, 3H), 4.56 (q, J = 6.7 Hz, 1H), 6.14 (br d, J = 3.2 
Hz, 1H), 6.28 (dd, J = 3.2, 1.8 Hz, 1H), 6.59-6.63 (m, 2H), 6.74-6.78 (m, 2H), 7.34 (dd, J 
= 1.8, 0.8 Hz, 1H); 13C NMR δ 20.92 (CH3), 48.48 (CH), 55.72 (CH3), 105.12 (CH), 
110.08 (CH), 114.78 (2 × CH), 115.30 (2 × CH), 141.04 (C), 141.42 (CH), 157.44 (C); 
HPLC analysis (Chiralcel OJ-H, hexane – propan-2-ol (70:30), 0.70 mL/min, tmajor = 
42.237 min, tminor = 52.590 min) or (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 
mL/min, tminor = 14.719 min, tmajor = 15.203 min) showed 56/62% ee (amine 9 at room 
temperature /- 20 ºC respectively), [lit.36b gives Chiralpak OJ, hexane – propan-2-ol 
(80:20), 1.0 mL/min, t(–)-minor  = 12.6 min, t(+)-major = 16.2 min]. 
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(–)-N-(4-Methoxyphenyl)-N-[1’-(5”-methylfuran-2”-yl)ethyl]amine (488k), 
C14H17NO2, FW = 231.32 
HN
OMe
O
488k
 
488k: colourless oil; [α]D –44 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.51 (d, J = 
6.7 Hz, 3H), 2.27 (d, J = 0.9 Hz, 3H), 3.61 (br s, 1H), 3.74 (s, 3H), 4.50 (q, J = 6.7 Hz, 
1H), 5.86 (dq, J = 3.0, 1.0 Hz, 1H), 6.02 (dq, J = 3.0, 0.4 Hz, 1H), 6.60-6.64 (m, 2H), 6.75-
6.79 (m, 2H); 13C NMR δ 13.64 (CH3), 20.96 (CH3), 48.38 (CH), 55.74 (CH3), 105.83 
(CH), 105.92 (CH), 114.75 (2 × CH), 115.21 (2 × CH), 141.30 (C), 151.02 (C), 152.33 (C), 
155.56 (C); IR ν 3407, 3006, 2931, 1512, 1235 cm-1; MS (EI) m/z (%) 231 (M˙+, 34), 216 
(8), 123 (45), 109 (100); HRMS (EI) 231.1259 (C14H17NO2 requires 231.1260); HPLC 
analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 12.27 min, tmajor 
= 13.07 min) showed 45 % ee. 
 
(–)-N-(4-Methoxyphenyl)-N-[1’-(5”-trimethylsilylfuran-2”-yl)ethyl]amine (488l), 
C16H23NO2Si, FW = 289.58 
HN
OMe
O
488l
Si
 
488l: colourless oil; [α]D –39 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.24 (s, 9H), 
1.54 (d, J = 6.7 Hz, 3H), 3.62 (br s, 1H), 3.74 (s, 3H), 4.58 (q, J = 6.7 Hz, 1H), 6.10 (dd, J 
= 3.1, 0.7 Hz, 1H), 6.50 (d, J = 3.1 Hz, 1H), 6.59-6.63 (m, 2H), 6.74-6.78 (m, 2H); 13C 
NMR δ –1.59 (3 × CH3), 20.99 (CH3), 48.60 (CH), 55.69 (CH3), 104.88 (CH), 114.68 (2 × 
CH), 115.21 (2 × CH), 120.15 (CH), 141.26 (C), 152.30 (C), 159.10 (C), 161.86 (C); IR ν 
3396, 2957, 2900, 2831, 1512, 1464, 1294, 1181 cm-1; MS (EI) m/z (%) 289 (M˙+, 21), 167 
(70), 123 (15), 86 (50), 85 (95), 84 (80), 83 (100); HRMS (EI) 289.1495 (C16H23NO2Si 
requires 289.1498); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 
mL/min, tminor = 9.06 min, tmajor = 9.73 min) showed 63 % ee. 
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(–)-Ethyl 5-[1’-(4”-methoxyphenylamino)ethyl]furan-2-yl-carboxylate (488m), 
C16H19NO4, FW = 289.36 
O
EtOOC
HN
488m OMe
 
488m: colourless oil; [α]D –35 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.36 (t, J = 
7.1 Hz, 3H), 1.57 (d, J = 6.8 Hz, 3H), 3.71 (br s, 1H), 3.72 (s, 3H), 4.34 (q, J = 7.1 Hz, 
2H), 4.68 (q, J = 6.7 Hz, 1H), 6.23 (dd, J = 3.4, 0.5 Hz, 1H), 6.53-6.57 (m, 2H), 6.72-6.76 
(m, 2H), 7.05 (d, J = 3.4 Hz, 1H); 13C NMR δ 14.42 (CH3), 21.30 (CH3), 48.63 (CH), 
55.70 (CH3), 60.85 (CH2), 107.50 (CH), 114.78 (2 × CH), 115.01 (2 × CH), 118.79 (CH), 
140.65 (C), 143.68 (C), 152.53 (C), 158.89 (C), 162.45 (C); IR ν 3384, 2981, 1714, 1512, 
1299, 1235, 1137 cm-1; MS (EI) m/z (%) 289 (M˙+, 85), 274 (32), 216 (36), 167 (100), 139 
(67), 123 (82), 122 (45), 118 (28), 93 (32), 86 (32), 84 (51); HRMS (EI) 289.1315 
(C16H19NO4 requires 289.1314); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(99:1), 0.75 mL/min, tmajor = 50.21 min, tminor = 55.85 min) showed 70 % ee. 
 
(–)-N-[1’-(Furan-2”-yl)-2’-methylprop-1’-yl]-N-4-methoxyphenylamine (488n), 
C15H19NO2, FW = 245.35 
HN
OMe
O
488n
 
488n: colourless oil; [α]D –97 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.94 (d, J = 
6.8 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H), 2.16 (oct, J = 6.7 Hz, 1H), 3.72 (s, 3H), 4.16 (d, J = 
6.1 Hz, 1H), 6.12 (d, J = 3.2 Hz, 1H), 6.27 (dd, J = 3.2, 1.8 Hz, 1H), 6.55-6.59 (m, 2H), 
6.72-6.76 (m, 2H), 7.33 (dd, J = 1.8, 0.8 Hz, 1H); 13C NMR δ 19.07 (CH3), 19.12 (CH3), 
32.88 (CH), 55.75 (CH3), 58.94 (CH), 106.67 (CH), 109.99 (CH), 114.77 (2 × CH), 114.88 
(2 × CH), 141.25 (CH), 141.78 (C), 152.19 (C), 155.73 (C); IR ν 3398, 2959, 2831, 1513, 
1464, 1233 cm-1; MS (EI) m/z (%) 245 (M˙+, 20), 203 (20), 202 (100), 134 (10), 123 (25); 
HRMS (EI) 245.1415 (C15H19NO2 requires 245.1416); HPLC analysis (Chiralcel OJ-H, 
hexane – propan-2-ol (90:10), 0.75 mL/min, tmajor = 25.14 min, tminor = 28.60 min) showed 
85 % ee. 
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(–)-N-[1’-(Furan-3”-yl)ethyl]-N-(4-methoxyphenyl)amine (488o), C13H15NO2, FW = 
217.29 
O HN
488o
OMe
 
488o: colourless oil; [α]D –17 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.48 (d, J = 
6.6 Hz, 3H), 3.48 (br s, 1H), 3.74 (s, 3H), 4.45 (q, J = 6.6 Hz, 1H), 6.37 (d, J = 0.8 Hz, 
1H), 6.57-6.61 (m, 2H), 6.75-6.79 (m, 2H), 7.33 (d, J = 0.6 Hz, 1H), 7.33 (t, J = 1.6 Hz, 
1H); 13C NMR δ 22.73 (CH3), 46.42 (CH), 55.78 (CH3), 109.08 (CH), 114.84 (2 × CH), 
115.00 (2 × CH), 129.69 (C), 138.90 (CH), 141.48 (C), 143.14 (CH), 152.21 (C); IR ν 
3397, 2967, 1511, 1299, 1235 cm-1; MS (EI) m/z (%) 217 (M˙+, 90), 202 (52), 123 (60), 
122 (26), 108 (67), 95 (100); HRMS (EI) 217.1107 (C13H15NO2 requires 217.1103); 
HPLC analysis (Chiralcel OJ-H, hexane – propan-2-ol (80:20), 0.70 mL/min, tmajor = 37.33 
min, tminor = 40.73 min) showed 77 % ee. 
 
(–)-N-[1’-(2”,5”-Dimethylfuran-3”-yl)ethyl]-N-(4-methoxyphenyl)amine (488p), 
C15H19NO2, FW = 245.35 
O HN
488p
OMe
 
488p: yellow oil; [α]D –4.5 (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.42 (d, J = 6.7 
Hz, 3H), 2.21 (br s, 3H), 2.25 (br s, 3H), 3.36 (br s, 1H), 3.74 (s, 3H), 4.29 (q, J = 6.6 Hz, 
1H), 5.88 (br s, 1H), 6.53-6.57 (m, 2H), 6.73-6.77 (m, 2H); 13C NMR δ 11.86 (CH3), 13.61 
(CH3), 23.18 (CH3), 46.37 (CH), 55.75 (CH3), 104.64 (CH), 114.76 (2 × CH), 114.94 (2 × 
CH), 123.55 (C), 141.79 (C), 144.85 (C), 149.72 (C), 152.10 (C); IR ν 3398, 2964, 2921, 
1583, 1511, 1450, 1234 cm-1; MS (EI) m/z (%) 245 (M˙+, 25), 123 (100), 86 (35), 84 (54); 
HRMS (EI) 245.1414 (C15H19NO2 requires 245.1416); HPLC analysis (Chiralpak IB, 
hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 12.78 min, tmajor = 14.55 min) showed 
91 % ee. 
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(–)-N-[1’-(Benzofuran-2”-yl)ethyl]-N-(4-methoxyphenyl)amine (488q), C17H17NO2, 
FW = 267.35 
HN
OMe
O
488q
 
488q: colourless oil; [α]D –121 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.51 (d, J = 
6.7 Hz, 3H), 1.65 (d, J = 0.9 Hz, 3H), 3.74 (s, 3H), 4.67 (q, J = 6.7 Hz, 1H), 6.54 (d, J = 
0.7 Hz, 1H), 6.63-6.67 (m, 2H), 6.75-6.79 (m, 2H), 7.17-7.27 (m, 2H), 7.45-7.50 (m, 2H); 
13C NMR δ 21.17 (CH3), 48.88 (CH), 55.73 (CH3), 102.14 (CH), 111.07 (CH), 114.85 (2 × 
CH), 115.20 (2 × CH), 120.80 (CH), 122.63 (CH), 123.67 (CH), 128.47 (C), 140.89 (C), 
152.59 (C), 154.77 (C), 160.39 (C); IR ν 3424, 3017, 2832, 1512 1235, 1216 cm-1; MS 
(EI) m/z (%) 267 (M˙+, 65), 145 (100), 123 (46), 117 (28), 115 (40), 91 (22); HRMS (EI) 
267.1261 (C17H17NO2 requires 267.1259); HPLC analysis (Chiralpak IB, hexane – 
propan-2-ol (99:1), 0.75 mL/min, tminor = 21.69 min, tmajor = 24.21 min) showed 70 % ee. 
 
(–)-N-[1’-(Benzofuran-3”-yl)ethyl]-N-(4-methoxyphenyl)amine (488r), C17H17NO2, 
FW = 267.35 
O HN
488r OMe
 
488r: colourless oil; [α]D –93 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.66 (d, J = 
6.8 Hz, 3H), 3.75 (s, 3H), 4.70 (q, J = 6.8 Hz, 1H), 6.56 (s, 1H), 6.65-6.69 (m, 2H), 6.78-
6.82 (m, 2H), 7.22 (ddd, J = 7.4, 7.3, 1.0 Hz, 1H), 7.27 (ddd, J = 7.9, 7.3, 1.4 Hz, 1H), 
7.48-7.52 (m, 2H); 13C NMR δ 21.20 (CH3), 48.85 (CH), 55.74 (CH3), 102.14 (CH), 
111.10 (CH), 114.88 (2 × CH), 115.17 (2 × CH), 120.80 (CH), 122.67 (CH), 123.70 (CH), 
128.50 (C), 140.99 (C), 152.57 (C), 154.80 (C), 160.48 (C); IR ν 3396, 3060, 2974, 2931, 
2832, 1584, 1512, 1454, 1236 cm-1; MS (CI/isobutane) m/z (%) 268 [(M+H)+, 55], 267 
(29), 145 (100), 124 (33); HRMS (CI/isobutane) 268.1339 (C17H18NO2 requires 
268.1338); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (97:3), 0.75 mL/min, tminor 
= 14.44 min, tmajor = 16.17 min) showed 65 % ee. 
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(–)-N-(4-Methoxyphenyl)-N-[1’-(1”-methyl-1H-indol-2”-yl)ethyl]amine (488s), 
C18H20N2O, FW = 280.40 
N HN OMe
488s
 
488s: pale yellow crystals; mp 74-75 ºC (hexane/CH2Cl2); [α]D –64 (c 1.0, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 1.53 (d, J = 6.6 Hz, 3H), 3.38 (br s, 1H), 3.636 (s, 3H), 3.638 
(s, 3H), 4.61 (q, J = 6.5 Hz, 1H), 6.37 (br s, 1H), 6.49-6.53 (m, 2H), 6.66-6.70 (m, 2H), 
7.00 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 7.11 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.21 (dd, J = 8.2, 
0.7 Hz, 1H), 7.48 (ddd, J = 7.8, 1.0, 0.8 Hz, 1H); 13C NMR δ 20.27 (CH3), 29.75 (CH3), 
46.81 (CH), 55.71 (CH3), 99.63 (CH), 108.89 (CH), 114.64 (2 × CH), 114.93 (2 × CH), 
119.36 (CH), 120.37 (CH), 121.34 (CH), 127.27 (C), 137.79 (C), 140.99 (C), 142.57 (C), 
152.25 (C); IR ν 3395, 3009, 2975, 1933, 2834, 1511, 1467, 1306, 1233, 1216 cm-1; MS 
(EI) m/z (%) 280 (M˙+, 18), 159 (12), 158 (100), 157 (55), 156 (30), 123 (62), 108 (85); 
HRMS (EI) 280.1578 (C18H20N2O requires 280.1576); HPLC analysis (Chiralpak IB, 
hexane – propan-2-ol (95:5), 0.75 mL/min, tminor = 20.16 min, tmajor = 29.08 min) showed 
91 % ee. 
 
 
6.4.2. Amines without Heterocycles     
 
(–)-N-(4-Methoxyphenyl)-N-(1’-phenylprop-1’-yl)amine (492a), C16H19NO, FW = 
241.35 
492a
HN
OMe
 
492a:225,36b colourless oil; [α]D –20 (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.85 (t, 
J = 7.4 Hz, 3H),1.62-1.78 (m, 2H), 3.59 (s, 3H), 3.72 (br s, 1H), 4.06 (t, J = 6.7 Hz, 1H), 
6.36-6.40 (m, 2H), 6.57-6.61 (m, 2H), 7.10-7.14 (m, 1H), 7.19-7.26 (m, 4H); 13C NMR δ 
10.87 (1 × CH3), 31.74 (1 × CH2), 55.78 (1 × CH3), 60.61 (1 × CH), 114.52 (2 × CH), 
114.81 (2 × CH), 126.59 (2 × CH), 126.87 (1 × CH), 128.51 (2 × CH), 141.86 (1 × C), 
144.2 (1 × C), 151.87 (1 × C); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(80:20), 0.75 mL/min, tminor = 12.80 min, tmajor = 13.63 min) showed 92 % ee, [lit.225 gives 
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Chiralcel OD, hexane – propan-2-ol (97:3), 1.0 mL/min, t(+)-major = 8.9 min, t(–)-minor  = 9.8 
min]. 
 
(–)-N-(4-Methoxyphenyl)-N-(2’-methyl-1’-phenylprop-1’-yl)amine (492b), C17H21NO, 
FW = 255.39 
HN
492b OMe
 
492b:227 colourless oil; [α]D –22 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.82 (d, J 
= 6.8 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H), 1.92 (oct, J = 6.8 Hz, 1H), 3.58 (s, 3H), 3.78 (br s, 
1H), 3.96 (d, J = 5.8 Hz, 1H), 6.35-6.39 (m, 2H), 6.56-6.60 (m, 2H), 7.09-7.15 (m, 1H), 
7.20-7.21 (m, 4H); 13C NMR δ 18.65 (CH3), 19.63 (CH3), 34.85 (CH), 55.66 (CH3), 64.55 
(CH), 114.28 (2 × CH), 114.65 (2 × CH), 126.65 (CH), 127.17 (2 × CH), 128.09 (2 × CH), 
141.95 (C), 142.71 (C), 151.60 (C); IR ν 3412, 3025, 2958, 2931, 2871, 2831, 1511, 1465, 
1298, 1233 cm-1;  MS (EI) m/z (%) 255 (M˙+, 12), 212 (100); HRMS (EI) 255.1622 
(C17H21NO requires 255.1623); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(99:1), 0.75 mL/min, tminor = 10.39 min, tmajor = 10.84 min) showed 97 % ee. 
 
 (+)-N-[Cyclopropyl(phenyl)methyl]-N-(4-methoxyphenyl)amine (492c), C17H19NO, 
FW = 253.37 
HN
OMe492c
 
492c: colourless oil; [α]D +66 (c 1.0, CHCl3);1H NMR (400 MHz, CDCl3) δ 0.29 (ddd, J = 
14.3, 5.2, 4.1 Hz, 1H), 0.36 (ddd, J = 9.5, 5.0, 4.5 Hz, 1H), 0.39-0.49 (m, 1H), 0.51 (dddd, 
J = 14.2, 8.0, 5.4, 4.0 Hz, 1H), 1.08 (dtd, J = 8.2, 5.0, 5.0 Hz, 1H), 3.48 (d, J = 8.4 Hz, 
1H), 3.58 (s, 3H), 4.02 (br s, 1H), 6.32-6.36 (m, 2H), 6.55-6.59 (m, 2H), 7.14 (dddd, J = 
8.1, 6.4, 2.2, 1.4 Hz, 1H), 7.20-7.25 (m, 2H), 7.29-7.32 (m, 2H); 13C NMR δ 3.50 (CH2), 
4.26 (CH2), 19.86 (CH), 55.76 (CH3), 63.87 (CH), 114.67 (2 × CH), 114.74 (2 × CH), 
126.54 (2 × CH), 127.02 (CH), 128.53 (2 × CH), 141.98 (C), 143.63 (C), 151.97 (C); IR ν 
3405, 3062, 3005, 2951, 2832, 1512, 1452, 1297, 1234 cm-1;  MS (EI) m/z (%) 253 (M˙+, 
43), 136 (20), 131 (100), 91 (38); HRMS (EI) 253.1473 (C17H19NO requires 253.1467); 
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HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 12.98 
min, tmajor = 15.24 min) showed 95 % ee. 
 
(–)-N-[Cyclobutyl(phenyl)methyl]-N-(4-methoxyphenyl)amine (492d), C18H21NO, FW 
= 267.40 
HN
OMe492d
 
492d: colourless oil; [α]D –0.8 (c 1.0, CHCl3), [α]436 –17.2 (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 1.63-1.85 (m, 5H), 1.98-2.08 (m, 1H), 2.38-2.48 (m, 1H), 3.57 (s, 3H), 
3.67 (br s, 1H), 4.01 (d, J = 9.1 Hz, 1H), 6.34-6.38 (m, 2H), 6.55-6.59 (m, 2H), 7.12 (dddd, 
J = 7.7, 6.2 2.4, 1.6 Hz, 1H), 7.17-7.25 (m, 3H); 13C NMR δ 17.59 (CH2), 25.53 (CH2), 
26.20 (CH2), 42.67 (CH), 55.77 (CH3), 64.71 (CH), 114.62 (2 × CH), 114.77 (2 × CH), 
126.66 (2 × CH), 126.90 (CH), 128.41 (2 × CH), 142.06 (C), 142.81 (C), 151.90 (C); IR ν 
3405, 3026, 2936, 2831, 1512, 1452, 1295, 1238 cm-1;  MS (EI) m/z (%) 267 (M˙+, 22), 
212 (100), 91 (20), 85 (55), 84 (31), 83 (82); HRMS (EI) 267.1624 (C18H21NO requires 
267.1623); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor 
= 10.49 min, tmajor = 10.97 min) showed 94 % ee.  
 
(–)-N-[Cyclohexyl(phenyl)methyl]-N-(4-methoxyphenyl)amine (492e), C20H25NO, FW 
= 295.46 
HN
OMe492e
 
492e:228 colourless oil; [α]D –11.6 (c 1.0, CHCl3), [lit.228 gives [α]435 –70.1 (c 1.59, EtOH)]; 
1H NMR (400 MHz, CDCl3) δ 1.02-1.30 (m, 5H), 1.57 (br d, J = 12.9 Hz, 1H), 1.63-1.81 
(m, 4H), 1.93 (br d, J = 12.6, 1H), 3.70 (s, 3H), 4.07 (d, J = 6.2 Hz, 1H), 6.46-6.50 (m, 
2H), 6.67-6.71 (m, 2H), 7.20-7.26 (m, 1H), 7.29-7.34 (m, 4H); 13C NMR δ 26.41 (CH2), 
26.44 (CH2), 26.48 (CH2), 29.55 (CH2), 30.24 (CH2), 44.99 (CH), 55.78 (CH3), 64.32 
(CH), 114.35 (2 × CH), 114.78 (2 × CH), 126.70 (CH), 127.31 (2 × CH), 128.17 (2 × CH), 
142.16 (C), 142.94 (C), 151.71 (C); IR ν 3421, 3023, 2928, 2853, 1512, 1451, 1236, 1217 
cm-1; MS (EI) m/z (%) 295 (M˙+, 37), 213 (50), 212 (100), 197 (10), 168 (15), 134 (10), 91 
(23); HRMS (EI) 295.1935 (C20H25NO requires 295.1936); HPLC analysis (Chiralcel OJ-
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H, hexane – propan-2-ol (85:15), 0.75 mL/min, tminor = 12.85 min, tmajor = 15.83 min) 
showed 76 % ee, [lit.228 gives Chiralcel OJ, hexane – propan-2-ol (25:1), 1.0 mL/min, t(–)-
(S)-major  = 14.7 min, t(+)-(R)-minor = 36.0 min showing 98 % ee].  
 
N-(2’,2’-Dimethyl-1’-phenylprop-1’-yl)-N-(4-methoxyphenyl)amine (492f), C18H23NO, 
FW = 269.42 
HN
OMe492f
 
492f:228 colourless oil; 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 3.57 (s, 3H), 3.88 (s, 
1H), 3.93 (br s, 1H), 6.33-6.37 (m, 2H), 6.54-6.58 (m, 2H), 7.10-7.14 (m, 1H), 7.16-7.24 
(m, 3H); 13C NMR δ 27.05 (3 × CH3), 34.88 (C), 55.68 (CH3), 68.03 (CH), 114.21 (2 × 
CH), 114.65 (2 × CH), 126.69 (CH), 127.62 (2 × CH), 128.47 (2 × CH), 141.35 (C), 
142.08 (C), 151.53 (C), 180.15 (C); IR ν 3430, 3026, 2954, 2604, 2869, 2831, 1511, 1396, 
1366, 1237 cm-1; MS (EI) m/z (%) 269 (M˙+, 8), 212 (100); HRMS (EI) 269.1783 
(C18H23NO requires 269.1780); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(99:1), 0.45 mL/min, tminor = 12.91 min, tmajor = 13.39 min) showed 10 % ee, [lit.228 gives 
Chiralcel OJ, hexane – propan-2-ol  (100:1), 0.5 mL/min, t(+)-(R)-minor = 33.6 min, t(–)-(S)-major  
= 39.3 min showing 90 % ee].  
 
(–)-N-(3’,3’-Dimethyl-but-2’-yl)-N-(4-methoxyphenyl)amine (492i), C13H21NO, FW = 
207.35 
HN
OMe492i
 
492i: colourless oil; [α]D –19 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 9H), 
1.08 (d, J = 6.5 Hz, 3H), 3.09 (br s, 1H), 3.12 (q, J = 6.5 Hz, 1H), 3.76 (s, 3H), 6.56-6.60 
(m, 2H), 6.76-6.80 (m, 2H); 13C NMR δ 15.73 (CH3), 26.52 (3 × CH3), 34.66 (C), 55.79 
(CH3), 58.55 (CH), 114.46 (2 × CH), 114.87 (2 × CH), 142.84 (C), 151.50 (C); IR ν 3399, 
2960, 2869, 2831, 1511, 1465, 1371, 1233 cm-1; MS (EI) m/z (%) 207 (M˙+, 12), 150 
(100); HRMS (EI) 207.1624 (C13H21NO requires 207.1623); HPLC analysis (Chiralpak 
IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tmajor = 6.73 min, tminor = 7.53 min) showed 
39 % ee.  
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N-(4-Methoxyphenyl)-N-[(4’-methoxyphenyl)(4”-
trifluoromethylphenyl)methyl]amine (492j) C21H20O2NF3, FW = 387.43 
HN
F3C OMe
492j OMe
 
492j: colourless oil; 1H NMR (400 MHz, CDCl3) δ 3.73 (s, 3H), 3.80 (s, 3H), 3.98 (br s, 
1H), 5.44 (s, 1H), 6.48-6.52 (m, 2H), 6.72-6.76 (m, 2H), 6.86-6.90 (m, 2H), 7.22-7.26 (m, 
2H), 7.53 (d, J = 8.2 Hz, 2H), 7.60 (d, J = 8.2 Hz, 2H); 13C NMR δ 55.28 (CH3), 55.72 
(CH3), 62.95 (CH), 114.29 (2 × CH), 114.73 (2 × CH), 114.81 (2 × CH), 124.23 (q, J = 
272.0 Hz, CF3), 125.68 (q, J = 3.8 Hz, 2 × CH), 127.52 (2 × CH), 128.70 (2 × CH), 129.40 
(q, J = 32.3 Hz, C), 134.79 (C), 141.29 (C), 147.45 (C), 152.43 (C), 159.14 (C); 19F NMR 
δ –62.32; IR ν 3398, 3006, 2935, 2835, 1617, 1511, 1326, 1246, 1165 cm-1; MS (EI) m/z 
(%) 387 (M˙+, 20), 265 (100), 153 (10), 122 (10), 86 (16), 84 (25); HRMS (EI) 387.1445 
(C22H20NO2F3 requires 387.1446); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(97:3), 0.75 mL/min, t1 = 22.79 min, t2 = 26.83 min) showed 6 % ee. 
 
N-(4-Methoxyphenyl)-N-(1’,2’,3’,4’-tetrahydronaphth-1’-yl)amine (492k), C17H19NO, 
FW = 253.37 
492k
HN
OMe
 
492k:224 colourless oil; 1H NMR (400 MHz, CDCl3) δ 1.76-2.02 (m, 4H), 2.74-2.90 (m, 
2H), 3.62 (br s, 1H), 3.78 (s, 3H), 4.56 (dd, J = 5.0, 4.4 Hz, 1H), 6.64-6.68 (m, 2H), 6.81-
6.85 (m, 2H), 7.13-7.23 (m, 3H), 7.44 (dd, J = 6.8, 1.7 Hz, 1H); 13C NMR δ 19.34 (CH2), 
28.66 (CH2), 29.39 (CH2), 52.15 (CH), 55.90 (CH3), 114.51 (2 × CH), 115.05 (2 × CH), 
126.09 (CH), 127.14 (CH), 129.06 (CH), 129.34 (CH), 137.64 (C), 138.35 (C), 141.64 (C), 
152.06; IR ν 3398, 3018, 2933, 2860, 1513, 1452, 1239 cm-1; MS (EI) m/z (%) 253 (M˙+, 
28), 199 (13), 131 (50), 123 (52), 108 (26), 91 (22), 86 (37), 84 (60); HRMS (EI) 
253.1469 (C17H19NO requires 253.1467); HPLC analysis (Chiralpak IB, hexane – propan-
2-ol (99:1), 0.75 mL/min, t1 = 11.95 min, t2 = 12.76 min) showed 0 % ee, [lit.224 gives 
Chiralcel OD, heptanes – propan-2-ol (97:3), 0.5 mL/min, t(+)-major = 10.5 min, t(–)-minor  = 
13.0 min]. 
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(–)-3-Phenyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-one (264), C14H11NO2, FW = 
225.26 
N
H
O O
264
 
264:123 yellowish crystals; mp 78-79 ºC (hexane/CH2Cl2); [α]D –64 (c 1.0, CHCl3), [lit.123 
gives [α]D –46.3 (c 1.0, CHCl3)]; 1H NMR (400 MHz, CDCl3) δ 4.33 (br s, 1H), 5.04 (s, 
1H), 6.80-6.82 (m, 1H), 6.87 (ddd, J = 8.1, 7.4, 1.5 Hz, 1H), 7.01-7.05 (m, 2H), 7.34-7.42 
(m, 5H); 13C NMR δ 57.51 (CH), 113.20 (CH), 115.22 (CH), 118.62 (CH), 123.50  (CH), 
125.77 (2 × CH), 127.27 (2 × CH), 130.70 (C), 134.63 (C), 139.15 (C), 163.61 (C); IR ν 
3368, 3020, 2927, 1766, 1619, 1597, 1502, 1298, 1214 cm-1; MS (EI) m/z (%) 225 (M˙+, 
58), 197 (65), 196 (70), 120 (100), 104 (12), 84 (30); HRMS (EI) 225.0792 (C14H11NO2 
requires 225.0790); HPLC analysis (Chiralcel OD-H, hexane – propan-2-ol (80:20), 0.60 
mL/min, tmajor = 16.27 min, tminor = 21.85 min) showed 41 % ee, [lit.123 gives Chiralcel OD-
H, hexane – propan-2-ol  (80:20), 0.60 mL/min, t(–)-major  = 18.6 min, t(+)-minor = 25.5 min 
showing 98 % ee]. 
 
(+)-3-(3’-Bromophenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine (260), C14H12NOBr, FW 
= 290.17  
N
H
O
260
Br
 
260:123 yellowish oil; [α]D +31 (c 1.0, CHCl3), [lit.123 gives [α]D –118.2 (c 1.0, CHCl3)]; 1H 
NMR (400 MHz, CDCl3) δ 3.85 (dd, J = 10.7, 8.4 Hz, 1H), 3.89 (br s, 1H), 4.15 (dd, J = 
10.7, 2.9 Hz, 1H), 4.35 (dd, J = 8.4, 2.9 Hz, 1H), 6.58 (dd, J = 7.7, 1.5 Hz, 1H), 6.62 (td, J 
= 7.6, 1.6 Hz, 1H), 6.72 (dd, J = 7.6, 1.5 Hz, 1H), 6.75 (dd, J = 7.8, 1.4 Hz, 1H), 7.15 (t, J 
= 7.8 Hz, 1H), 7.22 (dt, J = 7.7, 1.1 Hz, 1H), 7.37 (ddd, J = 7.8, 1.9, 1.2, 1H), 7.46 (dd, J = 
1.9, 1.7 Hz, 1H; 13C NMR δ 53.73 (CH), 70.71 (CH2), 115.57 (CH), 116.65 (CH), 119.25 
(CH), 121.71 (CH), 122.99 (C), 125.96 (CH), 130.30 (CH), 130.45 (CH), 131.48 (CH), 
133.53 (C), 141.61 (C), 143.48 (C); IR ν 3363, 3058, 3018, 2922, 2871, 1730, 1609, 1591, 
1499, 1429, 1340, 1310, 1278, 1210 cm-1; MS (EI) m/z (%) 291 (M˙+, 90), 289 (M˙+, 100), 
184 (16), 182 (15), 180 (17), 134 (46), 120 (57), 105 (19), 103 (18), 103 (21); HRMS (EI) 
291.0085 (C14H12NO81Br requires 3291.0083), 289.0096 (C14H12NO79Br requires 
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289.0102); HPLC analysis (Chiralcel OD-H, hexane – propan-2-ol (80:20), 0.60 mL/min, 
tminor = 16.02 min, tmajor = 27.17 min) showed 26 % ee, [lit.123 gives Chiralcel OD-H, 
hexane – propan-2-ol  (80:20), 0.60 mL/min, t(–)-major  = 19.8 min, t(+)-minor = 30.6 min 
showing 98 % ee].  
 
2-Methoxy-1-(4’-methoxyphenyl)-5-phenyl-1H-pyrrole (494), C18H17NO2, FW = 
279.36 
N OMe
OMe494
 
494: white crystals; mp 101-102 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 3.80 (s, 3H), 
3.81 (s, 3H), 5.45 (d, J = 3.7 Hz, 1H), 6.26 (d, J = 3.7 Hz, 1H), 6.84-6.88 (m, 2H), 7.03-
7.16 (m, 7H); 13C NMR δ 54.30 (CH3), 56.71 (CH3), 82.86 (CH), 105.73 (CH), 112.92 (2 
× CH), 124.24 (CH), 125.80 (C), 126.13 (2 × CH), 126.95 (2 × CH), 128.10 (2 × CH), 
129.00 (C), 132.24 (C), 149.12 (C), 157.39 (C); IR ν 3019, 2956, 2931, 2832, 1599, 1564, 
1515, 1454, 1420, 1294, 1250, 1216 cm-1;  MS (EI) m/z (%) 279 (M˙+, 55), 264 (100), 193 
(10), 103 (10); HRMS (EI) 279.1258 (C18H17NO2 requires 279.1259). 
 
(–)-Methyl 4-[N-(4’-methoxyphenyl)amino]-4-phenylbutanoate (492m), C18H21NO3, 
FW = 299.40 
HN
OMe
COOMe
492m
 
492m: yellow oil; mp 59-60 ºC (hexane/CH2Cl2); [α]D –13.5 (c 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 2.03-2.19 (m, 2H), 2.41 (dd, J = 7.3, 7.2 Hz, 3H), 3.66 (s, 3H), 3.69 
(s, 3H), 3.98 (br s, 1H), 4.30 (dd, J = 7.2, 6.5 Hz, 1H), 6.45-6.49 (m, 2H), 6.66-6.70 (m, 
2H), 7.21-7.25 (m, 1H), 7.29-7.34 (m, 4H); 13C NMR δ 31.06 (CH2), 33.32 (CH2), 51.77 
(CH3), 55.75 (CH3), 58.52 (CH), 114.60 (2 × CH), 114.77 (2 × CH), 126.46 (2 × CH), 
127.21 (CH), 128.71 (2 × CH), 141.39 (C), 143.33 (C), 151.97 (C), 174.07 (C); IR ν 3394, 
3025, 3005, 2951, 2833, 1733, 1513, 1452, 1237 cm-1;  MS (EI) m/z (%) 299 (M˙+, 30), 
212 (100), 117 (23); HRMS (EI) 299.1518 (C18H21NO3 requires 299.1521); HPLC 
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analysis (Chiralpak IB, hexane – propan-2-ol (90:10), 0.75 mL/min, tminor = 16.52 min, 
tmajor = 28.60 min) showed 88 % ee. 
 
(–)-N-(4-Methoxyphenyl)-N-(1’-phenylhex-5’-en-1’-yl)amine (492n), C19H23NO, FW = 
281.43 
492n
HN
OMe
 
492n: colourless oil; [α]D –6.5 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.28-1.49 
(m, 2H), 1.61-1.78 (m, 2H), 1.96-2.02 (m, 2H), 3.60 (s, 3H), 3,73 (br s, 1H), 4.15 (t, J = 
6.8 Hz, 1H), 4.87 (ddt, J = 10.2, 2.0, 1.2 Hz, 1H),  4.92 (ddd, J = 17.1, 3.5, 1.6 Hz, 1H), 
5.68 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 6.37-6.41 (m, 2H), 6.58-6.62 (m, 2H), 7.11-7.16 (m, 
1H), 7.21-7.26 (m, 4H); 13C NMR δ 23.69 (CH2), 33.51 (CH2), 38.32 (CH2), 55.58 (CH3), 
58.87 (CH), 114.37 (2 × CH), 114.69 (2 × CH), 114.83 (CH2), 126.37 (2 × CH), 126.81 
(CH), 128.48 (2 × CH), 138.34 (CH), 141.64 (C), 144.34 (C), 151.74 (C); IR ν 3405, 3061, 
3026, 2933, 2857, 2832, 1639, 1513, 1453, 1237 cm-1; MS (EI) m/z (%) 281 (M˙+, 65), 212 
(100), 168 (20), 123 (37), 108 (23), 91 (68), 84 (22); HRMS (EI) 281.1778 (C19H23NO 
requires 281.1780); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 
mL/min, tminor = 13.09 min, tmajor = 14.20 min) showed 84 % ee. 
 
(–)-N-[1’-(3”-Chlorophenyl)hex-5’-en-1’-yl]-N-(4-methoxyphenyl)amine (492o), 
C19H22NOCl, FW = 315.87 
492o
HN
OMe
Cl
 
492o: colourless oil; [α]D –2.1 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.26-1.50 
(m, 2H), 1.59-1.75 (m, 2H), 1.90-2.02 (m, 2H), 3.61 (s, 3H), 3.71 (br s, 1H), 4.11 (t, J = 
6.8 Hz, 1H), 4.87-4.90 (m, 1H),  4.92 (ddd, J = 17.2, 3.5, 1.6 Hz, 1H), 5.68 (ddt, J = 17.1, 
10.2, 6.7 Hz, 1H), 6.34-6.38 (m, 2H), 6.59-6.63 (m, 2H), 7.09-7.17 (m, 3H), 7.24-7.25 (m, 
1H); 13C NMR δ 25.51 (CH2), 33.48 (CH2), 38.30 (CH2), 55.75 (CH3), 58.68 (CH), 114.46 
(2 × CH), 114.83 (2 × CH), 115.06 (CH2), 124.66 (CH), 126.54 (CH), 127.12 (CH), 129.84 
(CH), 134.49 (C), 138.19 (CH), 141.34 (C), 146.87 (C), 152.08 (C); IR ν 3406, 3072, 
2934, 2832, 1639, 1595, 1510, 1574, 1470, 1433, 1237 cm-1; MS (EI) m/z (%) 317 (M˙+, 
    200
8), 315 (M˙+, 20), 248 (25), 246 (70), 212 (10), 123 (13), 84 (40); HRMS (EI) 317.1367 
(C19H22NO37Cl requires 317.1367), 315.1386 (C19H22NO35Cl requires 315.1390); HPLC 
analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 15.44 min, tmajor 
= 16.73 min) showed 82 % ee. 
 
(–)-N-(4-Methoxyphenyl)-N-[1’-(3”-methoxyphenyl)hex-5’-en-1’-yl]amine (492p), 
C20H25NO2, FW = 311.46 
492p
HN
OMe
MeO
 
492p: yellowish oil; [α]D –5.0 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.28-1.48 
(m, 2H) 1.62-1.76 (m, 2H), 1.96-2.01 (m, 2H), 3.60 (s, 3H), 3.69 (s, 3H), 4.11 (t, J = 6.6 
Hz, 1H), 4.86-4.93 (m, 2H), 5.79 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 6.37-3.41 (m, 2H), 
6.58-6.61 (m, 2H), 6.67 (dd, J = 8.1, 2.4 Hz, 1H), 6.81 (d, J = 1.6 Hz, 1H), 6.83 (d, J = 7.8 
Hz, 1H), 7.14 (dd, J = 8.0, 7.6 Hz, 1H); 13C NMR δ 25.65 (CH2), 33.62 (CH2), 38.33 
(CH2), 55.19 (CH3), 55.77 (CH3), 59.02 (CH), 111.91 (CH), 112.29 (CH), 114.48 (2 × 
CH), 114.77 (2 × CH), 114.93 (CH2), 118.89 (CH), 129.55 (CH), 138.45 (CH), 141.74 (C), 
146.34 (C), 151.87 (C), 159.86 (C); IR ν 3404, 2935, 2833, 1600, 1586, 1513, 1486, 1455, 
1438, 1237 cm-1; MS (EI) m/z (%) 311 (M˙+, 98), 243 (94), 242 (100), 226 (46), 207 (45), 
147 (48), 134 (80), 123 (84), 122 (66), 121 (90), 108 (68), 107 (40), 91 (59), 84 (35); 
HRMS (EI) 311.1886 (C20H25NO2 requires 311.1885); HPLC analysis (Chiralpak IB, 
hexane – propan-2-ol (99:1), 0.75 mL/min, tminor = 20.32 min, tmajor = 23.48 min) showed 
90 % ee. 
 
(–)-N-4-(Methoxyphenyl)-N-[1’-(3”-methoxyphenyl)pent-4’-en-1’-yl]amine (492q), 
C22H23NO2, FW = 297.43 
492q
HN
OMe
MeO
 
492q: colourless oil; [α]D –9.1 (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.71-1.85 
(m, 2H), 1.97-2.10 (m, 2H), 3.59 (s, 3H), 3.69 (s, 3H), 4.14 (t, J = 6.7 Hz, 1H), 4.89-4.97 
(m, 2H), 5.74 (ddt, J = 17.0, 10.3, 6.6 Hz, 1H), 6.38-6.41 (m, 2H), 6.58-6.62 (m, 2H), 6.67 
(ddd, J = 8.2, 2.6, 0.8 Hz, 1H), 6.81 (dd, J = 2.4, 1.6 Hz, 1H), 7.20 (br d, J = 7.6 Hz, 1H), 
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7.14 (t, J = 7.9 Hz, 1H); 13C NMR δ 30.54 (CH2), 37.80 (CH2), 55.17 (CH3), 55.74 (CH3), 
58.65 (CH), 112.03 (CH), 112.34 (CH), 114.60 (2 × CH), 114.76 (2 × CH), 115.29 (CH2), 
118.93 (CH), 129.58 (CH), 137.95 (CH2), 141.59 (C), 146.02 (C), 151.95 (C), 159.88 (C); 
IR ν 3403, 2936, 2833, 1600, 1513, 1454, 1238 cm-1; MS (EI) m/z (%) 297 (M˙+, 23), 243 
(15), 242 (100), 212 (10), 154 (18), 123 (15), 121 (28), 108 (12), 91 (13), 84 (10); HRMS 
(EI) 297.1728 (C19H23NO2 requires 297.1729); HPLC analysis (Chiralpak IB, hexane – 
propan-2-ol (98:2), 0.75 mL/min, tminor = 14.09 min, tmajor = 16.16 min) showed 95 % ee. 
 
(–)-N-(1’,3’-Diphenylprop-1’-yl)-N-(4-methoxyphenyl)amine (492v), C22H23NO, FW = 
317.46 
492v
HN
OMe
 
492v: colourless oil; [α]D –2.5 (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.94-2.09 
(m, 2H), 2.52-2.66 (m, 2H), 3.58 (s, 3H), 3.75 (br s, 1H), 4.17 (t, J = 6.8 Hz, 1H), 6.33-
6.37 (m, 2H), 6.56-6.60 (m, 2H), 7.06-7.25 (m, 10H); 13C NMR δ 32.70 (CH2), 40.25 
(CH2), 55.76 (CH3), 58.66 (CH), 114.68 (2 × CH), 114.79 (2 × CH), 126.04 (CH), 126.57 
(2 × CH), 127.06 (CH), 128.50 (4 × CH), 128.65 (2 × CH), 141.47 (C), 141.61 (C), 144.04 
(C), 151.99 (C); IR ν 3405, 3026, 2943, 2831, 1602, 1512, 1453, 1295, 1237 cm-1; MS 
(EI) m/z (%) 317 (M˙+, 34), 212 (100), 123 (11), 91 (40); HRMS (EI) 317.1782 
(C22H23NO requires 317.1780); HPLC analysis (Chiralpak IB, hexane – propan-2-ol 
(98:2), 0.75 mL/min, tmajor = 29.00 min, tminor = 32.68 min) showed 95 % ee. 
 
(–)-N-{1’-[3-(tert-Butyldimethylsilyloxy)phenyl]ethyl}-N-(4-methoxyphenyl)amine 
(492w), C21H31NO5Si, FW = 357.62 
HN
TBDMSO
OMe
492w
 
492w: yellowish oil; [α]D –2.1 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.16 (s 6H), 
0.98 (s, 9H), 1.49 (d, J = 6.7 Hz, 3H), 3.71 (s, 3H), 4.37 (d, J = 6.7 Hz, 3H), 6.46-6.50 (m, 
2H), 6.68-6.72 (m, 3H), 6.85 (br s, 1H), 6.96 (br d, J = 7.6 Hz, 1H), 7.18 (dd, J = 7.8, 7.7 
Hz, 1H); 13C NMR δ –4.39 (2 × CH3), 18.25 (C), 25.04 (CH3), 25.74 (3 × CH3), 54.08 
(CH3), 55.79 (CH3), 114.65 (2 × CH), 114.75 (2 × CH), 117.75 (CH), 118.49 (CH), 118.93 
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(CH), 129.54 (CH), 141.57 (C), 147.24 (C), 151.90 (C), 155.92 (C); IR ν 3406, 2957, 
2931, 2858, 1602, 1586, 1511, 1483, 1442, 1235 cm-1; MS (CI/isobutane) m/z (%) 358 
[(M+H)+, 100], 235 (8), 124 (8); HRMS (CI/isobutane) 358.2202 (C21H32NO2Si requires 
358.2200); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor 
= 9.21 min, tmajor = 10.65 min) showed 93 % ee. 
 
(–)-N-(4-Methoxyphenyl)-N-[(E)-3’-methyl-4’-phenylbut-3’-en-2’-yl]amine (492s), 
C18H21NO, FW = 267.40 
HN
492s OMe
 
492s: colourless oil; [α]D –63 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.41 (d, J = 
6.7 Hz, 3H), 1.86 (d, J = 1.3 Hz, 3H), 3.59 (br s, 1H), 3.75 (s, 3H), 3.94 (q, J = 6.6 Hz, 
1H), 6.58 (br s, 1H), 6.60-6.64 (m, 2H), 6.76-6.80 (m, 2H), 7.19-7.23 (m, 1H), 7.26-7.28 
(m, 2H), 7.31-7.35 (m, 2H); 13C NMR δ 13.78 (CH3), 21.57 (CH3), 55.80 (CH3), 57.67 
(CH), 114.57 (2 × CH), 114.80 (2 × CH), 125.10 (CH), 126.17 (CH), 128.07 (2 × CH), 
128.92 (2 × CH), 138.09 (C), 140.83 (C), 141.86 (CH), 151.91 (C); IR ν 3405, 3023, 2963, 
2930, 2831, 1511, 1442, 1234 cm-1; MS (CI/isobutane) m/z (%) 268 [(M+H)+, 45], 145 
(100), 124 (32), 85 (25); HRMS (CI/isobutane) 268.1701 (C18H22NO requires 268.1701); 
HPLC analysis (Chiralpak IB, hexane – propan-2-ol (98:2), 0.75 mL/min, tminor = 11.09 
min, tmajor = 12.76 min) showed 84 % ee. 
 
 
6.4.3. Racemic Amines   
 
(±)-N-(4-Methoxyphenyl)-N-[1’-(1”-methyl-1H-indol-3”-yl)ethyl]amine (488t), 
C18H20N2O, FW = 280.40 
N HN488t OMe
 
488t: pale yellow crystals; mp 96-97 ºC (hexane/CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 
1.63 (d, J = 6.6 Hz, 3H), 3.731 (s, 3H), 3.732 (s, 3H), 4.85 (q, J = 6.5 Hz, 1H), 6.59-6.63 
(m, 2H), 6.72-6.76 (m, 2H), 6.98 (br s, 1H), 7.12 (ddd, J = 6.9, 6.9, 1.1 Hz, 1H), 7.24 (ddd, 
J = 7.1, 6.9, 1.1 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 7.69 (d, J = 7.9 Hz, 1H); 13C NMR δ 
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22.88 (CH3), 32.75 (CH3), 47.35 (CH), 55.81 (CH3), 109.38 (CH), 114.64 (2 × CH), 
114.80 (2 × CH), 118.64 (C), 118.91 (CH), 119.38 (CH), 125.83 (CH), 126.34 (C), 137.41 
(C), 142.01 (C), 151.88 (C); IR ν 3406, 3005, 2962, 2832, 1509, 1467, 1371, 1232 cm-1; 
MS (EI) m/z (%) 280 (M˙+, 64), 273 (20), 159 (74), 158 (100), 157 (100), 156 (88), 143 
(50), 123 (100), 115 (93), 108 (100); HRMS (EI) 280.1577 (C18H20N2O requires 
280.1576). 
 
(±)-N-(4-Methoxyphenyl)-N-[1’-(1”-methylpyridinium-4”-yl)ethyl]amine iodide 
(488z), C15H19N2OI, FW = 370.26 
N
HN
I
488z
OMe
 
488z: brown oil; 1H NMR (400 MHz, CDCl3) δ 1.56 (d, J = 6.8 Hz, 3H), 3.67 (s, 3H), 4.42 
(br s, 3H), 4.62 (q, J = 6.8 Hz, 1H), 6.36-6.40 (m, 2H), 6.65-6.69 (m, 2H), 8.02 (d, J = 6.1 
Hz, 2H), 8.88 (d, J = 6.1 Hz, 2H). 
 
(±)-N-(4-Methoxyphenyl)-N-(3’,5’,5’-trimethylcyclohex-2’-enyl)amine (492l), 
C16H23NO, FW = 245.40 
HN
492l
OMe
 
492l: colourless oil; 1H NMR (400 MHz, CDCl3) δ 0.96 (s, 3H), 1.00 (s, 3H), 1.11 (dd, J = 
12.4, 10.1 Hz, 1H), 1.63-1.67 (m, 1H), 1.67 (d, J = 1.2 Hz, 2H), 1.82 (dddd, J = 12.4, 5.5, 
1.7, 1.2 Hz, 1H), 1.83-1.89 (m, 1H), 3.75 (s, 3H), 3.92-3.96 (m, 1H), 5.45 3.84 (q, J = 1.1 
Hz, 1H), 6.60-6.64 (m, 2H), 6.77-6.81 (m, 2H); 13C NMR δ 23.63 (CH3), 25.88 (CH3), 
30.74 (C), 31.54 (CH3), 43.15 (CH2), 44.32 (CH2), 49.40 (CH), 55.80 (CH3), 114.96 (2 × 
CH), 115.15 (2 × CH), 122.15 (CH), 135.34 (C), 141.70 (C), 152.08 (C); IR ν 3365, 2951, 
2868, 2828, 1510, 1464, 1264, 1232, 1179 cm-1; MS (EI) m/z (%) 245 (M˙+, 38), 123 
(100), 108 (20); HRMS (EI) 245.1776 (C16H23NO requires 245.1780). 
 
 
 
 
 
    204
(±)-N-[1’-(Ferrocen-1”yl)ethyl]-4-(methoxyphenyl)amine (492t), C19H21NOFe, FW = 
335.26   
Fe
HN OMe
492t
 
492t: yellow crystals; 1H NMR (400 MHz, CDCl3) δ 1.51 (d, J = 6.4 Hz, 3H), 3.62 (br s, 
1H), 3.78 (s, 3H), 4.13-4.16 (m, 2H), 4.18-4.22 (m, 1H), 4.21 (s, 5H), 4.23-4.24 (m, 1H), 
4.26 (q, J = 6.4 Hz, 1H), 6.63-6.67 (m, 2H), 6.80-6.84 (m, 2H); 13C NMR δ 21.17 (CH3), 
48.40 (CH), 55.86 (CH3), 66.16 (CH), 67.06 (CH), 67.49 (CH), 67.71 (CH), 68.43 (5 × 
CH), 93.80 (C), 114.95 (2 × CH), 115.02 (2 × CH), 141.89 (C), 152.09 (C); IR ν 3393, 
3092, 2969, 2930, 2831, 1510, 1463, 1294, 1233 cm-1; MS (EI) m/z (%) 335 (M˙+, 25), 213 
(100), 120 (30); HRMS (EI) 335.0970 (C19H21NO56Fe requires 335.0973). 
 
(±)-N-(4-Methoxyphenyl)-N-[(E)-4’-phenylpent-3’-en-2’-yl]amine (485), C17H21NO, 
FW = 267.40 
HN
485 OMe
 
A solution of methyllithium (22.5 mL, 36 mmol, 1.6 M in ether, 1.2 equiv) was added 
dropwise to a solution of aldimine 484 (7.54 g, 30.0 mmol, 1.0 equiv) in anhydrous THF 
(50 mL) at 0 ºC after which it was quenched with water (100 mL). The aqueous layer was 
extracted with ether (3 × 50 mL) and the combined organic layers were washed with brine 
(50 mL), dried over MgSO4 and evaporated. The residue was purified on a silica gel 
column (200 mL) with a solvent gradient from a mixture of petroleum ether – ethyl acetate 
(98:2) to (95:5) to afford the amine 485 (2.03 g, 7.59 mmol, 25 %): red thick oil; 1H NMR 
(400 MHz, CDCl3) δ 1.34 (d, J = 6.5 Hz, 3H), 2.14 (d, J = 1.3 Hz, 3H),  3.74 (s, 3H), 4.25 
(dq, J = 8.1, 6.6 Hz, 1H), 5.69 (dq, J = 8.3, 1.2 Hz, 1H), 6.58-6.62 (m, 2H), 6.74-6.78 (m, 
2H), 7.20-7.25 (m, 1H), 7.28-7.32 (m, 2H), 7.36-7.38 (m, 2H). 
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7. Applications in Synthesis of Alkaloids (I)  
 
7.1.  N-Acetylcolchinol and Other Allocholchicinoids  
 
7.1.1. Historical Overview229,230 and Biological Properties231,232 
 
The toxic effects of plant extracts from Colchicum autumnale have been known for 
two millennia – already ancient Greeks used the Colchicum extracts for treatment of gout, 
first described by Pedanius Dioscorides in De Materia Medica, 78 AD. The active species 
– colchicine 495 (Figure 7.1) – was isolated only in 19th century (1820) by two French 
chemists P. J. Pelletier and J. B. Caventou. It took another hundred years to determine 
the structure of colchicine, the main contributions are indebted to A. O. R. Windaus 
(1923), J. W. Cook (1940) and M. J. S. Dewar (1945). The biological properties, the anti-
tumour activity in particular, were of high interest after the observation of tumour growth 
inhibition (C. Dominici, 1932), followed by mechanistic explanations made by F. Lits 
(1934), A. P. Dustin (1934) and E. C. Amoroso (1935).  
 
NHAc
OR
MeO
MeO
OMe
NHAc
MeO
MeO
OMe
NHAc
COOMe
MeO
MeO
OMeOMe
O
(−)-495 
(−)-(aR,7S)-Colchicine
(−)-497: R = H 
(−)-(aR,7S)-N-Acetylcolchinol 
(−)-498: R = Me
(−)-(aR,7S)-N-Acetylcolchinol-methylether
(−)-499: R = P(O)(OH)2
(−)-(aR,7S)-N-Acetylcolchinol-phosphate
(−)-496
(−)-(aR,7S)-Allocolchicine
A
B
C A
B
CA
B
C
 
 
Figure 7.1. Colchicine and Family of Allocolchicinoid Alkaloids 
 
 However, after years of research, the high toxicity proved it clinically unusable 
and the attention turned to its close biphenyl-derived analogues called allocolchicinoids as 
allocholchicine 496, N-acetylcholchinol 497 and its methylether 498. These compounds 
contain six-membered aromatic C-ring instead of the seven-membered tropolone ring.   
The numbering of the allocolchicinoid structures is as follows (Figure 7.2), the 
oxygenated substituents on A-ring in positions 1, 2 and 3, and on ring-C in position 9; N-
acetamide of the ring-B in position 7; the bond of axial chirality is the 11a(11b) biaryl link.  
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NHAc
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MeO
MeO
OMe
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4a 7a
 
 
Figure 7.2. Numbering of Allocholchicinoids Structures 
 
The main mode of action of tumour regression when low doses of colchicine (or 
allocolchicinoids) are administered is binding to cytoskeletal protein tubulin and disruption 
of the tubulin-microtubule equilibrium (in microtubulin polymerisation) in the cell, thereby 
suppression of the mitosis and cell division. Methylether 498 has higher tubulin affinity 
and better stability than colchicine 495 and it serves as in vitro anti-tubulin standard. It is 
well accepted that the primary pharmacophore of these alkaloids is the ring-A – any 
alteration of the trioxygenated-phenyl moiety leads to compromised tubulin-binding 
ability. The biological activity of the C-ring varies with its size, position and substitution. 
The character of B-ring influences significantly the conformational mobility of the A-C-
biphenyl backbone and any change (e.g. five-, six- or eight-membered B-ring analogues) 
results in inability to affect the tubulin-binding. The natural (–)-(7S)-colchicine adopts 
(aR)-configuration and it is the only isomer active in the tubulin polymerisation process. 
Regarding the allocolchicinoids, in general, they are conformationally unstable, dominated 
by the (aR,7S)-atropoisomer. However, it is not clear whether the major (aR,7S)- or the 
minor (aS,7S)-isomer is the active species.  
 
N-Acetylcholchinol (NAC) has been tested successfully in vivo and its phosphate 
pro-drug 499 (Figure 7.1) has been used in clinical trials (Astra-Zeneca). Because of this 
pharmaceutical potential, in recent years, much attention has been dedicated to developing 
effective ways of obtaining NAC. Unfortunately, adverse blood vessels congestion has 
been observed in clinical trials and further development has ceased.230b  
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Scheme 7.1. Degradation of Colchicine to N-Acetylcolchinol 
 
 
In principle, the production methods are: 
 
-  low yielding extraction from North Indian lily Gloriosa superba,  
-  synthesis by degradation of natural (–)-colchicine230 (Scheme 7.1),  
-  synthesis from commercially available starting materials (Chapter 8.1.1).  
 
1.  One-step-degradation of colchicine to N-acetylcolchinol (in red):  
- treating colchicine with aqueous hydrogen peroxide offers NAC.  
 
2.  Two-step-degradation to N-acetylcolchinol:  
- oxidative ring-C contraction of colchiceine (500, in green) – a product of acidic 
hydrolysis of colchicine – with basic hydrogen peroxide leads to NAC in 
overall 20 % yield,   
-  reviewed original Windaus procedure (in blue) affords NAC in overall 79 % 
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yield by reaction of colchicine with sodium hypoiodite and subsequent 
reductive deiodination of 501.  
 
3.  Three-step-degradation to N-acetylcolchinol:  
- the contraction of ring-C can also be achieved by using methanolic methoxide 
or hydroxide affording allocolchicine (496, in pink) or allocolchiceine (503, in 
black), respectively, 
-  addition of methylithium to allocolchicine (496, in pink) gives tertiary alcohol 
502 which is then oxidised with hydrogen peroxide and rearranged under acidic 
conditions to NAC in overall 76 % yield,  
-  allocolchiceine (503, in black), can be converted to aniline 504 and its 
diazotisation with subsequent elimination leads to NAC in yield as low as 7 %.  
 
NHAc
OMe
O
1O2
NHAc
OMe
OOO
NHAc
OMe
MeO
MeO
OMe
80 %
(−)-498(−)-495 505
50 %
PPh3
(−)-497
K2CO3/MeI/Et4NF
 
 
Scheme 7.2. Degradation of Colchicine to N-Acetylcolchinol-methylether 
 
4.  Preparation of N-acetylcolchinol-methylether (Scheme 7.2):  
- singlet oxygen is used to form bridged 505 from colchicine  
-  triphenylphosphine-induced ring-C contraction affords N-acetylcolchinol-
methylether 498 in overall 40 % yield,  
-  methylation of NAC prepared by any of previously mentioned methods can be 
performed with methyliodide/potassium carbonate providing 498 in good yield.  
 
 
7.1.2. Syntheses of N-Acetylcolchinol and Closely Related Allocolchicinoids  
 
In principle, there are three synthetic approaches how to construct the 
dibenzocycloheptadiene tricyclic system:  
 
    210
-  cleavage of the B-ring of phenanthrene and recyclication to seven-membered ring, 
-  aldol condensation of two components and subsequent oxidative coupling of 
substituted diphenylpropane,  
-  metal-mediated coupling of two components and subsequent aldol condensation.  
 
MeO
MeO OMe
HOOC
OMe
508
A CA C
HOOC
MeO
MeO OMe
OMe
O
O2N
2 steps
63 %
+
506
507
 
 
Scheme 7.3. Synthesis of 2,3,4,7-Tetramethoxyphenanthroic Acid 
 
The first total synthesis was published in 1950 by Rapoport and Cisney.233 It was 
based on popular phenanthrene chemistry since the 9(10)-double bond was known to be 
oxidatively cleaved to highly functionalised biphenyl structures. Their synthesis started 
from 2,3,4,7-tetramethoxyphenanthoic acid 508 which was prepared in two steps from 
3,4,5-trimethoxyphenylacetic acid 506 and 2-nitro-5-methoxybenzaldehyde 507 (Scheme 
7.3).  
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OMe
MeO
MeO
OMe
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OMe
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NOH
76 %
CNHOOC
MeO
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Scheme 7.4. First Total Synthesis of N-Acetylcolchinol-methylether 
 
Phenanthroic acid 508 was derivatised in three steps to monoxime 509 and its 
Beckmann rearrangement afforded cyanoacid 510. Recyclisation of 510 was achieved in 
three steps leading to dibenzocycloheptadienone 511, an intermediate known from various 
degradation works. This classical synthesis provided racemic colchinol-methylether 512 in 
13 steps and 4.5 % overall yield (Scheme 7.4). Resolution of 512 with d-tartaric acid 
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afforded crystalline salt from which the free amine was released and acetylated to (–)-N-
acetylcolchinol-methylether 498. 
 
65 %
MeO
MeO OMe
OMe
O
OMe
MeO
MeO
OMe
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MeO
MeO OMe
OMe
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Me HO OHMe
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1. Pb(OAc)4
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511 A C
 
 
Scheme 7.5. Alternative Synthesis of N-Acetylcolchinol-methylether 
 
Under competitive conditions, Cook234 published a similar synthesis, using 2,3,4,7-
tetramethoxy-9-methylphenanthrene derivative 513 as the crucial precursor (Scheme 7.5). 
This aromatic compound was dihydroxylated on the reactive 9(10)-double bond. The 
resulting dialcohol 514 was cleaved with lead tetraacetate and recyclised under acidic 
conditions to conjugated ketone 515 which was hydrogenated over Pd-black to above-
mentioned dibenzocycloheptadienone 511.  
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Scheme 7.6. First Total Synthesis of N-Acetylcolchinol 
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The first total synthesis of NAC235 appeared 37(!) years later and it approached the 
construction of tricyclic core in very different way (Scheme 7.6). Addition of 3-(tert-
butyldimethylsilyloxy)phenylmagensium bromide to 3,4,5-trimethoxyphenylpropanal 
(prepared from corresponding acid 516) afforded racemic 1,3-diphenylpropanol 517 which 
was converted to acetamide 518 in three steps and 48 % yield. Non-phenolic oxidative 
coupling of precursor 518 gave racemic N-acetylcolchinol.  
 
The Sawyer’s synthesis was very effective – short (six steps) and the high yielding 
(26 % overall). The only drawback was the use of toxic Tl3+ salt for the oxidative biaryl 
coupling. Due to the toxicity of thallium, other coupling reagents have been tried since 
then. Racemic colchicine and two members from allocolchicinoid family (salimine 526) 
and jerusalemine 527, isolated from Colchicum decaisnei) have been synthesised236 using 
lead tetraacetate for the crucial step of oxidative mono-phenolic coupling (Scheme 7.7).  
 
AMeO
R1O OMe
519: R1 = Me
520: R1 = TBDMS
B
NHR3
OH
R1O
MeO
OMe
A C
OMe
R1O
MeO OH
OHO
OBn
OMe
O
+ C
521
3 steps
70-85 % OMe
522: R1 = Me
523: R1 = TBDMS
1. Pb(OAc)4
2. TFA
42-54 %
O
OH
R1O
MeO
OMe OMe
524: R1 = Me
525: R1 = TBDMS
526: R1 = Me, R1 = COOH, R3 = Ac (0.3 %)
527: R1 = H, R1 = OH , R3 = Me (34 %)
7 steps
R2
 
 
Scheme 7.7. Total Syntheses of Salimine and Jerusalemine 
 
The coupling precursor of Banwell’s synthesis were the 1,3-diphenylpropanes 522 
and 523 which were subjected to Umezawa cyclisation with reagent sequence of lead 
tetraacetate/trifluoroacetic acid. Resulting ketones 524 or 525 were converted to the final 
products in additional seven steps. However, the overall yield differed significantly for 
salimine 526 (0.3 %) and jerusalemine 527 (34 %).  
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Scheme 7.8. Total Synthesis of (–)-Allocolchicine by Diels-Alder Reaction 
 
A very original approach was adopted by Wulff et al.232 employing Diels-Alder 
reaction for constructing the ring-C around the A-B-framework (Scheme 7.8). The starting 
material was benzosuberone 528 which was derivatised to bicyclic Diels-Alder diene 529. 
The Diels-Alder reaction, using methyl propiolate as dienophile, afforded the tricyclic core 
in correct regiochemistry and its rearomatisation with DDQ led to 530. A series of 
deprotection and oxidation-reduction steps on the C-7 oxygen functionality led to the 
desired natural (–)-allocolchicine 496. The only stereocentre was set up by reduction of 
corresponding C-7 ketone with (+)-TarB-NO2/LiBH4 in 91 % ee.  
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Scheme 7.9. Syntheses of Allocolchicinoids by Direct Arylation 
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Another novel approach for synthesis of allocolchicinoids exploited several 
palladium-catalysed reactions (Scheme 7.9),237 starting with a coupling of 3-(3’,4’,5’-
trimethoxyphenyl)propyne 531 and acid chlorides 532 or 533. The resulting ketone was 
enantioselectively reduced with (S)-pinene/9-BBN in 97 % ee followed by a short 
sequence, including Pd-catalysed carboxylation (R2 substituent). The formed intermediates 
534 or 535 were cyclised by direct arylation method to 536/537 in overall 39 % yield. 
Unnatural allo-analogue 538 was prepared in three steps and 86 % yield from 537.  
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Scheme 7.10. First Enantioselective Synthesis of (–)-N-Acetylcolchinol 
 
Wu and Chong238 have used their own enantioselective protocol of alkynylation of 
N-acetylaldimines (formed in situ from aldehyde as 539) to form the stereogenic centre in 
enantioenriched diphenylpropyne 540 (72 % yield, 94 % ee) which was hydrogenated to 
known precursor (–)-518 (Scheme 7.10). Sawyer’s Tl3+-mediated oxidative coupling 
afforded cyclised (–)-N-acetylcolchinol 497 in 53 % yield. This synthesis featured only 
three separate synthetic steps and 38 % overall yield.  
 
In co-operation with Astra-Zeneca, Kocienski and Boyle230 have published several 
syntheses of NAC, three of them based on Sawyer’s synthesis (however, employing IIII-
based oxidant)230a and one based on metal-catalysed aryl coupling.230b The first synthesis 
(Scheme 7.11) starts with sequence of aldol condensation of 519 and 462 and 
hydrogenation of the chalcone product. The resulting saturated ketone was reduced 
enantioselectively in 92 % ee using Noyori’s hydrogenation protocol to afford the alcohol 
(+)-517 which was converted to azide (–)-541 by Mitsunobu reaction. Hydrogenation of (–
    215
)-541 and acetylation of the free amine gave the enantioenriched (–)-518 which was 
cyclised to (–)-NAC either with thallium tris(trifluoroacetate) in 31 % yield (in contrast to 
Sawyer’s 71 %) or with phenyliodonium bis(trifluoroacetate) (PIFA) in 50 % yield.  
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Scheme 7.11. Enantioselective Synthesis of (–)-N-Acetylcolchinol 
 
An alternative way of preparing alcohol (+)-517 (Scheme 7.12) utilised 
stereospecific Matteson-type [1,2]-metallate rearrangement of an α-
(carbamoyloxy)alkylboronate (+)-543, which was synthesised from alcohol 542 in 2 steps.  
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Scheme 7.12. Alternative Route for Synthesis of Alcohol 517 
 
Their third synthesis (Scheme 7.13) exploited addition of a Grignard reagent onto 
chiral tert-butylsulfinyl aldimine (+)-545 (made from the corresponding aldehyde 544). 
The major diastereomer of tert-butylsulfinyl amine 546 was obtained in 88 % de and series 
of protection-deprotection steps then provided the acetamide (–)-518 which was cyclised 
as stated previously.  
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Scheme 7.13. Enantioselective Synthesis of (–)-N-Acetylcolchinol 
 
The following two syntheses have applied a complementary approach of 
constructing the biaryl backbone by means of metal-catalysed or metal-mediated coupling 
reactions and successive cyclisation providing the seven-membered ring-B.  
 
OMe
Br
O
A
B(OH)2MeO
MeO
OMe
C
547 548
+
5 steps
59 %
MeO
MeO
MeO 549
OMe
AcO
Co2(CO)6
1. BF3.OEt2
2. Et3SiH
3. TFA (71 %)
B
OH
MeO
MeO
OMe
A C OMe
MeO
MeO
OMe 550
OMe
2 steps
77 %
(−)-498
(+)-551
3 steps
56 %
 
 
Scheme 7.14. Enantioselective Synthesis of (–)-N-Acetylcolchinol-methylether 
 
In the synthesis of Djurdjevic and Green239 (Scheme 7.14), the Suzuki-Miyaura 
coupling partners 547 and 548 afforded a biaryl which was derivatised further to the 
cobalt-coordinated cyclisation precursor 549. The cyclisation mediated by a Lewis acid 
(boron trifluoride etherate) afforded dibenzocycloheptadienyne coordinated with 
hexacarbonyldicoblalt which was decomplexed by hydrosilylation-acidic desilylation 
method to 550. Dibenzosuberone 550 was hydroborated and oxidised to the C-7 ketone 
511 which was enantioselectively reduced to alcohol (+)-551 with (+)-TarB-NO2/LiBH4 in 
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95 % ee. Mitsunobu reaction, reduction of the azide and acetylation of the free amine 
provided N-acetylcolchinol-methylether 498. The overall yield of this 11-step synthesis 
was 18 %.  
 
519 462
2 steps
84 %
MeO
MeO
OMe
552
NCy
Br
OBn
Br
553
3 steps
59 %
OO
 
 
Scheme 7.15. Precursors for Astra-Zeneca’s Synthesis of (–)-NAC 
 
Astra-Zeneca has been involved in the development of a pro-drug (–)-499, a 
phosphate of (–)-NAC240 (Scheme 7.16). Their approach employed Ullmann cyclisation of 
precursors 552 and 553 (Scheme 7.15) to biaryl 554 which on ketal-deprotection 
condensed to unsaturated ketone 555 (a 9-benzyloxy analogue of 515, Scheme 7.5). 
Ketone 555 was converted in three steps to enamine 556, a substrate for enantioselective 
hydrogenation over ruthenium/(S)-iso-propyl-ferroTANE catalyst to afford (–)-NAC. The 
linear sequence of seven steps provided the (–)-497 in 32 %.  
 
552 OBn
554 1. HCl
2. K2CO3
1. n-BuLi/CuBr.P(OEt3)
2. 553
3. AcOH
77 %
O
MeO
MeO OMe
O
O
91 %
MeO
MeO
OMe 555
OBn
O
B
A C
3 steps
46 %
MeO
MeO
OMe 556
OH
NHAc
(−)-497
A C
[red] = (S)-i-Pr-FerroTANE/Ru(methallyl)2, H2
100 %
[red]
 
 
Scheme 7.16. Synthesis of (–)-NAC from Astra-Zeneca 
 
A modification of this synthesis was published by Kocienski and Boyle230c 
(Scheme 7.17) who utilised palladium-catalysed Suzuki-Miyaura coupling instead of the 
copper-mediated Ullmann reaction. The resulting biaryl 558 was cyclised in basic 
conditions to 555 which was transformed to alcohol (+)-559 in 98 % ee (a 9-benzyloxy 
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analogue of (+)-551, Scheme 7.14). (+)-559 was converted to (–)-497 in similar fashion as 
was (+)-551. The length (11 steps) of the synthesis caused drop of the overall yield to 22 % 
in comparison to the synthesis of Astra-Zeneca. 
 
(−)-497
MeO
MeO
OMe
557
3 steps
85 % B(OH)2
519
OBn
55852 %
O
MeO
MeO OMe
A
C
O Pd(PPh3)4/Na2CO3
OBn
O O
MeO
MeO
OMe (+)-559
OBn
OH
555
K2CO3 (68 %)
4 steps
89 %
2 steps
81 %
 
 
Scheme 7.17. Alternative Synthesis of (–)-NAC 
 
 
 
 
7.2. Our Synthesis of N-Acetylcolchinol  
 
7.2.1. Synthesis of Precursors, Imine and Its Reduction to Amine 
 
As it was previously explained, N-acetylcolchinol is a biologically active 
compound with useful anti-tumour activity. Our synthesis of this molecule is based on the 
synthesis of an appropriate imine (Scheme 7.18) which can be organocatalytically reduced 
with trichlorosilane according to our method.  
 
(−)-497
NH2
TBDMSO
OMe
OMe
OMe
NPMP
TBDMSO
OMe
OMe
OMe
560 561
462 + 519
 
 
Scheme 7.18. Retrosynthetic Analysis 
 
    219
The beginning of the synthesis (Scheme 7.19) was carried out according to known 
procedures. The core was constructed in the first step by sodium methoxide-catalysed aldol 
condensation of 3,4,5-trimethoxybenzaldehyde 519 and 3-hydroxyacetophenone 462. This 
step afforded chalcone 562 which needed to be hydrogenated to saturated ketone 563. 
 
O
OMe
OMe
HO
OMe
O
OMe
OMe
TBDMSO
OMe
TBDMSCl
Et3N/DMAP
THF
r.t., overnight
563 (90 %)564 (93 %)
O
OMe
OMe
HO
OMe
NaOMe
MeOH
r.t., 3 d
562 (96 %)
462 + 519
[(PPh3)3Rh]Cl /H2
AcOEt/MeOH
r.t., 3 d
 
 
Scheme 7.19. Synthesis of Ketone for Imination 
 
Literature230 describes hydrogenation on PtO2 affording 563 in 85 % yield. 
However, with attempted methods of heterogenous hydrogenation over different palladium 
or platinum catalysts (Table 7.1), a mixture of ketone 563 (not more than 70 % content) 
and over-hydrogenated saturated alcohol 565 (Figure 7.3) was produced when 
disappearance of starting material was detected. Homogenous hydrogenation over 
Wilkinson catalyst proved to be more efficient, affording 563 selectively in 90 % isolated 
yield.  
 
Table 7.1. Hydrogenation of chalcone 562  
 
Catalyst / H2 balloon 10 % Pd/carbon 
(2.4 % Pd) 
PtO2 
(2.0 % Pt) 
10 % Pt/active coal 
(2.4 % Pt) 
Wilkinson  
(5 % Rh) 
563:565 ratio  1:1 2:1 5:3 < 95 :5 
 
OH
OMe
OMe
HO
OMe565
 
 
Figure 7.3. Over-hydrogenated Product 
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The subsequent step of silylation of the phenol moiety was performed according to 
literature171 and afforded the ketone 564 in 93 % yield; 80 % over 3 steps. Imination 
proceeded smoothly in agreement with previous model of imine 476w. Standard reaction 
time of 18 h afforded the desired imine 561 only in ~ 50 % yield; however, prolonged time 
to 36 h improved the yield to 78 % (Scheme 7.20).  
 
564
HN
OMe
OMe
TBDMSO
OMe
OMe
benzene, 
reflux, 36 h
561
(78 %)
H2N OMe
p-TsOH
toluene, 
r.t., 18 h
Sigamide (5 %)
HSiCl3 (2 eq)
(−)-(S)-566
(69 %, 96 % ee)
 
 
Scheme 7.20. Synthesis of Amine Intermediate 
 
The reduction of imine 561 followed the expectations and enantioenriched amine 
566 was obtained in moderate yield (69 %) and excellent enantioselectivity (96 % ee), 43 
% yield after 5 steps. Attempts to crystallise this amine for X-ray analysis failed, however, 
according to the broad library of amines synthesised previously, the anticipated absolute 
configuration was (S).  
 
 
7.2.2. Amine Deprotection and Oxidative Coupling   
 
Obtaining the amine 566 successfully provided two possible synthetic approaches 
towards the advanced stages of synthesis of colchinol (Scheme 7.21). The first one was a 
novel route by performing phenolic or non-phenolic coupling on the amine intermediate 
566, also expecting that the oxidative conditions would deprotect the para-methoxyphenyl 
group from nitrogen. A straightforward, but somewhat lengthy sequence of deprotection of 
the PMP-group and carrying out the synthesis as in previously published works230 was kept 
as a back-up method.  
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566
H2N
RO
OMe
OMe
MeO
NH2
OMe
OMe
RO
OMe569568
 
 
Scheme 7.21. Two Possible Synthetic Routes 
 
The non-phenolic oxidative coupling was trialled on amine 566 (Scheme 7.22), 
even if there was no literature precedent for a coupling of a substrate containing secondary 
amino-group. Different oxidants were used according to the literature procedures. Attempts 
of coupling with ruthenium(IV)241 or molybdenum(V)242 resulted in no coupling reaction 
and only provided the deprotected phenol 570. On the other hand, vandium(V)243 and 
standard BF3-activated PIFA were too reactive and tar material was obtained. The 
alternative reagent, heteropolyacid-activated PIFA,244 did mediate a reaction, however 
according to 1H NMR, no coupled product was obtained.   
 
HN
HO
PMP
570 (97 %)
[coupling e.]
[coupling c. and d.][coupling a. and b.]
tar
unknown, no coupled product obtained
566
OMe
OMe
OMe
[coupling]:
a. RuO2 (2.0 equiv), BF3.OEt2 (2 eq), CH2Cl2/TFA/TFAA, r.t., 24 h
b. MoCl5 (1.9 or 3.2 equiv), TiCl4 (1.9 or 3.2 equiv), CH2Cl2, 0-20 °C, 16 h
c. VOCl3 (2.5 equiv), CH2Cl2 or ether, −80 °C to r.t., 5 h
d. PIFA (1.2 equiv),  BF3.OEt2 (2 eq), CH2Cl2/TFA/TFAA, −5 °C to r.t., 5 h
e. PIFA (1.0 equiv), PMA (1.0 eq), MeCN, −10 °C to r.t., 1.5 h
 
 
Scheme 7.22. Attempts of Oxidative Coupling of Amine 566 
 
The N-acetamide 571 was prepared from 566 by standard acetylation procedure in 
virtually quantitative yield (Scheme 7.23). The same coupling procedure with 
ruthenium(IV) was applied on this substrate. The result was very similar to the previous 
case, only desilylated phenol 572 was recovered. This phenol was subjected to 
molybdenum(V) and vanadium(V)-mediated coupling conditions, again leading to similar 
results as before. This synthetic approach was left due to probable problems with removal 
of PMP-group, even if the coupling did afford the desired product.  
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NPMP
TBDMSO
Ac
571 (98 %) [coupling a.]
tar
[coupling b.]recovered
572
[coupling c.]
566
OMe
OMe
OMe
NPMP
HO
Ac
572 (85 %)
OMe
OMe
OMe
[acetylation]: 
a. Ac2O (10 eq), pyridine (20 eq)
   benzene, r.t., 60 h
b. AcCl (2.4 equiv), Et3N (3.0 eq)
   CHCl3, reflux, 15 min
[acetylation a. or b]
 
 
Scheme 7.23. Attempts of Oxidative Coupling of Acetamide 571 
 
The PMP-deprotection reaction was carried out using established methods with 
cerium(IV)-ammonium nitrate (CAN)245 or trichlorocyanuric acid (TCCA)246 (Scheme 
7.24). Despite some variation of conditions, i.e. change of amount of the oxidant and/or 
solvent system, they failed to produce the free amine and only small quantities of tar 
material were isolated (Table 7.2).  
 
Table 7.2. Deprotection of PMP-group of Amine 566 
 
Oxidant Temp., Time Additives, Solvents Product  
TCCA (0.5 equiv) r.t., 75 min 1M H2SO4, MeCN / H2O (1:1) tar 
CAN (4 equiv) 0 ºC, 4 h MeCN / H2O (4:1) tar 
CAN (2 equiv) r.t., 4 h  MeOH / H2O (1:1)  tar 
 
Partial success was achieved with less active periodic acid.246 However, this 
method afforded the free amino alcohol 573 in extremely variable yields! Unfavourable 
outcome of biaryl couplings and other deprotection methods has led us to optimisation of 
the reaction conditions rather than trying more deprotection reagents (Table 7.3). The 
reproduction of literature procedure246 (run 1) afforded the free amine 573 in 38 % yield. 
Increasing the content of acetonitrile and keeping the temperature under 16 ºC seemed to 
improve the yield (run 2). Decreasing the amount of sulfuric acid or not adding it at all, 
caused faster side reactions and isolation of only traces of the desired product (runs 4 to 6). 
On contrary, higher content of acid appeared to be beneficial (runs 7 and 8).   
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[deprotection a. or b.]
tar
[deprotection]: 
a. TCCA (0.5-1 eq), 1M H2SO4, MeCN/H2O, r.t., 1.5 h
b. CAN (2-4 eq), MeOH/H2O, 0-20 °C, 1.5-4 h
c. H5IO6 (1 eq), 1M H2SO4, MeCN/H2O, 0-20 °C, 6 h
[deprotection c.]
566
NH2
HO
573 (0-74 %)
OMe
OMe
OMe
 
 
Scheme 7.24. Attempts of Deprotection of the PMP-group from amine 566 
 
 
From the results of these experiments, it could be concluded that important features 
of this oxidative deprotection reaction were acidity of the aqueous acetonitrile, reaction 
temperature and work-up:  
 
-  the cleanliness of the reaction benefited from higher content of acid (H2SO4),  
-  lowered temperature to 12-16 ºC had also positive impact; however, temperature 
close to 0 ºC significantly slowed down the deprotection reaction, and higher 
temperature (~ 20 ºC) caused faster decomposition of the substrate (presumably by 
over-oxidation at other sites of the electron rich aryl rings or free phenol),   
-  pH of the work-up – extraction from aqueous phase must have been done at pH 8, 
as the amino alcohol 573 is well soluble in acidic or basic aqueous layer.  
 
Table 7.3. Deprotection of PMP-amine 566 (0.033 M solution) with Periodic Acid (H5IO4, 1 equiv) 
 
Run 1M H2SO4  Time, Temp. Solvents  Product 
1 1 mL  overnight, r.t. MeCN / H2O (1:1) 573 (38 %) 
2 1 mL  1h at 0 ºC then 3 h at 16 ºC MeCN / H2O (2:1) 573 (74 %) 
3 1 mL  2h at 0 ºC then 3 h at 18 ºC MeCN / H2O (2:1) tar 
4 - SM disappearance,  
200 min at 16 ºC 
MeCN / H2O (2:1) tar 
5 0.1 mL  SM disappearance,  
3 h at 16 ºC 
MeCN / H2O (2:1) tar + 566 in acid washes 
6 2 mL  SM disappearance,  
6.5 h at 16 ºC 
MeCN / H2O (2.5:1) 573 (trace) 
7 10 mL  SM disappearance,  
2.5 h at 16 ºC 
MeCN  
 
573 (trace) + 570 in acid 
washes 
8 10 mL completion, 5 h at 16 ºC MeCN  573 (69 % overall) 
 
These observations helped to develop the improved procedure that is as follows: the 
0.033 M concentration of the substrate 566 was kept by using two-components solvent 
system of acetonitrile and 1M sulfuric acid in 2:1 (V/V) ratio while the temperature was 
held between 12-16 ºC. These modifications increased the reliability of the deprotection; 
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however, the yields stayed mediocre (47 % in average) and the reaction time varied (Table 
7.4).   
 
Table 7.4. Deprotection of PMP-group of Amine 566 with Periodic Acid (1 equiv) 
 
Amine   Time, Temp. Product 
566 6 h at 14-16 ºC 573 (41 %) 
566  5 h at 11 ºC 573 (63 %) 
566  20 h at 9-15 ºC 573 (27 %) 
(–)-566 5 h at 11 ºC (–)-573 (63 %) 
(–)-566 9 h at 12-16 ºC (–)-573 (42 %) 
 
Having obtained the free amine, O-resilylation and N-acetylation was required to 
reach the known intermediate 518 for the iodine(III)-mediated oxidative coupling (Scheme 
7.25). In parallel, amido ester 574 was also synthesised as it was reported230 to be a 
suitable substrate for the coupling and it would have saved some protection steps. 
Unfortunately, the coupling of this substrate yielded tar material. Therefore, amino alcohol 
573 was protected as silylether 560. Interestingly, resilylation171 using triethylamine as a 
base and mopping reagent did not proceed to completion and 1:1 mixture was obtained 
even if 2.5 equivalents of the silicon source was used. Applying another common silylation 
procedure230 with imidazole base solved this inconvenience.  
 
NHAc
AcO
574 (80 %)
[silylation 
a. or b.]
NH2
TBDMSO
tar
[acetylation a.]
[acetylation a.]
[coupling d.]
[coupling d.]
(−)-497
(45 %)
[acetylation]: 
a. Ac2O (10-20 eq), pyridine (excess), benzene, r.t., 5 h
[silylation]: 
a. TBDMSCl (2.2 eq), Et3N (3.0 eq), DMAP (5 %), THF, r.t., 16 h
b. TBDMSCl (2.4 eq), imidazole (5 eq), CH2Cl2, r.t., 16 h
[coupling]:
d. PIFA (1.2 equiv),  BF3.OEt2 (2 eq), CH2Cl2/TFA/TFAA, −5 °C to r.t., 5 h
OMe
OMe
OMe
OMe
OMe
OMe
(−)-518
(91-96 %)
(−)-560
(51-86 %)
573
(+)-573
 
 
Scheme 7.25. Synthesis of NAC from amine 573 
 
Acetylation of the silylether 560 afforded the crucial coupling substrate 518 
(Scheme 7.25), also known from literature. The coupling itself was a reproduction of 
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Kocienski et al.230 method using phenyliodonium bis(trifluoroacetate) and it proceeded as 
described. However, the purification was more laborious as crystallisation was not feasible 
in our scale (30 mg), the yield was 45 % (compared to published 53 %). 
 
 
7.2.3. Conclusions   
 
The optical rotation of the coupling product was in very good agreement with 
literature sources,229,230,238 therefore we can assume that the natural occurring (–)-N-
acetylcolchinol was successfully prepared, in 9-step linear sequence and 7 % overall yield.  
 
 
 
7.3. Experimental Part (I)  
 
 
(E)-1-(3’-Hydroxyphenyl)-3-(3”,4”,5”-trimethoxyphenyl)prop-2-en-1-one (562), 
C18H18O5, FW = 314.36 
O
OMe
OMe
HO
OMeC147
 
A solution of 3,4,5-trimethoxybenzaldehyde (9.81 g, 50.0 mmol, 1 equiv) was added drop-
wise to a solution of freshly prepared MeONa in MeOH (2.0 M, 100 mL) at 0 ºC and 3-
hydroxyacetophenone (6.81 g, 50.0 mmol, 1 equiv) in anhydrous MeOH (100 mL) over 1 
h.230 The resulting solution was let to stir at ambient temperature for 60 h. The solvent was 
then removed in vacuo and the residue was dissolved in water (150 mL). The basic 
aqueous layer (pH 12) was washed with Et2O (3 × 40 mL) and acidified by addition of 
conc. HCl to pH 1. The precipitate was filtered, thoroughly washed with water and dried 
under reduced pressure to obtain chalcone 562230 (15.2 g, 48.3 mmol, 96 %) which was 
used without further purification: yellow crystals; mp 150-151 ºC (AcOEt), [lit.230 177-
178.5 ºC (EtOH-water), lit.247 173-174 ºC (EtOH)]; 1H NMR (400 MHz, CDCl3) δ 3.91 (s, 
3H), 3.92 (s, 6H), 6.17 (br s, 1H), 6.86 (s, 2H), 7.11 (ddd, J = 8.1, 2.6, 0.9 Hz, 1H), 7.39 
(dd, J = 7.9, 7.8 Hz, 1H), 7.38 (d, J = 15.6 Hz, 1H), 7.57-7.60 (m, 2H), 7.73 (d, J = 15.6, 
1H); 13C NMR δ 56.26 (2 × CH3), 61.08 (CH3), 105.72 (2 × CH), 115.18 (CH), 120.29 
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(CH), 120.98 (CH), 121.27 (CH), 129.94 (CH), 130.28 (C), 139.67 (C), 140.49 (C), 145.53 
(CH), 153.49 (2 × C), 156.36 (C), 190.55 (C); IR ν 3020, 1650, 1576, 1459, 1504, 1418, 
1287, 1215 cm-1; MS (CI/isobutane) m/z (%) 315 [(M+H)+, 13], 113 (34), 97 (28), 95 (42), 
93 (28), 85 (78); HRMS (CI/isobutane) 315.1234 (C18H19O5 requires 315.1232). 
 
1-(3’-Hydroxyphenyl)-3-(3”,4”,5”-trimethoxyphenyl)propan-1-one (563), C18H20O5, 
FW = 316.38 
O
OMe
OMe
HO
OMe563
 
A solution of Wilkinson catalyst (97 mg, 0.100 mmol, 5 mol %) and chalcone 562 (629 
mg, 2.00 mmol, 1 equiv) in an ethyl acetate (20 mL) – methanol (2 mL) mixture was 
placed under an atmosphere of H2 (balloon). The reaction was monitored by TLC and 
when the starting material was consumed (ca 70 h) the mixture was concentrated in vacuo. 
The residue was dissolved in ethyl acetate and the resulting suspension was filtered 
through a Celite pad and washed with ethyl acetate. The filtrate was evaporated to afford 
563 as a crystalline residue (573 mg, 1.81 mmol, 90 %), which was used without further 
purification: white crystals; mp 119-120 ºC (hexane);  1H NMR (400 MHz, CDCl3) δ 
2.98-3.02 (m, 2H), 3.25-3.29 (m, 2H), 3.82 (s, 3H), 3.83 (s, 6H), 6.24 (br s, 1H), 6.45 (s, 
2H), 7.11 (ddd, J = 8.1, 2.6, 0.9 Hz, 1H), 7.39 (ddd, J = 8.1, 7.7, 0.7 Hz, 1H), 7.49-7.52 
(m, 2H); 13C NMR δ 30.63 (CH2), 40.70 (CH2), 55.09 (2 × CH3), 60.91 (CH3), 105.34 (2 × 
CH), 114.59 (CH), 120.51 (CH), 120.65 (CH), 129.95 (CH), 136.15 (C), 137.08 (C), 
138.20 (C), 153.18 (2 × C), 156.44 (C), 199.82 (C); IR ν 2942, 1684, 1592, 1508, 1450, 
1421, 1216 cm-1; MS (EI) m/z (%) 316 (M˙+, 93), 302 (13), 195 (100), 181 (75), 121 (70), 
94 (38), 84 (33); HRMS (EI) 316.1310 (C18H20O5 requires 316.1311.  
 
1-[3’-(tert-Butyldimethylsilyloxy)phenyl]-3-(3”,4”,5”-trimethoxyphenyl)propan-1-one 
(564), C24H34O5Si, FW = 430.67 
O
OMe
OMe
TBDMSO
OMe564
 
A solution of tert-butyldimethylsilyl chloride (1.64 g, 10.8 mmol, 1.3 equiv) in anhydrous 
THF (4 mL) was added to a mixture of ketone 563 (2.64 g, 8.34 mmol), triethylamine 
(2.52 mL, 1.60 g, 16.7 mmol, 2.0 equiv) and 4-(N,N-dimethylamino)pyridine (102 mg, 
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0.830 mmol, 5 mol%) in THF (9 mL) at 0 ºC.171 The mixture was let to warm to room 
temperature and to stir overnight. The reaction was quenched with a saturated NH4Cl 
solution (80 mL) and the aqueous layer was extracted with ether (2 × 80 mL). The 
combined organic layers were dried over MgSO4 and evaporated to afford 564 (3.35 g, 
7.77 mmol, 93%) which was used in the next step without further purification: colourless 
oil which solidified upon standing; mp 66-67 ºC (hexane); 1H NMR (400 MHz, CDCl3) δ 
0.20 (s, 6H), 0.98 (s, 9H), 2.97-3.01 (m, 2H), 3.23-3.27 (m, 2H), 3.81 (s, 3H), 3.83 (s, 6H), 
6.45 (s, 2H), 7.02 (ddd, J = 8.1, 2.5, 1.0 Hz, 1H), 7.30 (dd, J = 8.0, 7.8 Hz, 1H), 7.41 (dd, J 
= 2.1, 1.8 Hz, 1H), 7.53 (dd, J = 7.8, 1.6 Hz, 1H), 7.49-7.52 (m, 2H); 13C NMR δ –4.42 (2 
× CH3), 18.19 (C), 25.64 (3 × CH3), 30.65 (CH2), 40.69 (CH2), 56.05 (2 × CH3), 60.84 
(CH3), 105.30 (2 × CH), 119.28 (CH), 121.19 (CH), 124.96 (CH), 129.62 (CH), 136.24 
(C), 137.13 (C), 138.32 (C), 153.19 (2 × C), 156.01 (C), 199.01 (C); IR ν 2955, 2932, 
2858, 1686, 1590, 1508, 1461, 1434, 1284, 1252, 1129 cm-1; MS (CI/isobutane) m/z (%) 
431 [(M+H)+, 70], 251 (13), 133 (82); HRMS (CI/isobutane) 431.2252 (C24H35O5Si 
requires 431.2254). 
 
(E)-N-{1’-[3”-(tert-Butyldimethylsilyloxy)phenyl]-3’-(3’”,4’”,5’”-
trimethoxyphenyl)prop-1’-ylidene}-4-methoxyaniline (561), C31H41NO5Si, FW = 
535.82 
N
OMe
OMe
TBDMSO
OMe561
OMe
 
561 prepared according general procedure for imination, Method A: yellow crystals; mp 
76-77 ºC (hexane); 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 5:1, 
the minor one is marked *) δ 0.01* (s, 1.2H), 0.24 (s, 6H), 0.90* (s, 1.8H), 1.01 (s, 9H), 
2.70 (dd, J = 8.0, 7.2 Hz, 2H), 2.91-3.00 (m, 2.4H), 3.02-3.07* (m, 0.4H),  3.70* (s, 0.6H), 
3.74 (s, 6H), 3.78 (s, 3H), 3.81 (s, 3H), 3.830-3.833* (m, 1.8H), 6.08 (s, 2H), 6.44-6.48 (m, 
2.4H), 6.54-6.58* (m, 0.4H), 6.62-6.74* (m, 1.0H), 6.81-6.85 (m, 2H), 6.96 (ddd, J = 8.0, 
2.4, 0.9 Hz, 1H), 7.12* (dd, J = 8.0, 7.7 Hz, 0.2H), 7.33 (dd, J = 8.0, 7.9 Hz, 1H), 7.40 (dd, 
J = 2.0, 2.0 Hz, 1H), 7.51 (ddd, J = 7.8, 1.5, 1.0 Hz, 1H); 13C NMR δ –4.60* (2 × CH3), –
4.28 (2 × CH3), 18.14* (C), 18.24 (C), 25.61* (3 × CH3), 25.68 (3 × CH3), 32.26 (CH2), 
33.10* (CH2), 34.34 (CH2), 43.04* (CH2), 55.27* (CH3), 55.44 (CH3), 55.93 (2 × CH3), 
56.04* (2 × CH3), 60.88 (2 × CH3), 105.16 (2 × CH), 105.38* (2 × CH), 113.94* (2 × CH), 
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114.02 (2 × CH), 119.32 (CH), 119.81* (CH), 120.21 (2 × CH), 120.50* (CH), 120.74 
(CH), 120.87* (CH), 121.96 (CH), 122.12* (2 × CH), 129.46* (CH), 129.56 (CH), 
136.10* (C), 136.30 (C), 136.28 (C), 137.29* (C), 139.19* (C), 140.11 (C), 143.78* (C), 
144.59 (C), 153.09 (4 × C), 155.36* (C), 155.73 (C), 155.83* (C), 155.95 (C), 169.11 (C), 
170.74* (C); IR ν 2954, 2932, 2858, 1624, 1590, 1503, 1462, 1423, 1240, 1128 cm-1; MS 
(+FAB) m/z (%) 536 [(M+H)+, 100], 535 (75), 340 (20), 181 (70); HRMS (+FAB) 
536.2830 (C31H42O5NSi requires 536.2832). 
 
(–)-N-{1’-[3”-(tert-Butyldimethylsilyloxy)phenyl]-3’-(3’”,4’”,5’”-
trimethoxyphenyl)prop-1’-yl}-N-(4-methoxyphenyl)amine (566), C31H43NO5Si, FW = 
537.84 
HN
OMe
OMe
TBDMSO
OMe566
OMe
 
566 prepared according to general procedure for imine reduction: colourless oil; [α]D –11.0 
(c, 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.16 (s, 6H), 0.97 (s, 9H), 2.02-2.17 (m, 
2H), 2.68 (dd, J = 7.7, 7.5 Hz, 2H), 3.69 (s, 3H), 3.80 (s, 6H), 3.85 (s, 3H), 4.21 (dd, J = 
7.0, 6.5 Hz, 1H), 6.39 (s, 2H), 6.44-6.48 (m, 2.4H), 6.67-6.71 (m, 2H), 6.73 (ddd, J = 8.0, 
2.4, 0.9 Hz, 1H), 6.83 (dd, J = 2.0, 1.8 Hz, 1H), 6.94 (br d, J = 7.7 Hz, 1H), 7.40 (dd, J = 
7.8, 7.8 Hz, 1H); 13C NMR δ –4.56 (CH3), –4.51 (CH3), 18.11 (C), 25.59 (3 × CH3), 32.97 
(CH2), 39.92 (CH2), 55.62 (CH3), 55.84 (2 × CH3), 58.06 (CH), 60.73 (CH3), 105.13 (2 × 
CH), 114.50 (2 × CH), 114.60 (2 × CH), 118.28 (CH), 118.55 (CH), 119.42 (CH), 129.40 
(CH), 135.95 (C), 137.15 (C), 141.40 (C), 145.66 (C), 151.80 (C), 153.01 (2 × C), 155.73 
(C); IR ν 3397, 3008, 2932, 2857, 1589, 1512, 1463, 1239 cm-1; MS (CI/isobutane) m/z 
(%) 206 [(M+H)+, 65], 537 (25), 415 (28), 308 (40), 161 (52), 143 (47), 85 (83); HRMS 
(CI/isobutane) 538.2991 (C31H44NO5Si requires 538.2989); HPLC analysis [Chiralpak IB, 
hexane – propan-2-ol (75:25), 0.75 mL/min, tminor = 12.37 min, tmajor = 19.67 min] showed 
96 % ee. 
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N-[1’-(3”-Hydroxyphenyl)-3’-(3’”,4’”,5’”-trimethoxyphenyl)prop-1’-yl]-N-(4-
methoxyphenyl)amine (570), C25H29NO5, FW = 423.55 
HN
HO OMe
OMe
OMe
OMe
570
 
570: white crystals; mp 139-140 ºC (CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 2.04-2.09 
(m, 2H), 2.67 (dd, J = 7.6, 7.4 Hz, 2H), 3.69 (s, 3H), 3.78 (s, 3H), 3.83 (s, 3H), 4.19 (dd, J 
= 7.0, 6.4 Hz, 1H), 6.36 (s, 2H), 6.41-6.45 (m, 2H), 6.66-6.70 (m, 2H), 6.81 (dd, J = 2.1, 
1.8 Hz, 1H), 6.89 (d, J = 6.7 Hz, 1H), 7.19 (dd, J = 7.8, 7.8 Hz, 1H); 13C NMR δ 33.14 
(CH2), 40.01 (CH2), 55.83 (CH3), 56.01 (2 × CH3), 58.25 (CH), 60.92 (CH3), 105.29 (2 × 
CH), 113.30 (CH), 114.05 (CH), 114.63 (2 × CH), 114.83 (2 × CH), 118.78 (CH), 129.80 
(CH), 135.98 (C), 137.30 (C), 141.52 (C), 146.15 (C), 151.89 (C), 153.12 (2 × C), 156.15; 
IR ν 3300, 3019, 2635, 1835, 1589, 1511, 1460, 1216 cm-1; MS (EI) m/z (%) 423 (M˙+, 
14), 300 (10), 228 (50), 181 (20); HRMS (EI) 423.2047 (C25H29NO5 requires 423.2046). 
 
General Procedure for Acetylation of Amines and Amino Alcohols: 
Acetanhydride (10-20 equiv) was added to a solution of amine (1 equiv) and pyridine (<12 
equiv) in solvent and the mixture was let stir at room temperature. Then diluted HCl (7 %, 
5 mL) was added and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layer was washed with saturated NaHCO3 (5 mL), brine (5 mL), dried 
over MgSO4 and concentrated in vacuo. The crude amide was purified on a silica gel 
column (7 or 15 mL) with a gradient of petroleum ether – ethyl acetate (1:1) to pure ethyl 
acetate and the amide was obtained as a thick oil. Reaction details in Table 7. 5.   
 
N-{1’-[3”-(tert-Butyldimethylsilyloxy)phenyl]-3’-(3’”,4’”,5’”-trimethoxyphenyl)prop-
1’-yl}-N-(4-methoxyphenyl)acetamide (571), C33H45NO6Si, FW = 579.88 
N
TBDMSO
O
OMe
OMe
OMe
OMe
571
 
Acetyl chloride (64 µL, 71 mg, 0.900 mmol, 3 equiv) was added drop-wise to a solution of 
amine 566 (161 mg, 0.300 mmol, 1 equiv) and triethylamine (209 µL, 152 mg, 1.50 mmol, 
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5 equiv) in CHCl3 (3 mL) at 0 ºC. The mixture was heated to reflux for 15 min and let to 
cool to room temperature. Then water (15 mL) was added and the aqueous phase was 
extracted with CH2Cl2 (3 × 7 mL). The combined organic layer was washed with saturated 
NaHCO3 (15 mL), brine (15 mL), dried over MgSO4 and concentrated in vacuo. The crude 
amide was purified on a silica gel column (10 mL) with a petroleum ether – ethyl acetate 
mixture (1:1) to afford the amide 571 as a thick oil (170 mg, 0.293 mmol, 98 %): 
colourless thick oil; 1H NMR (400 MHz, CDCl3) δ 0.11 (s. 3 H), 0.12 (s, 3H), 0.94 (s, 9H), 
1.76 (s, 3H), 1.98-2.15 (m, 2H), 2.52-2.70 (m, 2H), 3.76 (s, 3H), 3.81 (s, 3H), 3.84 (s, 6H), 
6.12 (dd, J = 7.7, 7.7 Hz, 1H), 6.39 (s, 2H), 6.57 (dd, J = 1.9, 1.9 Hz, 1H), 6.73 (ddd, J = 
8.0, 2.4, 0.8 Hz, 1H), 6.76 (br d, J = 7.7 Hz, 1H), 7.11 (dd, J = 7.8, 7.8 Hz, 1H), very broad 
signal in aromatic region (4H); 13C NMR δ –4.42 (CH3), –4.39 (CH3), 18.17 (C), 23.39 
(CH3), 25.67 (3 × CH3), 33.06 (CH2), 33.35 (CH2), 55.32 (CH3), 56.09 (2 × CH3), 56.44 
(CH), 60.83 (CH3), 105.39 (2 × CH), 114.03 (4 × CH), 119.38 (CH), 120.38 (CH), 122.21 
(CH), 129.10 (CH), 129.10 (C), 131.69 (C), 136.21 (C), 137.52 (C), 141.05 (C), 153.13 (2 
× C), 155.48 (C), 159.13 (C), 170.85 (C); IR ν 2955, 2932, 2858, 1653, 1589, 1510, 1463, 
1250 cm-1; MS (CI/isobutane) m/z (%) 580 [(M+H)+, 50], 417 (30), 166 (100); HRMS 
(CI/isobutane) 580.3099 (C33H46NO6Si requires 580.3094). 
 
 Table 7. 5. Acetylations with Acetanhydride According to Method A  
 
Substrate  Acetanhydride / Pyridine  Solvent   Time  Product  
566 (108 mg, 
0.200 mmol) 
 95 µL, 102 mg, 1.00 mmol /  
 97 µL, 95 mg, 1.20 mmol 
benzene  
(1 mL)  
64 h 571 (55 mg, 0.0949 
mmol, 95 %)  
560 (40 mg, 
0.0902 mmol) 
 85 µL, 92 mg, 0.902 mmol /  
 88 µL, 86 mg, 1.08 mmol 
benzene  
(1.5 mL)  
5 h  574 (42 mg, 0.0865 
mmol, 96 %) 
573 (62 mg, 
0.195 mmol) 
 369 µL, 398 mg, 3.90 mmol /  
 1 mL 
CH2Cl2  
(1 mL)   
5 h  518 (63 mg, 0.157 
mmol, 80 %)  
 
 
N-[1’-(3”-Hydroxyphenyl)-3’-(3’”,4’”,5’”-trimethoxyphenyl)prop-1’-yl]-N-(4-acetyl-
4-methoxyphenyl)amine (572), C22H27NO6, FW = 401.50 
N
HO
O
OMe
OMe
OMe
OMe
572
 
572: colourless thick oil; 1H NMR (400 MHz, CDCl3) δ 2.03-2.09 (m, 2H), 2.04 (s, 3H), 
2.55-2.73 (m, 2H), 3.79 (s, 3H), 3.80 (s, 3H), 3.84 (s, 3H), 6.20 (br s, 1H), 6.21 (dd, J = 
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7.7, 7.5 Hz, 2H), 6.41 (s, 2H), 6.41 (br s, 1H), 6.66 (br s, 1H), 6.81 (dd, J = 8.0, 2.3 Hz, 
1H), 6.89 (br s, 1H), 7.08 (dd, J = 7.9, 7.8 Hz, 1H), 7.12 (s, 1H). 
 
Procedures for Deprotection of PMP-group with H5IO6:  
 
Method A:246 Periodic acid (34.2 mg, 0.150 mmol, 1.0 equiv) was added portion-wise to a 
solution of amine 566 (80.7 mg, 0.150 mmol, 1.0 equiv) in a mixture of MeCN (3 mL), 
water (1.5 mL) and diluted H2SO4 (1.0 M, 0.15 mL) at 0 ºC. The mixture was let to warm 
to 16 ºC and let to stir for 3 hours at this temperature. Then water was added (3 ml) and the 
aqueous phase was extracted with CH2Cl2 (3 × 3 mL). The aqueous layer was basified to 
pH 8 (!) and the observable precipitate was extracted into AcOEt (3 × 10 mL). The 
combined AcOEt layers were dried over MgSO4 and evaporated affording crude amino 
alcohol 573 as off-white solid (35 mg, 0.110 mmol, 74 %) which was used without further 
purification. 
 
Method B: Periodic acid (98.3 mg, 0.431 mmol, 1.0 equiv) was added portion-wise to a 
solution of amine 566 (232 mg, 0.431 mmol, 1.0 equiv) in a mixture of MeCN (8.6 mL) 
and diluted H2SO4 (1.0 M, 4.3 mL) at 0 ºC. The mixture was let to stir for 8 hours at 
temperature between 10-16 ºC. Work-up as in Method A afforde 573 as off-white solid 
(114 mg, 0.359 mmol, 42 %) which was used without further purification.  
 
(+)-N-[1-(3’-Hydroxyphenyl)-3-(3”,4”,5”-trimethoxyphenyl)prop-1-yl]amine (573), 
C18H23NO4, FW = 317.42 
NH2
HO
OMe
OMe
OMe
573
 
573: white solid; mp 132-133 ºC (CH2Cl2); [α]D +4.8 (c 1.0, MeOH); 1H NMR (400 MHz, 
CDCl3) δ 2.00-2.07 (m, 2H), 2.49 (dd, J = 7.8, 7.8 Hz, 2H), 3.80 (s, 9H), 6.33 (s, 2H), 6.73 
(dd, J = 7.9, 2.0 Hz, 1H), 6.78 (d, J = 7.4 Hz, 1H), 6.84 (s, 1H), 7.12 (dd, J = 7.8, 7.7 Hz, 
1H); IR ν 3426, 3019, 1937, 1591, 1462, 1214 cm-1.  
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N-{1-[3’-(tert-Butyldimethylsilyloxy)phenyl]-3-(3”,4”,5”-trimethoxyphenyl)prop-1-yl} 
amine (560), C25H37NO4Si, FW = 443.72  
NH2
OMe
OMe
TBDMSO
OMe560
 
tert-Butyldimethylsilyl chloride (41.0 mg, 0.272 mmol, 2.4 equiv) was added in one 
portion to a solution of amino alcohol 573 (36 mg, 0.113 mmol, 1.0 equiv) and imidazole 
(38.5 mg, 0.567 mmol, 5.0 equiv) in anhydrous CH2Cl2 (5 mL) at 0 ºC.230 The mixture was 
let to warm to room temperature and stir overnight. Then water was added (10 ml) and the 
aqueous phase (at pH 8) was extracted with CH2Cl2 (3 × 5 mL). The combined organic 
layer was dried over MgSO4 and evaporated. The crude silylated amino alcohol was 
filtered on a short silica gel column (5 mL) with a mixture of petroleum ether – ethyl 
acetate (1:1) and ethyl acetate – methanol (5:1) to elute the free amine 560 which was 
concentrated to oil (40 mg, 0.0902 mmol, 79 %): colourless thick oil; 1H NMR (400 MHz, 
CDCl3) δ 0.20 (s, 6H), 0.98 (s, 9H), 1.93-2.06 (m, 2H), 2.15 (br s, 2H), 2.45-2.59 (m, 2H), 
3.81 (s, 3H), 3.82 (s, 6H), 4.95 (br s, 2H), 6.36 (s, 2H), 6.73 (ddd, J = 8.0, 2.4, 0.8 Hz, 1H), 
6.81 (dd, J = 2.0, 1.8 Hz, 1H), 6.91 (d, J = 7.7 Hz, 1H), 7.19 (dd, J = 7.8, 7.8 Hz, 1H).  
 
N-[1’-(3”-Acetoxyphenyl)-3’-(3’”,4’”,5’”-trimethoxyphenyl)prop-1’-yl]-N-(4-acetyl-4-
methoxyphenyl)amine (574), C22H27NO6, FW = 401.50 
NH
O
O
OMe
OMe
OMe
574
O
 
574 prepared according to acetylation Method A (vide supra): colourless thick oil; 1H 
NMR (400 MHz, CDCl3) δ 1.94 (s, 3H), 2.04-2.16 (m, 2H), 2.27 (s, 3H), 2.51-2.57 (m, 
2H), 3.80 (s, 3H), 3.81 (s, 3H), 5.01 (ddd, J = 7.9, 7.8, 7.4 Hz, 1H), 6.02 (d, J = 7.9 Hz, 
1H), 6.35 (s, 2H), 6.98 (ddd, J = 8.0, 2.2, 0.9 Hz, 1H), 7.15 (d, J = 8.0 Hz, 1H), 7.33 (dd, J 
= 7.8, 7.8 Hz, 1H); 13C NMR δ 21.15 (CH3), 23.34 (CH3), 32.89 (CH2), 37.26 (CH2), 
52.74 (CH3), 56.04 (2 × CH3), 60.84 (CH), 105.17 (2 × CH), 119.94 (CH), 120.74 (CH), 
124.27 (CH), 129.75 (CH), 136.05 (C), 136.96 (C), 143.64 (C), 150.92 (C), 153.13 (2 × C), 
169.47 (C), 171.24 (C); IR ν 3286, 2938, 1765, 1650, 1590, 1508, 1459, 1371, 1206, 1127 
cm-1; MS (EI) m/z (%) 401 (M˙+, 40), 195 (55), 182 (40); HRMS (EI) 401.1836 
(C22H27NO6 requires 401.1838). 
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(–)-N-{1’-[3”-(tert-Butyldimethylsilyloxy)phenyl]-3’-(3’”,4’”,5’”-
trimethoxyphenyl)prop-1’-yl}-N-(4-acetyl-4-methoxyphenyl)amine (518), 
C26H39NO5Si, FW = 473.75 
NH
TBDMSO
O
OMe
OMe
OMe
518
 
518:230,235,238 colourless thick oil; [α]D –39.8 (c 1.0, CHCl3), [lit.230a gives [α]D –42 (c 1.0, 
CHCl3) for 99.6 % ee, lit.238 gives [α]D25 –35 (c 1.1, CHCl3) for 94 % ee]; 1H NMR (400 
MHz, CDCl3) δ 0.20 (s, 6H), 0.98 (s, 9H), 1.97 (s, 3H), 1.00-2.08 (m, 1H), 2.13-2.22 (m, 
1H), 2.45-2.60 (m, 2H), 3.81 (s, 3H), 3.83 (s, 6H), 7.97 (ddd, J = 7.9, 7.5, 7.5 Hz, 1H), 
5.72 (d, J = 8.0 Hz, 1H), 6.36 (s, 2H), 6.76 (ddd, J = 6.8, 2.4, 0.9 Hz, 1H), 6.77 (d, J = 1.3 
Hz, 1H), 6.89 (d, J = 7.7 Hz, 1H), 7.21 (dd, J = 8.8, 7.5 Hz, 1H); 13C NMR δ –4.36 (2 × 
CH3),  18.20 (C), 23.41 (CH3), 25.68 (3 × CH3), 32.94 (CH2), 37.48 (CH2), 53.28 (CH3), 
56.03 (2 × CH3), 60.84 (CH), 105.23 (2 × CH), 118.58 (CH), 119.18 (CH), 119.60 (CH), 
129.80 (CH), 136.17 (C), 137.09 (C), 143.22 (C), 153.15 (2 × C), 156.03 (C), 169.33 (C); 
MS (EI) m/z (%) 473 (M˙+, 50), 416 (20), 222 (25), 185 (90), 182 (100), 181 (80), 47 (30), 
116 (32), 91 (45); HRMS (EI) 473.2602 (C26H39NO5Si requires 473.2598); HPLC 
analysis [Chiralpak IB, hexane – propan-2-ol (80:20), 0.75 mL/min, tminor = 13.326 min, 
tmajor = 16.529 min] showed 96 % ee.  
 
(–)-N-Acetylcolchinol (497), C20H23NO5, FW = 357.44 
AcHN
HO
OMe
OMe
MeO497
 
An oven-dried flask was charged with phenyliodonium bis(trifluoroacetate) (PIFA, 105 
mg, 0.244 mmol, 1.2 equiv) and dissolved in anhydrous CH2Cl2 (3 mL) under an argon 
atmosphere.230 After trifluoroacetic acid (2.0 mL) and trifluoroacetic acid anhydride (0.4 
mL) were added, the mixture was cooled to –4 ºC. A solution of the acetamide 518 (93 mg, 
0.203 mmol, 1.0 equiv) in anhydrous CH2Cl2 (1 mL) was added and followed immediately 
by BF3.OEt2 (60 µL, 69 mg, 0.487 mmol, 2.4 equiv). The reaction mixture turned yellow 
on addition of the acetamide and then from yellow to green and dark brown on addition of 
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BF3.OEt2. The reaction mixture was allowed to warm to room temperature and stir for 4 
hours at room temperature. The reaction was quenched by drop-wise addition of saturated 
NaHCO3 solution and the organic layer was separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 10 mL). The combined organic layer was washed with brine, dried over 
MgSO4 and evaporated under reduced pressure. The brown residue was purified on a silica 
gel column (10 mL) twice: first with a gradient of petroleum ether – ethyl acetate (1:1) to 
pure ethyl acetate and then with CH2Cl2 – methanol (98:2) to afford acetylcolchinol 497 as 
off-white solid (29 mg, 0.0820 mmol, 40 %):229,230,235,238 off-white amorphous solid; [α]D23 
–30.1 (c 0.5, CHCl3), [lit.229b gives [α]D20 –51.6 (c 1.23, CHCl3), lit.230a gives [α]D20 –45.2 
(c 0.6, CHCl3) for 94 % ee, lit.238 gives [α]D27 –34.0 (c 1.0, CHCl3) for 94 % ee]; 1H NMR 
(400 MHz, MeOH-d4) δ 1.90-1.96 (m, 1H), 2.01 (s, 3H), 2.25-2.27 (m, 2H), 2.49-2.51 (m, 
1H), 3.49 (s, 3H), 3.86 (s, 3H), 3.88 (s, 3H), 4.58-4.65 (m, 1H), 6.71 (s, 1H), 6.72 (dd, J = 
8.6, 2.6 Hz, 1H), 6.79 (d, J = 2.7 Hz, 1H), 7.23 (d, J = 8.3 Hz, 1H), 8.49 (d, J = 7.8 Hz, 
1H); 13C NMR δ 22.66 (CH3), 31.55 (CH2), 39.92 (CH2), 50.53 (CH), 56.62 (CH3), 61.33 
(CH3), 61.62 (CH3), 109.07 (CH), 110.86 (CH), 114.19 (CH), 126.55 (C), 126.77 (C), 
132.14 (CH), 136.68 (C), 142.39 (C), 142.46 (C), 152.14 (C), 153.71 (C), 157.98 (C), 
172.45 (C); IR ν 3284, 2930, 2855, 1643, 1608, 1535, 1483, 1452, 1404, 1325, 1236, 1142 
cm-1; MS (EI) m/z (%) 357 (M˙+, 18), 298 (10); HRMS (EI) 357.1573 (C20H23NO5 
requires 357.1576).  
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8. Applications in Synthesis of Alkaloids (II)  
 
8.1.  Properties and Synthesis of Atracurium   
 
8.1.1. What is Atracurium  
 
Atracurium 402 is a drug designed to act as a non-depolarising neuromuscular 
blocker binding to acetylcholine (Ach) receptors (Figure 8.1). Its development was based 
on the previously widely used suxamethonium 401, a polarising blocker.248 The 
pharmaceutical outcome of these two drugs is similar, as both block the muscle activity 
required during surgery. However, the substantial difference between them is the mode of 
muscle blockage. Suxamethonium is acetylcholine agonist, relatively stable to degradation 
by Ach-esterase; thus, it depolarises the plasma membrane of the muscle and the muscle 
fibre becomes resistant to stimulation of acetylcholine. This results in muscle twitching 
during the depolarising phase and post-experience pains. Atracurium acts as a post-
synaptic competitive acetylcholine-receptor antagonist that only blocks the receptors 
without further effects.  
 
OMe3N
576: Suxamethonium
O
O
O
NMe3
O
O
NMe3
575: Acetylcholine
N
OMe
OMe
OMe
MeO
O
OO
O
N
OMe
OMe
MeO
OMe
577: Atracurium
 
 
Figure 8.1. Neuromuscular Transmitter Acetylcholine and Blockers Suxamethonium and Atracurium 
 
Stenlake and co-workers provided extensive study on the synthesis, stereochemical 
analysis,249 structure-and-properties relationships248,249 and pharmacological data which 
was very successful and the drug became commercial from Borroughs Wellcome, NC, 
USA under the name Tracrium (for atracurium) or Nimbex (for cisatracurium, vide infra).  
 
Atracurium means a mixture of ten possible isomeric molecules, each containing 
four stereocentres – the asymmetric carbon in the tetrahydropapaverin part and the 
asymmetric quaternary nitrogen. Its synthesis is very short, only five steps, starting from 
    236
homoveratrylamine 578 and 3,4-dimethoxyphenylacetic acid 579 (Scheme 8.1). The amide 
580 was prepared just by heating the components to 200 ºC and collecting the crystals. 
Bischler-Napieralski cyclisation of 580 with phosphorus oxytrichloride afforded the 
protonated dihydropapaverine 581 which was reduced with sodium borohydride to 
tetrahydropapaverine 582 in overall 23 % yield.   
 
NH2
MeO
OMe HOOC OMe
OMe
MeO
OMe
+
O
NH
OMe
OMe
200 °C, 2 h
578
579
580 (57 %)
POCl3 (excess)
toluene, reflux, 3 h
NH
MeO
OMe
OMe
OMe
NaBH4 (4.4 eq)
EtOH
 r.t., 18 h
Cl-NH
MeO
OMe
OMe
OMe
581
582: Tetrahydropapaverine, THP 
(40 % over 2 steps)
 
 
Scheme 8.1. Synthesis of Tetrahydropapaverine, Intermediate in Synthesis of Atracurium 
 
Michael addition of 582 to pentandiol diacrylate afforded the tertiary diamine 583 
which was quaternised with methyl besylate to salt of atracurium 577 in 39 % yield 
(Scheme 8.2).  
 
O
O O
O(0.5 eq)
benzene, reflux, 48 h
582
583 (53 %)
O-(CH2)5-O
O MeOBs(excess)
577 (73 %)
MeCN
r.t., 48 h
O
THPN NTHP
 
 
Scheme 8.2. Synthesis Atracurium from Tetrahydropapaverine 
 
The main pathway for biological degradation250 is via non-enzymatic Hofmann 
elimination and ester hydrolysis that produce inactive metabolites (pH of blood is ~ 7.4; 
Scheme 8.3). Hofmann elimination of atracurium provides laudanosine 584 and 
monoacrylate 585, whereas ester hydrolysis produces alcohol 586 and quaternary acid 587 
and these processes can be interlinked.  
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Scheme 8.3. Biodegradation of Atracurium 
 
Optimisation of the structure according to the knowledge of its pharmacology 
provided valuable data, but it proved difficult to combine all of the factors and build “an 
ideal blocker”:248,250,251 
 
1. Fit of the quaternary nitrogen centre with the ACh receptors to enhance:  
- the uptake – the nature and size of the quaternary centre, the overall 
lipophilicity, 
-  the potency – lipid substituents at or near the quaternary centre facilitate 
binding.  
 
2. Increasing the rate of biodegradation:  
- minimise the concurrent hydrolysis to 587 which is not susceptible to Hofmann 
elimination and being hydrophilic, has also reduced affinity to ACh receptor,  
-  substitution patterns and electron properties on the nitrogen heterocycle or 
polyalkylene chain – duration of action decreases with the electron-
withdrawing power of the acylating group and smaller steric hindrance.  
 
3. Pharmacology, pharmacokinetics:  
- effect of counter anion on solubility – besylate of 577 is soluble in water up to 
60 mg.ml-1 at 25 ºC,   
-  inter-quaternary spacer – 13-14 methylene or spatially equivalent groups allow 
adequate chain flexibility.  
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Atracurium was synthesised in the late 1970s and even though research continued 
for 15 more years, a more suitable analogue has not been identified. The only improvement 
was the analysis of the mixture and resolution to separate isomers or subgroups of isomers 
which have different potency. As mentioned earlier, the mixture consists of four racemates 
and two meso-compounds. Each isomer can be defined by absolute configuration at the 
carbon stereocentre and relative configuration at the quaternary nitrogen. Considering that 
the synthetic methods afford the cis-isomer 3.07 times more likely than the trans (attack of 
the methylating reagent is more probable from the less hindered site; thus, furnishing cis-
isomer) and assuming that quaternisation at one THP-unit is not affected by the other one, 
the cis-cis, cis-trans and trans-trans isomers are in 10.5:6.2:1 ratio.249  
 
N
OMe
OMe
OMe
MeO
O
OO
O
N
OMe
OMe
MeO
OMe SO3
2
(R-cis,R'-cis)-577: Cisatracurium besylate
 
 
Figure 8.2. Cisatracurium 
 
The potency of these isomers decreases in order (R-cis) > (R-trans) > (S-cis) > (S-
trans) for each centre and it was quantified that the potency in series (R-cis,R-cis), (R-
cis,S-cis) and (S-cis,S-cis) is in ratio 2.6:1.5:1.249a The most potent isomer (R-cis,R-cis) is 
called cisatracurium (Figure 8.2).  
 
 
8.1.2. Our Synthesis of Atracurium  
 
Our synthesis of atracurium was based on Stenlake’s approach, using 
tertahydropapaverine 582 as the crucial intermediate. However, it was expected that 
Sigamide catalyst would afford the (S)-isomer of the THP-core. The retrosynthetic analysis 
from it to phenylacetic acid was designed through an open-chain secondary amine 588 
(Scheme 8.4) as it was already known (see Chapter 5) that cyclic imines are unsuitable 
substrates.  
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Scheme 8.4. Retrosynthetic Analysis of Tetrahydropapaverine Unit 
 
Thus, the first synthetic step provided the 1,2-diphenylethane structure, easily 
prepared by Friedel-Crafts acylation of 579 by another molecule of 579 in polyphosphoric 
acid medium.252 This procedure afforded essentially pure keto acid 589, though only in 35 
% yield. The acid functionality was protected as methyl ester 590.253  
 
579
r.t., 24 h MeO
OMe
OMe
OMe
HOOC
589 (35 %)
O MeI (8 eq) 
K2CO3 (4 eq)
acetone
50 °C, 40 min MeO
OMe
OMe
OMe
MeOOC
590
Opolyphosphoric
acid
 
 
Scheme 8.5. Synthesis of Keto Ester Substrate 
 
Keto ester 590 was used in subsequent imination step; however, all methods used 
so far were unsuccessful, slow reaction rate was accompanied with the formation of tar 
material. Assumption that the ester group is reactive enough to interact with the activated 
keto-group led us to an alternative route where the crude ester was reduced with lithium 
aluminium hydride to diol 592 (Scheme 8.6).  
 
590
Imination
Method A, B or C
MeO
OMe
OMe
OMe
MeOOC
591
NPMP
MeO
OMe
OMe
OMe
592 (71 % from 589)
OHHO
THF
r.t ., 18 h
LiAlH4 (4 eq)
 
 
Scheme 8.6. Alternative Route from Ester 590 
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It should be possible to oxidise an activated secondary alcohol selectively in the 
presence of a primary one. From the numerous reports in the literature describing this 
transformation, two representative reagents were tried – manganese dioxide and sodium 
hypochlorite, known for selective oxidation of benzylic alcohols, in particular (Scheme 
8.7). However, NaOCl254 afforded a mixture of compounds, from which several were 
identified as aldehydes. Freshly prepared manganese dioxide either did not react when 4 
equivalents were used or it caused cyclisation to isochroman 594 when a large excess was 
used. Reaction proceeded presumably via radical mechanism.  
 
592
a. or c.
MeO
OMe
OMe
OMe
593
OHO
a. MnO2 (4 eq), CH2Cl2, r.t., 24 h
b. MnO2 (40 eq), CH2Cl2,r.t., 24 h
c. NaOCl (1 eq), AcOH/H2O, 15 °C, 3 h
MeO
OMe
OMe
OMe
594
O
b.
 
 
Scheme 8.7. Attempts for Selective Oxidation of the Secondary Alcohol in 592 
 
At this point, the synthesis was becoming rather lengthy, but it was interesting to 
find out whether it is possible to prepare the desired open-chain imine and reduce it to 
amine as this molecule is, obviously, very prone to close a six-membered ring. The 
primary alcohol group of 592 was selectively protected as silylether 595 which was then 
oxidised at the benzylic position to ketone 596 (Scheme 8.8).  
 
MeO
OMe
OMe
OMe
595 (89 %)
OH
OTBDMS
TBDMSCl (1.1 eq)
imidazol  (2.2 eq)
592
CH2Cl2
r.t., 3 h MeO
OMe
OMe
OMe
596 (52 %)
O
OTBDMS
PCC (1.5 eq)
Celite
CH2Cl2
r.t., 3 h
 
 
Scheme 8.8. Alternative Route to Ketone Substrate 
 
The mildest, Lewis-acid-mediated imination method was chosen and to our initial 
delight, a yellow foam was obtained. Unfortunately, the 1H NMR analysis of this 
compound was complicated by signal overlapping in the aromatic and methoxy region of 
both of the C=N isomers. Thus, we decided not to perform full characterisation and 
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submitted the semi-purified sample to reduction (Scheme 8.9). However, only confusing, 
mixed material was isolated and amine 598 was not detected in the mixture. Racemic 
reduction either with NaBH4 or DMF/HSiCl3 did not afford the desired product.  
 
596
Imination
Method C
MeO
OMe
OMe
OMe
597
NPMP
OTBDMS
Reduction
MeO
OMe
OMe
OMe
598
NHPMP
OTBDMS
 
 
Scheme 8.9. Attempts for Imination of Ketone 596 and Concominant Reduction 
 
This synthetic approach proved unsuitable for a molecule, which contains benzylic 
carbonyl group and a side chain which can cyclise to a six-membered ring. However, our 
methodology does not afford N-cyclic amines in useful levels of enantioselectivity which 
means that it is not possible to apply our method onto dihydropapaverine-like substrates.  
 
 
 
8.2.  Other Applications     
 
8.2.1. PMP-Deprotection Study     
 
While the synthesis of atracurium was in process, model deprotections of the p-
methoxyphenyl group were carried out with 3,4,5-trimethoxy- and 3,4-dimethoxy-
acetophenone-derived amines (Table 8.1; Scheme 8.10) to simulate the impact of the 
methoxy-groups on the oxidative cleavage.  
 
Table 8.1. PMP-deprotection of Electron-rich Amines 
 
PMP-
Amine 
Free Amine  
(Yield) 
Oxidant (Method),  
React. Time   
PMP-
Amine 
Free Amine  
(Yield)  
599  601 (47 %)  TCCA (C), 1.5 h 600 602 (58 %) 
599  601 (80 %) H5IO6 (A), 1.5 h 600  602 (66 %) 
599 601 (52 %) H5IO6 (B), 2 h 600  602 (25 %)  
(+)-599  (–)-601 (85 %) H5IO6 (A), 4 h (–)-600  (–)-602 (66 %) 
 
    242
It was shown that the cleavage with trichlorocyanuric acid (TCCA) was fast, 
affording the free amines 601 and 602 in moderate yields (47-58 %). Better yields of the 
free amines (66-80 %) were achieved by employing the original Rutjes’ procedure246 
(Method A) with peroxyiodic acid (H5IO6). On the other hand, the procedure optimised for 
the deprotection of amino alcohols (Method B, see also Chapter 7.2.2) furnished the 
amines 601 or 602 only in unsatisfactory yields (25-52%). Thus, the Method A was also 
used for preparing the enantioenriched amines, which occurred in yields comparable to the 
racemates.  
 
MeO
MeO
R
NHPMP
MeO
MeO
R
NH2
599: R = OMe
600: R = H
a., b. or c.
601 (47-85 %)
602 (25-66 %)
a. H5IO6 (1 eq), 1M H2SO4, MeCN/H2O, 18 °C, 1.5-4 h
b. H5IO6 (1 eq), 1M H2SO4, MeCN, 18 °C, 2 h
c. TCCA (0.5 eq), MeCN/H2O, 18 °C, 1.5 h
 
 
Scheme 8.10. Deprotection of Polymethoxy-substrates 
 
Owing to the disappointing results of the deprotection of the p-methoxyphenyl 
group from the amine intermediate in the synthesis of colchinol (Chapter 7.2.2), some 
additional experiments were carried out with the model amine 476w prepared previously. 
The same three methods were used – with TCCA and the two procedures with H5IO6 
(Scheme 8.11).  
 
476w
TBDMSO
NHPMP
a. or b.c.
603
HO
NH2
604
TBDMSO
NH2
a. H5IO6 (1 eq), 1M H2SO4, MeCN/H2O, 18 °C, 2.5-5 h
b. H5IO6 (1 eq), 1M H2SO4, MeCN, 18 °C, 6-12 h
c. TCCA (0.5 eq), MeCN/H2O, 18 °C, 0.5 h
 
 
Scheme 8.11. Deprotection of Amine 476w 
 
The deprotection of 476w with TCCA was very fast; however, only small amounts 
of material were isolated (15 %) being the amino silylether 604. Also in the case of 
colchinol, this method produced only traces of isolable material that was not examined 
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further. The use of H5IO6 in either modification afforded the free amino alcohol 603 in 
variable yields (Table 8.2), strongly dependent on the reaction time and temperature, 74 % 
at the best.  
 
Table 8.2. PMP-deprotection of Amino Silylether 476w  
 
PMP-
Amine 
Free Amine  
(Yield) 
Oxidant (Method),  
React. Time   
476w 604 (15 %) TCCA (C), 0.5 h 
476w 603 (24 %) H5IO6 (A), 5.5 h 
476w 603 (75 %) H5IO6 (B), 6 h 
(–)-476w (–)-603 (34 %) H5IO6 (B), 12 h 
 
Similar fluctuations of yields were also observed in deprotection of the model 
amine 476w to 603. Interestingly, in both cases, the enatioenriched free amine 603 was 
obtained in significantly lower yield and with longer reaction times (disappearance of the 
starting material was monitored). It is hard to explain why the reactivity should be different 
for the racemate and either of the enantiomers. Possibly, presence of trace of chiral 
impurities could catalyse over-oxidation of the major enantiomers. 
 
(a)
RTBDMSO
NHPMP
(d)
RHO
NH2
(b)
RHO
NHPMP
H+
(c)
RTBDMSO
NH2H5IO6
H+
tar
H5IO6
 
 
Scheme 8.12. Parallel Pathways for Deprotection of Amines 476w or 566 
 
It seems plausible that the generally low yields and unreliability of the reaction 
were caused by the fast acid-catalysed deprotection of the silylether group of (a) or (c) to 
free phenols (b) or (d). This was indicated by isolation of phenol (b) or mixtures of (b) and 
(d) when the disappearance of the starting material (a) was observed. Further oxidative 
processes can occur at the PMP-site affording the desired amino alcohol (d) from (b) or at 
their phenolic sites leading to uncontrolled reactivity (Scheme 8.12).   
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Scheme 8.13. Use of Alternative O-Protecting Groups 
 
In conjunction with the results of deprotections of polymethoxy-analogues, where 
the reactivity problem was not observed, this knowledge could be (have been) exploited for 
improvement of the synthesis of colchinol (see Chapter 7.2). Benzylether or acetate 
protecting group instead of the TBDMS silylether would be probably tolerated better 
during the PMP-deprotection step (Scheme 8.13).   
 
Ph
HN
OTMS
Ph
HN
OH
Ph
NH2
H+
Oxidative
deprotection
605 606 607
fast fast
 
 
Scheme 8.14. Use of Alternative N-Protecting Groups 
 
Another possible way of improving the yield of the free amine would be using a 
different protecting group on nitrogen instead of the p-methoxyphenyl group. Two 
possibilities arose, the use of p-trimethylsilyloxyphenyl or p-nitrophenyl group. The first 
type (Scheme 8.14) is the acid-labile silylether 605 which would easily hydrolyse to free 
phenol 606 and its oxidative deprotection should be very fast. However, this approach 
could not be trialled as the corresponding imine was not isolated.  
 
Ph
HN
NO2
Ph
HN
NH2
Ph
NH2SnCl2
Oxidative
deprotection
608 609 610
fast
 
 
Scheme 8.15. Use of Alternative N-Protecting Groups 
 
The other alternative was relatively unreactive p-nitroaniline derivative 608 
(Scheme 8.15) which could be selectively reduced to p-aminoaniline derivative 609 that is 
known to be oxidised fast. Unfortunately, the reduction of the corresponding imine to 608 
proceeded in low yields so this method could not have had a practical outcome and the 
deprotection was not attempted.  
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8.2.2. Synthesis of 11β-HSD Inhibitor255     
 
Besides the electron-rich amines resembling alkaloid structures, the method of 
imine reduction was successfully applied to the synthesis of an electron-poor amine 
derived from o-fluoroacetophenone. The high-yielding imination of the ketone afforded the 
corresponding imine which was reduced in high yield and enantioselectivity (95 %) to 
amine 232.  The PMP-group was oxidatively cleaved using the Rutjes’ method with 
TCCA,246 which was the most efficient time- or yield-wise, and the free amine 611 was 
obtained in good 71 % yield (Scheme 8.16).  
 
O
234
F
2 steps
HN
232 (63 %)
OMe
F
NH2
611 (71 %)
F
TCCA (0.5 eq)
1M H2SO4
MeCN/H2O
r.t., 2h
 
 
Scheme 8.16. Synthesis of an Electron-poor Amine  
 
Thiazolone 613 (Scheme 8.17) is a precursor of 11β-hydroxysteroid dehydrogenase 
(HSD). In mammals, 11β-HSD serves for reduction of cortisone to the active 
glucocorticoid cortisol (in humans, type 1) and oxidation back to cortisone (type 2). 
Metabolic disorders (obesity, insulin-resistance in diabetes 2) caused by glucocorticoid 
excess or over-expression of 11β-HSD-1 could be treated by inhibiting this enzyme. 
Simple synthesis of a family of 11β-HSD inhibitors was published recently255 and our 
methodology was exploited for preparing the enantioenriched amine unit.  
 
611
F
HN
∗
F
HN
N
∗
S
O
613 (47%)
               (1.1 eq)
NaOAc (2.5 eq)
EtOH
reflux, 2 h
COOH
S
NHR
612b
1. BzNCS (1 eq)
    Et3N(1.1 eq)
    CH2Cl2, 0 °C, 1.5 h
    (R = Bz)
2. KOH (2 eq) 
    MeOH, r.t., 3 h
    (R = H)
Br
 
 
Scheme 8.17. Synthesis of Thiazolone 11β-HSD Inhibitor from Amine 611 
 
The free amine 611 was converted into the desired thiazolone 613 in three steps 
(Scheme 8.17). The first two steps were the formation of the N-benzoyl-N’-[1-(2’-
fluorophenyl)ethyl]-thiourea 612a and direct hydrolysis to the N-[1-(2’-
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fluorophenyl)ethyl]-thiourea 612b. The thiazolone ring was constructed by reaction of the 
crude thiourea material with racemic 2-bromopropionic acid. Thus, the final structure 613 
was prepared from the free amine 611 in three steps in overall 47 % yield. It is noteworthy 
to say that 613 was obtained as a mixture of four isomers – a pair Ar-C*-N epimers 
resulting from the enantioselective reduction (in 97.5:2.5 ratio) and a pair of S-C*-CO 
epimers (in 1:1 ratio) as a result of the cyclisation with racemic 2-bromopropionic acid. 
Further derivatisation at the thiazolone H-C*-CH3 position would lead to a series of 11β-
HSD inhibitors.255   
 
 
 
8.3.  Experimental Part (II)   
 
8.3.1. Atracurium    
 
2-{2’-[2”-(3’”,4’”-Dimethoxyphenyl)acetyl]-4’,5’-dimethoxyphenyl}acetic acid (589), 
C20H22O7, FW = 374.42  
O OMe
MeO
MeO OMe
COOH589
 
2-(3’,4’-Dimethoxyphenyl)acetic acid (50.0 g, 255 mmol) was mixed into polyphosphoric 
acid (84 % P2O5, 1 kg) and the thick suspension was let to stand (with occasional stirring) 
for 24 h at room temperature.252 Then the mixture was poured into cold water (4 L) and 
stirred occasionally. When the precipitation was finished (no brown oily material left), the 
yellow precipitate was filtered off and pre-dried with suction of air. The wet crude solid 
was crystallised from water-EtOH (2:1) mixture to afford 589 (18.9 g, 45.1 mmol, 35 %): 
yellowish crystals; mp 132-133 ºC (water: EtOH) [lit.253 gives 135-136 ºC (water:EtOH)]; 
1H NMR (400 MHz, CDCl3) δ 3.78 (s, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 3.88 (s, 3H), 3.92 
(s, 3H), 4.19 (s, 2H), 6.75-6.83 (m, 4H), 7.37 (s, 1H); 13C NMR δ 41.03 (CH2), 47.35 
(CH2), 55.90 (2 × CH3), 56.20 (2 × CH3), 111.43 (CH), 112.28 (CH), 113.12 (CH), 115.07 
(CH), 121.47 (CH), 126.69 (C), 128.57 (C), 129.29 (C), 147.59 (C), 148.22 (C), 152.51 
(C), 173.78 (C), 201.62 (C); IR (ATR) ν 2939, 2839, 1699, 1664, 1606, 1568, 1452, 1516, 
1452, 1427, 1352, 1331, 1273, 1215 cm-1; MS (CI/isobutane) m/z (%) 375 [(M+H)+, 25], 
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357 (25), 331 (50), 223 (45), 167 (55); HRMS (CI/isobutane) 375.1448 (C20H23O7 requires 
375.1444).  
 
Methyl 2-{2’-[2”-(3’”,4’”-dimethoxyphenyl)acetyl]-4’,5’-dimethoxyphenyl}acetate 
(590), C21H24O7, FW = 388.45  
O OMe
MeO
MeO OMe
COOMe590
 
Methyl iodide (19.9 mL, 45.6 g, 321 mmol, 8 equiv) was added to a suspension of acid 589 
(15.0 g, 40.1 mmol, 1 equiv) and potassium carbonate (22.1 g, 160 mmol, 4 equiv) in 
acetone (400 mL) and the mixture was heated to 50 ºC for 40 min.253 Then solids were 
filtered off and the filtrate was concentrated in vacuo. The crude solid ester 590253 was 
used without further purification: yellowish crystals; mp 104-106 ºC (hexane) [lit.253 gives 
130-132 ºC (MeOH)]; 1H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H), 3.84 (s, 3H), 3.85 (s, 
3H), 3.87 (s, 3H), 3.89 (s, 2H), 3.92 (s, 3H), 4.16 (s, 2H), 6.71 (s, 1H), 6.76-6.83 (m, 3H), 
7.39 (s, 1H); 13C NMR δ 40.08 (CH2), 47.37 (CH2), 51.85 (CH3), 55.83 (CH3), 55.88 
(CH3), 55.99 (CH3), 56.15 (CH3), 111.34 (CH), 112.39 (CH), 113.50 (CH), 115.37 (CH), 
121.44 (CH), 127.51 (C), 128.62 (C), 129.71 (C), 147.26 (C), 147.98 (C), 151.70 (C), 
172.13 (C), 199.06 (C); IR (ATR) ν 2951, 1736, 1605, 1522, 1462, 1339, 1265, 1234, 
1126 cm-1; MS (CI/isobutane) m/z (%) 389 [(M+H)+, 30], 167 (25), 113 (32), 97 (45), 85 
(70); HRMS (CI/isobutane) 389.1601 (C21H25O7 requires 389.1600).  
 
1-(2’-(2’-Hydroxyethyl)-4”,5”-dimethoxyphenyl)-2-(3’”,4’”-dimethoxyphenyl)ethanol 
(592), C20H26O6, FW = 362.46  
OH OMe
MeO
MeO OMe
OH592
 
A solution of ester 590 (15.5 g, 41 mmol, 1 equiv) in anhydrous THF (300 mL) was added 
drop-wise to a suspension of lithium aluminium hydride (6.08 g, 160 mmol, 4 equiv) in 
THF (100 mL) under an argon atmosphere at 0 ºC. The mixture was allowed to warm to 
room temperature and then heated to reflux for 16 h. The mixture was then cooled down to 
0 ºC and the excess of LiAlH4 was quenched with ethyl acetate and water. The aqueous 
layer was neutralised and extracted with AcOEt (3 × 200 mL), the combined organic layers 
were washed with brine (200 mL), dried over MgSO4 and evaporated. The crude solid was 
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crystallised from ethyl acetate to yield the alcohol 592 (10.3 g, 28.4 mmol, 71 % over two 
steps): off-white crystals; mp 122-123 ºC (AcOEt) [lit.253 gives 135-136 ºC (AcOEt)]; 1H 
NMR (400 MHz, CDCl3) δ 2.60 (ddd, J = 15.8, 4.1, 4.0 Hz, 1H), 2.78-2.85 (m, 1H), 3.02 
(dd, J = 14.3, 7.8 Hz, 1H), 3.10 (dd, J = 14.3, 4.7 Hz, 1H), 3.71-3.77 (m, 1H), 3.78 (s, 3H), 
3.84 (s, 3H), 3.85 (s, 6H), 4.11 (ddd, J = 11.1, 4.8, 4.7 Hz, 1H), 4.94 (dd, J = 7.4, 4.8 Hz, 
1H), 6.50 (s, 1H), 6.59 (s, 1H), 6.79 (s, 1H), 6.797 (s, 1H), 6.799 (s, 1H); 13C NMR δ 
28.49 (CH2), 42.19 (CH2), 55.67 (CH3), 55.71 (CH3), 55.77 (CH3), 55.80 (CH3), 62.79 
(CH2), 76.19 (CH), 108.23 (CH), 110.93 (CH), 111.32 (CH), 112.63 (CH), 121.53 (CH), 
126.15 (C), 129.35 (C), 131.09 (C), 147.04 (C), 147.35 (C), 147.42 (C), 148.46 (C); IR ν 
3411, 3019, 2960, 2938, 1608, 1515, 1465, 1261, 1217 cm-1; MS (CI/isobutane) m/z (%) 
345 {[M–OH)+H]+, 100}, 327 (15), 195 (20); HRMS (CI/isobutane) 345.1703 (C20H25O5 
requires 345.1702).  
 
1-{2’-[2’-(tert-Butydimethylsilyloxy]ethyl]-4”,5”-dimethoxyphenyl}-2-(3’”,4’”-
dimethoxyphenyl)ethanol (595), C26H40O6Si, FW = 476.75  
OH OMe
MeO
MeO OMe
OTBDMS595
 
Neat tert-butyldimethylsilyl chloride (4.57 g, 30.4 mmol, 1.1 equiv) was added to a 
solution of diol 592 (10.0 g, 27.6 mmol, 1.0 equiv) and imidazole (4.12 g, 20.7 mmol, 2.2 
equiv) in anhydrous CH2Cl2 (270 mL) under an argon atmosphere and the mixture was let 
to stir at room temperature for 3 h.253 The reaction was quenched with water (400 mL) and 
the aqueous layer was extracted with CH2Cl2 (3 × 150 mL). The combined organic layers 
were washed with water (100 mL), brine (200 mL), dried over MgSO4 and evaporated. The 
crude oil was purified on a silica gel column (300 mL) with a gradient of petroleoum ether 
– ethyl acetate mixture (80:20 to 50:50) to afford mono-protected alcohol 595 (11.7 g, 24.5 
mmol, 89 %): colourless oil; 1H NMR (400 MHz, CDCl3) δ –0.07 (s, 6H), 0.84 (s, 9H), 
2.78 (dd, J = 6.8, 6.8 Hz, 2H), 2.96 (s, 1H), 2.98 (d, J = 2.7 Hz, 1H), 3.74 (dd, J = 6.7, 6.7 
Hz, 2H), 3.80 (s, 3H), 3.84 (s, 3H), 3.849 (s, 3H), 3.854 (s, 3H), 5.05 (dd, J = 7.1, 6.0 Hz, 
1H), 6.65 (s, 1H), 6.66 (s, 1H), 6.73 (dd, J = 8.2, 1.8 Hz, 1H), 6.78 (d, J = 8.2 Hz, 1H), 
6.96 (s, 1H); 13C NMR δ –5.47 (2 × CH3), 18.29 (C), 25.86 (3 × CH3), 35.04 (CH2), 44.56 
(CH2), 55.67 (CH3), 55.71 (CH3), 55.79 (CH3), 55.87 (CH3), 64.45 (CH2), 71.59 (CH), 
109.15 (CH), 111.08 (CH), 112.63 (CH), 112.91 (CH), 121.37 (CH), 128.37 (C), 130.86 
(C), 134.27 (C), 147.50 (C), 147.60 (C), 147.94 (C), 148.65 (C); IR ν 3410, 3018, 2955, 
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2933, 2856, 1608, 1515, 1465, 1259 cm-1; MS (CI/isobutane) m/z (%) 459 {[M–H2O)+H]+, 
100}, 329 (50), 327 (95), 325 (40); HRMS (CI/isobutane) 459.2570 (C26H39O5Si requires 
459.2567).  
 
1-(3’,4’-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydro-1H-isochromene (594), 
C20H24O5, FW = 344.44  
O OMe
MeO
OMe
594 OMe
 
Manganese dioxide (959 mg, 11.0 mmol, 40 equiv) was added to a solution of diol 592 
(100 mg, 0.276 mmol, 1 equiv) in anhydrous CH2Cl2 (5 mL) under an argon atmosphere 
and the mixture was let to stir at room temperature for 3 h. The solids were filtered off and 
the filtrate was concentrated in vacuo. The crude was purified on a silica gel column (20 
mL) with a gradient of petroleoum ether – ethyl acetate mixture (80:20 to 60:40) to afford 
the cyclised product 594253 (71 mg, 0.206 mmol, 75 %): colourless oil; 1H NMR (400 
MHz, CDCl3) δ 2.60 (ddd, J = 15.8, 4.1, 4.0 Hz, 1H), 2.77-2.84 (m, 1H), 3.02 (dd, J = 
14.3, 7.7 Hz, 1H), 3.10 (dd, J = 14.3, 4.7 Hz, 1H), 3.71-3.77 (m, 1H), 3.78 (s, 3H), 3.84 (s, 
3H), 3.85 (s, 6H), 4.11 (ddd, J = 11.2, 6.5, 4.7 Hz, 1H), 4.95 (dd, J = 7.4, 4.9 Hz, 1H), 6.50 
(s, 1H), 6.58 (s, 1H), 6.78 (s, 1H), 6.79 (s, 1H), 6.80 (s, 1H); 13C NMR δ 28.55 (CH2), 
42.26 (CH2), 55.72 (CH3), 55.77 (CH3), 55.79 (CH3), 55.86 (CH3), 62.85 (CH2), 76.25 
(CH), 108.28 (CH), 110.93 (CH), 111.36 (CH), 112.67 (CH), 121.52 (CH), 126.18 (C), 
129.37 (C), 131.11 (C), 147.09 (C), 147.40 (C), 147.47 (C), 148.52 (C); IR ν 3002, 2934, 
2834, 1609, 1516, 1465, 1259, 1217 cm-1; MS (EI) m/z (%) 344 (M˙+, 5), 193 (100), 151 
(30); HRMS (EI) 344.1626 (C20H24O5 requires 344.1624).  
 
2-(3”,4”-Dimethoxyphenyl)-2’-(2’”-hydroxyethyl)-4’,5’-dimethoxyacetophenone 
(596), C26H38O6Si, FW = 474.74  
O OMe
MeO
MeO OMe
OTBDMS596
 
Oxidation of alcohol 595 with PCC according to general procedure in Chapter 6.2. The 
crude mixture was purified on a silica gel column (300 mL) with a gradient of petroleoum 
ether – ethyl acetate mixture (80:20 to 70:30) to afford the ketone 596 (5.67 g, 11.9 mmol, 
52 %): colourless oil; 1H NMR (400 MHz, CDCl3) δ –0.034 (s, 3H), –0.029 (s, 3H), 0.83 
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(s, 9H), 3.00 (t, J = 6.3 Hz, 2H), 3.80 (t, J = 6.3 Hz, 1H), 3.84 (s, 3H), 3.85 (s, 3H), 3.87 (s, 
3H), 3.90 (s, 3H), 4.12 (s, 2H), 6.75-6.78 (m, 2H), 6.80-6.82 (s, 2H), 7.264 (s, 1H); 13C 
NMR δ –5.39 (2 × CH3), 18.31 (C), 25.96 (3 × CH3), 37.59 (CH2), 48.09 (CH2), 55.81 
(CH3), 55.86 (2 × CH3), 56.15 (CH3), 64.21 (CH2), 111.29 (CH), 112.30 (CH), 112.63 
(CH), 115.44 (CH), 121.48 (CH), 127.46 (C), 129.22 (C), 135.14 (C), 146.46 (C), 147.95 
(C), 149.02 (C), 151.06 (C), 199.70 (C); IR ν 2933, 2855, 1737, 1681, 1605, 1568, 1517, 
1464, 1348, 1264 cm-1; MS (CI/isobutane) m/z (%) 475 [(M+H)+, 100], 417 (35), 343 (20), 
323 (20); HRMS (CI/isobutane) 475.2514 (C26H39O6Si requires 475.2516).  
 
N-(1-(2’-(2’”-(tert-Butyldimethylsilyloxy)ethyl)-4’,5’-dimethoxyphenyl)-2-[3”,4”-
dimethoxyphenyl)ethylidene]-4-methoxyaniline (597), C33H45O6NSi, FW = 579.88  
? 
N
OMe
MeO
MeO OMe
MeO
OTBDMS597
 ? 
597 prepared according general procedure for imination, Method C: semipurified sample, 
yellow foam; 1H NMR (400 MHz, CDCl3, a mixture of (E/Z) isomers in ratio ca. 2:1, the 
minor one is marked *) δ –0.08* (s, 1.5H), –0.03 (s, 3H), 0.81* (s, 4.5 H), 0.85 (s, 9H), 
2.54* (t, J = 6.7 Hz, 1H), 3.20 (t, J = 6.8 Hz, 2H), 3.705 (s, 3H), 3.713* (s, ?H), 3.74 (s, 
3H), 3.75* (s, ?H), 3.86 (s, 4.5H), 3.89 (s, 3H), 3.91 (s, 3H), 3.95* (s, 1.5H), 3.97* (s, 
1.5H), 6.65-6.78 (m, 6.5H), 6.82-6.96 (m, 6.5H), 7.34 (d, J = 2.0 Hz, 1H), 7.38 (dd, J = 
8.4, 2.0 Hz, 1H), 7.77* (d, J = 1.9 Hz, 0.5H), 7.95* (dd, J = 8.4, 2.0 Hz, 0.5H); IR ν 3020, 
2955, 2934, 2855, 1658, 1593, 1513, 1464, 1266 cm-1; MS (CI/isobutane) m/z (%) 594 
(80), 580 [(M+H)+, 30], 475 (100), 446 (50), 272 (50), 183 (22), 124 (20).  
 
 
8.3.2. Other Syntheses     
 
4-(Trimethylsilyloxy)aniline (614), C9H15NOSi, FW = 181.34 
H2N OTMS
614
 
n-Butyllithium (1.6 M in hexane, 28.9 mL, 45.3 mmol, 1.01 equiv) was added drop-wise to 
a suspension of 4-aminophenol (5.00 g, 45.8 mmol, 1.00 equiv) in anhydrous THF (50 mL) 
at 0 ºC and let to stir at room temperature for 1 hour.256 Then the solvent was evaporated in 
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vacuo, the solid residue was washed with hexane (3 × 20 mL) and re-dissolved in 
anhydrous THF (50 mL). Neat trimethylsilyl chloride was added drop-wise to the solution 
of the crude lithium phenolate and let to stir for 3.5 h at room temperature. Then the 
solvent was evaporated in vacuo and the residue was washed with hexane (3 × 20 mL). 
The crude silylether 614256 (5.99 g, 33.0 mmol, 72 %) was used without further 
purification: brown oil; 1H NMR (400 MHz, CDCl3) δ 0.22 (s, 9H), 3.42 (br s, 2H), 6.57-
6.59 (m, 2H), 6.65-6.67 (m, 2H).  
 
Imination of Ketones:  
 
Table 8.3. Preparation of Imines from the Corresponding Ketones  
 
Method Ketone 
p-substituted aniline  
p-TsOH (mg) or TiCl4 (mL) 
SiO2 (mL)  
PE – EA  
Imine 
B  
 
500 mg, 2.38 mmol  
322 mg, 2.62 mmol 
45 mg, 0.238 mmol 
20 mL 
85:15  
 
615 (467 mg, 1.48 mmol, 62 %) 
2:1 P:SM 
C 500 mg, 2.38 mmol   
876 mg, 7.11 mmol 
2.4 mL, 0.238 mmol 
20 mL 
85:15  
615 (341 mg, 1.08 mmol, 46 %) 
5:1 P:SM 
B  
 
1.00 g, 5.55 mmol  
752 mg, 6.10 mmol 
105 mg, 0.555 mmol 
40 mL 
85:15  
616 (824 mg, 2.89 mmol, 52 %) 
3:1 P:SM 
C 1.00 g, 5.55 mmol  
2.05 g, 16.6 mmol 
5.6 mL, 5.55 mmol 
40 mL 
85:15  
616 (596 mg, 2.09 mmol, 38 %) 
9:1 P:SM 
B 1.00 g, 8.32 mmol  
1.27 g, 9.16 mmol 
157 mg, 0.832 mmol 
40 mL 
95: 5  
617 (566 mg, 2.36 mmol, 28 %) 
B 500 mg, 3.62 mmol 
490 mg, 3.98 mmol  
69 mg, 0.362 mmol 
25 mL 
99: 1  
(PE:EA) 
231 (468 mg, 2.66 mmol, 74 %) 
 
(E)-N-[1’-(3”,4”,5”-Trimethoxyphenyl)ethylidene]-4-
methoxyaniline (615), C17H21NO3, FW = 287.39: yellow 
solid; 1H NMR (400 MHz, CDCl3) δ 2.29 (br s, 3H), 3.82 
(s, 3H), 3.91 (s, 3H), 3.95 (s, 6H), 6.84 (br s, 2H), 6.90-6.94 (m, 2H), 7.29 (br s, 2H). No 
further data provided as the imine was obtained only in a mixture with the corresponding 
ketone. 
 
(E)-N-[1’-(3”,4”-Dimethoxyphenyl)ethylidene]-4-
methoxyaniline (616),120 C17H21NO3, FW = 287.39: yellow 
solid; 1H NMR (400 MHz, CDCl3) δ 2.23 (s, 3H), 3.81 (s, 
N
MeO
MeO
MeO
OMe
615
N
MeO
MeO
OMe
616
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3H), 3.93 (s, 3H), 3.97 (s, 3H), 6.75-6.78 (m, 2H), 6.87-6.92 (m, 3H), 7.44 (dd, J = 8.4, 2.1 
Hz, 1H), 7.44 (d, J = 2.0 Hz, 1H). No further data provided as the imine was obtained only 
in a mixture with the corresponding ketone. 
 
(E)-N-(1’-Phenylethylidene)-4-nitroaniline (617),257 
C14H12N2O2, FW = 240.28: yellow solid; 1H NMR (400 MHz, 
CDCl3) δ 1.85 (s, 3H), 7.05-7.08 (m, 2H), 7.47-7.51 (m, 3H), 
7.97-7.98 (m, 2H), 8.18-8.22 (m, 2H). No further data provided as the imine was obtained 
only in a mixture with the corresponding ketone.  
 
(E)-N-[1’-(2”-Fluorophenyl)ethylidene]-4-methoxyaniline (231), C15H14NOF, FW = 
243.30 
N
231
OMe
F
 
231119,120 (Method B, Table 8.3): yellow oil; 1H NMR (400 MHz, CDCl3, a mixture of 
(E,Z)- isomers in ratio ca. 5:1, the minor one is marked*) δ 2.27 (d, J = 3.5 Hz, 3H), 2.51* 
(d, J = 0.6 Hz, 0.6H), 3.68* (s, 0.6H), 3.81 (s, 3H), 6.62-6.65* (m, 0.4H), 6.65-6.67* (m, 
0.4H), 6.78-6.82 (m, 2H), 6.90-6.94 (m, 2H), 6.94-6.97* (m, 0.6H), 7.10 (ddd, J = 11.4, 
8.3, 1.0 Hz, 1H), 7.17-7.21* (m, 0.2H), 7.20 (ddd, J = 7.6, 7.4, 1.1 Hz, 1H), 7.39 (dddd, J 
= 8.2, 7.1, 5.1, 1.9 Hz, 1H), 7.83 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H); 13C NMR δ 20.69 (d, J = 
6.6 Hz, CH3), 28.54* (d, J = 1.2 Hz, CH3), 55.10* (CH3), 55.32 (CH3), 113.59* (2 × CH), 
114.15 (2 × CH), 115.60* (d, J = 21.8 Hz, CH), 116.07 (d, J = 22.9, CH), 120.66 (2 × CH), 
121.57* (2 × CH), 123.90* (d, J = 3.4 Hz, CH), 124.14 (d, J = 3.4 Hz, CH), 126.63* (d, J 
= 18.0 Hz, C), 128.72* (d, J = 4.6 Hz, CH), 128.90* (d, J = 12.3 Hz, C), 129.90 (d, J = 3.6 
Hz, CH), 130.06* (d, J = 8.0 Hz, CH), 131.29 (d, J = 8.6 Hz, CH), 143.39* (C), 143.65 
(C), 155.96* (C), 156.07 (C), 158.41* (d, J = 247.0 Hz, CF), 160.91 (d, J = 250.3 Hz, CF), 
161.95* (C), 162.15 (C), 164.86* (unresolved, C), 165.14 (d, J = 2.4 Hz, C); 19F NMR δ –
113.44; IR (ATR) ν 2951, 2833, 1624, 1611, 1501, 1449, 1288, 1238, 1207 cm-1; MS 
(CI/isobutane) m/z (%) 244 [(M+H)+, 100], 102 (28); HRMS (CI/isobutane) 244.1141 
(C15H15NOF requires 244.1138).  
 
 
 
 
N NO2617
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Reduction of Imines:  
 
Table 8.4. Reductions of Imines 
 
Imine  PE – EA  Amine 
615 (630 mg) 85:15  599rac (424 mg, 1.34 mmol, 67 %) 
616 (570 mg) 85:15 600rac (560 mg, 1.95 mmol, 97 %) 
617 (361 mg) 90:10 608rac (49 mg, 0.202 mmol, 13 %) 
615 (126 mg) 85:15 599 (119 mg, 0.375 mmol, 94 %) 
616 (114 mg) 85:15 600 (100 mg, 0.348 mmol, 87 %) 
617 (96.1 mg) 95:5 → 90:10 608 (21 mg, 0.867 mmol, 22 %) 
231 (243 mg) 98:2 232rac (225 mg, 0.917 mmol, 92 %) 
231 (195 mg) 98:2 232 (166 mg, 0.677 mmol, 85 %) 
 
 (+)-N-[1’-(3”,4”,5”-Trimethoxyphenyl)ethyl]-N-(4-methoxyphenyl)amine (599), 
C18H23NO4, FW = 317.42 
HN
MeO
MeO
MeO
OMe
599
 
599: white crystals; mp 66-67 ºC; [α]D +7.1 (c 1.0, CHCl3), [α]436 +17 (c 1.0, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 1.51 (d, J = 6.7 Hz, 3H), 3.71 (s, 3H), 3.82 (s, 3H), 3.83 (s, 
6H), 4.31 (q, J = 6.7 Hz, 1H), 6.51-6.54 (m, 2H), 6.60 (s, 2H), 6.70-6.72 (m, 2H); 13C 
NMR δ 24.80 (CH3), 55.43 (CH3), 55.66 (CH3), 56.04 (2 × CH3), 60.78 (CH), 102.70 (2 × 
CH), 114.63 (2 × CH), 114.75 (C), 115.22 (2 × CH), 136.62 (C), 140.81 (2 × C), 152.41 
(C), 153.34 (2 × C); IR ν 3387, 2937, 2833, 1592, 1513, 1462, 1325, 1234 cm-1; MS (EI) 
m/z (%) 317 (M˙+, 42), 195 (100); HRMS (EI) 317.1628 (C18H23NO4 requires 317.1627); 
HPLC analysis (Chiralpak IB, hexane – propan-2-ol (87:13), 0.75 mL/min, tmajor = 20.14 
min, tminor = 21.70 min) showed 86 % ee (not baseline separation).  
 
 (–)-N-[1’-(3”,4””-Dimethoxyphenyl)ethyl]-N-(4-methoxyphenyl)amine (600), 
C17H21NO3, FW = 287.39 
HN
MeO
MeO
OMe
600
 
600:120 white crystals; mp 116-118 ºC; [α]D –5.7 (c 1.0, CHCl3), [α]436 –8.6 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 1.51 (d, J = 6.7 Hz, 3H), 3.70 (s, 3H), 3.85 (s, 3H), 3.86 (s, 
3H), 4.35 (q, J = 6.7 Hz, 1H), 6.51-6.55 (m, 2H), 6.68-6.72 (m, 2H), 6.81 (d, J = 8.2 Hz, 
1H), 6.89 (dd, J = 8.2, 1.8 Hz, 1H), 6.92 (d, J = 1.9 Hz, 1H); 13C NMR δ 24.80 (CH3), 
54.77 (CH3), 55.74 (CH), 55.90 (2 × CH3), 109.25 (CH), 111.19 (CH), 114.72 (2 × CH), 
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115.31 (2 × CH), 117.99 (CH), 137.55 (C), 140.82 (C), 147.91 (C), 149.16 (C), 152.42 (C); 
IR ν 3395, 2960, 2833, 1593, 1513, 1464, 1234 cm-1; MS (EI) m/z (%) 287 (M˙+, 48), 165 
(100), 150 (30), 123 (42), 91 (40); HRMS (EI) 287.1523 (C17H21NO3 requires 287.1521); 
HPLC analysis (Chiralpak IB, hexane – propan-2-ol (87:13), 0.75 mL/min, tminor = 16.492 
min, tmajor = 17.613 min) showed 94 % ee, [lit.120 gives Chiralpak AS-H, heptane – propan-
2-ol (90:10), 0.5 ml/min, tmajor = 24.22 min, tminor = 30.96 min showing 89 % ee].  
 
 (–)-N-(4-Nitrophenyl)-N-(1’-phenylethyl)amine (608), C14H14N2O2, FW = 242.30 
HN NO2608
 
608: 119 yellow oil; [α]D –77 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.60 (d, J = 6.7 
Hz, 3H), 4.59 (q, J = 6.7 Hz, 1H), 6.47-6.55 (m, 2H), 7.29-7.38 (m, 5H), 7.99-8.03 (m, 
2H); 13C NMR δ 24.47 (CH3), 53.65 (CH), 112.22 (2 × CH), 125.72 (2 × CH), 126.22 (2 × 
CH), 127.61 (CH), 129.01 (2 × CH), 138.40 (C), 143.04 (C), 152.06 (C); IR ν 3373, 3026, 
2972, 2927, 1601, 1524, 1503, 1473, 1315, 1278, 1185 cm-1; MS (EI) m/z (%) 242 (M˙+, 
20), 227 (20), 120 (20), 118 (22), 105 (60), 87 (85), 85 (100), 83 (100); HRMS (EI) 
242.1056 (C14H14N2O2 requires 242.1055); HPLC analysis (Chiralpak IB, hexane – 
propan-2-ol (94:6), 0.75 mL/min, tmajor = 32.17 min, tminor = 39.01 min) showed 88 % ee 
(negative peaks).  
 
(–)-N-[1’-(2”-Fluorophenyl)ethyl]-N-(4-methoxyphenyl)amine (232), C15H16NOF, FW 
= 245.32 
HN
232
OMe
F
 
232119,120 (Table 8.4): colourless oil; [α]D –17.0 (c 1.0, CHCl3), [lit.119 gives [α]D25 +8.4 (c 
1.0, CHCl3) for 84 % ee]; 1H NMR (400 MHz, CDCl3) δ 1.56 (d, J = 6.7 Hz, 3H), 3.72 (s, 
3H), 3.85 (br s, 1H), 4.80 (q, J = 6.7 Hz, 1H), 6.51-6.55 (m, 2H), 6.72-6.76 (m, 2H), 7.07 
(ddd, J = 17.5, 8.1, 1.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 1H), 7.19-7.25 (m, 1H), 7.41 (ddd, J = 
8.1, 7.5, 1.7 Hz, 1H); 13C NMR δ 23.27 (CH3), 48.20 (d, J = 2.6 Hz, CH), 55.57 (CH3), 
114.47 (2 × CH), 114.69 (2 × CH), 115.34 (d, J = 21.9 Hz, CH), 124.27 (d, J = 3.4 Hz, 
CH), 127.19 (d, J = 4.8, CH), 128.14 (d, J = 8.2 Hz, CH), 131.79 (d, J = 13.2 Hz, C), 
140.96 (C), 152.01 (C), 160.43 (d, J = 244.6 Hz, CF); 19F NMR δ –120.37; IR ν 3400, 
2968, 2931, 2832, 1512, 1451, 1236 cm-1; MS (EI) m/z (%) 245 (M˙+, 65), 230 (78), 123 
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(65), 108 (30), 103 (25), 85 (55), 83 (100); HRMS (EI) 245.1218 (C15H16NOF requires 
245.1216); HPLC analysis (Chiralpak IB, hexane – propan-2-ol (99:1), 0.75 mL/min, tminor 
= 12.85 min, tmajor = 14.63 min) showed 95 % ee or (Chiralcel OD-H, hexane – propan-2-ol 
(98:2), 0.60 mL/min, tminor = 15.74 min, tmajor = 18.79 min) showed 95 % ee, [lit.119 gives 
Chiralcel OD-H, hexane – propan-2-ol (98:2), 0.60 mL/min, t(+)-major  = 14.55 min, t(–)-minor 
= 17.24 min showing 84 % ee, lit.120 gives Chiralcel OD-H, heptane – propan-2-ol (98:2), 
0.50 mL/min, t(R)-minor  = 15.58 min, t(S)-major = 18.11 min showing 85 % ee].  
 
Deprotection of PMP-group:  
 
Method A: Periodic acid (1.0 equiv) was added portion-wise to a solution of amine (1.0 
equiv) in a mixture of MeCN, water (both 10 mL per 1 mmol of amine) and diluted H2SO4 
(1.0 M, 1 mL per 1 mmol of amine) at room temperature. The mixture was let to stir at this 
temperature for the time indicated. Then water was added (3 mL) and the aqueous phase 
was extracted with CH2Cl2 (3 × 3 mL). The aqueous layer was basified to pH 10 (to pH 8 
in the case of amino alcohols) and the precipitate was extracted into AcOEt (3 × 10 mL). 
The combined AcOEt layers were dried over MgSO4 and evaporated affording crude free 
amine as off-white solid which was used without further purification. 
 
Method B: Periodic acid (1.0 equiv) was added portion-wise to a solution of amine (1.0 
equiv) in a mixture of MeCN (20 mL per 1 mmol of amine) and diluted H2SO4 (1.0 M, 10 
mL per 1 mmol of amine) in 10:1 ratio at room temperature. The mixture was let to stir at 
room temperature for the time indicated. Work-up as in Method A.  
 
Method C: Trichloroisocyanuric acid (TCCA, 0.5 equiv) was added portion-wise to a 
solution of amine (1.0 equiv) in a mixture of MeCN and water (both 10 mL per 1 mmol of 
amine) at room temperature. The mixture was let to stir at room temperature for the time 
indicated. Work-up as in Method A.   
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Table 8.5. PMP-deprotection of Amines 
 
PMP-Amine  
 
(Method) React. Time  
Oxidant  
Free Amine 
599rac (0.2 mmol, 63.5 mg) 601rac (~ 20 mg, 0.0947 mmol, 47 %)  
mix with unknown, P:U (2:1) 
600rac (0.2 mmol, 57.5 mg) 
(C) 1.5 h  
23.2 mg, 0.1 mmol 
 602rac (21 mg, 0.116 mmol, 58 %) 
599rac (0.2 mmol, 63.5 mg) 601rac (34 mg, 0.161 mmol, 80 %) 
600rac (0.2 mmol, 57.5 mg) 
(A) 1.5 h  
45.6 mg, 0.2 mmol 602rac (24 mg, 0.132 mmol, 66 %) 
599rac (0.2 mmol, 63.5 mg) 601rac (22 mg, 0.104 mmol, 52 %) 
600rac (0.2 mmol, 57.5 mg) 
(B) 2 h  
45.6 mg, 0.2 mmol)  602rac (9 mg, 0.0492 mmol, 25 %)  
mix with SM, P:SM (5:1) 
599 (0.1 mmol, 31.7 mg) 601 (18 mg, 0.0852 mmol, 85 %) 
600 (0.1 mmol, 28.7 mg) 
(A) 4 h  
22.8 mg, 0.1 mmol 602 (12 mg, 0.0662 mmol, 66 %) 
476w rac (0.4 mmol, 143 mg) (C) 0.5 h  
0.1 mmol, 23.2 mg  
604rac (15 mg, 0.0596 mmol, 15 %) 
476w rac (0.4 mmol, 143 mg) (A) 5.5 h  
91.2 mg, 0.4 mmol   
603rac (13 mg, 0.0948 mmol, 24 %) 
476w rac (0.4 mmol, 143 mg) (B) 6 h  
91.2 mg, 0.4 mmol 
603rac (41 mg, 0.299 mmol, 75 %) 
476w (0.3 mmol, 107 mg) (B) 12 h  
68.4 mg, 0.3 mmol  
603 (14 mg, 0.102 mmol, 34 %) 
232 (570 mg, 2.32 mmol) (C) 3 h  
270 mg, 1.16 mmol 
611 (228 mg, 1.64 mmol, 71 %) 
 
 (–)-N-[1-(3’,4’,5’-Trimethoxyphenyl)ethyl]amine (601),258 
C11H17NO3, FW = 211.29: white solid; [α]D –9.8 (c 0.5, CHCl3); 
[lit.258 gives [α]D25 +24.4 (c 1.06, CHCl3) for (S)-enantiomer 96 % 
ee]; 1H NMR (400 MHz, CDCl3) δ 1.39 (d, J = 6.6 Hz, 3H), 2.16 (br s, 2H), 3.83 (s, 3H), 
3.86 (s, 6H), 4.09 (q, J = 6.6 Hz, 1H), 6.59 (s, 2H).   
 
(–)-N-[1-(3’,4’,5’-Trimethoxyphenyl)ethyl]amine (602),258 
C10H15NO2, FW = 181.26: white solid; [α]D –33 (c 0.5, CHCl3); [lit.258 
gives [α]D25 –24.2 (c 1.01, CHCl3) for (S)-enantiomer 82 % ee]; 1H 
NMR (400 MHz, CDCl3) δ 1.38 (d, J = 6.6 Hz, 3H), 2.05 (br s, 1H), 3.85 (s, 3H), 3.89 (s, 
3H), 4.09 (q, J = 6.6 Hz, 1H), 6.81 (d, J = 8.2 Hz, 1H), 6.87 (dd, J = 8.2, 1.8 Hz, 1H), 6.92 
(d, J = 1.9 Hz, 1H).  
 
(±)-N-{1-[2’-(tert-Butyldimethylsilyloxy)phenyl]ethyl}amine (604), 
C14H25NOSi, FW = 251.49: white solid; 1H NMR (400 MHz, CDCl3) δ 
0.19 (s, 6H), 0.98 (s, 9H), 1.47 (d, J = 6.6 Hz, 3H), 3.55 (br s, 2H), 4.15 (q, 
J = 6.6 Hz, 1H), 6.73 (dd, J = 8.0, 1.8 Hz, 1H), 6.75 (dd, J = 2.5, 1.8 Hz, 1H), 6.98 (d, J = 
7.6 Hz, 1H), 7.19 (dd, J = 7.9, 7.8 Hz, 1H).  
 
NH2
MeO
MeO
602
NH2
604 OTBDMS
NH2
MeO
MeO
MeO601
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(–)-N-[1-(2’-Hydroxyphenyl)ethyl]amine, (–)-2-(1’-Aminoethyl)phenol 
(603),259 C8H11NO, FW = 137.20: white solid; [α]436 –80 (c 0.5, l 10 mm, 
MeOH); [lit.259 gives [α]D –77.6 (c 1, MeOH) for (S)-enantiomer 95 % ee]; 
1H NMR (400 MHz, MeOH-d4) δ 1.38 (d, J = 6.7 Hz, 3H), 3.99 (q, J = 6.7 Hz, 1H), 6.67 
(ddd, J = 8.0, 2.5, 1.0 Hz, 1H), 6.77 (dd, J = 2.3, 1.8 Hz, 1H), 6.80-6.83 (m, 1H), 7.13 (dd, 
J = 7.8, 7.8 Hz, 1H).  
 
(±)-N-[1’-(2”-Fluorophenyl)ethyl]amine (611),260 C8H9NF, FW = 
138.18: brown liquid; 1H NMR (400 MHz, CDCl3) δ 1.44 (d, J = 6.7 Hz, 
3H), 2.24 (br s, 2H), 4.42 (br q, J = 6.5 Hz, 1H), 7.01 (ddd, J = 10.8, 8.1, 
1.2 Hz, 1H), 7.12 (d, J = 7.5, 7.5, 1.2 Hz, 1H), 7.18-7.24 (m, 1H), 7.42 (ddd, J = 7.6, 7.6, 
1.8 Hz, 1H); 19F NMR δ –119.73.  
 
 
Three-step Procedure for Synthesis of Thiazolone 399255 (Scheme 8.18):  
 
a. BzNCS (1 eq), Et3N(1.1 eq), CH2Cl2, 0 °C, 1.5 h
b. KOH (2 eq), MeOH, r.t., 3 h
c.
                     (1.1 eq), NaOAc (2.5 eq), EtOH, reflux, 2 hCOOH
Br
611
R R
N
S
O
613 (47%)
S
NH2
612b
a. b. c.
R
S
NHBz
R =
F
HN
612a
R-H
 
 
Scheme 8.18. Synthesis of Thiazolone 11β-HSD Inhibitor from Amine 611 
 
Benzoyl isothiocyanate (284 µL, 345 mg, 2.11 mmol, 1.0 equiv) was added drop-wise to a 
solution of amine 611 (294 mg, 2.11 mmol, 1.0 equiv) and triethylamine (324 µL, 235 mg, 
2.32 mmol, 1.1 equiv) in anhydrous CH2Cl2 (3 mL) at 0 °C under an argon atmosphere. 
The reaction mixture was let to stir at 0 °C for 1.5 h and then quenched with water (20 
mL). The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined organic 
layers were washed with diluted HCl (7 %, 20 mL), saturated NaHCO3 solution (20 mL), 
dried over MgSO4, and concentrated in vacuo to provide crude N-benzoylthiourea 612a 
which was used without further purification.  
 
NH2
603 OH
NH2
611 F
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Crushed solid KOH (237 mg, 4.22 mmol, 2.0 equiv) was added in one portion to a solution 
of the crude N-benzoylthiourea 612a (657 mg) in MeOH (3 mL). The reaction mixture was 
let to stir at room temperature for 3 h, then water (15 mL) was added and the mixture was 
let to stir for further 16 h at room temperature. The solution was diluted with CH2Cl2 (20 
mL) and water (50 mL), the aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the 
combined organic layers were washed with diluted KOH solution (1 M, 20 mL), brine (20 
mL), dried over MgSO4, and concentrated in vacuo to furnish the crude thiourea derivative 
612b which was used without further purification.  
 
2-Bromopropionic acid (211 µL, 359 mg, 2.32 mmol, 1.1 equiv) was added drop-wise to a 
solution of the crude thiourea derivative 612b (372 mg) and sodium acetate (433 mg, 5.28 
mmol, 2.5 equiv) in anhydrous EtOH (2.5 mL). The suspension was refluxed for 2 h, then 
cooled to room temperature and quenched with water (50 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers were washed with 
brine (20 mL), dried over MgSO4, and concentrated in vacuo. The crude thiazolone 399 
was purified on a silica gel column (40 mL) with a gradient of dichloromethane – methanol 
mixture (100:0 to 98:2) to afford 613 as white foam (249 mg, 0.987 mmol, 47 %).  
 
(+)-N-[1’-(2”-Fluorophenyl)ethyl]-N-(5-methylthiazol-4(4H)-on-2-yl)amine (613), 
C12H12N2OSF, FW = 245.32  
F
HN
N
S
O
613
2
5
4
1'
2'
4" 1"
2"
5"
 
613: an inseparable mixture of (1’S,4S) and (1’S,4R) diastereoisomers in 1:1 ratio; white 
foam; [α]D +14.5 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3, a mixture of 5-epimers in 
ca. 1:1 ratio, one is marked * and ^, unassigned signals are not marked) δ 1.58^ (d, J = 7.3 
Hz, 3H, 5-CH- CH3), 1.65* (d, J = 7.3 Hz, 3H, 5-CH-CH3), 1.78^ (d, J = 6.8 Hz, 3H, 2’-
CH3), 1.79* (d, J = 6.8 Hz, 3H, 2’-CH3), 4.04* (q, J = 7.3 Hz, 1H, 5-CH), 4.14^ (q, J = 7.3 
Hz, 1H, 5-CH), 4.98* (q, J = 6.8 Hz, 1H, 1’-CH), 4.99^ (q, J = 6.8 Hz, 1H, 1’-CH), 7.02-
7.05* (m, 1H, 3”-CH), 7.03-7.07^ (m, 1H, 3”-CH), 7.15* (ddd, J = 7.5, 7.5, 1.1 Hz, 1H, 
4”-CH), 7.16^ (ddd, J = 7.5, 7.5, 1.1 Hz, 1H, 4”-CH), 7.23-7.27* (m, 1H, 5”-CH), 7.25-
7.29^ (m, 1H, 5”-CH), 7.58* (ddd, J = 7.7, 7.6, 1.7 Hz, 1H, 6”-CH), 7.61^ (ddd, J = 7.7, 
7.6, 1.7 Hz, 1H, 6”-CH); 13C NMR δ 18.51^ (5-CH3), 18.88^ (2’-CH3), 21.52* (5-CH3), 
21.60* (2’-CH3), 49.20^ (5-CH), 49.26* (5-CH), 49.28 (2 × 1’-CH), 115.15 (d, J = 21.9, 2 
    259
× 3”-CH), 124.78* (d, J = 3.4 Hz, 5”-CH), 124.79^ (d, J = 3.4 Hz, 5”-CH), 127.98* (d, J = 
3.5 Hz, 6”-CH), 128.05^ (d, J = 3.5 Hz, 6”-CH), 128.88 (d, J = 10.9 Hz, 1”-C), 129.02 (d, 
J = 10.9 Hz, 1”-C), 129.16* (d, J = 2.4 Hz, 4”-CH), 129.24^ (d, J = 2.4 Hz, 4”-CH), 
159.13 (d, J = 246.0 Hz, 2 × 2”-CF), 181.62^ (2-C), 181.72* (2-C), 188.84 (4-C), 188.86 
(4-C); 19F NMR δ –119.90, –119.97; IR ν 3192, 2979, 2933, 1686, 1599, 1583, 1492, 
1450, 1251 cm-1; MS (EI) m/z (%) 252 (M˙+, 40), 237 (90), 149 (20), 123 (100), 103 (38), 
91 (44), 83 (40), 77 (39); HRMS (EI) 252.0730 (C12H13N2OSF requires 252.0733); HPLC 
analysis (Chiralpak IB, hexane – propan-2-ol (85:15), 0.75 mL/min, t1, major = 16.96 min, t1, 
minor = 19.79 min, t2, major = 21.61 min, t2, minor = not resolved) showed 93 % ee for 
diastereomer 1 and >95 % ee for diastereomer 2 (not baseline separation).  
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